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Four-membered heterocycles such as oxetanes and azetidines represent a unique class of 
small, strained rings. These scaffolds are found in a variety of biologically active natural products 
and also function as important structural building blocks in pharmaceutical products due to their 
desirable pharmacokinetic properties. However, from a synthetic standpoint, four-membered 
heterocycles are often considered the most difficult to access in comparison to their smaller, three-
membered, as well as their larger, five- and six-membered analogs. Thus, there is a strong demand 
for the development of new synthetic methods that allow for the synthesis of four-membered 
heterocycles in an efficient and practical fashion. The synthetic challenges in accessing four-
membered rings are commonly associated with their high ring-strain, yet this inherent property 
provides these scaffolds with unique reactivity that can also be harvested in catalytic 
transformations. This dissertation discusses the development of new methods for the synthesis of 
azetidines relying on visible light photocatalysis, as well as investigations into the Lewis acid-
catalyzed carbonyl–olefin metathesis reaction that utilizes oxetanes as reactive intermediates. 
The first chapter of this dissertation studies the divergent reactivity in Lewis acid-mediated 
transformations between carbonyls and olefins. Herein, it is demonstrated that relatively simple 
metal salts can achieve remarkable selectivity, resulting in either carbonyl–olefin metathesis or 
carbonyl–ene reaction products. Furthermore, parametrization of relevant reaction intermediates 
through DFT calculations allowed for the development of predictive statistical models that provide 
important insights into the observed divergent reactivity. 
 xxi 
The second and third chapter of this dissertation discuss the development of new methods 
for the synthesis of azetidines via visible light-mediated [2+2] cycloadditions. This strategy is 
advantageous over traditional approaches as it utilizes readily available oxime and alkene 
precursors that are reacted in a single, highly atom-economic transformation. A method for the 
synthesis of azetidines via an intramolecular [2+2] cycloaddition is reported herein that proceeds 
via triplet energy transfer from a commercially available iridium photocatalyst. This reaction 
utilizes substrates containing styrenes, which possess low triplet energies and are amenable to 
activation via energy transfer. This intramolecular strategy readily affords highly functionalized 
azetidine products, yet it cannot be translated into an intermolecular variant due to the limited 
excited state lifetime of styrenes. Therefore, a new method is presented that relies on 2-isoxazoline-
3-carboxylates as a previously unexplored imine reagent. This class of compound can be activated 
via triplet energy transfer from an iridium photocatalyst to react with unactivated alkenes with high 
efficiency. This new intermolecular strategy complements the limitations of previous methods for 





Chapter 1: Divergent Reactivity in Lewis Acid-Catalyzed Transformations Between 
Carbonyls and Olefins 
Portions of this chapter have been published in Becker, M. R.; Reid, J. P.; Rykaczewski, 
K. A.; Schindler, C. S. Models for Understanding Divergent Reactivity in Lewis Acid-Catalyzed 
Transformations of Carbonyls and Olefins. ACS Catal. 2020, 10, 4387−4397. 
1.1. Introduction 
1.1.1. Traditional Reactivity Between Carbonyls and Olefins 
Lewis acid-catalyzed carbon–carbon bond-forming reactions between carbonyls and 
olefins represent highly important processes in organic synthesis that rely on ubiquitous starting 
materials.1 Coordination of a Lewis acid (LA) complex to a Lewis basic carbonyl functionality 
achieves lowering of the lowest unoccupied molecular orbital (LUMO) resulting in activation of 
the carbonyl to undergo subsequent reactions.2 In the presence of an alkene, carbonyls (1.1) 
commonly undergo carbonyl–ene3–7 or Prins reaction8–11 pathways upon activation with a Lewis 
acid. The carbonyl-ene reaction produces a homoallylic alcohol product (1.4) after transfer of an 
allylic hydrogen, proceeding either via a concerted (1.2) or stepwise mechanistic scenario 
involving a carbocation intermediate (1.3) (Figure 1.1A). A similar carbocationic intermediate 1.3 
is produced in the Prins reaction, which, however, is subsequently trapped by an exogenous 
nucleophile (1.5) to generate the corresponding alcohol 1.6 (Figure 1.1B). More recently, two 
additional reaction pathways between carbonyls and olefins have been established by our group: 
namely the carbonyl–olefin metathesis12–15 and the interrupted carbonyl–olefin metathesis 
reaction.16 In the carbonyl–olefin metathesis reaction, activation of the carbonyl results in an initial 
 2 
asynchronous, concerted [2+2] cycloaddition with the olefin moiety, and the resulting oxetane 
intermediate (1.7) subsequently fragments via a [2+2] cycloreversion to provide an olefin-
containing product (1.9) as well as a carbonyl by-product (1.8) (Figure 1.1C).17 This mode of 
reactivity has recently been applied to a broad scope of metathesis transformations, including ring-
closing metathesis,13,18,27–30,19–26 ring-opening metathesis,31 intermolecular cross metathesis32,33 
and transannular carbonyl–olefin metathesis.34 Finally, the interrupted carbonyl–olefin metathesis 
reaction converts carbonyl- and olefin-containing substrates to the corresponding 
tetrahydrofluorenes (1.11) in the presence of catalytic amounts of Brønsted acid.16 Analysis of 
possible reaction pathways using DFT calculations support a distinct mechanistic scenario 
involving an oxygen atom transfer step (1.10), which directly provides a benzylic carbocation that 
subsequently undergoes dehydration and Friedel-Crafts alkylation (Figure 1.1D). 
 
Figure 1.1: Different modes of reactivity between carbonyls and olefins via (A) the carbonyl-ene reaction, (B) the Prins reaction, 
(C) the carbonyl–olefin metathesis reaction, and (D) the interrupted carbonyl–olefin metathesis reaction. 
Studies on the carbonyl–olefin metathesis by our group revealed that the carbonyl–ene 
reaction can occur as a competing pathway, oftentimes kinetically favored over the desired 
carbonyl–olefin metathesis pathway. Although in competition, the carbonyl–ene pathway is 





































































carbonyl–olefin metathesis product.16,25,34 However, in some cases the homoallylic alcohols 
formed in the carbonyl–ene reaction can be prone to dehydration, rendering the carbonyl–ene 
pathway irreversible for these types of substrates. This was found to be a synthetic challenge during 
the development of a carbonyl–olefin metathesis reaction for the synthesis of polycyclic aromatic 
hydrocarbons.30 In the presence of catalytic amounts of iron(III) chloride biaryl 1.12 containing an 
alkene with allylic hydrogens, carbonyl–ene product 1.14 was formed as the major product in 47% 
yield (Figure 1.2). The undesired carbonyl–ene pathway could be suppressed by instead using a 
stilbenyl alkene (1.13) that lacks the allylic hydrogen required for the carbonyl–ene reaction. 
 
Figure 1.2: Competing carbonyl–olefin metathesis and carbonyl–ene reactions discovered during the synthesis of polycyclic 
aromatic hydrocarbons. 
Unfortunately, this strategy was not applicable to prevent undesired carbonyl–ene 
reactivity for the development of a gallium(III) chloride-catalyzed ring-opening carbonyl–olefin 
metathesis as it required cyclic, aliphatic alkenes such as 1-methylcyclopentene (1.17).31 This 
reaction produced the desired ring-opening metathesis products (1.19) in only modest yields of up 
to 47% due to the formation of carbonyl–ene reaction-derived products 1.21 and 1.22 (Figure 1.3). 
These two products are proposed to arise from an initial carbonyl–ene reaction between the two 
starting materials 1.16 and 1.17 to form diene 1.20 after dehydration of the corresponding 
homoallylic alcohol. Intermediate 1.20 was never observed during the reaction, likely due to the 
fact that it rapidly reacts with an equivalent of alkene 1.17 or aldehyde 1.16 to the observed 
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Figure 1.3: The carbonyl-ene reaction is in competition with the intermolecular ring-opening carbonyl–olefin metathesis reaction. 
While carbonyl–olefin metathesis can be efficiently achieved with relatively simple Lewis 
acids such as FeCl3 or GaCl3, these catalyst systems discriminate only poorly between multiple 
reaction pathways for at least some substrate classes. In this case only limited options are available 
to improve the selectivity, most often relying on synthetic modifications to the substrate. 
Therefore, the design of new catalyst systems with an improved selectivity for one pathway over 
the other is required. This would hold great promise to advance existing protocols for carbonyl–
olefin metathesis, specifically those that currently suffer from competing carbonyl–ene reaction 
pathways. 
1.1.2. Previous Models Developed to Describe Lewis Acid Reactivity 
Lewis acidity describes the strength with which a Lewis acid binds to a corresponding 
Lewis base, and it is a commonly used metric to define the efficiency of a Lewis acid towards 
bond activation or in catalysis.1,35–37 Considering the importance to rationally select a catalyst 
based on its expected reactivity, it might be surprising that there exists no broadly accepted scale 
for Lewis acidity. Unlike Brønsted acidity, which is strictly defined via the pKa scale, a number of 
scales for Lewis acidity exist that typically differ in the physical method used to measure Lewis 


































Historically, the Gutmann-Beckett method has been widely used to determine Lewis 
acidity based on triethylphosphine oxide as a 31P NMR probe. With this method, the change in 31P 
NMR resonance upon coordination of a Lewis acid can be correlated to the respective Lewis 
acidity.39–41 This approach was later extended by Childs in which crotonaldehyde serves as the 
NMR probe, often referred to as the Childs method. In this case, stoichiometric adducts of substrate 
and Lewis acid are analyzed by both 1H and 13C NMR spectroscopy and the change in resonance 
of certain signals is measured in reference to the free probe.42,43 While NMR-based methods allow 
for a relatively straightforward assessment of Lewis acid strength, those methods are limited to 
non-paramagnetic Lewis acids to avoid NMR disturbances. As a result, commonly used iron-based 
Lewis acids are typically not included in NMR-derived Lewis acid scales. Furthermore, the 
solubility of Lewis acids, their sensitivity to moisture or oxygen as well as achieving precise 
solution concentrations provide additional challenges with this approach.43 
 
Figure 1.4: Select examples of methods to quantitatively assess Lewis acidity. 
Consequently, alternative methods have been developed to quantify Lewis acidity. 
Considering that Lewis acids are oftentimes used in organic synthesis to activate carbonyl 
compounds, infrared spectroscopy (IR) of Lewis acid–carbonyl complexes has become a practical 
method to determine Lewis acidity. In that regard, carbonyl-containing IR probes such as 
xanthone,44,45 ethyl acetate46 or phenalen-1-one47 have been investigated for which the change in 
carbonyl stretching frequency is correlated with the strength of a Lewis acid. Although relatively 











































have been reported, this approach typically requires the isolation of the stoichiometric Lewis acid-
carbonyl complexes, therefore requiring rigorous air and moisture free conditions.45 Notably, 
infrared spectroscopy is not only useful to quantify Lewis acidity, but has also recently been 
utilized to study solution interactions of carbonyls and Lewis acids in Lewis acid-catalyzed 
carbonyl–olefin metathesis reactions.48,49 
Fluorescence spectroscopy is another way to study the interaction of Lewis acids with 
organic substrates. For example, 10-methylacridone has been utilized as a probe to rank a broad 
range of Lewis acids based on the change in the fluorescence maxima.50 Specifically, stronger 
Lewis acids caused a more pronounced red-shift in the fluorescence emission of the stoichiometric 
complex with the organic probe. Recently, this approach was further improved by Baumgartner, 
Caputo and coworkers, who developed a robust Lewis acidity scale for a broad range of Lewis 
acid classes, which included main group, cationic and transition metal-based Lewis acids.51 In 
contrast to previous reports, the authors utilized multiple dithienophosphole oxide probes instead 
of just one. In addition, the chromaticity of the resulting fluorescent Lewis adduct was measured 
rather than the red-shift in fluorescence emission. Methods based on the emission of Lewis acid 
adducts have been shown to provide Lewis acidity data that is closer in line with experimental 
observations.51 This is likely due to the fact that the Lewis acidity is determined in solution, thus 
allowing to consider effects such as coordinative flexibility, aggregation as well as other solution 
effects.52 
Computational methods have become popular to determine Lewis acidity as they negate 
the need for any direct experimental efforts.43,53,54 Specifically, fluoride ion affinity, which is 
classified as the enthalpy released through binding of a fluoride ion, has emerged as a frequently 
used technique to estimate Lewis acidities computationally.55–57 More recently, related hydride or 
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methyl anion affinity methods have been developed.58 Although these computational techniques 
allow to rapidly generate Lewis acidity values through computations, parameters such as the 
fluoride ion affinity might more closely resemble fluoridophilicity as opposed to a more general 
Lewis acidity. In addition, computational methods typically only consider a single molecular 
species, thus disregarding the possibility of aggregation or solution interactions, which both have 
been reported to contribute to the strength of a Lewis acid.48,49 
1.2. Statistical Tools to Characterize Lewis Acid Reactivity 
Understanding the strength of a Lewis acid is an important task in developing an efficient 
catalytic transformation.1 As discussed in the previous chapter, there exists a plethora of different 
methods to estimate Lewis acidity, yet these approaches typically suffer from various drawbacks 
that limit their application in the development of new Lewis acid-catalyzed reactions. Specifically, 
the majority of reported Lewis acidity scales were developed using a single Lewis base, thus, 
Lewis acidity trends cannot be directly translated to a substrate of choice. Similarly, most methods 
are incompatible with certain classes of Lewis acids, which limits their general applicability, while 
others are unable to reflect solution effects, which have been shown to play an important role in 
some Lewis acid-catalyzed transformations.49 Furthermore, most approaches to date are rarely tied 
to experimentally observed reactivity, which limits their use as a predictive tool. 
Prochazka and coworkers utilized a computer-assisted strategy that relied on a set of 10 
Lewis acid descriptors including various physical-organic and thermodynamic parameters, for 
example dipole moments, enthalpies and Gibbs energies of formation, bond lengths and bond 
energies (Figure 1.5A).59 Based on this data the authors developed a statistically significant two-
component model that was capable of aiding the reaction optimization process of three Lewis acid-
catalyzed transformations, specifically an enol ether alkylation, Diels-Alder reaction and Friedel-
Crafts acylation (Figure 1.5B–D). 
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Figure 1.5: Statistical analysis by Prochazka and coworkers (A) Development of a two-component model based on a set of Lewis 
acids and descriptors utilized for the optimization of (B) an alkylation (C) a Diels-Alder reaction and (D) a Friedel-Crafts acylation. 
dM–X = mean bond length; DfHo = standard enthalpy of formation; DfGo = standard Gibbs energy of formation. LA = Lewis acid. 
The authors used the two-component model to choose Lewis acids with a maximum spread 
in regard to their properties as an initial starting point for the reaction optimization. Subsequently, 
the corresponding results were further refined through a simplex search in which the Lewis acid 
with the poorest performance out of a set of three was replaced with one that was oriented away 
from the poorest candidate in the two-component model. Ultimately, this led to the identification 
of optimal catalysts for all three reactions, specifically TiCl4 for the alkylation reaction and AlCl3 
for both the Diels-Alder reaction and the Friedel-Crafts acylation. Although this report represents 
one of the first examples in which multivariate analysis was used for the optimization of a Lewis 
acid-catalyzed reaction, this approach has only found limited application since the original report 
in 1986.60 In this context it is noteworthy that the descriptor set from Prochazka and coworkers 
was entirely based on literature values. Consequently, most Lewis acids were not described by a 
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acids. In addition, no reactivity data was used directly for the statistical model development, 
limiting its predicting capabilities. As a result, the two-component model mostly functioned as a 
guide for the selection of Lewis acid candidates during the reaction optimization. 
To gain further insight into the controlling features of Lewis acid-catalyzed reactions we 
envisioned utilizing a combination of both computational and experimental methods for the 
development of statistical models. Specifically, we hypothesized that generating a library of 
physical-organic descriptors through computational analysis of relevant Lewis acid-base 
complexes would hold several advantages over previous methods that aimed at analyzing and 
predicting Lewis acid reactivity. For example, this approach would be in principle applicable to 
any Lewis acid, as it foregoes the requirement of preexisting literature parameters and does not 
rely on a physical method to determine Lewis acidity that is likely to be limited in scope. Our 
initial interest was focused on the carbonyl–olefin metathesis and carbonyl–ene reaction, 
considering that these two pathways are closely related and oftentimes occur competitively, while 
the underlying Lewis acid features are only poorly understood. Successful development of a 
predictive statistical model for these reactions would advance our mechanistic understanding and 
hold the potential for the development of improved Lewis acid catalysts. 
1.3. Lewis Acid Evaluation and Scope 
At the outset of our studies, we sought to establish a training set of substrates and Lewis 
acids that could be subsequently investigated through computational and statistical methods. We 
hypothesized that biaryl compound 1.31 represented a suitable model substrate. This type of 
compound has previously been demonstrated to undergo both the carbonyl–ene or carbonyl–olefin 
metathesis reaction in the presence of a Lewis acid, providing either phenanthrene (1.32) or 
carbonyl–ene products 1.33 and 1.34, the latter arising from the elimination of water from 1.33 
(Table 1.1).30 As the next step, we evaluated the reactivity of 1.31 with more than 30 commercially 
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available metal salts. For the majority of the tested Lewis acids, full conversion of 1.31 to 
carbonyl–olefin metathesis (1.32) or carbonyl–ene products (1.33 and 1.34) was achieved within 
30 minutes at room temperature utilizing 10 mol% of Lewis acid catalyst in 1,2-dichloroethane as 
the reaction solvent. 
Table 1.1: Evaluation of Lewis acids with a biaryl substrate. 
 
Conditions: Reactions were performed with biaryl 1.31 (0.1 mmol) in dichloroethane (0.1 M) at rt for 0.5 h. ain toluene (0.1 M); 
bat 50 ºC. Evaluated Lewis acids with low conversion (< 20%): FeCl2, CrCl3, ZnCl2, Zn(OTf)3, RuCl3. All yields and conversions 
were determined by 1H NMR analysis of the crude reaction mixture using an internal standard. 
With FeCl3 as the Lewis acid, biaryl substrate 1.31 preferentially formed carbonyl–olefin 
metathesis product 1.32 in 33% yield (Table 1.1, entry 1), while other iron-based Lewis acids such 
as FeBr3 and Fe(OTf)3 provided carbonyl–ene product 1.34 as the major product in 56% and 82%, 
respectively, while 1.32 was only formed in 15% yield (Table 1.1, entries 2+3). These results are 
in agreement with previous observations from our laboratory in which FeCl3 was identified as the 


































































































































































































investigated. AlCl3 and AlBr3 displayed a strong preference for the carbonyl–ene reaction pathway 
and resulted in a mixture of products 1.33 and 1.34 with only trace amounts of carbonyl–olefin 
metathesis product 1.32 (Table 1.1, entries 4+5). Similarly, alkyl aluminum Lewis acids Et2AlCl, 
EtAlCl2 and Me2AlCl afforded high yields for the carbonyl–ene reaction pathway with an overall 
preference for alcohol 1.33 (Table 1.1, entries 6–8). The yield of Me2AlCl for alcohol 1.33 could 
be further improved to 94% by utilizing toluene as the solvent with lowered catalyst loadings of 
5 mol% (Table 1.1, entry 9). Notably, these conditions resulted in complete suppression of the 
carbonyl–olefin metathesis pathway. In contrast, gallium-based Lewis acids provided vinyl 
phenanthrene 1.34 as the major product in 79–82% yield (Table 1.1, entries 10–12). This class of 
Lewis acids was previously found as the optimal catalyst for intermolecular ring-opening 
carbonyl–olefin metathesis reactions, in which a carbonyl–ene reaction occurred as an undesired 
reaction pathway.31 In contrast, only small amounts (5–14%) of carbonyl–olefin metathesis 
product 1.32 were formed with biaryl substrate 1.31. Lewis acids BF3•OEt2 and BCl3 preferentially 
formed vinyl phenanthrene 1.34 in 80% and 39% yield, respectively (Table 1.1, entries 13+14), 
while TiCl4 provided a mixture of carbonyl–olefin metathesis and carbonyl–ene products with 
vinyl phenanthrene 1.34 as the major product in 59% yield (Table 1.1, entry 15). Interestingly, the 
Lewis acid SnCl2 afforded alcohol 1.33 as the exclusive product, albeit in low overall conversion 
(Table 1.1, entry 16). In contrast, the more electrophilic Sn(OTf)2 provided high conversion and 
resulted in vinyl phenanthrene 1.34 as the major product in 63% yield (Table 1.1, entry 17). 
Utilizing SnCl4 as the Lewis acid catalyst further improved the yield of 1.34 to 83% (Table 1.1, 
entry 18). In this case, switching the solvent to toluene dramatically reduced but not fully 
suppressed the carbonyl–olefin metathesis pathway from 10% to 3% (Table 1.1, entry 19). Slightly 
increasing the catalyst loading as well as the reaction temperature ultimately afforded 1.34 in 95% 
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(Table 1.1, entry 20). Evaluation of a series of indium-based Lewis acids resulted in mixtures of 
carbonyl–olefin metathesis and carbonyl–ene products with In(OTf)3 exhibiting a particularly high 
selectivity for vinyl phenanthrene 1.34 (Table 1.1, entries 21–24). In contrast to most other tested 
Lewis acids, InCl3, InBr3 and InI3 provided relatively high amounts of carbonyl–olefin metathesis 
product 1.32 with yields of 22–29%. Similarly, utilizing Sc(OTf)3 as the catalyst resulted in 21% 
yield of phenanthrene (1.32), while carbonyl–ene products 1.33 and 1.34 were formed in 26% and 
44% yield, respectively (Table 1.1, entry 25). In contrast, ScCl3 was highly selective for alcohol 
1.33 in 99% yield, highlighting how small modifications to these relatively simple metal salts can 
have dramatic impacts onto their selectivity (Table 1.1, entry 26). Finally, YCl3 was found to be 
selective for alcohol 1.33, but provided overall only low conversion (Table 1.1, entry 27). Other 
Lewis acids that resulted in poor reactivity as highlighted by conversions below 20% were FeCl2, 
CrCl3, ZnCl2, Zn(OTf)3 and RuCl3. 
Next, we sought to investigate the effect of substrate modifications onto the established 
selectivity. Specifically, we were interested in probing the generality of the carbonyl–ene reaction 
with Me2AlCl and SnCl4 as the Lewis acid catalyst, which provided either alcohol 1.33 or vinyl 
phenanthrene 1.34 in high yield (Figure 1.6). Biaryl substrates containing silyl protecting groups, 
as well as electron-donating and -withdrawing substituents and halides were tolerated by both 
Me2AlCl and SnCl4 in 86–99% yield (1.35+1.36, 1.37–1.47). Interestingly, electron-rich 
aldehydes were prone to undergo dehydration upon cyclization and required the use of 
stoichiometric amounts of Me2AlCl to achieve full consumption of starting material, which 
resulted in the formation of 1.42 in 66% yield. In contrast, SnCl4 converted the same biaryl 
substrate in 80% yield. Furthermore, the reaction tolerated tosyl and triflate groups, resulting in 
products 1.48–1.50 and 1.53 in excellent yields. Notably, substrates containing acetate groups as 
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well as unprotected phenols could not be successfully converted with Me2AlCl, but reacted 
smoothly with SnCl4 as the Lewis acid catalyst to afford vinyl phenanthrenes 1.51 and 1.52 in 97% 
and 74% yield, respectively. Similarly, substrate containing heterocycles such as thiophenes, 
benzothiophenes or indoles were not tolerated by Me2AlCl, but could be converted with SnCl4, 
although in slightly reduced yields of 59–89% yields (1.56–1.58). Finally, substrates containing 
an aryl ketone moiety instead of an aldehyde provided substantial amounts of carbonyl–olefin 
metathesis products with SnCl4, but selectively underwent the carbonyl–ene reaction with 
Me2AlCl in 68% and 51% yield (1.54+1.55). 
 
Figure 1.6: Substrate scope of the Me2AlCl- and SnCl4-catalyzed carbonyl–ene reaction. Reactions were performed with biaryl 
substrate (0.2 mmol), Lewis acid (5 or 20 mol%) in toluene (0.1 M) at rt or 50 ºC for 0.3–1 h unless noted; for Me2AlCl, isolated 
yields are given; for SnCl4, yields were determined by 1H NMR analysis of the crude reaction mixture; aisolated yield; bwith 
100 mol% Me2AlCl at –20 ºC; cwith 30 mol% SnCl4. 
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These substrates required stoichiometric amounts of Lewis acid catalyst to achieve full 
consumption of starting material as the tertiary alcohol formed upon cyclization was prone to 
dehydration. Overall, evaluation of the substrate scope of the Me2AlCl- and SnCl4-mediated 
carbonyl–ene reaction demonstrated that substrate effects only have minimal effects on the 
selectivity. Typically, only trace amounts of carbonyl–olefin metathesis products were observed 
with both catalysts, highlighting the selectivity of these two Lewis acids for the carbonyl–ene 
reaction pathway. 
1.4. Mechanistic Investigations 
To this end, we collected reactivity data that demonstrated the selectivities for carbonyl–
olefin metathesis and carbonyl–ene reaction pathways for a broad range of commercially available 
Lewis acids. As the next step, we sought to understand the role of each reaction component to gain 
valuable mechanistic insights. We hypothesized that a detailed understanding of the two divergent 
mechanisms would assist the subsequent statistical analysis of the reaction. Therefore, the 
mechanism of the Lewis acid-catalyzed carbonyl–olefin metathesis and carbonyl–ene reaction was 
probed computationally. Me2AlCl and FeCl3 were chosen as the Lewis acids for this study as they 
were selective catalysts for either the carbonyl–ene or the carbonyl–olefin metathesis pathway. 
Free energies in solution were obtained from structures optimized at the B97-D/6-31G(d) level of 
theory, and solvent effects were added as energy corrections using the CPCM implicit solvent 
model for 1,2-dichloroethane. Previously conducted mechanistic investigations from our lab 
revealed a mechanism for carbonyl–olefin metathesis that commences with coordination of the 
Lewis acid catalyst to the carbonyl moiety of the substrate, followed by a concerted, asynchronous 
[2+2] cycloaddition reaction with the alkene. The resulting oxetane subsequently undergoes a 




Figure 1.7: Quantum chemical investigation into the carbonyl–ene and carbonyl–olefin metathesis reaction paths catalyzed by 
FeCl3 and Me2AlCl. (A) Free energy Profile (B) Reaction Path. 
Similarly, the carbonyl–olefin metathesis reaction of biaryl intermediate 1.60 was 
calculated to proceed via a concerted, asynchronous [2+2] cycloaddition (1.63) with an activation 
barrier of 18.9 kcal mol-1 for FeCl3 (Figure 1.7). In contrast, the same step was found to be 6.1 kcal 
mol-1 higher in energy for Me2AlCl. Relative to intermediate 1.60 the resulting Lewis acid-
coordinated oxetane (1.64) is 3.6 and 2.9 kcal mol-1 higher in energy for FeCl3 and Me2AlCl, 
respectively. The subsequent concerted, asynchronous retro-[2+2] cycloaddition step (1.65) that 
provides phenanthrene 1.66 and acetone as the two metathesis products was calculated to occur 
with an activation barrier of 10.5 kcal mol-1 for FeCl3, while the Me2AlCl-catalyzed step was found 
to be 5.5 kcal mol-1 higher in energy. In comparison, the calculations revealed substantially higher 
energy barriers for the uncatalyzed pathway with 49.9 kcal mol-1 for the [2+2] cycloaddition and 
 














































































42.1 kcal mol-1 for the cycloreversion step. Activation barriers for the carbonyl–ene reaction 
pathway proceeding via transition state 1.61 were found to be lower relatively to the carbonyl–
olefin metathesis pathway. Specifically, energy barriers of 16.1 kcal mol-1 and 17.6 kcal mol-1 
were calculated for FeCl3 and Me2AlCl, while the uncatalyzed step would proceed with a 
substantially increased activation barrier of 32.4 kcal mol-1. The calculations suggest that the 
carbonyl–ene pathway is kinetically favored over the carbonyl–olefin metathesis pathway. Yet, 
the carbonyl–ene reaction is likely reversible with activation barriers of 8.9 kcal mol-1 and 12 kcal 
mol-1 for the reverse reaction. Under FeCl3-catalyzed conditions, both the carbonyl–olefin 
metathesis and the carbonyl–ene reaction pathway proceed with relatively similar activation 
barriers, but the metathesis product 1.66 is ultimately formed irreversibly under these conditions. 
This result is in agreement with the experimental data, in which phenanthrene (1.32) was the major 
product obtained from the reaction of biaryl 1.31 with FeCl3. In contrast, the barrier for carbonyl–
olefin metathesis for Me2AlCl with 25.0 kcal mol-1 is prohibitively high at room temperature, 
providing a rational for the observed high selectivity of this catalyst for the carbonyl–ene reaction 
pathway. 
1.5. Reaction Profiling and Model Development 
Multivariate linear regression models relying on both computationally and empirically 
derived physical organic molecular descriptors have recently been employed as a valuable tool for 
the optimization of chemical reactions and the interrogation of their underlying mechanisms.61–63 
These models are generated based on a mathematical relationship between a set of molecular 
descriptors and an experimental outcome, for example enantio-, regio- or chemoselectivities, 
reaction rates or yields.64–68 The resulting mathematical equation can subsequently be deployed to 
inform mechanistic understanding as well as predict reaction outcomes. Over the last years, this 
methodology has found frequent application in the optimization of catalytic systems for 
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stereoselective transformations.61–63 To this end, we hypothesized that this approach would be 
similarly suited to improve our understanding of the underlying characteristics of Lewis acids for 
their selectivity in catalytic transformations, specifically the carbonyl–olefin metathesis and 
carbonyl–ene reaction. 
Table 1.2: Overview of traditional Lewis acid parameters and experimental results for the selectivity of Lewis acids towards the 
carbonyl–olefin metathesis (COM) and carbonyl–ene (CE) pathway. 
 
COM/CE ratios were determined by dividing the yield of carbonyl–olefin metathesis (COM) product 1.32 and the combined yields 
of carbonyl–ene products 1.33 and 1.34; yield (CE) represents the combined yield of products 1.33 and 1.34; aliterature values 
reported by Brown69; bliterature values reported by Cook45; cliterature values reported by Kepp70; dliterature values reported by 
Zhang71; eliterature values reported by Shannon72. 
At the outset of our investigations, we questioned whether the observed divergent reactivity 
could be rationalized with previously reported Lewis acid parameters. Therefore, we selected a 
small number of Lewis acids and compared the observed selectivity against benchmark Lewis acid 
parameters (Table 1.2). In that context, we selected literature values from two different Lewis 
acidity scales as well as oxophilicity, electronegativity and ionic radii as additional Lewis acidity 
parameters.45,69–72 Within this subset of Lewis acids, FeCl3 provided the highest selectivity for 
carbonyl–olefin metathesis (Table 1.2, entry 1). Yet, both weaker and stronger Lewis acids such 
as SnCl4 and TiCl4 were found substantially more selective for the carbonyl–ene pathway, 
indicating that Lewis acidity alone is insufficient to rationalize the observed reactivity (Table 1.2, 
entries 4+7). Similarly, no clear correlation between the other parameters and the obtained 























































































































inform our understanding of Lewis acid reactivity. At the same time, these findings emphasize the 
limitations of existing Lewis acid parameters, which in most cases are not reported for all Lewis 
acids of interest or do not take the counterion of a Lewis acid into considerations. 
 
Figure 1.8: Workflow for model development. (A) Lewis acid-substrate complex parameterization (B) Lewis acids & substrates 
used for model development (C) computational workflow. CE = carbonyl–ene reaction; COM = carbonyl–olefin metathesis. 
Therefore, we sought to adapt a workflow for our model development that would solely 
rely on a computationally derived library of physical organic molecular descriptors. Considering 
that pathway divergence originates upon coordination of a Lewis acid to a substrate, the resulting 
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mechanics (MM) conformational search, which provided representative low-energy conformers, 
geometry optimization was carried out via density-functional theory (DFT) (Figure 1.8A). 
Relevant parameters were then collected at the M06-2X/def2-TZVP level of theory. The generated 
library contained more than 45 descriptors consisting of bond lengths and angles, IR vibrational 
parameters,73 Sterimol values74,75 and natural bond orbital (NBO) charges.76,77 Notably, the 
collected parameters can be divided into two main groups as they contain information that either 
correspond to substrate or Lewis acid characteristics (Figure 1.8A). 
To maintain the number of calculations to be completed at a tractable level, we selected 
five Lewis acids, namely FeCl3, ScCl3, AlCl3, EtAlCl2 and Me2AlCl, for our further analysis. 
These Lewis acids were chosen based on their high selectivity for either the carbonyl–olefin 
metathesis or the carbonyl–ene pathway, while only forming minimal amounts of dehydration 
product (1.34). The elimination step provided difficulties to be investigated computationally, as 
the calculations suggested that different leaving groups are likely involved. Therefore, this step 
was omitted from our further analysis. Reaction profiling via multivariate linear regression 
typically requires a robust experimental output.62 Unfortunately, standard outputs such as reaction 
rates or product yields and distributions were found to be unsuitable in this case due to the rapid 
conversion of starting material and incomplete mass balance for some Lewis acids. Therefore, we 
hypothesized whether accurate predictive models could also be developed relying on 
computationally derived energy barriers as an alternative output. As this approach would forego 
the requirement for collection of experimental data, it could potentially allow to rapidly generate 
robust output data considering the recent advances in computational methods and resources. To 
test this hypothesis, we selected seven substrates (1.31, 1.67–1.72) that, combined with the 
previously selected five Lewis acids, would provide a theoretical matrix for the subsequent 
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statistical analysis (Figure 1.8B). Importantly, these substrate contained a broad range of 
substitution patterns, but also provided sufficient overlap in the molecular space. The resulting 
data set, which is diversified in both the substrate as well as the catalyst dimension, contained a 
total of 35 unique Lewis acid-substrate combinations (Figure 1.8C). For each of these 
combinations we subsequently calculated the activation barriers (DG‡) for the carbonyl–ene 
pathway, proceeding via transition state 1.61, as well the barrier for the [2+2] cycloaddition step 
of the carbonyl–olefin metathesis pathway, proceeding via transition state 1.63. 
 
Figure 1.9: Developed statistical models for (A) the carbonyl–olefin metathesis pathway and (B) the carbonyl–ene reaction pathway 
(C) Model interpretation.  
Next, multivariate linear regression was performed, which found that most of the output 
(DG‡) for both the carbonyl–olefin metathesis and the carbonyl–ene pathway can be expressed in 
five terms (Figure 1.9A+B). The averaged natural bond orbitals energies of the Lewis acid 
(NBOLA(avg)) as well the Lewis acid size (B1) describe Lewis acid properties, while the natural 
bond orbitals at the carbonyl carbon (NBOC), C4 (NBOC4) and C6 (NBOC6) represent substrate 
effects (Figure 1.9C). This outcome suggests that not only the Lewis acid but also the substrate 
influences the selectivity between the two pathways. Furthermore, the magnitude of the coefficient 
for each parameter corresponds to the contribution of each term to the overall activation barrier. 
Interestingly, Lewis acid effects seemingly dominate for the carbonyl–olefin metathesis pathway, 
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and a lower barrier for this pathway is expected for Lewis acids with a small steric profile (B1) 
and an increased positive charge (NBOLA(avg)). While the terms for the carbonyl–ene pathway are 
overall conserved, both Lewis acid and substrate parameters contribute similarly to the overall 
activation barrier. Thus, relative to the carbonyl–olefin metathesis pathway, substrate effects can 
be expected to play a larger role in determining the barrier height for the carbonyl–ene pathway. 
Specifically, NBOC corresponds to the electrophilicity of the carbonyl carbon and rather intuitively 
suggests that a more electrophilic carbonyl will have a lower activation barrier. Interestingly, the 
opposite can be observed for C4 and C6 for which increasing the positive charge (NBOC4 or 
NBOC6) in these positions results in a higher barrier. This may be interpreted as that substrates 
with substituents in this position require more energy to distort the Lewis acid-carbonyl complex 
to the required transition state. Ultimately, the conclusions of these models are in line with our 
experimental observations, in which a strong Lewis acid dependency was observed for carbonyl–
olefin metathesis, while the carbonyl–ene reaction was favored across a broad range of Lewis acids 
as well as substrates. 
 
Figure 1.10: Evaluating the prediction capabilities of the developed statistical models with a control substrate not included in the 























































Next, we sought to test the model’s ability to predict both in the substrate as well as the 
Lewis acid space. Specifically, we chose 1.73 as a control substrate that was not included in the 
initial training set and contained distinct substrate features. The developed model accurately 
predicted the activation barriers for both pathways for all five Lewis acids, highlighting that the 
models can serve as a robust prediction platform for new substrates (Figure 1.10). Similarly, we 
were able to utilize the developed models to make predictions for Lewis acids not included in the 
initial model. We selected Et2AlCl as the Lewis acid, which had provided a reactivity pattern with 
minimal amounts of dehydration product, similar to the five previously selected Lewis acids. 
Utilizing the two models, we were able to predict the activation barriers for both pathways with 
high precision (Figure 1.11). In agreement with our experimental observations in which Et2AlCl 
was identified as a selective catalyst for the carbonyl–ene pathway, the barrier for this pathway 
was substantially lower than that for the carbonyl–olefin metathesis pathway. 
Although the successful development of these models provided proof-of-principle that 
multivariate analysis can be employed to glean key mechanistic insights and predict in both the 
substrate as well as the Lewis acid dimension, we recognized that these models are limited to 
substrates containing the molecular features required for all five key descriptors. Especially 
substrate descriptors NBOC4 or NBOC6 limit the model to biaryl substrates. Thus, we evaluated 
whether the generated parameter set could also be employed for the development of a more broadly 
applicable model. 
 
Figure 1.11: Evaluating the prediction capabilities of the developed statistical models with a Lewis acid not included in the training 































Indeed, multivariate linear regression identified a secondary model that consisted of only 
three terms: the distance between Lewis acid and carbonyl (d(LA–O)), the averaged natural bond 
orbitals energies of the Lewis acid (NBOLA(avg)) and the intensity of the carbonyl stretch (iC=O) 
(Figure 1.12). Similar to our previous findings, a Lewis acid with a more positive charge 
(NBOLA(avg)) results in a lower activation barrier, while an increased distance between Lewis acid 
and carbonyl (d(LA–O)) results in a higher barrier for this pathway. The parameter d(LA–O) can likely 
be interpreted as a readout for the strength of Lewis acid binding and the corresponding activation 
of the carbonyl. 
 
Figure 1.12: Development of a secondary model that accurately predicts the activation energy for carbonyl–olefin metathesis of an 
aryl ketone substrate. 
Although compromised in its ability to predict in the biaryl substrate space, the model could 
accurately predict the carbonyl–olefin metathesis activation barrier for aryl ketone 1.78, a substrate 
previously reported by our lab to be suitable for this reaction.13 These results highlight that the 
established parameter library holds the potential to be used for the development of new models 
that can be highly useful for the development of Lewis acid-catalyzed reactions involving new 
substrate classes. 
1.6. Conclusion 
In summary, we have evaluated a broad range of simple Lewis acid catalysts for their 
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general substrate structures
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effects were subsequently probed using Me2AlCl and SnCl4 as selective catalysts. To gain 
mechanistic insight into the underlying controlling features of these reactions, we established an 
extensive library of parameters through computational analysis of Lewis acid-carbonyl complexes. 
Multivariate linear regression models for the two competing pathways were subsequently 
developed based on the correlation of computationally derived activation barriers with a set of five 
molecular descriptors that consisted of both Lewis acid and substrate parameters. These models 
proved to be robust, provided valuable mechanistic insight and allowed prediction in both the 
Lewis acid and substrate space. These results demonstrate that computationally derived activation 
barriers can function as an alternative output for the development of statistical models, particularly 
for reactions for which experimental data is difficult to obtain. Furthermore, we expect that the 
library of parameters established herein will be highly valuable to further our mechanistic 
understanding or Lewis acid reactivity and advance the use of statistical models as a tool for the 
development of new Lewis acid-catalyzed reactions.  
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1.7. Experimental Section 
1.7.1. General Information 
General Laboratory Procedures. All air- or moisture-sensitive reaction were carried out in 
flame-dried glassware under an atmosphere of nitrogen. Thin-layer chromatography (TLC) was 
performed on Merck silica gel 60 F254 plates using UV light (254 or 366 nm), KMnO4 or CAM 
stain for visualization. Flash chromatography was performed using silica gel Silia Flash® 40-63 
micron (230-400 mesh) from Silicycle unless noted. 
Materials and Instrumentation. All chemicals were purchased from Sigma-Aldrich, Alfa Aesar, 
Acros Organics, Oakwood, TCI America, Frontier Scientific, Matrix Scientific, Ark Pharm, and 
Chem Impex International, and were used as received unless otherwise stated. THF, CH2Cl2, 
toluene, DMF and DMSO were dried by being passed through a column of activated alumina under 
argon using a JC-Meyer Solvent Systems. Triethylamine and diisopropylamine were freshly 
distilled prior to use over calcium hydride and potassium hydroxide, respectively. 2-bromo-5-
((tert-butyldimethylsilyl)oxy)benzaldehyde78 and 1-(2'-(2-methylprop-1-en-1-yl)-[1,1'-biphenyl]-
2-yl)ethan-1-one30 were prepared according to literature procedures. Proton nuclear magnetic 
resonance (1H NMR) spectra were recorded on Varian MR400, Varian vnmrs 500, Varian Inova 
500, and Varian vnmrs 700 spectrometers and are referenced to residual protic NMR solvent 
(CDCl3: d 7.26 ppm, CD3OD: d 3.31 ppm, CD2Cl2: d 5.32 ppm). Data for 1H NMR are reported 
as follows: chemical shift (d ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, 
m = multiplet, br = broad), coupling constant (Hz), integration. Carbon nuclear magnetic 
resonance (13C NMR) spectra were recorded on Varian vnmrs 500 and Varian vnmrs 700 
spectrometers and are referenced to the carbon resonances of the NMR solvent (CDCl3: 
d 77.16 ppm, CD3OD: d 49.00 ppm, CD2Cl2: d 54.00 ppm). Fluorine nuclear magnetic resonance 
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(19F NMR) specta were recorded on Varian vnmrs 500 and Varian vnmrs 700 spectrometers. High-
resolution mass spectroscopic (MS) data was recorded at the Mass Spectrometry Facility at the 
Department of Chemistry of the University of Michigan in Ann Arbor, MI on an Agilent 6230 
TOF HPLC-MS (ESI) or Micromass AutoSpec Ultima Magnetic Sector mass spectrometer (ESI, 
EI). Infrared (IR) spectra were obtained using a Thermo-Nicolet IS-50 spectrometer. IR data are 
represented as frequency of absorption (cm-1). 
1.7.2. Reaction Optimization 
For solid Lewis acids: In a glovebox, a flame-dried 1-dram glass vial equipped with a magnetic 
stir bar was charged with the Lewis acid (x mol%) and the vial sealed with a rubber septum. The 
vial was transferred out of the glovebox and a solution of aryl aldehyde 1.31 (24 mg, 0.1 mmol, 
1.0 equiv.) in 1,2-dichloroethane (0.1 M; 0.1 mmol, 1 mL) was added via syringe. The mixture 
was stirred for 0.5 h at rt, then passed through a short silica plug eluting with CH2Cl2 (5–10 mL). 
The filtrate was concentrated and dried in vacuo. The yield and conversion were subsequently 
determined by quantitative 1H NMR using dimethyl terephthalate as the internal standard. 
For liquid Lewis acids or solutions: A flame-dried 1-dram glass vial equipped with a magnetic 
stir bar was sealed under an atmosphere of nitrogen. A solution of aryl aldehyde 1.31 (24 mg, 
0.1 mmol, 1.0 equiv.) in 1,2-dichloroethane (0.1 M; 0.1 mmol, 1 mL) was added to the vial via 
syringe followed by a solution of the respective Lewis acid (x mol%; entries 6–9: 1 M in hexanes; 
entry 13: neat; entry 15: 1 M in DCE; entries 18–20: 1 M solution in DCE or toluene). The mixture 
was stirred for 0.5 h at rt and passed through a short silica plug eluting with CH2Cl2 (5-10 mL). 
The filtrate was concentrated and dried in vacuo. The yield and conversion were subsequently 
determined by quantitative 1H NMR using dimethyl terephthalate as internal standard.  
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1.7.3. Experimental Procedures 
Synthesis of Starting Materials and Characterization 
General Procedure for Suzuki-Coupling (GP-1.1) 
 
A flame-dried round-bottom flask equipped with a magnetic stir bar was charged with 
isopropyltriphenylphosphonium iodide (1.25 equiv.) and sealed under a nitrogen atmosphere. Dry 
THF (0.3 M) was added via syringe and the heterogeneous mixture cooled to 0 °C with an ice bath, 
followed by dropwise addition of n-BuLi (2.5 M in hexanes; 1.2 equiv.). After stirring for 30 min 
at 0 °C, the respective aryl aldehyde (1.0 equiv.) was added slowly and the reaction mixture 
allowed to gradually warm up to rt and stirred until complete as determined by TLC analysis (4–
18 h). The reaction was quenched by the addition of a NH4Cl solution (aq., sat.) and the biphasic 
mixture partitioned between water and EtOAc. The organic layer was separated and the aqueous 
layer extracted with EtOAc (3x). The combined organic extracts were dried over Na2SO4, filtered 
and concentrated in vacuo. The crude product was purified by flash column chromatography (0–
5% EtOAc/hexanes) to afford the pure olefin product. 
 
1-Bromo-2-(2-methylprop-1-en-1-yl)benzene (A1.1): Prepared according to GP-1.1 from 2-
bromobenzaldehyde (24.9 mmol). Purification by flash column chromatography (100% hexanes) 
afforded the title compound (4.80 g, 92%) as a colorless oil. Spectroscopic data were consistent 
with those reported in the literature.30 
1H NMR (400 MHz, CDCl3): d 7.56 (d, J = 7.7 Hz, 1H), 7.29 – 7.20 (m, 2H), 7.10 – 7.02 (m, 1H), 
6.24 (s, 1H), 1.94 (s, 3H), 1.75 (s, 3H). 
H
O i-PrPPh3I (1.25 equiv.)
n-BuLi (1.20 equiv.)
THF (0.3 M), 0 °C to rt











(4-Bromo-3-(2-methylprop-1-en-1-yl)phenoxy)(tert-butyl)dimethylsilane (A1.2): Prepared 
according to GP-1.1 from 2-bromo-5-((tert-butyldimethylsilyl)oxy)benzaldehyde (15.9 mmol). 
Purification by flash column chromatography (100% hexanes) afforded the title compound as a 
colorless oil (4.96 g, 92%). 
1H NMR (400 MHz, CDCl3): d 7.38 (d, J = 8.6 Hz, 1H), 6.72 (s, 1H), 6.58 (d, J = 8.5 Hz, 1H), 
6.19 (s, 1H), 1.92 (s, 3H), 1.76 (s, 3H), 0.98 (s, 9H), 0.19 (s, 6H); 13C NMR (176 MHz, CDCl3): 
d 154.6, 139.6, 136.8, 133.0, 124.9, 122.7, 119.9, 115.7, 26.3, 25.8, 19.6, 18.4, -4.3; IR (cm-1): 
2956, 2929, 2857, 158207, 1562, 1462, 1396, 1290, 1252, 1176, 984, 888, 860, 836, 779, 671; 
HRMS: m/z calculated for C16H26BrOSi+ [M+H]+: 341.0931; found: 341.0931. 
 
1-Bromo-4-methoxy-2-(2-methylprop-1-en-1-yl)benzene (A1.3): Prepared according to GP-1.1 
from 2-bromo-5-methoxybenzaldehyde (4.65 mmol). Purification by flash column 
chromatography (5% EtOAc/hexanes) afforded the title compound as a colorless oil (982 mg, 
88%). 
1H NMR (700 MHz, CDCl3): d 7.44 (d, J = 8.7 Hz, 1H), 6.79 (d, J = 3.0 Hz, 1H), 6.65 (dd, J = 
8.7, 3.0 Hz, 1H), 6.22 (s, 1H), 3.78 (s, 3H), 1.93 (s, 3H), 1.77 (s, 3H); 13C NMR (176 MHz, 
CDCl3): d 158.5, 139.5, 137.1, 133.0, 124.9, 116.7, 115.0, 113.5, 55.6, 26.3, 19.6; IR (cm-1): 2933, 
2909, 1589, 1565, 1461, 1290, 1237, 1197, 1166, 1047, 1015, 867, 798, 700, 644; HRMS: m/z 









1-Bromo-2-(2-methylprop-1-en-1-yl)-4-(trifluoromethyl)benzene (A1.4): Prepared according 
to GP-1.1 from 2-bromo-5-(trifluoromethyl)benzaldehyde (2.69 mmol). Purification by flash 
column chromatography (100% hexanes) afforded the title compound as a colorless oil (640 mg, 
85%). 
1H NMR (500 MHz, CDCl3): d 7.68 (d, J = 8.3 Hz, 1H), 7.47 (d, J = 1.7 Hz, 1H), 7.31 (dd, J = 
8.3, 2.0 Hz, 1H), 6.24 (s, 1H), 1.96 (s, 3H), 1.76 (s, 3H); 13C NMR (176 MHz, CDCl3):d 139.6, 
138.7, 133.1, 129.5 (q, J = 32.6 Hz), 128.2 (q, J = 1.7 Hz), 127.7 (q, J = 3.8 Hz), 124.3 (q, J = 
3.7 Hz), 124.1 (q, J = 272.2 Hz), 123.9, 26.3, 19.5; IR (cm-1): 2916, 1603, 1409, 1324, 1264, 1166, 
1122, 1078, 1027, 908, 821, 762, 723, 653; HRMS: m/z calculated for C11H10BrF3+ [M]+: 
277.9918; found: 277.9908. 
 
2-Bromo-4-chloro-1-(2-methylprop-1-en-1-yl)benzene (A1.5): Prepared according to GP-1.1 
from 2-bromo-4-chlorobenzaldehyde (4.56 mmol). Purification by flash column chromatography 
(100% hexanes) afforded the title compound as a colorless oil (990 mg, 89%). 
1H NMR (500 MHz, CDCl3): d  7.57 (d, J = 2.0 Hz, 1H), 7.24 (dd, J = 8.3, 2.0 Hz, 1H), 7.15 (d, 
J = 8.3 Hz, 1H), 6.18 (s, 1H), 1.93 (s, 3H), 1.73 (s, 3H); 13C NMR (126 MHz, CDCl3): d 137.7, 
137.3, 132.5, 132.1, 131.7, 127.2, 124.6, 123.9, 26.3, 19.5; IR (cm-1): 2973, 2908, 1654, 1581, 
1548, 1465, 1374, 1180, 1097, 1034, 864, 841, 801, 746, 690; HRMS: m/z calculated for 








5-Bromo-6-(2-methylprop-1-en-1-yl)benzo[d][1,3]dioxole (A1.6): Prepared according to GP-
1.1 from 6-bromobenzo[d][1,3]dioxole-5-carbaldehyde (4.37 mmol). Purification by flash column 
chromatography (100% hexanes) afforded the title compound as a colorless oil (1.04 g, 93%). 
1H NMR (700 MHz, CDCl3): d  7.02 (s, 1H), 6.72 (s, 1H), 6.13 (s, 1H), 5.96 (s, 2H), 1.90 (s, 3H), 
1.73 (s, 3H); 13C NMR (176 MHz, CDCl3): d 146.9, 146.8, 136.3, 132.0, 124.8, 114.8, 112.5, 
110.6, 101.7, 26.2, 19.5; IR (cm-1): 2970, 2907, 1501, 1470, 1407, 1319, 1226, 1161, 1113, 1036, 
972, 933, 871, 836, 682, 644; HRMS: m/z calculated for C11H11BrO2+ [M]+: 253.9942; found: 
253.9935. 
 
3-Bromo-2-(2-methylprop-1-en-1-yl)thiophene (A1.7): Prepared according to GP-1.1 from 
A1.13 (5.23 mmol). Purification by flash column chromatography (100% hexanes) afforded the 
title compound as a pale-yellow oil (948 mg, 83%). 
1H NMR (400 MHz, CDCl3): d  7.19 (d, J = 5.3 Hz, 1H), 6.97 (d, J = 5.3 Hz, 1H), 6.40 (s, 1H), 
1.97 (d, J = 3.7 Hz, 6H); 13C NMR (126 MHz, CDCl3): d 137.7, 135.4, 129.8, 123.8, 117.2, 109.8, 
27.5, 20.3; IR (cm-1): 2969, 2909, 1644, 1492, 1448, 1373, 1336, 1186, 1141, 1080, 1048, 974, 
867, 794, 691, 607; HRMS: m/z calculated for C8H9BrS+ [M]+: 215.9608; found: 215.9609. 
 
3-Bromo-2-(2-methylprop-1-en-1-yl)benzo[b]thiophene (A1.8): Prepared according to GP-1.1 
from 3-bromobenzo[b]thiophene-2-carbaldehyde (3.11 mmol). Purification by flash column 














1H NMR (500 MHz, CDCl3): d 7.80 (d, J = 8.0 Hz, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.43 (t, J = 
7.6 Hz, 1H), 7.35 (t, J = 7.5 Hz, 1H), 6.60 (s, 1H), 2.08 (s, 3H), 2.03 (s, 3H); 13C NMR (126 MHz, 
CDCl3): d 140.4, 137.9, 137.5, 135.7, 125.2, 125.1, 123.0, 122.1, 117.8, 107.0, 27.8, 20.6; IR (cm-
1): 3058, 2968, 2852, 1641, 1444, 1375, 1303, 1255, 1218, 1174, 1018, 924, 846, 750, 725; HRMS: 
m/z calculated for C12H11BrS+ [M]+: 265.9765; found: 265.9760. 
 
1-Bromo-2-(2-methylprop-1-en-1-yl)naphthalene (A1.9): Prepared according to GP-1.1 from 
1-bromo-2-naphthaldehyde (1.12 mmol). Purification by flash column chromatography (100% 
hexanes) afforded the title compound as a colorless oil (251 mg, 85%). 
1H NMR (500 MHz, CDCl3): d  8.34 (d, J = 8.5 Hz, 1H), 7.81 (d, J = 8.1 Hz, 1H), 7.75 (d, J = 
8.4 Hz, 1H), 7.58 (t, J = 7.7 Hz, 1H), 7.49 (t, J = 7.4 Hz, 1H), 7.37 (d, J = 8.4 Hz, 1H), 6.48 (s, 
1H), 2.00 (s, 3H), 1.79 (s, 3H); 13C NMR (126 MHz, CDCl3): d 137.1, 137.0, 133.2, 132.6, 128.7, 
128.1, 127.4, 127.3, 127.0, 126.2, 126.1, 123.8, 26.6, 19.7; IR (cm-1): 3054, 2969, 2908, 1650, 
1550, 1376, 1323, 1187, 1061, 975, 835, 806, 759, 663, 641; HRMS: m/z calculated for C14H13Br+ 
[M]+: 260.0201; found: 260.0194. 
General Procedure for Suzuki-Miyaura Cross-Coupling (GP-1.2) 
 
A flame-dried round-bottom flask was charged with aryl bromide (1.0 equiv.), aryl boronic acid 
(1.2 equiv.), K2CO3 (3.2 equiv.) and Pd(PPh3)4 (2.5–5 mol%). After addition of a solution of 
toluene/EtOH (1:1, 0.3 M), the flask was equipped with a reflux condenser and heated at 80 °C 






Me Me Pd(PPh3)4 (2.5 - 5 mol%)
K2CO3 (3.2 equiv.)
toluene/EtOH (1:1) (0.3 M)










the mixture was diluted with EtOAc and washed with water (3x) and brine (1x). The organic phase 
was dried over Na2SO4, filtered and concentrated in vacuo. The crude product was purified by 
flash column chromatography to afford the pure cross-coupled product. 
 
2'-(2-Methylprop-1-en-1-yl)-[1,1'-biphenyl]-2-carbaldehyde (1.31): Prepared according to GP-
1.2 with A1.1 (16.6 mmol). Purification by flash column chromatography (0–5% EtOAc/hexanes) 
afforded the title compound as a colorless oil (3.59 g, 92%). 
1H NMR (700 MHz, CD3OD): d 9.52 (s, 1H), 7.91 (d, J = 7.8 Hz, 1H), 7.68 (t, J = 7.9 Hz, 1H), 
7.51 (t, J = 7.6 Hz, 1H), 7.42 (t, J = 7.1 Hz, 1H), 7.36 (t, J = 7.4 Hz, 1H), 7.33 (d, J = 7.5 Hz, 2H), 
7.31 (d, J = 7.6 Hz, 1H), 5.72 (s, 1H), 1.71 (s, 3H), 1.65 (s, 3H); 13C NMR (176 MHz, CD3OD): 
d 193.2, 146.6, 139.4, 138.5, 138.0, 135.4, 134.9, 132.2, 131.2, 130.9, 129.1, 128.9, 127.8, 127.4, 
125.7, 26.1, 19.3; IR (cm-1): 3059, 2907, 2847, 2747, 1692, 1595, 1441, 1390, 1252, 1194, 1111, 
1047, 825, 752, 646; HRMS: m/z calculated for C17H16NaO+ [M+H]+: 259.1093; found: 259.1100. 
 
4'-((Tert-butyldimethylsilyl)oxy)-2'-(2-methylprop-1-en-1-yl)-[1,1'-biphenyl]-2-
carbaldehyde (S1.35): Prepared according to GP-1.2 with A1.2 (8.79 mmol). Purification by flash 
column chromatography (0–5% EtOAc/hexanes) afforded the title compound as a white solid 
(2.54 g, 79%). 
1H NMR (500 MHz, CDCl3): d  9.60 (s, 1H), 7.95 (d, J = 7.8 Hz, 1H), 7.59 (t, J = 7.5 Hz, 1H), 









1H), 6.78 (d, J = 2.0 Hz, 1H), 5.70 (s, 1H), 1.75 (s, 3H), 1.67 (s, 3H), 1.02 (s, 9H), 0.26 (s, 6H); 
13C NMR (126 MHz, CDCl3): d 192.4, 155.5, 145.1, 139.5, 137.3, 134.4, 133.5, 131.5, 131.4, 
130.2, 127.5, 126.7, 124.5, 121.2, 118.4, 26.2, 25.8, 19.3, 18.3, -4.2; IR (cm-1): 2928, 2857, 1688, 
1594, 1471, 1403, 1279, 1254, 1229, 1182, 981, 863, 823, 775, 637; HRMS: m/z calculated for 
C23H30O2SiNa+ [M+H]+: 389.1907; found: 389.1908. 
 
4'-Methoxy-2'-(2-methylprop-1-en-1-yl)-[1,1'-biphenyl]-2-carbaldehyde (1.68): Prepared 
according to GP-1.2 with A1.3 (0.82 mmol). Purification by flash column chromatography (5% 
EtOAc/hexanes) afforded the title compound as a white solid (151 mg, 69%). 
1H NMR (500 MHz, CD3OD): d 9.52 (s, 1H), 7.88 (d, J = 7.8 Hz, 1H), 7.65 (t, J = 7.5 Hz, 1H), 
7.47 (t, J = 7.5 Hz, 1H), 7.32 (d, J = 7.6 Hz, 1H), 7.25 (d, J = 8.4 Hz, 1H), 6.94 (dd, J = 8.4, 2.1 Hz, 
1H), 6.84 (d, J = 2.0 Hz, 1H), 5.71 (s, 1H), 3.85 (s, 3H), 1.71 (s, 3H), 1.64 (s, 3H); 13C NMR 
(126 MHz, CD3OD): d 193.5, 160.9, 146.4, 140.6, 138.3, 135.7, 134.8, 132.5, 132.4, 130.8, 128.6, 
127.4, 125.8, 116.3, 113.2, 55.8, 26.1, 19.4; IR (cm-1): 2909, 2836, 1690, 1596, 1467, 1441, 1389, 
1295, 1230, 1194, 1166, 1048, 1002, 828, 763, 710, 639; HRMS: m/z calculated for C18H18O2Na+ 
[M+H]+: 289.1199; found: 289.1200. 
 
2'-(2-Methylprop-1-en-1-yl)-4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carbaldehyde (1.69): 










chromatography (5% EtOAc/hexanes) afforded the title compound as a colorless oil (560 mg, 
92%). 
1H NMR (700 MHz, CDCl3): d  9.57 (s, 1H), 8.00 (dd, J = 7.8, 1.1 Hz, 1H), 7.65 (td, J = 7.5, 
1.3 Hz, 1H), 7.59 (d, J = 8.0 Hz, 1H), 7.56 (s, 1H), 7.52 (t, J = 7.6 Hz, 1H), 7.43 (d, J = 7.9 Hz, 
1H), 7.28 (d, J = 7.6 Hz, 1H), 5.74 (s, 1H), 1.75 (d, J = 1.0 Hz, 3H), 1.70 (d, J = 1.1 Hz, 3H); 
13C NMR (176 MHz, CDCl3): d 191.1, 143.4, 140.7, 138.9, 138.8, 133.9, 133.6, 130.7, 130.6, 
130.2 (q, J = 32.3 Hz), 128.4, 127.1, 126.5 (q, J = 3.8 Hz), 124.1 (q, J = 272.4 Hz), 123.2 (q, J = 
3.8 Hz), 123.1, 26.1, 19.1; IR (cm-1): 2913, 1695, 1597, 1327, 1285, 1165, 1119, 1077, 909, 836, 
765, 730, 657; HRMS: m/z calculated for C18H15F3ONa+ [M+Na]+: 327.0967; found: 327.0971. 
 
5'-Chloro-2'-(2-methylprop-1-en-1-yl)-[1,1'-biphenyl]-2-carbaldehyde (1.67): Prepared 
according to GP-1.2 with A1.5 (2.04 mmol). Purification by flash column chromatography (2% 
EtOAc/hexanes) afforded the title compound as a colorless oil (425 mg, 77%). 
1H NMR (500 MHz, CDCl3): d 9.58 (s, 1H), 7.97 (d, J = 7.7 Hz, 1H), 7.63 (t, J = 7.5 Hz, 1H), 
7.49 (t, J = 7.6 Hz, 1H), 7.37 (dd, J = 8.3, 2.0 Hz, 1H), 7.32 (d, J = 2.0 Hz, 1H), 7.29 (d, J = 7.6 Hz, 
1H), 7.23 (d, J = 8.3 Hz, 1H), 5.66 (s, 1H), 1.72 (s, 3H), 1.67 (s, 3H); 13C NMR (126 MHz, 
CDCl3): d  191.6, 143.7, 138.9, 138.2, 136.8, 134.1, 133.8, 132.3, 131.1, 130.8, 130.1, 128.3, 
128.1, 127.1, 123.3, 26.2, 19.3; IR (cm-1): 2974, 2850, 2747, 1694, 1597, 1466, 1442, 1385, 1253, 
1194, 1101, 1019, 867, 766, 736, 681, 647; HRMS: m/z calculated for C17H15ClONa+ [M+Na]+: 







5-Methoxy-2'-(2-methylprop-1-en-1-yl)-[1,1'-biphenyl]-2-carbaldehyde (1.72): Prepared 
according to GP-1.2 with A1.1 (2.00 mmol). Purification by flash column chromatography (5–
15% EtOAc/hexanes) afforded the title compound as a colorless oil (530 mg, 99%). 
1H NMR (500 MHz, CD3OD): d  9.35 (s, 1H), 7.90 (d, J = 8.7 Hz, 1H), 7.41 (t, J = 7.4 Hz, 1H), 
7.35 (t, J = 7.3 Hz, 1H), 7.31 (t, J = 7.1 Hz, 2H), 7.05 (dd, J = 8.7, 2.0 Hz, 1H), 6.80 (d, J = 2.3 Hz, 
1H), 5.76 (s, 1H), 3.89 (s, 3H), 1.73 (s, 3H), 1.67 (s, 3H); 13C NMR (126 MHz, CD3OD): d 192.3, 
165.5, 149.3, 139.2, 138.4, 137.7, 131.0, 130.8, 130.0, 129.1, 128.9, 127.7, 125.6, 116.7, 114.9, 
56.2, 26.2, 19.3; IR (cm-1): 2970, 2839, 1682, 1591, 1438, 1394, 1329, 1297, 1222, 1124, 1031, 
1016, 825, 766, 741, 633, 616; HRMS: m/z calculated for C18H18O2Na+ [M+H]+: 289.1199; found: 
289.1202. 
 
5-Methyl-2'-(2-methylprop-1-en-1-yl)-[1,1'-biphenyl]-2-carbaldehyde (1.71): Prepared 
according to GP-1.2 with A1.1 (2.0 mmol). Purification by flash column chromatography (3% 
EtOAc/hexanes) afforded the title compound as a colorless oil (420 mg, 84%). 
1H NMR (700 MHz, CD3OD): d 9.42 (s, 1H), 7.79 (d, J = 8.0 Hz, 1H), 7.39 (t, J = 7.5 Hz, 1H), 
7.33 (t, J = 7.5 Hz, 1H), 7.30 (d, J = 8.0 Hz, 1H), 7.29 – 7.27 (m, 2H), 7.12 (s, 1H), 5.70 (s, 1H), 
2.43 (s, 3H), 1.71 (s, 3H), 1.63 (s, 3H); 13C NMR (176 MHz, CD3OD): d 193.0, 146.7, 146.2, 










IR (cm-1): 2972, 2910, 2845, 2745, 1690, 1602, 1441, 1391, 1256, 1207, 1177, 1122, 981, 822, 
766, 741, 705, 637; HRMS: m/z calculated for C18H18ONa+ [M+Na]+: 273.1250; found: 273.1251. 
 
2-(6-(2-Methylprop-1-en-1-yl)benzo[d][1,3]dioxol-5-yl)benzaldehyde (1.70): Prepared 
according to GP-1.2 with A1.6 (2.40 mmol). Purification by flash column chromatography (5–
15% EtOAc/hexanes) afforded the title compound as a pale-yellow oil (460 mg, 82%). 
1H NMR (400 MHz, CDCl3): d  9.60 (s, 1H), 7.94 (dd, J = 7.8, 1.1 Hz, 1H), 7.59 (td, J = 7.5, 
1.4 Hz, 1H), 7.44 (t, J = 7.5 Hz, 1H), 7.27 (d, J = 6.9 Hz, 1H), 6.79 (d, J = 9.5 Hz, 2H), 6.03 (s, 
2H), 5.61 (s, 1H), 1.72 (s, 3H), 1.63 (s, 3H); 13C NMR (176 MHz, CD3OD): d 193.4, 148.9, 147.9, 
146.3, 137.5, 135.8, 134.9, 133.4, 132.3, 131.8, 128.8, 127.4, 125.6, 111.0, 110.7, 102.8, 26.0, 
19.3; IR (cm-1): 2973, 2906, 1691, 1595, 1473, 1446, 1360, 1246, 1214, 1192, 1035, 933, 875, 
824, 765, 737, 643; HRMS: m/z calculated for C18H16O3Na+ [M+Na]+: 303.0992; found: 
303.0995. 
 
2-(2-(2-Methylprop-1-en-1-yl)thiophen-3-yl)benzaldehyde (S1.56): Prepared according to GP-
1.2 with A1.7 (3.60 mmol). Purification by flash column chromatography (0–5% EtOAc/hexanes) 
afforded the title compound as a pale-yellow oil (820 mg, 94%). 
1H NMR (400 MHz, CDCl3): d  9.81 (s, 1H), 8.01 (dd, J = 7.8, 1.1 Hz, 1H), 7.63 (td, J = 7.5, 
1.4 Hz, 1H), 7.48 (t, J = 7.6 Hz, 1H), 7.37 (d, J = 7.7 Hz, 1H), 7.30 (d, J = 5.2 Hz, 1H), 7.03 (d, 











140.9, 138.9, 137.9, 134.8, 134.5, 133.7, 131.5, 129.7, 127.9, 127.4, 123.6, 116.8, 27.3, 20.3; IR 
(cm-1): 2910, 2848, 1691, 1596, 1448, 1390, 1373, 1255, 1193, 1047, 887, 765, 738, 689, 660, 
646; HRMS: m/z calculated for C15H14OSNa+ [M+Na]+: 265.0658; found: 265.0661. 
 
2-(2-(2-Methylprop-1-en-1-yl)benzo[b]thiophen-3-yl)benzaldehyde (S1.57): Prepared 
according to GP-1.2 with A1.8 (1.87 mmol). Purification by flash column chromatography (0–5% 
EtOAc/hexanes) afforded the title compound as a pale-yellow oil (468 mg, 86%). 
1H NMR (700 MHz, CDCl3): d 9.69 (s, 1H), 8.11 (d, J = 7.8 Hz, 1H), 7.85 (d, J = 8.0 Hz, 1H), 
7.72 (td, J = 7.5, 1.1 Hz, 1H), 7.57 (t, J = 7.6 Hz, 1H), 7.43 (d, J = 7.5 Hz, 1H), 7.35 – 7.32 (m, 
1H), 7.32 – 7.29 (m, 2H), 6.08 (s, 1H), 2.03 (s, 3H), 1.82 (s, 3H); 13C NMR (176 MHz, CDCl3): 
d 192.3, 140.2, 140.0, 139.6, 139.5, 138.7, 135.3, 134.2, 132.1, 129.6, 128.5, 127.6, 124.9, 124.7, 
122.6, 122.1, 117.4, 27.7, 20.5; IR (cm-1): 2969, 2845, 1692, 1596, 1444, 1393, 1264, 1193, 932, 
847, 825, 761, 687, 651, 633; HRMS: m/z calculated for C19H16OSNa+ [M+Na]+: 315.0814; found: 
315.0812. 
 
2-(3-(2-Methylprop-1-en-1-yl)-1-tosyl-1H-indol-2-yl)benzaldehyde (S1.58): Prepared 
according to GP-1.2 with A1.10 (4.55 mmol). Purification by flash column chromatography (10–
20% EtOAc/hexanes) afforded the title compound as a pale-yellow foam (1.40 g, 72%). 
1H NMR (500 MHz, CDCl3): d  9.31 (s, 1H), 8.41 (d, J = 8.4 Hz, 1H), 7.98 (d, J = 7.8 Hz, 1H), 









– 7.32 (m, 2H), 7.22 (d, J = 8.3 Hz, 2H), 7.05 (d, J = 8.1 Hz, 2H), 5.58 (s, 1H), 2.30 (s, 3H), 1.70 
(s, 3H), 1.30 (s, 3H); 13C NMR (176 MHz, CDCl3): d 191.0, 145.3, 141.4, 137.8, 135.3, 134.9, 
134.6, 133.8, 132.6, 131.9, 130.4, 129.7, 129.1, 126.7, 126.6, 126.0, 125.8, 124.4, 120.7, 116.4, 
113.9, 25.6, 21.7, 20.4; IR (cm-1): 2912, 2851, 1735, 1693, 1597, 1444, 1372, 1244, 1174, 1089, 
1065, 967, 850, 813, 749, 704, 663; HRMS: m/z calculated for C26H23NO3SNa+ [M+Na]+: 
452.1291; found: 452.1286. 
 
2-(2-(2-Methylprop-1-en-1-yl)naphthalen-1-yl)benzaldehyde (1.73): Prepared according to 
GP-1.2 with A1.9 (0.88 mmol). Purification by flash column chromatography (0–5% 
EtOAc/hexanes) afforded the title compound as a pale-green oil (199 mg, 79%). 
1H NMR (700 MHz, CDCl3): d  9.46 (s, 1H), 8.10 (d, J = 7.8 Hz, 1H), 7.89 (d, J = 8.4 Hz, 2H), 
7.70 (td, J = 7.5, 1.1 Hz, 1H), 7.57 (t, J = 7.6 Hz, 1H), 7.49 (d, J = 8.5 Hz, 1H), 7.46 (t, J = 7.3 Hz, 
1H), 7.36 (t, J = 7.5 Hz, 1H), 7.34 – 7.30 (m, 2H), 5.82 (s, 1H), 1.78 (s, 3H), 1.69 (s, 3H); 13C NMR 
(176 MHz, CDCl3): d 192.3, 143.5, 136.9, 136.2, 135.1, 133.9, 133.3, 133.2, 132.3, 131.9, 128.2, 
128.1, 128.0, 127.9, 127.1, 126.6, 126.1, 125.7, 124.8, 26.3, 19.6; IR (cm-1): 3056, 2974, 2582, 
1693, 1596, 1505, 1445, 1375, 1263, 1194, 1061, 867, 839, 762, 741, 645, 622; HRMS: m/z 
calculated for C21H18ONa+ [M+Na]+: 309.1250; found: 309.1248. 
Miscellaneous Procedures 
 
2-Bromo-1H-indole-3-carbaldehyde (A1.11): A 250-mL three-neck round-bottom flask 













3.0 equiv.) and CH2Cl2 (12 mL) under a nitrogen atmosphere. A solution of phosphorus 
oxybromide (10.21 g, 35.6 mmol, 2.4 equiv.) in CH2Cl2 (18 mL) was added dropwise at 0 °C and 
the resulting mixture heated at reflux for 15 min. After cooling down to rt, 2-oxindole (2.00 g, 
15.0 mmol, 1.0 equiv.) was added carefully and the reaction mixture heated at reflux for 1 h. The 
reaction was allowed to cool down to rt and quenched by the addition of ice. The aqueous layer 
was separated, neutralized with K2CO3 to pH 8–10 and stirred for 15 min. The resulting precipitate 
was collected via filtration and washed with water. The crude product was purified by flash column 
chromatography (30–50% EtOAc/hexanes) to afford the pure title compound as a orange solid 
(2.65 g, 79%). Spectroscopic data were consistent with those reported in the literature. 
1H NMR (400 MHz, CD3OD): d 9.91 (s, 1H), 8.13 (dd, J = 6.7, 1.7 Hz, 1H), 7.39 (dd, J = 6.9, 
1.4 Hz, 1H), 7.25 (pd, J = 7.2, 1.5 Hz, 2H). 
 
2-Bromo-3-(2-methylprop-1-en-1-yl)-1H-indole (A1.12): A 50-mL round-bottom flask 
equipped with a magnetic stir bar was charged with isopropyltriphenylphosphonium iodide 
(3.62 g, 8.40 mmol, 1.25 equiv.) and THF (15 mL), before cooling the resulting suspension to 
0 °C. Next, n-BuLi (1.6 M in hexanes; 5.0 mL, 8.0 mmol, 1.2 equiv.) was added and the solution 
stirred at 0 °C for 30 min under a nitrogen atmosphere. A solution of A1.11 (1.50 g, 6.70 mmol, 
1.0 equiv.) in THF (7 mL) that was pretreated with LiHMDS (1 M in THF, 6.7 mL, 6.7 mmol, 
1.0 equiv.) at 0 °C, was transferred to the reaction mixture at 0 °C via canula. The solution was 
gradually warmed up to rt and stirred for 1 h. Next, NH4Cl solution (aq., sat.) was added and the 
mixture partitioned between water and EtOAc. The organic layer was separated and the aqueous 











THF, 0 °C to rt
 40 
and concentrated in vacuo. The crude product was purified by flash column chromatography (10% 
EtOAc/hexanes) to afford the pure title compound as a yellow oil (1.40 g, 84%). 
1H NMR (500 MHz, CDCl3): d 8.04 (s, 1H), 7.43 (d, J = 7.8 Hz, 1H), 7.28 (d, J = 8.0 Hz, 1H), 
7.17 (t, J = 7.5 Hz, 1H), 7.11 (t, J = 7.5 Hz, 1H), 6.08 (s, 1H), 1.98 (s, 3H), 1.74 (s, 3H); 13C NMR 
(126 MHz, CDCl3): d 138.6, 136.1, 128.0, 122.4, 120.2, 119.7, 115.1, 115.0, 110.4, 108.5, 26.0, 
20.9; IR (cm-1): 3394, 2967, 2928, 1516, 1445, 1338, 1238, 1190, 1039, 742; HRMS: m/z 
calculated for C12H12BrN+ [M]+: 249.0153; found: 249.0165. 
 
2-Bromo-3-(2-methylprop-1-en-1-yl)-1-tosyl-1H-indole (A1.10): A 100-mL round-bottom 
flask equipped with a magnetic stir bar was charged with A1.12 (1.21 g, 4.84 mmol, 1.0 equiv.) 
and DMF (50 mL). NaH (60% dispersion in mineral oil; 271 mg, 6.77 mmol, 1.4 equiv.) was 
added at 0 °C and the solution stirred for 30 min at that temperature. Next, p-TsCl (1.44 g, 
7.55 mmol, 1.6 equiv.) was added and the mixture gradually warmed up to rt and stirred for 1.5 h 
under a nitrogen atmosphere. Then, NH4Cl solution (aq., sat.) was added and the mixture 
partitioned between water and EtOAc. The organic layer was separated and the aqueous layer 
extracted with EtOAc (3x). The combined organic extracts were washed with water (3x) and brine 
(1x), dried over Na2SO4, filtered and concentrated in vacuo. The crude product was purified by 
flash column chromatography (10% EtOAc/hexanes) to afford the pure title compound as a pale-
yellow foam (1.92 g, 98%). 
1H NMR (500 MHz, CDCl3): d 8.28 (d, J = 8.4 Hz, 1H), 7.74 (d, J = 8.2 Hz, 2H), 7.31 (dd, J = 
16.1, 8.0 Hz, 2H), 7.27 – 7.22 (m, 1H), 7.19 (d, J = 8.0 Hz, 2H), 5.88 (s, 1H), 2.34 (s, 3H), 1.94 









DMF, 0 °C to rt, 2 h
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127.2, 125.0, 124.6, 124.0, 119.9, 115.7, 114.2, 109.5, 25.8, 21.7, 20.8; IR (cm-1): 2912, 1596, 
1440, 1375, 1217, 1178, 1088, 1049, 971, 909, 811, 736, 703, 676, 657; HRMS: m/z calculated 
for C19H18BrNO2SH+ [M+H]+: 404.0314; found: 404.0316. 
 
4'-Hydroxy-2'-(2-methylprop-1-en-1-yl)-[1,1'-biphenyl]-2-carbaldehyde (S1.52): Adapted 
from a literature procedure with minor modifications.79 A 250-mL round-bottom flask equipped 
with a magnetic stir bar was charged with S1.35 (1.50 g, 4.09 mmol, 1.0 equiv.) and DMF 
(50 mL). NaH (60% dispersion in mineral oil; 491 mg, 12.3 mmol, 3.0 equiv.) was added in 
portions and the reaction stirred at rt for 4 h under a nitrogen atmosphere. The reaction mixture 
was cooled down to 0 °C, and NH4Cl solution (aq., sat.) was added. After diluting with EtOAc and 
separating the aqueous layer, the organic layer was washed with water (3x) and brine (1x), dried 
over Na2SO4, filtered and concentrated in vacuo. The crude product was purified by flash column 
chromatography (40% EtOAc/hexanes) to afford the pure title compound as a pale-yellow solid 
(1.03 g, quant.). 
1H NMR (500 MHz, CD3OD): d  9.53 (s, 1H), 7.87 (d, J = 7.7 Hz, 1H), 7.64 (t, J = 7.5 Hz, 1H), 
7.45 (t, J = 7.5 Hz, 1H), 7.31 (d, J = 7.6 Hz, 1H), 7.16 (d, J = 8.2 Hz, 1H), 6.80 (dd, J = 8.2, 2.2 Hz, 
1H), 6.75 (d, J = 1.9 Hz, 1H), 5.67 (s, 1H), 1.72 (s, 3H), 1.63 (s, 3H); 13C NMR (126 MHz, 
CD3OD): d 193.7, 158.5, 146.8, 140.6, 137.9, 135.7, 134.8, 132.5, 132.4, 129.5, 128.4, 127.3, 
125.9, 117.4, 114.8, 26.1, 19.3; IR (cm-1): 3217, 1656, 1596, 1472, 1396, 1293, 1263, 1170, 970, 











DMF, rt, 4 h
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2'-Formyl-2-(2-methylprop-1-en-1-yl)-[1,1'-biphenyl]-4-yl acetate (S1.51): A 25-mL round-
bottom flask equipped with a magnetic stir bar was charged with S1.52 (202 mg, 0.80 mmol, 
1.0 equiv.) and CH2Cl2 (5 mL). After cooling to 0 °C, acetic anhydride (0.09 mL, 0.96 mmol, 
1.2 equiv.), DMAP (4.9 mg, 0.04 mmol, 0.05 equiv.) and triethylamine (0.22 mL, 1.60 mmol, 
2.0 equiv.) were added sequentially under a nitrogen atmosphere and the reaction mixture allowed 
to warm up to rt. After stirring for 1.5 h, NH4Cl solution (aq., sat.) was added and the mixture 
extracted with EtOAc (3x). The combined organic extracts were dried over Na2SO4, filtered and 
concentrated in vacuo. Purification by flash column chromatography (10% EtOAc/hexanes) 
afforded the pure title compound as a white solid (216 mg, 92%). 
1H NMR (700 MHz, CD3OD): d 9.55 (s, 1H), 7.92 (d, J = 7.7 Hz, 1H), 7.70 (td, J = 7.5, 1.1 Hz, 
1H), 7.53 (t, J = 7.6 Hz, 1H), 7.37 (d, J = 8.2 Hz, 1H), 7.35 (d, J = 7.6 Hz, 1H), 7.12 (dd, J = 8.2, 
2.3 Hz, 1H), 7.06 (d, J = 2.3 Hz, 1H), 5.70 (s, 1H), 2.32 (s, 3H), 1.73 (s, 3H), 1.66 (s, 3H); 
13C NMR (176 MHZ, CD3OD): d 193.1, 171.2, 151.9, 145.6, 140.7, 139.2, 136.1, 135.6, 135.0, 
132.3, 132.2, 129.1, 127.6, 124.9, 124.0, 121.0, 26.1, 21.0, 19.2; IR (cm-1): 2971, 2928, 1764, 
1683, 1596, 1443, 1373, 1258, 1203, 1155, 1005, 910, 836, 772, 728, 637; HRMS: m/z calculated 
for C19H18O3Na+ [M+Na]+: 317.1148; found: 317.1152. 
 
2'-Formyl-2-(2-methylprop-1-en-1-yl)-[1,1'-biphenyl]-4-yl 4-methylbenzenesulfonate 




















CH2Cl2, 0 °C to rt
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(221 mg, 0.88 mmol, 1.0 equiv.) and CH2Cl2 (5 mL). After cooling to 0 °C p-TsCl (201 mg, 
1.05 mmol, 1.2 equiv.) and triethylamine (0.25 mL, 1.75 mmol, 2.0 equiv.) were added 
sequentially under a nitrogen atmosphere and the reaction mixture allowed to warm up to rt. After 
stirring for 1.5 h, NH4Cl solution (aq., sat.) was added and the mixture extracted with EtOAc (3x). 
The combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. 
Purification by flash column chromatography (10% EtOAc/hexanes) afforded the pure title 
compound as a colorless foam (343 mg, 96%). 
1H NMR (700 MHz, CD3OD): d 9.42 (s, 1H), 7.90 (d, J = 7.3 Hz, 1H), 7.76 (d, J = 8.3 Hz, 2H), 
7.68 (td, J = 7.5, 1.0 Hz, 1H), 7.53 (t, J = 7.6 Hz, 1H), 7.44 (d, J = 8.3 Hz, 2H), 7.31 (d, J = 8.3 Hz, 
1H), 7.29 (d, J = 7.6 Hz, 1H), 7.07 (dd, J = 8.3, 2.5 Hz, 1H), 6.86 (d, J = 2.4 Hz, 1H), 5.58 (s, 1H), 
2.45 (s, 3H), 1.61 (s, 3H), 1.50 (s, 3H); 13C NMR (176 MHz, CD3OD): d 192.7, 150.6, 147.8, 
144.9, 141.0, 139.7, 137.7, 135.5, 135.0, 133.6, 132.4, 132.1, 131.2, 129.7, 129.4, 127.9, 124.5, 
124.4, 121.7, 26.1, 21.6, 19.1; IR (cm-1): 2928, 2852, 1736, 1694, 1597, 1445, 1372, 1241, 1191, 
1144, 1092, 965, 840, 805, 765, 709, 661; HRMS: m/z calculated for C24H22O4SNa+ [M+Na]+: 
429.1131; found: 429.1131. 
 
2'-Formyl-2-(2-methylprop-1-en-1-yl)-[1,1'-biphenyl]-4-yl trifluoromethanesulfonate 
(S1.53): A 25-mL round-bottom flask equipped with a magnetic stir bar was charged with S1.52 
(204 mg, 0.81 mmol, 1.0 equiv.) and CH2Cl2 (5 mL). After cooling to 0 °C triflic anhydride 
(0.16 mL, 0.97 mmol, 1.2 equiv.), DMAP (4.9 mg, 0.04 mmol, 0.05 equiv.) and triethylamine 
(0.23 mL, 1.62 mmol, 2.0 equiv.) were added sequentially under a nitrogen atmosphere and the 
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added and the mixture extracted with EtOAc (3x). The combined organic extracts were dried over 
Na2SO4, filtered and concentrated in vacuo. Purification by flash column chromatography (5% 
EtOAc/hexanes) afforded the pure title compound as a white solid (229 mg, 74%). 
1H NMR (700 MHz, CD2Cl2): d 9.57 (s, 1H), 7.95 (d, J = 7.5 Hz, 1H), 7.66 (td, J = 7.5, 1.1 Hz, 
1H), 7.53 (t, J = 7.6 Hz, 1H), 7.41 (d, J = 8.4 Hz, 1H), 7.30 (d, J = 7.6 Hz, 1H), 7.27 (dd, J = 8.4, 
2.5 Hz, 1H), 7.25 (d, J = 2.5 Hz, 1H), 5.71 (s, 1H), 1.77 (s, 3H), 1.69 (s, 3H); 13C NMR (176 MHz, 
CD2Cl2): d 191.5, 149.6, 143.4, 141.1, 140.1, 138.3, 134.6, 134.2, 132.4, 131.5, 128.9, 127.6, 
123.3, 122.8, 119.6, 119.4 (q, J = 320.7 Hz), 26.4, 19.4; IR (cm-1): 2917, 2849, 1696, 1597, 1423, 
1244, 1209, 1138, 961, 894, 858, 830, 766, 656, 608; HRMS: m/z calculated for C18H15F3O4SNa+ 
[M+Na]+: 407.0535; found: 407.0538. 
 
2-Methyl-1-(2'-(2-methylprop-1-en-1-yl)-[1,1'-biphenyl]-2-yl)prop-2-en-1-one (S1.55): A 25-
mL round-bottom flask equipped with a magnetic stir bar was charged with 1.31 (250 mg, 
1.06 mmol, 1.0 equiv.) and THF (4 mL) under a nitrogen atmosphere. After cooling down to 0 °C, 
isopropenylmagnesium bromide (0.5 M in THF; 2.3 mL, 1.15 mmol, 1.1 equiv.) was added 
dropwise and the reaction mixture stirred for 30 min at 0 °C. Then, NH4Cl solution (aq., sat.) was 
added and the mixture extracted with EtOAc (3x). The combined organic extracts were dried over 
Na2SO4, filtered and concentrated in vacuo to yield the crude alcohol, which was used for the next 
step without further purification. 
A 10-mL round-bottom flask equipped with a magnetic stir bar was charged with crude 
alcohol from the previous step and DMSO (2 mL). 2-Iodoxybenzoic acid (355 mg, 1.27 mmol, 













precipitate removed via filtration through celite. The filtrate was extracted with EtOAc (3x), and 
the combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. The 
crude product was purified by flash column chromatography (0–5% EtOAc/hexanes) to afford the 
pure title compound as a colorless oil (201 mg, 69%). 
1H NMR (700 MHz, CDCl3): d 7.46 – 7.43 (m, 2H), 7.37 (t, J = 7.5 Hz, 1H), 7.28 – 7.25 (m, 2H), 
7.22 (d, J = 7.3 Hz, 1H), 7.18 (t, J = 7.4 Hz, 1H), 7.08 (d, J = 7.5 Hz, 1H), 5.84 (s, 1H), 5.63 (s, 
1H), 5.40 (s, 1H), 1.73 (s, 3H), 1.72 (s, 3H), 1.70 (s, 3H); 13C NMR (176 MHz, CDCl3): d 200.0, 
145.0, 140.7, 139.84, 139.78, 136.7, 135.7, 131.3, 130.4, 130.0, 129.5, 128.6, 127.5, 127.2, 126.7, 
126.1, 124.8, 26.5, 19.5, 17.4; IR (cm-1): 3058, 2969, 2024, 1657, 1435, 1374, 1326, 1195, 1050, 
1015, 977, 933, 748, 691; HRMS: m/z calculated for C20H20ONa+ [M+Na]+: 299.1406; found: 
299.1410. 
 
3-Bromothiophene-2-carbaldehyde (A1.13): To a round-bottom flask equipped with a magnetic 
stir bar containing a freshly prepared 0.5 M solution of LDA in THF (20 mL, 10 mmol, 1.1 equiv.), 
which was was cooled at –78 ºC, was added dropwise a solution of 3-bromothiophene (0.86 mL, 
9.2 mmol, 1.0 equiv.) in THF (2.5 mL). The resulting solution was stirred for 0.5 h at that 
temperature, before being gradually warmed up to 0 ºC. Next, DMF (0.85 mL, 11.0 mmol, 
1.2 equiv.) was added dropwise and the reaction allowed to warm up to rt and stirred for 1 h. Then, 
NH4Cl (aq., sat.) was added and the resulting mixture stirred for 0.5 h, before extracting with 
EtOAc (3x). The combined organic extracts were washed with water (3x) and brine, dried over 
Na2SO4, filtered and concentrated in vacuo. Purification by flash column chromatography (5% 
EtOAc/hexanes) afforded the pure title compound as a pale-yellow oil (1.35 g, 77%). 









Synthesis of Carbonyl–Ene Products and Characterization 
General Procedure for Carbonyl–Ene Reaction with Me2AlCl (GP-1.3) 
 
A 20-mL glass scintillation vial equipped with a magnetic stir bar was charged with aryl aldehyde 
(0.20 mmol, 1.0 equiv.). The vial was sealed with a rubber septum under a nitrogen atmosphere 
and toluene (2 mL) was added. To this solution was added Me2AlCl (1 M in hexane; 10 µL, 
1.0´10-2 mmol, 5 mol%) and the resulting mixture stirred for the indicated time at rt. Upon 
completion as determined by TLC analysis, the reaction mixture was passed through a short silica 
plug eluting with CH2Cl2 (25–50 mL). The filtrate was concentrated in vacuo and the crude 
product purified by flash column chromatography to obtain the pure alcohol product. 
Note: Relative stereochemistry was found to be syn for all alcohol products, as assigned based on 
1H NMR NOE correlations and coupling constants of J = 5.9–6.4 Hz between both benzylic 
protons.81 
 
10-(Prop-1-en-2-yl)-9,10-dihydrophenanthren-9-ol (1.33): Prepared according to GP-1.3 with 
aryl aldehyde 1.31 (0.20 mmol, 1.0 equiv.) with a total reaction time of 1 h. Purification by flash 
column chromatography (10% EtOAc/hexanes) afforded the pure title compound as a white solid 
(47 mg, 99%). 
1H NMR (700 MHz, CDCl3): d 7.82 (d, J = 7.8 Hz, 1H), 7.74 – 7.71 (m, 1H), 7.65 – 7.63 (m, 1H), 
7.39 – 7.34 (m, 3H), 7.30 – 7.26 (m, 2H), 5.10 (d, J = 6.3 Hz, 1H), 5.00 (s, 1H), 4.93 (s, 1H), 3.82 















136.1, 133.8, 133.3, 129.5, 128.4, 128.1, 128.0, 127.9, 124.7, 123.8, 124.6, 116.0, 69.5, 53.3, 21.0; 
IR (cm-1): 3288, 3068, 2959, 1636, 1482, 1451, 1374, 1199, 1099, 1074, 1011, 946, 886, 737, 675; 
HRMS: m/z calculated for C17H16ONa+ [M+Na]+: 259.1093; found: 259.1096. 
 
2-((Tert-butyldimethylsilyl)oxy)-10-(prop-1-en-2-yl)-9,10-dihydrophenanthren-9-ol (1.35): 
Prepared according to GP-1.3 with aryl aldehyde S1.35 (73 mg, 0.20 mmol, 1.0 equiv.) with a total 
reaction time of 20 min. Purification by flash column chromatography (5–10% EtOAc/hexanes) 
afforded the pure title compound as a colorless oil (64 mg, 87%). 
1H NMR (700 MHz, CDCl3): d 7.68 (d, J = 8.5 Hz, 1H), 7.63 (d, J = 7.5 Hz, 1H), 7.59 (d, J = 
7.4 Hz, 1H), 7.33 (t, J = 7.3 Hz, 1H), 7.29 (t, J = 7.0 Hz, 1H), 6.84 (dd, J = 8.4, 2.5 Hz, 1H), 6.74 
(d, J = 2.4 Hz, 1H), 5.05 (t, J = 5.7 Hz, 1H), 4.98 (s, 1H), 4.94 (s, 1H), 3.72 (d, J = 6.2 Hz, 1H), 
2.07 (b, 1H), 1.30 (s, 3H), 1.01 (s, 9H), 0.24 (s, 6H); 13C NMR (176 MHz, CDCl3): d 155.7, 143.8, 
137.7, 137.6, 133.3, 127.9, 127.5, 127.3, 125.1, 124.8, 123.0, 120.8, 119.6, 115.9, 69.6, 53.5, 25.8, 
21.1, 18.4, -4.18, -4.21; IR (cm-1): 2954, 2928, 2856, 1602, 1502, 1478, 1286, 1251, 1153, 1126, 
1077, 987, 869, 837, 770, 732, 680; HRMS: m/z calculated for C23H30O2SiNa+ [M+Na]+: 
389.1907; found: 389.1900. 
 
2-Methoxy-10-(prop-1-en-2-yl)-9,10-dihydrophenanthren-9-ol (1.36): Prepared according to 
GP-1.3 with aryl aldehyde 1.68 (53 mg, 0.20 mmol, 1.0 equiv.) with a total reaction time of 
20 min. Purification by flash column chromatography (5–10% EtOAc/hexanes) afforded the pure 








1H NMR (700 MHz, CDCl3): d 7.74 (d, J = 8.6 Hz, 1H), 7.64 (d, J = 7.6 Hz, 1H), 7.59 (d, J = 
7.4 Hz, 1H), 7.33 (t, J = 7.5 Hz, 1H), 7.29 (t, J = 7.4 Hz, 1H), 6.91 (dd, J = 8.6, 2.7 Hz, 1H), 6.80 
(d, J = 2.6 Hz, 1H), 5.06 (s, 1H), 4.99 (s, 1H), 4.94 (s, 1H), 3.85 (s, 3H), 3.76 (d, J = 6.3 Hz, 1H), 
2.08 (b, 1H), 1.30 (s, 3H); 13C NMR (176 MHz, CDCl3): d 159.6, 143.8, 137.7, 137.6, 133.3, 
127.9, 127.4, 126.7, 125.2, 124.7, 122.9, 116.1, 114.5, 113.6, 69.6, 55.5, 53.7, 21.0; IR (cm-1): 
2433, 2914, 2837, 1609, 1453, 1315, 1265, 1232, 1134, 1076, 1049, 899, 819, 770, 733; HRMS: 
m/z calculated for C18H18O2Na+ [M+Na]+: 289.1199; found: 289.1203. 
 
10-(Prop-1-en-2-yl)-2-(trifluoromethyl)-9,10-dihydrophenanthren-9-ol (1.40): Prepared 
according to GP-1.3 with aryl aldehyde 1.69 (61 mg, 0.20 mmol, 1.0 equiv.) with a total reaction 
time of 20 min. Purification by flash column chromatography (5–10% EtOAc/hexanes) afforded 
the pure title compound as a colorless oil (58 mg, 95%). 
1H NMR (700 MHz, CDCl3): d 7.90 (d, J = 8.2 Hz, 1H), 7.75 (d, J = 7.1 Hz, 1H), 7.66 (d, J = 
7.1 Hz, 1H), 7.61 (d, J = 8.1 Hz, 1H), 7.53 (s, 1H), 7.41 (pd, J = 7.4, 1.6 Hz, 2H), 5.09 (d, J = 
5.1 Hz, 1H), 5.02 (s, 1H), 4.99 (s, 1H), 3.85 (d, J = 6.2 Hz, 1H), 2.13 (b, 1H), 1.30 (s, 3H); 
13C NMR (176 MHz, CDCl3): d 142.9, 138.8, 137.3, 136.7, 132.0, 129.9 (q, J = 32.4 Hz), 129.5, 
128.3, 126.3 (q, J = 3.8 Hz), 125.2, 124.9 (q, J = 3.8 Hz), 124.24 (q, J = 272.1 Hz), 124.19, 124.15, 
116.9, 69.2, 53.1, 21.0; IR (cm-1): 3427, 3071, 2920, 1619, 1418, 1329, 1295, 1162, 1117, 1072, 







3-Chloro-10-(prop-1-en-2-yl)-9,10-dihydrophenanthren-9-ol (1.41): Prepared according to 
GP-1.3 with aryl aldehyde 1.67 (54 mg, 0.20 mmol, 1.0 equiv.) with a total reaction time of 
15 min. Purification by flash column chromatography (5–10% EtOAc/hexanes) afforded the pure 
title compound as a colorless oil (53 mg, 98%). 
1H NMR (500 MHz, CDCl3): d 7.77 (d, J = 1.7 Hz, 1H), 7.69 – 7.65 (m, 1H), 7.65 – 7.59 (m, 1H), 
7.40 – 7.34 (m, 2H), 7.24 (dd, J = 8.1, 2.0 Hz, 1H), 7.19 (d, J = 8.1 Hz, 1H), 5.04 (d, J = 6.1 Hz, 
1H), 4.97 (s, 1H), 4.93 (s, 1H), 3.77 (d, J = 6.3 Hz, 1H), 2.13 (b, 1H), 1.26 (s, 3H); 13C NMR 
(126 MHz, CDCl3):d 143.3, 138.4, 135.5, 134.4, 133.8, 132.1, 130.8, 129.0, 128.1, 127.9, 125.0, 
123.9, 123.7, 116.4, 69.3, 52.7, 20.9; IR (cm-1): 3435, 3069, 2919, 1637, 1595, 1559, 1483, 1446, 
1375, 1264, 1208, 1097, 1023, 946, 881, 818, 733, 690, 663; HRMS: m/z calculated for 
C17H15ClONa+ [M+Na]+: 293.0704; found: 293.0707. 
 
6-Methyl-10-(prop-1-en-2-yl)-9,10-dihydrophenanthren-9-ol (1.46): Prepared according to 
GP-1.3 with aryl aldehyde 1.71 (50 mg, 0.20 mmol, 1.0 equiv.) with a total reaction time of 
40 min. Purification by flash column chromatography (5–10% EtOAc/hexanes) afforded the pure 
title compound as a colorless oil (47 mg, 95%). 
1H NMR (700 MHz, CDCl3): d 7.80 (d, J = 7.8 Hz, 1H), 7.53 (s, 1H), 7.49 (d, J = 7.6 Hz, 1H), 
7.35 (td, J = 8.1, 7.4, 2.3 Hz, 1H), 7.29 – 7.24 (m, 2H), 7.16 (d, J = 7.8 Hz, 1H), 5.05 (d, J = 6.2 Hz, 
1H), 4.98 (s, 1H), 4.93 (s, 1H), 3.79 (d, J = 6.3 Hz, 1H), 2.41 (s, 3H), 1.29 (s, 3H); 13C NMR 








124.4, 123.8, 115.9, 69.5, 53.5, 21.6, 21.1; IR (cm-1): 3433, 3032, 2918, 1638, 1447, 1375, 1188, 
1140, 1124, 942, 897, 816, 738, 720; HRMS: m/z calculated for C18H18ONa+ [M+Na]+: 273.1250; 
found: 273.1245. 
 
6-(Prop-1-en-2-yl)-5,6-dihydrophenanthro[2,3-d][1,3]dioxol-5-ol (1.47): Prepared according 
to GP-1.3 with aryl aldehyde 1.70 (56 mg, 0.20 mmol, 1.0 equiv.) with a total reaction time of 
20 min. Purification by flash column chromatography (10% EtOAc/hexanes) afforded the pure 
title compound as a white solid (52 mg, 93%). 
1H NMR (700 MHz, CDCl3): d 7.59 (d, J = 7.3 Hz, 1H), 7.55 (d, J = 7.5 Hz, 1H), 7.33 (t, J = 
7.1 Hz, 1H), 7.30 (t, J = 6.9 Hz, 1H), 7.28 (s, 1H), 6.73 (s, 1H), 5.98 (d, J = 10.2 Hz, 2H), 5.04 (t, 
J = 7.3 Hz, 1H), 4.96 (s, 1H), 4.92 (s, 1H), 3.68 (d, J = 6.4 Hz, 1H), 2.04 (d, J = 9.2 Hz, 1H), 1.25 
(s, 3H); 13C NMR (176 MHz, CDCl3):d 147.8, 147.5, 143.8, 137.8, 133.8, 130.3, 127.94, 127.86, 
127.7, 124.6, 123.1, 116.1, 109.4, 104.2, 101.3, 69.6, 53.5, 20.8; IR (cm-1): 3310, 3908, 1638, 
1485, 1452, 1257, 1240, 1086, 1039, 938, 736, 619; HRMS: m/z calculated for C18H16O3Na+ 
[M+Na]+: 303.0992; found: 303.0997. 
 
9-Hydroxy-10-(prop-1-en-2-yl)-9,10-dihydrophenanthren-2-yl 4-methylbenzenesulfonate 
(1.48): Prepared according to GP-1.3 with aryl aldehyde S1.48 (81 mg, 0.20 mmol, 1.0 equiv.) 
with a total reaction time of 20 min. Purification by flash column chromatography (20% 








1H NMR (700 MHz, CDCl3): d 7.74 – 7.70 (m, 3H), 7.65 – 7.62 (m, 1H), 7.60 – 7.57 (m, 1H), 
7.37 – 7.33 (m, 2H), 7.30 (d, J = 8.1 Hz, 2H), 7.02 (dd, J = 8.5, 2.4 Hz, 1H), 6.80 (d, J = 2.4 Hz, 
1H), 5.00 (d, J = 6.1 Hz, 1H), 4.90 (s, 1H), 4.86 (s, 1H), 3.65 (d, J = 6.1 Hz, 1H), 2.44 (s, 3H), 
1.94 (b, 1H), 1.23 (s, 3H); 13C NMR (176 MHz, CDCl3): d 149.1, 145.5, 142.9, 138.1, 137.7, 
132.8, 132.4, 132.1, 129.9, 128.8, 128.7, 128.2, 125.2, 125.1, 123.8, 123.2, 122.0, 116.4, 69.2, 
52.9, 21.9, 21.1; IR (cm-1): 3532, 3067, 2919, 1733, 1597, 1479, 1451, 1370, 1187, 1175, 1141, 




(1.53): Prepared according to GP-1.3 with aryl aldehyde S1.53 (77 mg, 0.20 mmol, 1.0 equiv.) 
with a total reaction time of 20 min. Purification by flash column chromatography (5–10% 
EtOAc/hexanes) afforded the pure title compound as a white foam (72 mg, 94%). 
1H NMR (500 MHz, CDCl3): d (d, J = 8.7 Hz, 1H), 7.71 – 7.67 (m, 1H), 7.64 – 7.60 (m, 1H), 7.43 
– 7.37 (m, 2H), 7.27 (dd, J = 8.4, 2.7 Hz, 1H), 7.20 (d, J = 2.5 Hz, 1H), 5.08 – 5.03 (m, 1H), 5.01 
(d, J = 3.3 Hz, 2H), 3.80 (d, J = 5.9 Hz, 1H), 2.06 (d, J = 8.6 Hz, 1H), 1.37 (s, 3H); 13C NMR 
(126 MHz, CDCl3): d 148.94, 142.61, 138.66, 138.18, 134.28, 131.66, 129.28, 128.44, 125.68, 
125.47, 124.00, 122.1, 120.7, 118.9 (q, J = 320.9 Hz), 117.0, 69.19, 53.01, 21.24; IR (cm-1): 3430, 
2920, 1480, 1423, 1209, 1139, 1078, 971, 940, 884, 865, 772, 734, 639, 607; HRMS: m/z 




Stoichiometric Carbonyl–Ene Reaction with Me2AlCl 
 
3-Methoxy-9-(prop-1-en-2-yl)phenanthrene (1.42): A 20-mL glass scintillation vial equipped 
with a magnetic stir bar was charged with 1.72 (53 mg, 0.20 mmol, 1.0 equiv.), the vial sealed with 
a rubber septum under a nitrogen atmosphere and toluene (2 mL) was added. After cooling the 
solution to –20 °C, Me2AlCl (1 M in hexane; 0.20 mL, 0.22  mmol, 1.0 equiv.) was added 
dropwise. The resulting mixture was allowed to warm up to rt and stirred for 0.5 h. Then, the 
reaction mixture was passed through a short silica plug eluting with CH2Cl2 (25–50 mL). The 
filtrate was concentrated and dried in vacuo. The yield was determined to be 66% by 1H NMR 
analysis from the crude mixture using dimethyl terephthalate as the internal standard. 
1H NMR (500 MHz, CDCl3): d 8.65 (d, J = 8.1 Hz, 1H), 8.08 (d, J = 8.0 Hz, 1H), 8.05 (s, 1H), 
7.78 (d, J = 8.7 Hz, 1H), 7.62 (td, J = 14.8, 7.0 Hz, 2H), 7.52 (s, 1H), 7.24 (d, J = 8.7 Hz, 1H), 
5.43 (s, 1H), 5.14 (s, 1H), 4.03 (s, 3H), 2.25 (s, 3H); 13C NMR (126 MHz, CDCl3): d 158.5, 145.3, 
138.6, 131.2, 130.7, 130.1, 130.0, 126.7 (2C), 126.5, 126.0, 124.7, 123.1, 117.0, 116.2, 104.0, 
55.7, 25.2; IR (cm-1): 3059, 2917, 2850, 1642, 1492, 1447, 1423, 1370, 1188, 1144, 1042, 1010, 
908, 856, 770, 750, 734, 627; HRMS: m/z calculated for C18H16OH+ [M+H]+: 249.1274; found: 
249.1270. 
 
9-Methyl-10-(prop-1-en-2-yl)phenanthrene (1.54): A 20-mL glass scintillation vial equipped 
with a magnetic stir bar was charged with 1-(2'-(2-methylprop-1-en-1-yl)-[1,1'-biphenyl]-2-






nitrogen atmosphere and toluene (2 mL) was added. After cooling the solution to 0 °C, Me2AlCl 
(1 M in hexane; 0.22 mL, 0.22  mmol, 1.1 equiv.) was added, the resulting mixture allowed to 
warm up to rt and stirred for 0.5 h. Then, the reaction mixture was passed through a short silica 
plug eluting with CH2Cl2 (25–50 mL). The filtrate was concentrated and dried in vacuo. The yield 
was determined to be 81% by 1H NMR analysis from the crude mixture using dimethyl 
terephthalate as the internal standard. 
1H NMR (500 MHz, CDCl3): d 8.75 – 8.72 (m, 1H), 8.71 (d, J = 8.5 Hz, 1H), 8.15 – 8.11 (m, 1H), 
8.02 (d, J = 7.7 Hz, 1H), 7.67 – 7.63 (m, 2H), 7.59 (pd, J = 6.9, 1.5 Hz, 2H), 5.58 (s, 1H), 5.01 (s, 
1H), 2.70 (s, 3H), 2.15 (s, 3H); 13C NMR (126 MHz, CDCl3): d 144.6, 138.6, 132.1, 130.6, 129.8, 
129.7, 127.7, 126.8, 126.67, 126.65, 126.1, 125.7, 125.0, 122.9, 122.7, 116.9, 25.0, 16.6; IR (cm-
1): 3073, 2962, 1949, 1804, 1642, 1490, 1423, 1369, 1239, 1048, 1027, 1004, 898, 751, 723, 619; 
HRMS: m/z calculated for C18H16+ [M]+: 232.1252; found: 232.1249. 
 
9,10-Di(prop-1-en-2-yl)phenanthrene (1.55): A 20-mL glass scintillation vial equipped with a 
magnetic stir bar was charged with aryl enone S1.55 (55 mg, 0.20 mmol, 1.0 equiv.), the vial 
sealed with a rubber septum under a nitrogen atmosphere and toluene (2 mL) was added. After 
cooling the solution to 0 °C, Me2AlCl (1 M in hexane; 0.22 mL, 0.22  mmol, 1.1 equiv.) was 
added, the resulting mixture allowed to warm up to rt and stirred for 0.5 h. Then, the reaction 
mixture was passed through a short silica plug eluting with CH2Cl2 (25–50 mL). The filtrate was 
concentrated and in vacuo. Purification by flash column chromatography (100% hexanes) afforded 




1H NMR (700 MHz, CDCl3): d 8.72 (d, J = 8.2 Hz, 8.6H, A+B), 8.08 (d, J = 8.1 Hz, 2H, B), 8.03 
(d, J = 8.1 Hz, 6.6H, A), 7.64 (td, J = 8.1, 6.9, 1.2 Hz, 8.6H, A+B), 7.60 (td, J = 7.5, 6.9, 1.3 Hz, 
8.6H, A+B), 5.57 (s, 2H, B), 5.47 (s, 6.6H, A), 5.02 (s, 2H, B), 5.00 (s, 6.6H, A), 2.20 (s, 19.8H, 
A), 2.15 (s, 6H, B); 13C NMR (176 MHz, CDCl3): d 144.5 (A), 142.9 (B), 136.9 (A), 136.7 (B), 
130.5 (A), 130.4 (B), 130.0 (B), 129.9 (A), 127.3 (B), 126.78 (A), 126.75 (A), 126.7 (B), 126.2 
(2C, A+B), 122.7 (2C, A+B), 119.0 (B), 116.3 (A), 26.0 (A), 24.8 (B); IR (cm-1): 3070, 2967, 
2942, 1639, 1488, 1442, 1370, 1239, 1198, 1048, 1002, 915, 906, 863, 765, 629; HRMS: m/z 
calculated for C20H18H+ [M+H]+: 259.1481; found: 259.1478. 
General Procedure for Carbonyl–Ene Reaction with SnCl4 (GP-1.4) 
 
A 20-mL glass scintillation vial equipped with a magnetic stir bar was charged with aryl aldehyde 
(0.20 mmol, 1.0 equiv.). The vial was sealed with a rubber septum under a nitrogen atmosphere 
and toluene (2 mL) was added. After heating the solution to 50 °C, a freshly prepared SnCl4 
solution (1 M in toluene; 10 µL, 1.0´10-2 mmol, 20–30 mol%) was added and the resulting 
mixture stirred for the indicated time at 50 °C. Upon completion (as determined by TLC analysis) 
the reaction mixture was allowed to cool down to rt and passed through a short silica plug eluting 
with CH2Cl2 (25-50 mL). The filtrate was concentrated and dried in vacuo and the yield 














9-(Prop-1-en-2-yl)phenanthrene (1.34): Prepared according to GP-1.4 with aryl aldehyde 1.31 
(47 mg, 0.20 mmol, 1.0 equiv.) with a total reaction time of 0.5 h. Purification by flash column 
chromatography (100% hexanes) afforded the pure title compound as a white solid (43 mg, 99%). 
Spectroscopic data are consistent with those reported in the literature.30 
1H NMR (500 MHz, CDCl3): d 8.76 (d, J = 8.1 Hz, 1H), 8.70 (d, J = 8.0 Hz, 1H), 8.14 (d, J = 
8.0 Hz, 1H), 7.89 (d, J = 7.6 Hz, 1H), 7.72 – 7.59 (m, 5H), 5.49 (s, 1H), 5.20 (s, 1H), 2.30 (s, 3H). 
 
Tert-butyldimethyl((10-(prop-1-en-2-yl)phenanthren-2-yl)oxy)silane (1.37): Prepared 
according to GP-1.4 with aryl aldehyde S1.35 (73 mg, 0.20 mmol, 1.0 equiv.) with a total reaction 
time of 0.5 h. The yield was determined to be 99% by quantitative 1H NMR analysis using 
dimethyl terephthalate as the internal standard. 
1H NMR (700 MHz, CDCl3): d 8.59 (d, J = 8.9 Hz, 1H), 8.56 (d, J = 8.3 Hz, 1H), 7.81 (d, J = 
7.8 Hz, 1H), 7.59 (td, J = 8.1, 7.0, 1.3 Hz, 1H), 7.53 (s, 1H), 7.51 (t, J = 7.4 Hz, 1H), 7.46 (d, J = 
2.5 Hz, 1H), 7.21 (dd, J = 8.9, 2.5 Hz, 1H), 5.43 (s, 1H), 5.12 (s, 1H), 2.23 (s, 3H), 1.03 (s, 9H), 
0.27 (s, 6H); 13C NMR (176 MHz, CDCl3): d 154.5, 145.1, 140.3, 131.9, 130.9, 130.0, 128.6, 
126.5, 125.9, 125.41, 125.39, 124.5, 122.2, 121.0, 116.1, 115.3, 25.9, 25.0, 18.5, -4.2; IR (cm-1): 
2955, 2928, 2856, 1611, 1528, 1483, 1462, 1390, 1265, 1218, 1167, 1104, 961, 862, 832, 777, 






2-Methoxy-10-(prop-1-en-2-yl)phenanthrene (1.38): Prepared according to GP-1.4 with aryl 
aldehyde 1.68 (52 mg, 0.20 mmol, 1.0 equiv.) with a total reaction time of 0.5 h. The yield was 
determined to be 86% by quantitative 1H NMR analysis using dimethyl terephthalate as the internal 
standard. 
1H NMR (700 MHz, CDCl3): d 8.63 (d, J = 9.0 Hz, 1H), 8.57 (d, J = 8.3 Hz, 1H), 7.83 (d, J = 
7.8 Hz, 1H), 7.60 (td, J = 8.1, 7.1, 1.3 Hz, 1H), 7.56 (s, 1H), 7.52 (td, J = 7.7, 6.9, 0.8 Hz, 1H), 
7.47 (d, J = 2.6 Hz, 1H), 7.29 (dd, J = 9.0, 2.7 Hz, 1H), 5.44 (s, 1H), 5.17 (s, 1H), 3.96 (s, 3H), 
2.25 (s, 3H); 13C NMR (176 MHz, CDCl3): d 158.3, 145.2, 140.4, 131.8, 130.8, 130.1, 128.6, 
126.6, 125.9, 125.7, 125.0, 124.7, 122.1, 116.5, 116.2, 107.4, 55.5, 24.9; IR (cm-1): 2930, 2837, 
1614, 1531, 1451, 1434, 1361, 1276, 1221, 1106, 856, 898, 747, 710; HRMS: m/z calculated for 
C18H16OH+ [M+H]+: 249.1274; found: 249.1268. 
 
10-(Prop-1-en-2-yl)-2-(trifluoromethyl)phenanthrene (1.39): Prepared according to GP-1.4 
with aryl aldehyde 1.69 (61 mg, 0.20 mmol, 1.0 equiv.) with a total reaction time of 0.5 h. The 
yield was determined to be 88% by quantitative 1H NMR analysis using dimethyl terephthalate as 
the internal standard. 
1H NMR (700 MHz, CDCl3): d 8.82 (d, J = 8.6 Hz, 1H), 8.68 (d, J = 7.9 Hz, 1H), 8.37 (s, 1H), 
7.90 (d, J = 7.5 Hz, 1H), 7.85 (d, J = 8.6 Hz, 1H), 7.70 – 7.64 (m, 3H), 5.51 (s, 1H), 5.17 (s, 1H), 
2.26 (s, 3H); 13C NMR (176 MHz, CDCl3): d 144.1, 140.8, 132.8, 132.5, 129.9, 129.2, 128.8, 






(q, J = 3.4 Hz), 117.33, 25.21; IR (cm-1): 3081, 2917, 1626, 1418, 1372, 1323, 1238, 1124, 1081, 
1015, 912, 871, 786, 749, 693, 640; HRMS: m/z calculated for C18H13F3+ [M]+: 286.0969; found: 
289.0959. 
 
3-Chloro-10-(prop-1-en-2-yl)phenanthrene (1.43): Prepared according to GP-1.4 with aryl 
aldehyde 1.67 (54 mg, 0.20 mmol, 1.0 equiv.) with a total reaction time of 1 h. The yield was 
determined to be 85% by quantitative 1H NMR analysis using dimethyl terephthalate as the internal 
standard. 
1H NMR (700 MHz, CDCl3): d 8.67 (s, 1H), 8.58 (d, J = 8.0 Hz, 1H), 8.02 (d, J = 8.7 Hz, 1H), 
7.86 (d, J = 7.6 Hz, 1H), 7.63 (dt, J = 19.7, 7.0 Hz, 2H), 7.56 (s, 1H), 7.54 (d, J = 8.7 Hz, 1H), 
5.45 (s, 1H), 5.13 (s, 1H), 2.23 (s, 3H); 13C NMR (176 MHz, CDCl3): d 144.6, 140.5, 132.7, 132.2, 
132.0, 129.0, 128.8, 128.7, 128.2, 127.5, 127.1, 126.8, 125.3, 122.73, 122.69, 116.7, 25.2; IR (cm-
1): 3075, 2972, 1592, 1515, 1488, 1424, 1368, 1268, 1109, 1091, 1008, 887, 823, 818, 746, 642; 
HRMS: m/z calculated for C17H13ClH+ [M+H]+: 253.0779; found: 253.0776. 
 
3-Methoxy-9-(prop-1-en-2-yl)phenanthrene (1.42): Prepared according to GP-1.4 with aryl 
aldehyde 1.72 (53 mg, 0.20 mmol, 1.0 equiv.) with a total reaction time of 0.5 h. The yield was 







1H NMR (500 MHz, CDCl3): d 8.65 (d, J = 8.1 Hz, 1H), 8.08 (d, J = 8.0 Hz, 1H), 8.05 (s, 1H), 
7.78 (d, J = 8.7 Hz, 1H), 7.62 (td, J = 14.8, 7.0 Hz, 2H), 7.52 (s, 1H), 7.24 (d, J = 8.7 Hz, 1H), 
5.43 (s, 1H), 5.14 (s, 1H), 4.03 (s, 3H), 2.25 (s, 3H); 13C NMR (126 MHz, CDCl3): d 158.5, 145.3, 
138.6, 131.2, 130.7, 130.1, 130.0, 126.7 (2C), 126.5, 126.0, 124.7, 123.1, 117.0, 116.2, 104.0, 
55.7, 25.2; IR (cm-1): 3059, 2917, 2850, 1642, 1492, 1447, 1423, 1370, 1188, 1144, 1042, 1010, 
908, 856, 770, 750, 734, 627; HRMS: m/z calculated for C18H16OH+ [M+H]+: 249.1274; found: 
249.1270. 
 
3-Methyl-9-(prop-1-en-2-yl)phenanthrene (1.44): Prepared according to GP-1.4 with aryl 
aldehyde 1.71 (50 mg, 0.20 mmol, 1.0 equiv.) with a total reaction time of 0.5 h. The yield was 
determined to be 96% by quantitative 1H NMR analysis using dimethyl terephthalate as the internal 
standard. 
1H NMR (500 MHz, CDCl3): d 8.72 (d, J = 8.2 Hz, 1H), 8.46 (s, 1H), 8.07 (d, J = 8.0 Hz, 1H), 
7.75 (d, J = 8.0 Hz, 1H), 7.64 (td, J = 8.0, 6.9, 1.0 Hz, 1H), 7.59 (td, J = 7.6, 6.9, 1.4 Hz, 1H), 7.54 
(s, 1H), 7.42 (d, J = 8.1 Hz, 1H), 5.43 (s, 1H), 5.14 (s, 1H), 2.63 (s, 3H), 2.25 (s, 3H); 13C NMR 
(126 MHz, CDCl3): d 145.31, 140.0, 136.1, 130.5, 130.4, 130.0, 129.7, 128.6, 128.4, 126.6, 126.4, 
126.2, 124.9, 123.0, 122.4, 116.1, 25.2, 22.3; IR (cm-1): 3076, 2917, 1914, 1602, 1502, 1444, 1370, 
1257, 1184, 1162, 1045, 1014, 889, 804, 764, 724, 643; HRMS: m/z calculated for C18H16H+ 





6-(Prop-1-en-2-yl)phenanthro[2,3-d][1,3]dioxole (1.45): Prepared according to GP-1.4 with aryl 
aldehyde 1.70 (56 mg, 0.20 mmol, 1.0 equiv.) with a total reaction time of 0.5 h. The yield was 
determined to be 99% by quantitative 1H NMR analysis using dimethyl terephthalate as the internal 
standard. 
1H NMR (500 MHz, CDCl3): d 8.45 (d, J = 8.3 Hz, 1H), 8.06 (s, 1H), 7.82 (d, J = 7.8 Hz, 1H), 
7.57 (t, J = 7.5 Hz, 1H), 7.52 (t, J = 7.4 Hz, 1H), 7.48 (s, 1H), 7.45 (s, 1H), 6.11 (s, 2H), 5.42 (s, 
1H), 5.12 (s, 1H), 2.22 (s, 3H); 13C NMR (126 MHz, CDCl3): d 147.9, 147.7, 145.4, 140.6, 131.2, 
129.7, 128.6, 127.0, 126.8, 126.2, 126.0, 123.6, 122.4, 116.3, 104.2, 101.5, 101.2, 25.1; IR (cm-
1): 2916, 1633, 1498, 1466, 1378, 1259, 1340, 1208, 1120, 1040, 936, 882, 853, 826, 741, 617; 
HRMS: m/z calculated for C18H14O2H+ [M+H]+: 263.1067; found: 263.1061. 
 
10-(Prop-1-en-2-yl)phenanthren-2-yl 4-methylbenzenesulfonate (1.49): Prepared according to 
GP-1.4 with aryl aldehyde S1.48 (82 mg, 0.20 mmol, 1.0 equiv.) with a total reaction time of 0.5 h. 
The yield was determined to be 95% by quantitative 1H NMR analysis using dimethyl terephthalate 
as the internal standard. 
1H NMR (700 MHz, CDCl3): d 8.65 (d, J = 9.0 Hz, 1H), 8.57 (d, J = 8.2 Hz, 1H), 7.84 (d, J = 
7.7 Hz, 1H), 7.71 (d, J = 8.2 Hz, 2H), 7.63 (t, J = 7.1 Hz, 1H), 7.60 (t, J = 7.2 Hz, 1H), 7.56 (s, 
1H), 7.50 (d, J = 2.4 Hz, 1H), 7.38 (dd, J = 9.0, 2.5 Hz, 1H), 7.28 (d, J = 8.1 Hz, 2H), 5.32 (s, 1H), 
4.93 (s, 1H), 2.43 (s, 3H), 2.04 (s, 3H); 13C NMR (176 MHz, CDCl3): d 148.1, 145.5, 144.0, 140.2, 







119.3, 116.8, 24.8, 21.8; IR (cm-1): 2920, 1597, 1527, 1486, 1449, 1371, 1251, 1176, 1092, 1019, 
937, 897, 830, 776, 735, 703, 670, 652; HRMS: m/z calculated for C24H20O3SH+ [M+H]+: 
389.1206; found: 389.1201. 
 
10-(Prop-1-en-2-yl)phenanthren-2-yl acetate (1.51): Prepared according to GP-1.4 with aryl 
aldehyde S1.51 (59 mg, 0.20 mmol, 1.0 equiv.) with a total reaction time of 0.5 h. The yield was 
determined to be 96% by quantitative 1H NMR analysis using dimethyl terephthalate as the internal 
standard. 
1H NMR (700 MHz, CDCl3): d 8.73 (d, J = 8.9 Hz, 1H), 8.62 (d, J = 8.2 Hz, 1H), 7.85 (d, J = 
7.7 Hz, 1H), 7.78 (d, J = 2.4 Hz, 1H), 7.63 (t, J = 7.5 Hz, 1H), 7.60 (s, 1H), 7.59 (t, J = 7.2 Hz, 
1H), 7.42 (dd, J = 8.9, 2.4 Hz, 1H), 5.45 (s, 1H), 5.15 (s, 1H), 2.38 (s, 3H), 2.23 (s, 3H); 13C NMR 
(176 MHz, CDCl3): d 169.8, 149.2, 144.6, 140.4, 131.6, 131.4, 129.7, 128.7, 128.6, 126.9, 126.8, 
125.9, 124.5, 122.6, 120.8, 118.1, 116.7, 25.1, 21.4; IR (cm-1): 3075, 2962, 1742, 1617, 1488, 
1452, 1371, 1223, 1193, 1153, 1020, 946, 888, 825, 749, 666; HRMS: m/z calculated for 
C19H16O2H+ [M+H]+: 277.1223; found: 277.1223. 
 
10-(Prop-1-en-2-yl)phenanthren-2-yl trifluoromethanesulfonate (1.50): Prepared according to 
GP-1.4 with aryl aldehyde S1.53 (77 mg, 0.20 mmol, 1.0 equiv.) with a total reaction time of 1 h. 
The yield was determined to be 97% by quantitative 1H NMR analysis using dimethyl terephthalate 






1H NMR (500 MHz, CDCl3): d 8.78 (d, J = 9.1 Hz, 1H), 8.62 (d, J = 8.1 Hz, 1H), 7.99 (d, J = 
2.5 Hz, 1H), 7.89 (d, J = 7.6 Hz, 1H), 7.72 – 7.62 (m, 3H), 7.55 (dd, J = 9.1, 2.6 Hz, 1H), 5.51 (s, 
1H), 5.17 (s, 1H), 2.24 (s, 3H); 13C NMR (126 MHz, CDCl3): d 148.1, 143.8, 140.2, 132.0, 131.5, 
130.3, 129.2, 128.9, 127.7, 127.3, 127.0, 125.6, 122.8, 119.5, 119.0 (d, J = 320.9 Hz), 118.5, 117.5, 
25.0; IR (cm-1): 2921, 1488, 1416, 1374, 1250, 1236, 1196, 1140, 1126, 1017, 935, 901, 829, 743, 
665; HRMS: m/z calculated for C18H13F3O3SH+ [M+H]+: 367.0610; found: 367.0605. 
 
10-(Prop-1-en-2-yl)phenanthren-2-ol (1.52): Prepared according to GP-1.4 with aryl aldehyde 
S1.52 (51 mg, 0.20 mmol, 1.0 equiv.) with a total reaction time of 1 h. The yield was determined 
to be 74% by quantitative 1H NMR analysis using dimethyl terephthalate as the internal standard. 
1H NMR (700 MHz, CDCl3): d 8.62 (d, J = 8.9 Hz, 1H), 8.55 (d, J = 8.3 Hz, 1H), 7.82 (d, J = 
7.8 Hz, 1H), 7.60 (t, J = 7.6 Hz, 1H), 7.55 (s, 1H), 7.52 (t, J = 7.4 Hz, 1H), 7.44 (d, J = 2.5 Hz, 
1H), 7.22 (dd, J = 8.9, 2.6 Hz, 1H), 5.42 (s, 1H), 5.13 (s, 1H), 5.06 (s, 1H), 2.23 (s, 3H); 13C NMR 
(176 MHz, CDCl3): d 154.2, 145.0, 140.0, 132.0, 130.7, 130.0, 128.6, 126.6, 126.0, 125.8, 125.1, 
125.0, 122.1, 116.4, 116.3, 110.2, 25.0; IR (cm-1): 3304, 3077, 2917, 1614, 1531, 1263, 1215, 
1164, 1037, 1019, 939, 895, 822, 777, 735, 672; HRMS: m/z calculated for C17H14OH+ [M+H]+: 
235.1117; found: 235.1113. 
 
4-(Prop-1-en-2-yl)naphtho[2,1-b]thiophene (1.56): Prepared according to GP-1.4 with aryl 






determined to be 59% by quantitative 1H NMR analysis using dimethyl terephthalate as the internal 
standard. 
1H NMR (500 MHz, CDCl3): d 8.32 (d, J = 8.1 Hz, 1H), 8.03 (d, J = 5.4 Hz, 1H), 7.93 (d, J = 
8.0 Hz, 1H), 7.66 (s, 1H), 7.62 (d, J = 5.4 Hz, 1H), 7.58 (t, J = 7.6 Hz, 1H), 7.52 (t, J = 7.4 Hz, 
1H), 5.65 (s, 1H), 5.47 (s, 1H), 2.35 (s, 3H); 13C NMR (126 MHz, CDCl3): d 143.9, 136.6 (2C), 
136.0, 131.6, 128.74, 128.67, 126.4, 126.3, 125.7, 123.6, 122.7, 122.4, 116.0, 23.7; IR (cm-1): 
3058, 2970, 2919, 1626, 1498, 1447, 1374, 1284, 1208, 1181, 1162, 1140, 1092, 902, 883, 849, 
749, 715; HRMS: m/z calculated for C15H12H+ [M+H]+: 225.0732; found: 225.0734. 
 
6-(Prop-1-en-2-yl)benzo[b]naphtho[1,2-d]thiophene (1.57): Prepared according to GP-1.4 with 
aryl aldehyde S1.57 (59 mg, 0.20 mmol, 1.0 equiv.) and 30 mol% SnCl4 solution (60 µL, 
0.06 mmol, 0.3 equiv.) with a total reaction time of 0.5 h. The yield was determined to be 64% by 
quantitative 1H NMR analysis using dimethyl terephthalate as the internal standard. 
1H NMR (700 MHz, CDCl3): d 9.03 (d, J = 8.5 Hz, 1H), 8.89 (d, J = 8.2 Hz, 1H), 8.02 (d, J = 
7.9 Hz, 2H), 7.79 (s, 1H), 7.72 (t, J = 7.1 Hz, 1H), 7.60 (dt, J = 14.4, 7.6 Hz, 2H), 7.51 (t, J = 
7.4 Hz, 1H), 5.61 (s, 1H), 5.53 (s, 1H), 2.38 (s, 3H); 13C NMR (176 MHz, CDCl3): d 144.1, 140.0, 
138.3, 137.1, 136.5, 132.3, 129.9, 129.7, 129.5, 127.0, 125.33, 125.32, 125.2, 124.82, 124.79, 
123.2, 123.1, 116.5, 23.9; IR (cm-1): 3055, 2970, 1630, 1497, 1462, 1443, 1344, 1213, 1167, 1072, 






6-(Prop-1-en-2-yl)-11-tosyl-11H-benzo[a]carbazole (1.58): Prepared according to GP-1.4 with 
aryl aldehyde S1.58 (86 mg, 0.20 mmol, 1.0 equiv.) with a total reaction time of 20 min. 
Purification by flash column chromatography (5-10% EtOAc/hexanes) afforded the title 
compound as a white solid (74 mg, 90%). 
1H NMR (500 MHz, CDCl3): d 8.89 (d, J = 8.5 Hz, 1H), 8.31 (d, J = 8.2 Hz, 1H), 7.89 (d, J = 
8.1 Hz, 1H), 7.76 (d, J = 7.8 Hz, 1H), 7.64 (t, J = 7.6 Hz, 1H), 7.59 – 7.53 (m, 2H), 7.42 (t, J = 
7.7 Hz, 1H), 7.31 – 7.24 (m, 1H), 6.74 – 6.67 (m, 4H), 5.31 (s, 1H), 4.97 (s, 1H), 2.14 (s, 3H), 1.99 
(s, 3H); 13C NMR (126 MHz, CDCl3): d 144.3, 144.2, 142.4, 137.8, 136.6, 133.4, 130.6, 130.5, 
128.2, 127.8, 127.20, 127.19, 126.41, 126.37, 126.0, 125.9, 125.8 (2C), 125.6, 121.8, 120.4, 116.0, 
24.2, 21.5; IR (cm-1): 2917, 1597, 1448, 1365, 1173, 1054, 1026, 936, 911, 886, 872, 791, 757, 
661; HRMS: m/z calculated for C26H21NO2SH+ [M+H]+: 412.1366; found: 412.1358. 
 
6-(Prop-1-en-2-yl)benzo[c]phenanthrene (1.59): Prepared according to GP-1.4 with aryl 
aldehyde 1.73 (57 mg, 0.20 mmol, 1.0 equiv.) with a total reaction time of 0.5 h. The yield was 
determined to be 69% by quantitative 1H NMR analysis using dimethyl terephthalate as the internal 
standard. 
1H NMR (500 MHz, CDCl3): d 9.10 (d, J = 8.3 Hz, 1H), 9.06 (d, J = 8.1 Hz, 1H), 8.05 – 8.00 (m, 
2H), 7.99 (d, J = 7.6 Hz, 1H), 7.89 (d, J = 8.8 Hz, 1H), 7.73 (s, 1H), 7.69 – 7.58 (m, 4H), 5.48 (s, 
1H), 5.17 (s, 1H), 2.27 (s, 3H); 13C NMR (126 MHz, CDCl3): d 145.4, 140.8, 133.3, 133.1, 130.5, 






124.4, 116.7, 25.6; IR (cm-1): 3048, 2964, 1639, 1518, 1427, 1371, 1230, 1133, 1060, 946, 895, 
846, 748, 625; HRMS: m/z calculated for C21H16H+ [M+H]+: 269.1325; found: 269.1319.  
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1.7.4. Computational Details 
Full list of authors in the Gaussian09 reference 
M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, 
G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. 
Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, 
R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. 
Montgomery, Jr., J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. 
N. Staroverov, T. Keith, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. 
S. Iyengar, J. Tomasi, M. Cossi, N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. 
Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. 
Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, V. G. Zakrzewski, G. A. Voth, 
P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, O. Farkas, J. B. Foresman, J. V. Ortiz, 
J. Cioslowski, and D. J. Fox, Gaussian, Inc., Wallingford CT, 2013. 
Catalyst-substrate structures were optimized in the gas-phase with the M06 density 
functional,82 and the triple-ζ valence quality def2-TZVP basis set of Weigend and Ahlrichs,83 as 
implemented in Gaussian 09 (revision D.01).84 All of the optimized geometries were verified by 
frequency computations as minima (zero imaginary frequencies). Parameters were acquired from 
these ground state structures. NBO charges were calculated using NBO6,85  at the same level. 
Sterimol values were calculated using a modified version of Paton’s Python script.86 
Multidimensional regression analyses were performed using MATLAB®.87 
Transition states were located with the B97-D density functional,88 and the double-ζ, 
polarized basis set, 6-31G* as implemented in Gaussian 09 (revision D.01).89 Free energies in 
solution were derived from structures optimized in the gas phase by means of a single point 
calculation at the B97-D/6-31G(d) level of theory and the CPCM implicit solvent model 
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(dichloroethane).90 Cartesian coordinates of all stationary point structures utilized herein can be 
obtained free of charge from https://pubs.acs.org/doi/10.1021/acscatal.0c00489.  
Parameters Collected 
The parameters calculated and considered for the systems are reported in Tables 1.3–1.11. 
Sterimol parameters L, B1 and B5, respectively, represent the length, minimum and maximum 
widths of the considered substituent and are calculated using the Bondi radii.91,92 IR stretching 
frequencies, intensities, NBO charges have been found to be useful descriptors of electronic and 
steric properties, hence these have been calculated.62 The following substrates have been used for 
parameter collection: 1.31 (SubA); 1.67 (SubB); 1.68 (SubC); 1.69 (SubD); 1.71 (SubE); 1.70 
(SubF); 1.72 (SubG). 
 
Figure 1.13: Overview of collected parameters for the statistical analysis. 
  
 




























































Table 1.3: Collected carbonyl vibration parameters. 
  
 
Reaction nC=O iC=O nC=C iC=C
AlCl3/SubA 1681.96 457.0976 1715.84 104.9521
ScCl3/SubA 1683.36 537.9386 1717.24 110.1830
FeCl3/SubA 1687.77 508.8963 1719.22 103.1393
AlMe2Cl/SubA 1701.83 398.3102 1722.62 88.1080
AlEtCl2/SubA 1691.29 449.4920 1715.94 129.3676
AlEt2Cl/SubA 1700.97 388.9121 1720.46 69.5907
AlCl3/SubB 1684.67 579.3010 1725.88 48.3762
ScCl3/SubB 1719.99 504.6393 1718.51 285.7938
FeCl3/SubB 1717.13 666.4732 1721.80 38.1829
AlMe2Cl/SubB 1698.39 482.8228 1731.53 47.8177
AlEtCl2/SubB 1721.03 544.6320 1727.97 100.5127
AlCl3/SubC 1703.31 627.2359 1721.69 58.7228
ScCl3/SubC 1717.70 820.7021 1733.33 51.5321
FeCl3/SubC 1682.20 555.5332 1726.00 32.3757
AlMe2Cl/SubC 1736.18 563.9618 1723.23 20.1851
AlEtCl2/SubC 1716.32 569.7800 1722.49 101.8149
AlCl3/SubD 1686.54 549.3741 1722.52 56.5875
ScCl3/SubD 1720.21 706.1832 1722.94 96.3907
FeCl3/SubD 1717.75 661.8064 1724.86 54.6612
AlMe2Cl/SubD 1701.00 462.2865 1733.98 48.3201
AlEtCl2/SubD 1719.71 456.4744 1724.29 184.9137
AlCl3/SubE 1706.77 623.5470 1726.37 57.3256
ScCl3/SubE 1704.87 680.7312 1725.61 58.4823
FeCl3/SubE 1710.34 643.7958 1727.90 57.5678
AlMe2Cl/SubE 1729.41 459.2451 1731.66 171.8927
AlEtCl2/SubE 1683.18 399.1027 1730.68 39.8689
AlCl3/SubF 1707.46 629.0949 1724.89 31.6066
ScCl3/SubF 1722.72 692.9357 1719.13 147.1537
FeCl3/SubF 1714.40 657.7707 1728.31 45.1628
AlMe2Cl/SubF 1723.58 417.5163 1726.93 115.8390
AlEtCl2/SubF 1720.50 549.3308 1732.61 44.3065
AlCl3/SubG 1700.85 344.2036 1724.11 60.6351
ScCl3/SubG 1702.74 433.8963 1724.31 48.5639
FeCl3/SubG 1701.63 372.3702 1725.76 39.0981
AlMe2Cl/SubG 1719.09 373.1416 1723.53 137.7508
AlEtCl2/SubG 1687.39 335.3090 1736.45 25.4866
AlCl3/SubH 1685.31 638.3559 1733.03 38.2085
ScCl3/SubH 1718.30 460.8191 1720.27 323.0098
FeCl3/SubH 1717.05 491.7560 1720.28 208.7566
AlMe2Cl/SubH 1731.25 329.8320 1728.21 129.7487
AlEtCl2/SubH 1716.99 502.5801 1721.48 128.4073
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Table 1.4: Collected carbonyl lengths and angles. 
  
 
Reaction LA-O C=O COLA
AlCl3/SubA 1.87 1.24 129.9
ScCl3/SubA 2.10 1.24 132.5
FeCl3/SubA 2.02 1.23 128.3
AlMe2Cl/SubA 1.93 1.23 130.5
AlEtCl2/SubA 1.90 1.24 130.4
AlEt2Cl/SubA 1.93 1.23 129.2
AlCl3/SubB 1.87 1.24 128.2
ScCl3/SubB 2.11 1.23 130.3
FeCl3/SubB 2.03 1.23 123.3
AlMe2Cl/SubB 1.94 1.23 129.2
AlEtCl2/SubB 1.92 1.23 122.8
AlCl3/SubC 1.87 1.23 126.8
ScCl3/SubC 2.08 1.23 148.1
FeCl3/SubC 2.02 1.23 126.3
AlMe2Cl/SubC 1.94 1.22 128.0
AlEtCl2/SubC 1.90 1.23 127.4
AlCl3/SubD 1.88 1.24 128.6
ScCl3/SubD 2.10 1.23 132.9
FeCl3/SubD 2.04 1.23 123.2
AlMe2Cl/SubD 1.94 1.23 129.5
AlEtCl2/SubD 1.92 1.23 123.4
AlCl3/SubE 1.87 1.23 126.8
ScCl3/SubE 2.10 1.23 127.8
FeCl3/SubE 2.02 1.23 123.4
AlMe2Cl/SubE 1.95 1.23 124.4
AlEtCl2/SubE 1.90 1.24 128.7
AlCl3/SubF 1.87 1.23 127.1
ScCl3/SubF 2.09 1.23 141.3
FeCl3/SubF 2.03 1.23 124.4
AlMe2Cl/SubF 1.95 1.23 125.4
AlEtCl2/SubF 1.90 1.23 133.7
AlCl3/SubG 1.86 1.24 126.0
ScCl3/SubG 2.08 1.23 133.2
FeCl3/SubG 2.01 1.23 123.2
AlMe2Cl/SubG 1.93 1.23 126.8
AlEtCl2/SubG 1.90 1.24 127.8
AlCl3/SubH 1.87 1.24 128.3
ScCl3/SubH 2.10 1.23 132.6
FeCl3/SubH 2.02 1.23 124.9
AlMe2Cl/SubH 1.93 1.22 132.0
AlEtCl2/SubH 1.92 1.23 123.5
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Table 1.5: Collected key NBO charges. 
   
Reaction LA O C H C(mono) C(adj)
AlCl3/SubA 1.533 -0.689 0.505 0.186 -0.266 0.087
ScCl3/SubA 1.350 -0.652 0.500 0.177 -0.265 0.083
FeCl3/SubA 1.376 -0.655 0.486 0.175 -0.264 0.083
AlMe2Cl/SubA 1.689 -0.653 0.492 0.181 -0.260 0.080
AlEtCl2/SubA 1.625 -0.677 0.499 0.184 -0.268 0.089
AlEt2Cl/SubA 1.702 -0.657 0.488 0.183 -0.261 0.080
AlCl3/SubB 1.530 -0.684 0.500 0.188 -0.269 0.086
ScCl3/SubB 1.356 -0.623 0.501 0.149 -0.258 0.081
FeCl3/SubB 1.370 -0.624 0.484 0.150 -0.256 0.081
AlMe2Cl/SubB 1.691 -0.653 0.490 0.182 -0.262 0.075
AlEtCl2/SubB 1.630 -0.649 0.504 0.162 -0.259 0.081
AlCl3/SubC 1.536 -0.668 0.506 0.160 -0.256 0.075
ScCl3/SubC 1.354 -0.637 0.509 0.144 -0.244 0.055
FeCl3/SubC 1.378 -0.659 0.481 0.178 -0.269 0.083
AlMe2Cl/SubC 1.700 -0.627 0.496 0.150 -0.243 0.068
AlEtCl2/SubC 1.633 -0.656 0.507 0.159 -0.256 0.081
AlCl3/SubD 1.529 -0.681 0.500 0.187 -0.273 0.090
ScCl3/SubD 1.354 -0.622 0.504 0.149 -0.262 0.085
FeCl3/SubD 1.368 -0.623 0.485 0.150 -0.261 0.085
AlMe2Cl/SubD 1.690 -0.649 0.489 0.182 -0.265 0.079
AlEtCl2/SubD 1.629 -0.649 0.506 0.162 -0.264 0.088
AlCl3/SubE 1.536 -0.670 0.503 0.158 -0.256 0.078
ScCl3/SubE 1.354 -0.630 0.495 0.146 -0.256 0.078
FeCl3/SubE 1.374 -0.631 0.480 0.148 -0.254 0.077
AlMe2Cl/SubE 1.698 -0.630 0.495 0.149 -0.245 0.063
AlEtCl2/SubE 1.625 -0.685 0.495 0.185 -0.266 0.080
AlCl3/SubF 1.534 -0.665 0.509 0.161 -0.252 0.067
ScCl3/SubF 1.359 -0.630 0.510 0.147 -0.248 0.064
FeCl3/SubF 1.372 -0.628 0.486 0.148 -0.249 -0.066
AlMe2Cl/SubF 1.702 -0.631 0.498 0.159 -0.251 0.067
AlEtCl2/SubF 1.626 -0.652 0.499 0.158 -0.240 0.053
AlCl3/SubG 1.540 -0.684 0.490 0.158 -0.258 0.086
ScCl3/SubG 1.359 -0.643 0.486 0.144 -0.254 0.077
FeCl3/SubG 1.376 -0.643 0.470 0.148 -0.253 0.074
AlMe2Cl/SubG 1.703 -0.645 0.487 0.153 -0.255 0.078
AlEtCl2/SubG 1.623 -0.687 0.493 0.180 -0.258 0.066
AlCl3/SubH 1.530 -0.685 0.502 0.189 -0.270 0.080
ScCl3/SubH 1.356 -0.624 0.504 0.145 -0.256 0.075
FeCl3/SubH 1.373 -0.626 0.488 0.148 -0.254 0.072
AlMe2Cl/SubH 1.693 -0.627 0.485 0.162 -0.242 0.059
AlEtCl2/SubH 1.624 -0.643 0.500 0.162 -0.257 0.082
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Table 1.6: Collected average angles and NBO charges. 
  
 
Reaction Average O-LA-Halogen angle Average Halogen NBO Average Me(H)1 NBO Average Me(H)2 NBO 
AlCl3/SubA 103.1 -0.557 0.219 0.227
ScCl3/SubA 102.2 -0.501 0.219 0.226
FeCl3/SubA 103.1 -0.497 0.218 0.225
AlMe2Cl/SubA 101.4 -1.049 0.216 0.224
AlEtCl2/SubA 102.1 -0.727 0.219 0.227
AlEt2Cl/SubA 100.7 -0.877 0.213 0.223
AlCl3/SubB 102.9 -0.556 0.221 0.219
ScCl3/SubB 101.6 -0.501 0.213 0.226
FeCl3/SubB 102.3 -0.495 0.212 0.224
AlMe2Cl/SubB 101.2 -1.050 0.218 0.218
AlEtCl2/SubB 101.4 -0.734 0.214 0.223
AlCl3/SubC 102.7 -0.559 0.211 0.224
ScCl3/SubC 103.2 -0.503 0.209 0.221
FeCl3/SubC 103.2 -0.499 0.219 0.218
AlMe2Cl/SubC 100.1 -1.056 0.210 0.222
AlEtCl2/SubC 101.7 -0.734 0.213 0.223
AlCl3/SubD 102.8 -0.555 0.222 0.219
ScCl3/SubD 100.9 -0.500 0.213 0.228
FeCl3/SubD 102.2 -0.493 0.212 0.225
AlMe2Cl/SubD 101.1 -1.050 0.218 0.217
AlEtCl2/SubD 101.4 -0.733 0.215 0.225
AlCl3/SubE 102.6 -0.559 0.211 0.225
ScCl3/SubE 102.2 -0.503 0.212 0.225
FeCl3/SubE 102.5 -0.498 0.211 0.224
AlMe2Cl/SubE 100.4 -1.057 0.210 0.221
AlEtCl2/SubE 102.3 -0.727 0.220 0.217
AlCl3/SubF 102.5 -0.559 0.210 0.224
ScCl3/SubF 102.3 -0.504 0.210 0.224
FeCl3/SubF 102.7 -0.497 0.210 0.223
AlMe2Cl/SubF 100.7 -1.057 0.211 0.223
AlEtCl2/SubF 101.3 -0.725 0.208 0.223
AlCl3/SubG 102.9 -0.562 0.211 0.225
ScCl3/SubG 102.0 -0.506 0.211 0.225
FeCl3/SubG 102.8 -0.501 0.211 0.223
AlMe2Cl/SubG 100.8 -1.058 0.211 0.224
AlEtCl2/SubG 102.3 -0.729 0.216 0.215
AlCl3/SubH 102.9 -0.556 0.220 0.218
ScCl3/SubH 101.8 -0.502 0.211 0.225
FeCl3/SubH 102.1 -0.496 0.210 0.223
AlMe2Cl/SubH 100.2 -1.050 0.209 0.219
AlEtCl2/SubH 101.1 -0.731 0.211 0.222
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Table 1.7: Collected Lewis acid Sterimol descriptors. 
  
 
Reaction L B1 B5
AlCl3/SubA 4.54 2.76 3.82
ScCl3/SubA 4.86 2.80 4.05
FeCl3/SubA 4.72 2.77 3.89
AlMe2Cl/SubA 4.91 2.88 3.90
AlEtCl2/SubA 4.93 2.86 4.98
AlEt2Cl/SubA 4.92 2.97 5.01
AlCl3/SubB 4.51 2.75 3.83
ScCl3/SubB 4.94 2.82 4.05
FeCl3/SubB 4.72 2.77 3.89
AlMe2Cl/SubB 4.93 2.92 3.90
AlEtCl2/SubB 4.96 2.89 4.97
AlCl3/SubC 4.53 2.75 3.84
ScCl3/SubC 5.00 2.81 4.03
FeCl3/SubC 4.72 2.76 3.89
AlMe2Cl/SubC 4.71 2.77 3.89
AlEtCl2/SubC 5.54 2.72 4.74
AlCl3/SubD 4.52 2.75 3.83
ScCl3/SubD 4.84 2.83 4.05
FeCl3/SubD 4.75 2.76 3.89
AlMe2Cl/SubD 4.93 2.92 3.91
AlEtCl2/SubD 4.96 2.79 4.97
AlCl3/SubE 4.52 2.74 3.83
ScCl3/SubE 4.99 2.81 4.05
FeCl3/SubE 4.73 2.76 3.90
AlMe2Cl/SubE 4.71 2.79 3.89
AlEtCl2/SubE 4.96 2.77 4.98
AlCl3/SubF 4.52 2.75 3.83
ScCl3/SubF 4.92 2.83 4.05
FeCl3/SubF 4.75 2.77 3.89
AlMe2Cl/SubF 4.86 2.83 3.91
AlEtCl2/SubF 4.87 2.82 4.98
AlCl3/SubG 4.53 2.74 3.84
ScCl3/SubG 4.89 2.83 4.04
FeCl3/SubG 4.74 2.77 3.89
AlMe2Cl/SubG 4.89 2.84 3.91
AlEtCl2/SubG 4.98 2.85 4.98
AlCl3/SubH 4.52 2.75 3.83
ScCl3/SubH 4.95 2.81 4.05
FeCl3/SubH 4.69 2.76 3.90
AlMe2Cl/SubH 4.94 2.90 3.90
AlEtCl2/SubH 4.99 2.79 4.97
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Table 1.8: Collected NBO charges on the first aromatic ring. 
  
 
Reaction C1 C2 C3 C4 C5 C6
AlCl3/SubA -0.202 0.061 -0.210 -0.132 -0.215 -0.117
ScCl3/SubA -0.201 0.058 -0.210 -0.133 -0.215 -0.120
FeCl3/SubA -0.197 0.053 -0.209 -0.138 -0.214 -0.122
AlMe2Cl/SubA -0.194 0.051 -0.208 -0.142 -0.214 -0.126
AlEtCl2/SubA -0.199 0.059 -0.210 -0.136 -0.215 -0.121
AlEt2Cl/SubA -0.199 0.060 -0.210 -0.138 -0.216 -0.122
AlCl3/SubB -0.200 0.054 -0.208 -0.140 -0.212 -0.127
ScCl3/SubB -0.201 0.071 -0.205 -0.123 -0.223 -0.113
FeCl3/SubB -0.198 0.067 -0.205 -0.127 -0.223 -0.116
AlMe2Cl/SubB -0.192 0.046 -0.207 -0.149 -0.212 -0.135
AlEtCl2/SubB -0.199 0.065 -0.205 -0.126 -0.222 -0.111
AlCl3/SubC -0.207 0.086 -0.210 -0.123 -0.288 -0.112
ScCl3/SubC -0.204 0.091 -0.211 -0.120 -0.227 -0.114
FeCl3/SubC -0.202 0.062 -0.213 -0.146 -0.218 -0.133
AlMe2Cl/SubC -0.201 0.077 -0.210 -0.132 -0.226 -0.119
AlEtCl2/SubC -0.204 0.077 -0.208 -0.129 -0.225 -0.115
AlCl3/SubD -0.200 0.052 -0.208 -0.141 -0.210 -0.127
ScCl3/SubD -0.199 0.066 -0.205 -0.126 -0.220 -0.115
FeCl3/SubD -0.199 0.065 -0.207 -0.128 -0.220 -0.116
AlMe2Cl/SubD -0.192 0.043 -0.207 -0.150 -0.210 -0.134
AlEtCl2/SubD -0.199 0.062 -0.205 -0.128 -0.220 -0.112
AlCl3/SubE -0.215 0.090 -0.215 0.078 -0.235 -0.097
ScCl3/SubE -0.212 0.085 -0.214 0.075 -0.234 -0.100
FeCl3/SubE -0.210 0.082 -0.214 0.070 -0.232 -0.104
AlMe2Cl/SubE -0.208 0.078 -0.214 0.066 -0.231 -0.105
AlEtCl2/SubE -0.212 0.070 -0.217 0.051 -0.221 -0.121
AlCl3/SubF -0.205 0.083 -0.209 -0.124 -0.226 -0.122
ScCl3/SubF -0.203 0.081 -0.208 -0.127 -0.225 -0.118
FeCl3/SubF -0.200 0.075 -0.208 -0.129 -0.226 -0.118
AlMe2Cl/SubF -0.194 0.064 -0.206 -0.138 -0.221 -0.124
AlEtCl2/SubF -0.199 0.085 -0.209 -0.128 -0.225 -0.118
AlCl3/SubG -0.237 -0.093 -0.273 0.386 -0.311 0.114
ScCl3/SubG -0.235 0.111 -0.311 0.385 -0.272 -0.096
FeCl3/SubG -0.233 0.108 -0.311 0.381 -0.272 -0.098
AlMe2Cl/SubG -0.225 0.082 -0.252 0.373 -0.327 -0.091
AlEtCl2/SubG -0.235 0.084 -0.262 0.366 -0.318 -0.094
AlCl3/SubH -0.204 0.067 -0.209 -0.147 -0.214 -0.131
ScCl3/SubH -0.209 0.093 -0.210 -0.122 -0.225 -0.114
FeCl3/SubH -0.205 0.086 -0.208 -0.127 -0.224 -0.117
AlMe2Cl/SubH -0.200 0.080 -0.211 -0.133 -0.222 -0.119
AlEtCl2/SubH -0.208 0.085 -0.209 -0.127 -0.224 -0.114
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Table 1.9: Collected NBO charges on the second aromatic ring. 
  
 
Reaction C1 C2 C3 C4 C5 C6
AlCl3/SubA -0.074 -0.033 -0.185 -0.181 -0.202 -0.179
ScCl3/SubA -0.073 -0.033 -0.185 -0.181 -0.202 -0.179
FeCl3/SubA -0.071 -0.033 -0.185 -0.183 -0.202 -0.180
AlMe2Cl/SubA -0.068 -0.033 -0.185 -0.184 -0.202 -0.181
AlEtCl2/SubA -0.073 -0.032 -0.184 -0.182 -0.203 -0.180
AlEt2Cl/SubA -0.070 -0.035 -0.183 -0.186 -0.202 -0.183
AlCl3/SubB -0.058 -0.039 -0.164 -0.199 -0.031 -0.203
ScCl3/SubB -0.043 -0.035 -0.168 -0.204 -0.030 -0.209
FeCl3/SubB -0.041 -0.030 -0.169 -0.207 -0.031 -0.208
AlMe2Cl/SubB -0.054 -0.040 -0.163 -0.203 -0.032 -0.205
AlEtCl2/SubB -0.039 -0.029 -0.173 -0.212 -0.032 -0.208
AlCl3/SubC -0.102 0.003 -0.281 0.324 -0.247 -0.159
ScCl3/SubC -0.107 -0.010 -0.279 0.326 -0.244 -0.162
FeCl3/SubC -0.114 -0.002 -0.285 0.330 -0.247 -0.157
AlMe2Cl/SubC -0.091 -0.001 -0.287 0.319 -0.250 -0.165
AlEtCl2/SubC -0.095 0.002 -0.288 0.316 -0.249 -0.161
AlCl3/SubD -0.058 -0.028 -0.156 -0.125 -0.172 -0.177
ScCl3/SubD -0.039 -0.026 -0.154 -0.131 -0.174 -0.184
FeCl3/SubD -0.036 -0.022 -0.155 -0.136 -0.175 -0.184
AlMe2Cl/SubD -0.054 -0.028 -0.155 -0.128 -0.173 -0.179
AlEtCl2/SubD -0.037 -0.018 -0.161 -0.136 -0.178 -0.183
AlCl3/SubE -0.061 -0.025 -0.181 -0.185 -0.200 -0.186
ScCl3/SubE -0.060 -0.027 -0.183 -0.186 -0.200 -0.186
FeCl3/SubE -0.057 -0.025 -0.183 -0.188 -0.201 -0.186
AlMe2Cl/SubE -0.049 -0.029 -0.184 -0.194 -0.199 -0.188
AlEtCl2/SubE -0.076 -0.030 -0.179 -0.179 -0.202 -0.181
AlCl3/SubF -0.065 -0.025 -0.229 0.250 0.236 -0.235
ScCl3/SubF -0.063 -0.037 -0.228 0.253 0.240 -0.241
FeCl3/SubF -0.061 -0.026 -0.232 0.246 0.236 -0.237
AlMe2Cl/SubF -0.055 -0.027 -0.233 0.242 0.234 -0.236
AlEtCl2/SubF -0.065 -0.038 -0.225 0.252 0.241 -0.240
AlCl3/SubG -0.065 -0.021 -0.181 -0.185 -0.201 -0.187
ScCl3/SubG -0.061 -0.028 -0.181 -0.184 -0.199 -0.190
FeCl3/SubG -0.059 -0.025 -0.182 -0.189 -0.200 -0.189
AlMe2Cl/SubG -0.052 -0.026 -0.185 -0.193 -0.202 -0.186
AlEtCl2/SubG -0.077 -0.032 -0.179 -0.180 -0.201 -0.181
AlCl3/SubH -0.060 -0.019 -0.188 -0.147 -0.057 -0.035
ScCl3/SubH -0.046 -0.024 -0.185 -0.156 -0.054 -0.038
FeCl3/SubH -0.042 -0.021 -0.184 -0.159 -0.054 -0.037
AlMe2Cl/SubH -0.032 -0.031 -0.187 -0.166 -0.055 -0.035
AlEtCl2/SubH -0.039 -0.022 -0.187 -0.165 -0.056 -0.039
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Table 1.10: Collected Sterimol parameters from the C4 position on the first aromatic ring. 
  
 
Reaction L C4 B1 C4 B5 C4
AlCl3/SubA 2.57 1.09 1.09
ScCl3/SubA 2.57 1.09 1.09
FeCl3/SubA 2.57 1.09 1.09
AlMe2Cl/SubA 2.57 1.09 1.09
AlEtCl2/SubA 2.57 1.09 1.09
AlEt2Cl/SubA 2.57 1.09 1.09
AlCl3/SubB 2.57 1.09 1.09
ScCl3/SubB 2.57 1.09 1.09
FeCl3/SubB 2.57 1.09 1.09
AlMe2Cl/SubB 2.57 1.09 1.09
AlEtCl2/SubB 2.57 1.09 1.09
AlCl3/SubC 2.57 1.09 1.09
ScCl3/SubC 2.57 1.09 1.09
FeCl3/SubC 2.57 1.09 1.09
AlMe2Cl/SubC 2.57 1.09 1.09
AlEtCl2/SubC 2.57 1.09 1.09
AlCl3/SubD 2.57 1.09 1.09
ScCl3/SubD 2.57 1.09 1.09
FeCl3/SubD 2.57 1.09 1.09
AlMe2Cl/SubD 2.57 1.09 1.09
AlEtCl2/SubD 2.57 1.09 1.09
AlCl3/SubE 3.59 1.70 2.11
ScCl3/SubE 3.59 1.70 2.11
FeCl3/SubE 3.59 1.70 2.12
AlMe2Cl/SubE 3.59 1.70 2.11
AlEtCl2/SubE 3.59 1.70 2.11
AlCl3/SubF 2.57 1.09 1.09
ScCl3/SubF 2.57 1.09 1.09
FeCl3/SubF 2.57 1.09 1.09
AlMe2Cl/SubF 2.57 1.09 1.09
AlEtCl2/SubF 2.57 1.09 1.09
AlCl3/SubG 4.57 1.39 3.12
ScCl3/SubG 4.57 1.39 3.12
FeCl3/SubG 4.57 1.39 3.12
AlMe2Cl/SubG 4.57 1.39 3.12
AlEtCl2/SubG 4.57 1.39 3.12
AlCl3/SubH 2.57 1.09 1.09
ScCl3/SubH 2.57 1.09 1.09
FeCl3/SubH 2.57 1.09 1.09
AlMe2Cl/SubH 2.57 1.09 1.09
AlEtCl2/SubH 2.57 1.09 1.09
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Table 1.11: Collected Sterimol parameters from the C4–C6 position on the second aromatic ring. 
   
Reaction L C4 B1 C4 B5 C4 L C5 B1 C5 B5 C5 L C6 B1 C6 B5 C6
AlCl3/SubA 2.57 1.09 1.09 2.57 1.09 1.09 2.57 1.09 1.09
ScCl3/SubA 2.57 1.09 1.09 2.57 1.09 1.09 2.57 1.09 1.09
FeCl3/SubA 2.57 1.09 1.09 2.57 1.09 1.09 2.57 1.09 1.09
AlMe2Cl/SubA 2.57 1.09 1.09 2.57 1.09 1.09 2.57 1.09 1.09
AlEtCl2/SubA 2.57 1.09 1.09 2.57 1.09 1.09 2.57 1.09 1.09
AlEt2Cl/SubA 2.57 1.09 1.09 2.57 1.09 1.09 2.57 1.09 1.09
AlCl3/SubB 2.57 1.09 1.09 3.88 1.75 1.75 2.57 1.09 1.09
ScCl3/SubB 2.57 1.09 1.09 3.88 1.75 1.75 2.57 1.09 1.09
FeCl3/SubB 2.57 1.09 1.09 3.88 1.75 1.75 2.57 1.09 1.09
AlMe2Cl/SubB 2.57 1.09 1.09 3.88 1.75 1.75 2.57 1.09 1.09
AlEtCl2/SubB 2.57 1.09 1.09 3.88 1.75 1.75 2.57 1.09 1.09
AlCl3/SubC 4.56 1.39 3.13 2.57 1.09 1.09 2.57 1.09 1.09
ScCl3/SubC 4.56 1.52 3.13 2.57 1.09 1.09 2.57 1.09 1.09
FeCl3/SubC 4.57 1.39 3.13 2.57 1.09 1.09 2.57 1.09 1.09
AlMe2Cl/SubC 4.56 1.39 3.14 2.57 1.09 1.09 2.57 1.09 1.09
AlEtCl2/SubC 4.56 1.52 3.13 2.57 1.09 1.09 2.57 1.09 1.09
AlCl3/SubD 3.88 2.08 2.72 2.57 1.09 1.09 2.57 1.09 1.09
ScCl3/SubD 3.88 2.08 2.72 2.57 1.09 1.09 2.57 1.09 1.09
FeCl3/SubD 3.88 2.08 2.72 2.57 1.09 1.09 2.57 1.09 1.09
AlMe2Cl/SubD 3.88 2.08 2.72 2.57 1.09 1.09 2.57 1.09 1.09
AlEtCl2/SubD 3.88 2.08 2.71 2.57 1.09 1.09 2.57 1.09 1.09
AlCl3/SubE 2.57 1.09 1.09 2.57 1.09 1.09 2.57 1.09 1.09
ScCl3/SubE 2.57 1.09 1.09 2.57 1.09 1.09 2.57 1.09 1.09
FeCl3/SubE 2.57 1.09 1.09 2.57 1.09 1.09 2.57 1.09 1.09
AlMe2Cl/SubE 2.57 1.09 1.09 2.57 1.09 1.09 2.57 1.09 1.09
AlEtCl2/SubE 2.57 1.09 1.09 2.57 1.09 1.09 2.57 1.09 1.09
AlCl3/SubF 4.04 2.53 7.39 4.03 2.21 7.56 2.57 1.09 1.09
ScCl3/SubF 4.06 2.53 7.71 4.05 2.23 7.74 2.57 1.09 1.09
FeCl3/SubF 4.04 2.61 7.50 4.03 2.23 7.69 2.57 1.09 1.09
AlMe2Cl/SubF 4.03 2.60 7.67 4.03 2.23 7.82 2.57 1.09 1.09
AlEtCl2/SubF 4.07 2.47 7.35 4.07 2.21 7.26 2.57 1.09 1.09
AlCl3/SubG 2.57 1.09 1.09 2.57 1.09 1.09 2.57 1.09 1.09
ScCl3/SubG 2.57 1.09 1.09 2.57 1.09 1.09 2.57 1.09 1.09
FeCl3/SubG 2.57 1.09 1.09 2.57 1.09 1.09 2.57 1.09 1.09
AlMe2Cl/SubG 2.57 1.09 1.09 2.57 1.09 1.09 2.57 1.09 1.09
AlEtCl2/SubG 2.57 1.09 1.09 2.57 1.09 1.09 2.57 1.09 1.09
AlCl3/SubH 2.57 1.09 1.09 4.69 2.57 7.96 4.70 2.41 9.29
ScCl3/SubH 2.57 1.09 1.09 4.69 2.12 8.06 4.69 2.42 7.88
FeCl3/SubH 2.57 1.09 1.09 4.69 2.12 8.02 4.69 2.42 7.88
AlMe2Cl/SubH 2.57 1.09 1.09 4.69 2.09 7.97 4.69 2.32 7.80
AlEtCl2/SubH 2.57 1.09 1.09 4.69 2.16 8.17 4.69 2.48 8.02
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Model Development 
Calculated ΔG‡ values were computed using TS analysis and are quoted relative to the Lewis Acid-
carbonyl complex. Linear regression models were developed using an in-house script implemented 
in MATLAB® (version R2018b), to obtain the predicted ΔG‡.93 A good linear correlation (R2 close 
to 1.0 and intercept close to 0.0) between the predicted ΔG‡ and the calculated ΔG‡ indicates that 
the obtained model adequately approximates the system under study. 
 
Carbonyl–Olefin Metathesis Model 
 




Table 1.12: Training set used for the development of the carbonyl–olefin metathesis model. 
 
 






Carbonyl–Ene Reaction Model 
 




Table 1.14: Training set used for the development of the carbonyl–ene reaction model. 
 
 






Development of Secondary Model for Carbonyl–Olefin Metathesis 
In our analyses we collect a diverse array of molecular descriptor values from DFT 
optimized geometries to describe the structural features of the substrate and catalyst. 
Unfortunately, the lack of structural commonality for particular molecular subsets creates a 
challenge in identifying readily comprehensible and extensive parameter sets for each of these 
components. Despite this, we developed a model that contains features that would apply to a 
broader scope of substrates. We evaluated this secondary model for the carbonyl-olefin metathesis 
reaction of an aromatic ketone (1.78) using FeCl3 as the Lewis acid catalyst. The model predicts 
this result with complete precision despite being trained on a different substrate class. However, it 
is clear from the validation data that prediction in the biaryl substrate space with this model is 
compromised (secondary model PredR2 = 0.64 compared to the focused COM model PredR2 = 
0.86, values are derived from models in which all training data is used). 
 




Table 1.16: Training set used for the development of the secondary model for carbonyl–olefin metathesis. 
 
 







Chapter 2: Development of Intramolecular Visible Light-Mediated [2+2] Cycloaddition 
Reactions for the Synthesis of Functionalized Azetidines 
Portions of this chapter have been published in Becker, M.R.; Richardson, A.D.; Schindler, 
C.S. Functionalized azetidines via visible light-enabled aza Paternò-Büchi reactions. Nat. 
Commun. 2019, 10, 5095. DOI: 10.1038/s41467-019-13072-x and Richardson, A.D.; Becker, 
M.R.; Schindler, C.S. Synthesis of Azetidines by Aza Paternò-Büchi Reactions. Chem. Sci. 2020, 
11, 7553–7561. 
2.1. Introduction 
2.1.1. Azetidines in Pharmaceuticals 
 
Figure 2.1: Overview of the most commonly used nitrogen heterocycles in FDA-approved small-molecule drugs (2014). 
Nitrogen heterocycles are among the most significant components in current 
pharmaceuticals. This is highlighted by the fact that out of the 33 small-molecule drugs approved 
by the U.S. Food and Drug Administration (FDA) in 2019, a total of 27 (81%) contained at least 






































































59% of all small-molecule pharmaceuticals approved by the FDA contained at least one nitrogen 
heterocycle (Figure 2.1).95 
Six-membered heterocycles, such as piperidines, pyridines and piperazines, were the most 
frequently used motif, found in 59% of all small-molecule drugs. The next most common 
heterocycle class (39%) consists of five-membered rings, for example pyrrolidines, thiazoles, 
imidazoles and indoles. In contrast, four-membered nitrogen heterocycles are less commonly 
found in current pharmaceuticals. The majority of these compounds consists of b-lactam scaffolds, 
while other heterocycles, specifically azetidines are highly underrepresent among current 
pharmaceuticals. To date, a total of three pharmaceuticals that contain an azetidine ring have found 
approval (Figure 2.2). Cobimetinib (2.1) is a kinase inhibitor that has been approved in 2015 for 
the treatment of unresectable or metastatic melanoma.96 Delafloxacin (2.2) is an antibiotic that is 
used against acute bacterial skin and skin structure infections as well as pneumonia and has 
acquired approval in 2017.97 Additionally, baricitinib (2.3) has obtained its approval in 2018 as a 
kinase inhibitor for the treatment of severely active rheumatoid arthritis.98 
 
Figure 2.2: FDA-approved drugs containing an azetidine ring. 
In light of the increasing demand of new, saturated building blocks for drug discovery, the 
lack of azetidines in current pharmaceutical scaffolds can be considered as surprising, since the 
well-defined, three-dimensional structure and high degree of saturated content provides access to 
unique chemical space.99–102 At the same time, azetidine-containing lead compounds can exhibit 







































membered analogs. Azetidines are generally considered to display an increased metabolic stability 
due to the decreased carbon–content that provides less sites for metabolic degradation as well as a 
low lipophilicity.103 Similarly, azetidines exhibit an increased polarity in comparison to five- or 
six-membered rings, which was exploited by Brown and coworkers to improve the aqueous 
solubility of oxytocin antagonist 2.4.104 Structure-activity relationship (SAR) studies revealed 
aryloxyazetidines (2.5) as competent bioisosteres of the pyrazine ring in 2.4, resulting in a 10-fold 
improvement in aqueous solubility, while maintaining a high selectivity for the respective receptor 
(Figure 2.3A). 
 
Figure 2.3: Examples of azetidines in lead compounds. (A) Azetidines as bioisostere for pyrazine rings (B) Impact of an azetidine 
ring on the 5-HT2C agonist activity. 
Brown and coworkers also investigated lead scaffolds with high activity for the 
serotonin 2C (5-HT2C) receptor, a common target for the treatment of conditions such as obesity, 
schizophrenia, sexual dysfunction, and urinary incontinence.105 SAR studies were carried out that 
specifically focused on varying the central nitrogen heterocycle, which showed that substitution 
of the larger piperidine ring in 2.6 with a smaller azetidine (2.7) led to a significant increase in 5-
HT2C activity (Figure 2.3B). 
2.1.2. Traditional Methods for the Synthesis of Azetidines 
The small number of azetidines in current pharmaceuticals in comparison to their five- or 
six-membered counterparts is often attributed to the lack of synthetic methods to construct and 






























A. Azetidines as bioisostere for pyrazine rings
aqueous solubility:
6 µg/mL at pH 7.4
aqueous solubility:
59 µg/mL at pH 7.5 EC50 (nM) = 273 EC50 (nM) = 12
2.4 2.5 2.6 2.7
B. Impact of an azetidine ring on 5-HT2C agonist activity
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nitrogen heterocycles relies on intramolecular ring-closing reactions with substrates containing 
both a nitrogen nucleophile and a leaving group. However, the reactivity of these substrates is 
highly dependent on the chain length, and can alter drastically depending on the size of the ring 
being formed. While five- and six-membered undergo cyclization quite readily, the relative rate 
for ring-closing is diminished for aziridine and azetidine formation by several magnitudes 
(Figure 2.4A).110 The decreased reactivity for smaller rings can be attributed to the build-up of 
strain during the transition state for cyclization. However, ring strain alone does not explain the 
reactivity differences that can be observed between three- and four-membered rings. Specifically, 
the relative rate for aziridine formation is increased by a factor of 700 in comparison to azetidines. 
This can be rationalized by analyzing the reactive conformation undergoing cyclization for each 
substrate. For aziridines the reactive conformation also represents the most stable conformation, 
while in the case of azetidines, cyclization occurs from an unfavored eclipsed conformation.110 
Consequently, elevated temperature or highly activated leaving groups are typically required to 
obtain sufficient reactivity in azetidine-forming cyclization reactions (Figure 2.4A). 
 
Figure 2.4: Synthesis of azetidines. (A) Relative rates for the intramolecular ring-closing reaction of aliphatic amines (B) High-


































A. Relative rates in ring-closing reaction for the formation of saturated nitrogen heterocycles.

















For example, an efficient synthetic route for the synthesis of azetidine (2.11) was reported 
by Wadsworth, in which cyclization proceeded from tertiary amine 2.9 via an intermediate 
ammonium salt intermediate that subsequently undergoes dealkylation providing 2.10 
(Figure 2.4B).111 While this four-step sequence allowed access to azetidine (2.11) in high yields 
starting from 3-aminopropanol (2.8), high temperatures of 165–205 ºC were necessary to obtain 
sufficient reactivity in the intramolecular cyclization step. 
 
Figure 2.5: Alternative methods for azetidine synthesis. (A) Synthesis via b-lactam reduction (B) Azetidine synthesis via strain-
release of azabicyclobutanes. 
Consequently, alternative strategies for the synthesis of azetidines containing sensitive 
functional groups have been developed. One common approach to access azetidines under mild 
conditions is the reduction of b-lactams, as these scaffolds are readily synthesized,112,113 and the 
reduction process is facile. Common reagents to accomplish efficient lactam-reduction are 
diborane in tetrahydrofuran, LiAlH4 or Raney nickel (Figure 2.5A).106 Additionally, alanes such 
as DIBAL-H or chloroalanes (AlH2Cl, AlHCl2) have been demonstrated to be highly selective 
reagents for this process, as they often avoid undesired side reactions such as reductive cleavage 
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A. Azetidine synthesis via !-lactam reduction.
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molecule cholesterol absorption inhibitor, Carreira and coworkers identified AlH2Cl as optimal 
reagent for the reduction of b-lactams (2.12) in the presence of various sensitive functional groups 
in high yields, while other reagents such as LiAlH4 exclusively provided reductive cleavage of the 
lactam ring (Figure 2.5A).114 
More recently, the rapid synthesis of azetidines with functionalization in the 3-position has 
been accomplished through the strain-release reaction of azabicyclobutanes (2.16) with nitrogen 
nucleophiles (Figure 2.5B). This reactivity, initially reported by Funke in 1969,115,116 has been 
exploited by Baran and coworkers for the synthesis of a variety of azetidinylated amines (2.18–
2.22) in 42–60% yield.117–119 Azabicyclobutane (2.16) can be readily accessed in two steps via 
bromination of allylamine (2.14) and subsequent phenyllithium-mediated cyclization at cryogenic 
temperatures. The advantage of this method relies on the fact that 2.16 readily reacts with a series 
of amines, including drug scaffolds, to provide a series of azetidine products. 
 
Figure 2.6: Azetidine synthesis via a thermal [2+2] cycloaddition reaction. 
The [2+2] cycloaddition reaction between an alkene and an imine component represents a 
highly efficient way to synthesize azetidines. Overall, there exist only a limited number of 
examples in which azetidines are directly formed through a cycloaddition reaction, proceeding 
under either thermal or photochemical conditions.106 The thermal reaction typically requires highly 
polarized reagents to achieve successful cycloaddition, specifically imines featuring electron-
withdrawing substituents such as sulfonamides, while electron-rich alkenes such as enol ethers or 
allenes are commonly used as the alkene component (Figure 2.6). Additionally, these compounds 
require further activation to undergo cycloaddition, for example through high-pressure120 or the 
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2.1.3. Synthesis of Azetidines via Photochemical [2+2] Cycloaddition Reactions 
The photochemical [2+2] cycloaddition between an imine and an alkene, often referred to 
as the aza Paternò-Büchi reaction, was first reported by Tsuge in 1968.126 In contrast to 
photocycloadditions with carbonyls or alkenes, which have been used extensively for the synthesis 
of oxetanes127,128 or cyclobutanes,129 the aza Paternò-Büchi reaction is significantly less advanced 
as a result of the decreased reactivity of imines in the excited state towards [2+2] cycloadditions. 
In addition to common relaxation pathways such as fragmentation, photoreduction or 
rearrangement reactions,130,131 the imine excited state (2.27) is susceptible to radiationless decay 
to the ground state through rotation around the carbon–nitrogen p-bond (2.29), rendering it 
difficult to engage imines in photocycloadditions (Figure 2.7A).132 Nevertheless, some examples 
have been reported in which imines participate in both intra- and intermolecular aza Paternò-Büchi 
reactions, oftentimes utilizing cyclic imines to avoid the limiting isomerization. Generally, these 
reactions can occur from either the singlet or the triplet excited state. Direct irradiation of an imine 
(2.30) leads to population of the corresponding singlet excited state (2.31), which is short-lived, 
but can participate in cycloaddition reactions with an alkene (Figure 2.7B). Ultraviolet (UV) light 
is typically required to achieve successful excitation of an imine scaffold. Singlet state reactions 
often proceed in a concerted fashion, therefore, high levels of stereoselectivity can be 
accomplished. Alternatively, the singlet excited state imine (2.31) can undergo intersystem 
crossing (ISC) to the triplet excited state (2.33), which has a significantly longer lifetime as 
relaxation back to the ground state is spin-forbidden (Figure 2.7C).133 In contrast to the singlet 
state reaction, the cycloaddition process of a triplet state imine occurs stepwise via biradical 
intermediate 2.34. Upon intersystem crossing, which produces a highly reactive singlet state 
intermediate, cyclization occurs rapidly to afford the respective azetidine product (2.32). An 
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alternative way to access the triplet excited state represents transferring the triplet excited state 
from a sensitizer, a process referred to as triplet energy transfer or triplet sensitization, which will 
be described in more detail in chapter 2.14 (Figure 2.7D). 
 
Figure 2.7: Overview of imine photochemistry. (A) Challenges in aza Paternò-Büchi reactions (B) Singlet state reaction (C) Triplet 
state reaction (D) Aza Paternò-Büchi reactions via triplet energy transfer. 
The most common variant of the aza Paternò-Büchi reaction is the intermolecular process, 
which typically utilizes cyclic imines to increase the lifetime of the imine excited state by 
preventing rotation around the carbon–nitrogen bond. After the first report by Tsuge in 1968 
relying on 1,3,4-oxadiazoles (2.35),126 a series of other imine reagents have been reported, which 
show distinct differences in their structure, mechanism and scope of alkenes (Figure 2.8). Koch 
and coworkers reported the use of 3-ethoxyisoindolones (2.36) that react under UV light irradiation 
from the singlet state, although in low yields.134–137 In contrast, a quite efficient photocycloaddition 
in high yields can be achieved by using 6-azauracils (2.37) and a variety of aliphatic or electron-
rich alkenes, originally reported by Swenton and coworkers.138–140 In this case, acetone is used as 






































































A. Challenges in aza Paternò-Büchi reactions.
B. Aza Paternò-Büchi reaction from the singlet excited state. C. Aza Paternò-Büchi reaction from the triplet excited state.
D. Aza Paternò-Büchi reaction via triplet energy transfer.
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reagents that can be engaged in aza Paternò-Büchi reactions include 9-cyanophenanthridines 
(2.38)141,142 as well as quinoxaline-2(1H)-ones (2.39) and related compounds.143–146 
 
Figure 2.8: Overview of imines that participate in intermolecular aza Paternò-Büchi reactions. 
Mukai and coworkers established that 3-aryl-2-isoxazolines (2.40) are competent 
substrates to react in an intermolecular photocycloaddition under UV light irradiation, representing 
the first example in which oximes are used in this transformation.147–149 Based on the observed 
regioselectivity, the reaction was proposed to occur via a singlet exciplex between 2.40 and the 
styrenyl alkene. The mechanism was later corroborated computationally by Sampedro and 
coworkers, who found that an electron-withdrawing substituent on the aromatic substituent of 2.40 
was necessary to extend the lifetime of the imine excited state.150,151 To date, the only example in 
which an acyclic excited state imine was successfully used in an intermolecular aza Paternò-Büchi 
reaction has been reported by Maruoka and coworkers.152 In this reaction, aromatic N-
(arylsulfonyl)imines (2.41) undergo cycloaddition with styrenyl alkenes via a singlet exciplex 
intermediate, and as a result, the reaction was found stereospecific. 
 



























































































More recently, Bach and coworkers reported the first example of an enantioselective aza 
Paternò-Büchi reaction utilizing quinoxalinones (2.42) as the imine reagents, similar to those 
previously reported by Nishio, for the synthesis of chiral azetidines (Figure 2.9).153 The reaction 
relied on a chiral catalyst that contains an amide functionality, which is capable of interacting with 
the imine substrate via hydrogen-bonding, as well as a thioxanthone moiety that can sensitize the 
hydrogen-bonded quinoxalinone via energy transfer. The hydrogen-bonded complex (2.43) 
subsequentially undergoes the enantioselective [2+2] cycloaddition reaction with a styrenyl 
alkene, resulting in the formation of the desired chiral azetidine product (2.44). Utilizing 10 mol% 
of chiral catalyst, the cycloaddition proceeded in 50–99% yield and 86–98% ee. Although the 
transformation was limited to styrenyl alkenes, the authors demonstrated that this cycloaddition 
reaction can be carried out intramolecularly with a tethered aliphatic alkene. 
 
Figure 2.10: Intramolecular aza Paternò-Büchi reaction reported by Prinzbach and coworkers. 
During their investigations of bichromophoric systems, Prinzbach and coworkers 
synthesized polycyclic compound 2.45.154 In this scaffold the proximal imine and alkene moieties 
were poised to undergo photocycloaddition upon UV light irradiation, which was achieved via 
direct or acetone-sensitized excitation in 80–85% yield, representing the first example of an 
intramolecular aza Paternò-Büchi reaction (Figure 2.10). 
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Recently, Sivaguru and coworkers reported an alternative approach to achieve an 
intramolecular aza Paternò-Büchi reaction.155 To avoid the challenging photochemical behavior of 
excited state imines, the authors developed a “transposed” reaction protocol that instead relied on 
an excited state alkene initiating the cycloaddition process (Figure 2.11). Specifically, the authors 
demonstrated that enamides (2.47) can be used in this reaction to undergo cycloaddition with an 
adjacent oxime or hydrazone. The triplet excited state of the enamide was accessed through the 
use of 30–100 mol% xanthone as a photosensitizer under UV light irradiation. Under these 
conditions a series of polycyclic azetidines (2.48) were synthesized in 21–79% yield. Additionally, 
the authors carried out extensive mechanistic experiments that provided support for the proposed 
mechanism proceeding via a triplet state enamide intermediate. Based on the reaction efficiency 
observed with photosensitizers varying in triplet energy (ET) such as xanthone (ET = 74 kcal mol-
1) the authors propose a triplet energy of 63–74 kcal mol-1 for the enamide scaffold.156 
 
Figure 2.12: Dearomatization reaction of indoles via an energy transfer-mediated [2+2] cycloaddition reaction with oximes. 
Using a similar approach, You and coworkers developed a [2+2] cycloaddition reaction for 
the dearomatization of indoles resulting in the construction of functionalized indoles.157 Using an 

































































intramolecular cycloaddition reaction with a tethered oxime, obtaining the corresponding azetidine 
products (2.54–2.57) in 33–99% yield and typically excellent diastereoselectivity (Figure 2.12). 
Interestingly, the authors observed divergent reactivity for indoles containing a methyl group in 
the 3-position (2.50). Triplet sensitization resulted in the formation of biradical intermediate 2.52, 
which rapidly undergoes the [2+2] cycloaddition reaction. Mechanistic studies including a series 
of control reactions and DFT studies indicated that the cycloaddition pathway is reversible. As a 
result, extended reaction times lead to the formation of 2.53 as the thermodynamically favored 
product, resulting from an irreversible 1,5-HAT from biradical intermediate 2.52. The authors 
demonstrated the utility of the 1,5-HAT pathway by synthesizing  a broad range of indoles 
containing an exocyclic alkene moiety in 40–96% yield. 
2.1.4. Triplet Energy Transfer Catalysis 
In the context of photocatalysis, energy transfer and the corresponding electron transfer 
need to be clearly distinguished (Figure 2.13). Electron transfer catalysis, often referred to as 
photoredox catalysis, utilizes a photocatalyst with high redox potentials to achieve a single electron 
transfer event with a substrate. While this process occurs from an excited state catalyst, the 
substrate, which is oxidized or reduced during this process, remains in its ground state.158,159 
 
Figure 2.13. Distinguishing energy transfer and electron transfer (photoredox) catalysis. Cat* = catalyst (excited state); S = 
substrate (ground state); Cat = catalyst (ground state); S* = substrate (excited state). 
In contrast, triplet energy transfer represents an alternative way to access the triplet excited 
state of an organic molecule, which typically involves a photosensitizer that can transfer its triplet 
excited state to a substrate in its ground state.160–163 This process can have distinct advantages over 
 
Photocatalysis
Energy Transfer Catalysis Electron Transfer / Photoredox catalysis
Cat* S+ Cat S*+ Cat* S+ Cat+•/-• S-•/+•
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direct irradiation, since the absorbance properties of most organic molecules require irradiation 
with UV light, which can negatively impact the selectivity, functional group tolerance and the 
operational simplicity of a reaction. These limitations are avoided by utilizing a visible light-
absorbing photocatalyst that can achieve substrate sensitization without undesired background 
reactivity. Additionally, for substrates with inefficient intersystem crossing, where direct 
excitation is not an effective means to achieve high population of the triplet excited state, energy 
transfer provides a unique opportunity to access the reactivity of the triplet excited state. 
 
Figure 2.14: Photophysical principles for triplet energy transfer (top) and selected commercially available photosensitizers 
(bottom). Cat* = catalyst (excited state); S = substrate (ground state); Cat = catalyst (ground state); S* = substrate (excited state). 
The energy transfer process relies on a photosensitizer, typically a transition metal complex 































































































ET = 74.3 kcal mol–1
E1/2(M+/M*) = –1.42 V
E1/2(M*/M–) = +1.57 V
[Ir(dF(Me)ppy)2(dtbbpy)]+ (2.58)
ET = 60.2 kcal mol–1
E1/2(M+/M*) = –0.92 V
E1/2(M*/M–) = +0.97 V
[Ir(dF(CF3)ppy)2(dtbbpy)]+ (2.59)
ET = 60.1 kcal mol–1
E1/2(M+/M*) = –0.89 V
E1/2(M*/M–) = +1.21 V
[Ir(ppy)2(dtbbpy)]+ (2.62)
ET = 49.2 kcal mol–1
E1/2(M+/M*) = –0.96 V
E1/2(M*/M–) = +0.66 V
fac-[Ir(dFppy)3] (2.51)
ET = 60.1 kcal mol–1
E1/2(M+/M*) = –1.28 V
E1/2(M*/M–) = +0.36 V
fac-[Ir(4’-CF3-ppy)3] (2.60)
ET = 56.4 kcal mol–1
E1/2(M+/M*) = –1.70 V
E1/2(M*/M–) = +0.59 V
fac-[Ir(ppy)3] (2.61)
ET = 55.2 kcal mol–1
E1/2(M+/M*) = –1.73 V
E1/2(M*/M–) = +0.31 V
[Ru(bpz)3]2+ (2.63)
ET = 48.4 kcal mol–1
E1/2(M+/M*) = –0.26 V
E1/2(M*/M–) = +1.45 V
[Ru(phen)3]2+ (2.64)
ET = 46.9 kcal mol–1
E1/2(M+/M*) = –0.87 V
E1/2(M*/M–)= +0.82 V
[Ru(bpy)3]2+ (2.65)
ET = 46.5 kcal mol–1
E1/2(M+/M*) = –0.81 V
E1/2(M*/M–) = +0.77 V
Selected commercially available photosensitizers
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(Figure 2.14, top). The singlet state is often short-lived and rapidly relaxes back to the ground state 
(S0) via fluorescence and radiationless internal conversion, or undergoes intersystem crossing 
(ISC) to an excited triplet state (S1). Considering that relaxation back to the ground state for 
example via emission of a photon is spin-forbidden, the triplet state lifetime is sufficiently long to 
enable bimolecular interactions with a substrate. In addition to a long triplet state lifetime, a good 
photosensitizer should also possess a high intersystem crossing rate to achieve a high population 
of the triplet excited state. The energy transfer event typically proceeds via a simultaneous 
intermolecular exchange of an excited state electron from the photosensitizer and a corresponding 
ground state electron from the substrate (Figure 2.14, top). During this process, often referred to a 
Dexter energy transfer, both reaction components have to be in close proximity to afford sufficient 
electronic coupling. Similarly, energy transfer typically has to be energetically favored, which can 
be estimated based on the difference in triplet energy (ET) of the photosensitizer and the triplet 
energy of the substrate (Equation 2.1). 
 DET = ET (S) – ET (Cat) Equation 2.1  
An efficient energy transfer is likely when the difference between the two components is 
DET < 0 (exergonic), in other words the triplet energy of the photosensitizer should be higher than 
that of the substrate. In contrast, an endergonic energy transfer (DET > 0) is generally slow or does 
not occur at all. 
Over the last years, several research groups have recognized that many visible light 
photocatalysts, which have previously only been used in the context of photoredox catalysis, also 
hold great potential as photosensitizers for energy transfer-mediated transformations such as 
isomerization, cycloaddition or bond homolysis reactions.164 Figure 2.14 shows a selection of 
commercially available visible light photocatalysts (2.51, 2.58–2.65), which have found use as 
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triplet sensitizers.165 These catalysts possess triplet energy of up to 60 kcal mol-1, while sensitizers 
with higher triplet energies such as xanthone (2.49, ET = 74.3 kcal mol-1) require irradiation with 
UV light. As a result, transformations that can be currently carried out with visible light 
photosensitizers are limited to substrates with triplet energies that are not substantially higher than 
60 kcal mol-1. 
2.2. Reaction Design and Optimization 
To realize an aza Paternò-Büchi reaction of general synthetic utility, we sought to develop 
a reaction protocol that would avoid excitation of the imine component and associated undesired 
relaxation pathways. Specifically, we envisioned an orthogonal approach that would rely on 
selective excitation of the alkene component of the substrate (Figure 2.15). Activated alkenes such 
as styrenes and dienes possess relatively low triplet energies of approximately 60 kcal mol-1 that 
are amenable to triplet energy transfer from a visible light photocatalyst.166 
 
Figure 2.15: Reaction design for the intramolecular aza Paternò-Büchi reaction. 
Yoon and coworkers previously recognized this reactivity for the synthesis of cyclobutanes 
(2.67) via an alkene [2+2] photocycloaddition reaction. Under irradiation with visible light, the 
photocatalyst [Ir(dF(CF3)ppy)2(dtbbpy)]PF6 (2.59•PF6) successfully engaged with the styrene 
moiety to access a triplet styrene, which underwent intramolecular cycloaddition with the adjacent 
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similar protocol relying on dienes as alternative activated alkenes, although proceeding with lower 
stereoselectivities.168 
 
We hypothesized that a similar triplet excited state alkene might undergo cycloaddition 
with an adjacent imine to provide the desired azetidine product (Figure 2.15). Towards that goal, 
initial investigations were focused on oximes considering their straightforward preparation and 
increased stability towards hydrolysis in comparison to imines. At the same time, the azetidine 
product from the proposed cycloaddition reaction would contain a nitrogen–oxygen bond that 
could function as a nitrogen protecting group and could be cleaved in a subsequent, reductive step. 
To test this hypothesis, substrate 2.68 containing both a styrene and oxime moiety was submitted 
to a variety of reaction conditions. Direct irradiation with UV light (365 nm) provided only trace 
amounts of the desired product 2.69, while significant amount of substrate decomposition and 
oxime isomerization was observed (Table 2.1, entry 1). 
Table 2.1: Reaction optimization of the intramolecular aza Paternò-Büchi reaction. 
 
Consequently, a series of commercially available visible light photosensitizers were 
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[Ru(bpy)3](PF6)2 (2.65•(PF6)2) (2.5 mol%)
fac-[Ir(ppy)3] (2.61) (2.5 mol%)
fac-[Ir(dFppy)3] (2.51) (2.5 mol%)
fac-[Ir(Fppy)3] (2.70) (2.5 mol%)
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did not result in any reactivity (Table 2.1, entry 2), iridium-based photocatalysts 2.51, 2.61 and 
2.70 provided 30–52% yield of 2.69 (Table 2.1, entries 3–5). Further optimization identified 
iridium catalyst [Ir(dF(CF3)ppy)2(dtbbpy)]PF6 (2.59•PF6) as the optimal photosensitizer for the 
desired transformation to afford the desired product in 97% yield and >20:1 d.r. (Table 2.1, 
entry 6). The reaction was tolerant of solvents other than tetrahydrofuran and provided 72–88% 
yield with solvents such as dichloromethane, methanol, ethyl acetate or acetonitrile (Table 2.1, 
entry 7). Increasing the reaction concentration from 0.01 M to 0.1 M only led to a small reduction 
in yield (Table 2.1, entry 8). The reaction could be readily carried out with low catalyst loadings 
of 0.5 mol% providing 2.69 in 98% yield (Table 2.1, entry 9). Finally, control reactions revealed 
that both the photocatalyst and light irradiation are essential to obtain the desired reactivity, as 
removing one of the two components from the reaction did not provide any reactivity (Table 2.1, 
entries 10+11). 
2.3. Substrate Scope 
With optimal conditions identified, the scope of the imine moiety in the substrate was 
tested. Similar to the previously used O-methyl oxime 2.68, O-benzyl oxime 2.71 provided 2.75 
in excellent yield of 96%, which could be readily reproduced on gram-scale (Table 2.2, entry 2). 
Free oxime 2.72 provided the desired product in slightly diminished yields of 54% (Table 2.2, 
entry 3). Additionally, hydrazones were identified as a compatible class of substrates. N-Boc 
hydrazone 2.73 smoothly underwent the developed intramolecular cycloaddition reaction in 62% 
yield and 13:1 d.r. (Table 2.2, entry 4). Notably, the structural assignment of the azetidine products 
was further confirmed by X-ray crystallographic analysis of azetidine 2.77. Interestingly, dimethyl 
hydrazone 2.74 was found unreactive under optimal conditions with photocatalyst 2.59•PF6. Other 
substrates such N-tosyl imines could also be successfully engaged in the reaction, however, due to 
their poor stability towards hydrolysis these substrates could not be purified. While all evaluated 
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oxime and hydrazone substrates were typically isolated as an inconsequential mixture of E/Z 
isomers, the high diastereoselectivity observed in all reactions indicates that the isomer ratio is not 
important for the stereoselectivity of the cycloaddition process. 
Table 2.2: Evaluation of oxime and hydrazone substrates. *Yields in parentheses were obtained from a reaction on gram-scale. 
 
Based on the high yields obtained with O-alkyl substituted oximes, this class of oximes 
was used for the subsequent evaluation of the substrate scope of the intramolecular aza Paternò-
Büchi reaction (Figure 2.16). A series of electronically differentiated styrenes smoothly underwent 
the cycloaddition reaction in very good to excellent yields and stereoselectivities (2.79–2.83). 
Modifications to the substrate backbone were well tolerated and allowed for the incorporation of 
functional groups such as sulfonamides, esters or silyl ethers into the azetidine product (2.84–
2.88). The reaction protocol was also found tolerant of oxime substrates derived from a 
corresponding ketone precursor, as products 2.89–2.91 could be isolated 74–97% yield. Notably, 
2.91 contains a pyridine ring, which is a common motif found in pharmaceutical compounds. 
Lactone-containing azetidine 2.92 could be accessed in 60% yield and 14:1 d.r., although the 















































































Figure 2.16: Scope of the developed intramolecular aza Paternò-Büchi reaction. 
Furthermore, the reaction is amenable to tetrasubstituted styrenes (2.93) and also allows 
for the construction of six-membered rings, as azetidines 2.94 and 2.95 could be isolated in 42% 
and 93% yield, respectively. In light of the fact that many pharmaceutical or agrochemical products 
contain oxime or hydrazone motifs, we sought to demonstrate that the developed reaction protocol 
can be utilized for their late-stage modification. Therefore, oxime 2.97 was synthesized in two 
steps from herbicide safener isoxadifen ethyl (2.96) and submitted to the optimized conditions of 
the [2+2] photocycloaddition. The corresponding azetidine 2.98 could subsequently be isolated in 
87% yield and 4:1 d.r. (Figure 2.17). 
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Further investigations were focused on the compatibility of dienes as activated alkene 
components. These scaffolds possess similarly low triplet energies of approximately 60 kcal mol-
1 that are accessible for photocatalysts such as 2.59•PF6 via triplet energy transfer, as previously 
demonstrated by Yoon and coworkers.168 Towards that goal, diene 2.99 was submitted to the 
optimized reaction conditions and smoothly underwent the desired cycloaddition reaction, 
providing azetidine 2.100 in 99% yield, although in diminished diastereoselectivity (Figure 2.18). 
Similarly, diene-containing cyclopentane 2.101 was identified as a viable substrate for this 
transformation and could be converted to strained bicycle 2.102 in 39% yield. Notably, both 2.100 
and 2.102 contain an exocyclic alkene that could be potentially used for further synthetic 
modifications. 
 
Figure 2.18: Intramolecular aza Paternò-Büchi reaction with dienes. 
2.4. Mechanistic Studies 
To corroborate the initially postulated mechanism proceeding via triplet energy transfer 
from the iridium catalyst to the styrene moiety of the substrate, a Stern-Volmer quenching study 
was carried out. Quenching of photocatalyst 2.59•PF6 was observed for substrate 2.68, containing 
both a styrene and an oxime moiety (Figure 2.19). Similar quenching behavior was observed for 
2.103 lacking the oxime moiety, indicating that this structural feature is not important for efficient 
quenching. In agreement with that observation, substrate 2.104 lacking a styrene moiety did not 
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Figure 2.19: Stern-Volmer quenching study. 
Furthermore, the quenching interaction is unlikely to result from a single electron transfer 
process considering that the redox properties of 2.59•PF6 (E1/2III*/II = +1.21 V vs. SCE; E1/2IV/III* = 
–0.89 V vs. SCE) are not sufficient to oxidize or reduce substrate 2.68 (Ep/2 = +1.82 V vs SCE).165 
In contrast, triplet energy transfer from the iridium photocatalyst 2.59•PF6 (ET = 60.1 kcal mol-1) 
to the styrene moiety (ET approx. 60 kcal mol-1) is energetically favored, while the reaction 
efficiency decreases with photocatalysts with a triplet energy lower than 60 kcal mol-1. 
 
Figure 2.20: Control reactions demonstrating (A) the lack of reactivity of terminal alkenes, (B) the stereoconvergence of the 
developed [2+2] cycloaddition reaction. 
Similarly, the reaction protocol is not compatible with alkenes possessing triplet energies 
higher than those of the photocatalyst. No reactivity was observed with terminal alkene 2.105 
 
y = 0.0033x + 1.0301
R² = 0.238
y = 3.3828x + 1.1086
R² = 0.9999
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0.5 h, blue LEDs
(427 nm), 97%
(E)-2.68 (Z)-2.682.69, >20:1 d.r.
A. Control reaction with a terminal alkene.
B. Stereoconvergence of the intramolecular aza Paternò-Büchi reaction.
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under standard reaction conditions as a result of the high triplet energy (ET > 76 kcal mol-1) that is 
inaccessible for photocatalyst 2.59•PF6 (Figure 2.20A).166 Next, we tested whether the styrene 
geometry is influencing the diastereoselectivity of the intramolecular aza Paternò-Büchi reaction. 
Previous experiments had shown that (E)-2.68 provided 2.69 in 96% yield and >20:1 d.r. 
(Table 2.2, entry 1). When the corresponding (Z)-2.68 was subjected to identical reaction 
conditions, 2.69 was isolated in almost identical yield and diastereoselectivity, highlighting that 
the developed reaction is stereoconvergent (Figure 2.20B). 
 
Figure 2.21: Monitoring in situ styrene E/Z isomerization by 1H NMR. 
Monitoring the reaction by 1H NMR revealed rapid interconversion between both styrene 
isomers (Figure 2.21). Under standard reaction conditions, formation of (Z)-2.68 occurs at a 
similar rate than product formation. However, both isomers are ultimately converted to product 
2.69. The same experiment also allowed to observe the change in oxime E/Z isomer ratio of 
substrate 2.68, which was initially prepared as a 1.6:1 (E/Z) mixture of oxime isomers. 
Interestingly, scrambling of the oxime isomer ratio was observed when submitting 2.68 to standard 
reaction conditions. The ratio changed from 1.6:1 (E/Z) to 1:1 within a reaction time of two minutes 

























2.68, it does not explain the overall increase in concentration of ZO-2.68. Importantly, no oxime 
isomer scrambling was observed with oxime 2.104 lacking a styrene moiety. 
 
Figure 2.22: Monitoring in situ oxime E/Z isomerization by 1H NMR. 
Based on the conducted mechanistic experiments, a mechanistic proposal is outlined that 
starts out with efficient triplet energy transfer of the excited state iridium photocatalyst to the 
styrene moiety of 2.68 (Figure 2.23). The resulting triplet styrene (2.107) can subsequently 
undergo unproductive rotation around the carbon–carbon bond, which results in the observed E/Z 
styrene isomerization. Alternatively, the triplet styrene can undergo a stepwise [2+2] cycloaddition 
reaction with the oxime moiety. This step likely proceeds through an initial carbon–carbon bond 
formation to afford intermediate 2.108, which can freely rotate around the carbon–nitrogen single 
bond. We propose that this step is reversible based on the observed oxime isomer scrambling, 
which can occur upon relaxation back to the ground state. Intermediate 2.108 can subsequently 
undergo intersystem crossing (ISC) to provide a highly reactive singlet state biradical (2.109) that 
will rapidly recombine to the final azetidine product (2.69). Due to the biradical nature of the 
involved triplet state intermediates, the stereoinformation of both the oxime and alkene component 

























intramolecular cycloaddition reaction is independent of both the starting oxime and styrene isomer 
ratio. 
 
Figure 2.23: Proposed mechanism for the intramolecular aza Paternò-Büchi reaction. ET = energy transfer. 
2.5. Synthetic Applications 
We next sought to demonstrate the synthetic utility of the novel azetidine building blocks 
that are accessible via the developed intramolecular aza Paternò-Büchi reaction. Initial efforts 
focused on validating our initial hypothesis that the N–O bond can function as a readily removable 
protecting group. Common conditions for this type of reaction typically rely on zinc in acetic acid 
or palladium-mediated hydrogenolysis. While conditions relying on zinc in acetic acid did not 
provide any reactivity, we observed reduction of azetidine 2.75 with palladium on carbon under a 
hydrogen gas atmosphere. Interestingly, in addition to the desired nitrogen–oxygen bond cleavage, 
reduction of the benzylic carbon–nitrogen bond was also observed under these conditions, as 
tetrahydrofuran derivative 2.110 was isolated in 98% yield upon tosylation (Figure 2.24). In 
contrast, using zinc in hydrochloric acid resulted in selective cleavage of the nitrogen–oxygen 
bond to afford the deprotected azetidine 2.111 in 87% yield. Additionally, we could demonstrate 
that the 2-phenylazetidine motif of the cycloadducts can be converted to the corresponding 








































derivative 2.112, oxidation of the phenyl moiety was achieved using a RuO4-oxidant system and 
azetidine carboxylic acid 2.113 isolated in 38% yield.169 Finally, monocyclic azetidines can be 
accessed through reductive cleavage of azetidines containing a lactone functionality in the cyclic 
backbone. Utilizing LiAlH4 resulted in efficient reduction of 2.92 to afford the corresponding diol 
2.114 in 84% yield. 
 
Figure 2.24: Synthetic modification of the accessible azetidine products. 
2.6. Conclusion 
In summary, an intramolecular aza Paternò-Büchi reaction was developed that proceeds 
under very mild conditions enabled by visible light triplet energy transfer catalysis. Previously 
reported procedures for aza Paternò-Büchi reactions rely on direct excitation with UV light, 
limiting the functional group tolerance in addition to the inherently challenging reactivity of 
excited state imines. This work circumvents these limitations through selective activation of the 
alkene component via triplet energy transfer from a commercially available iridium photocatalyst, 
which allowed for the synthesis of highly functionalized azetidine products in generally high yields 
(39–99%) and diastereoselectivities (2:1 to >20:1 d.r.). The developed reaction platform enables 
the synthesis of novel azetidine building blocks and is expected to advance the development of 
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2.7. Experimental Section 
2.7.1. General Information 
General Laboratory Procedures. All air- or moisture-sensitive reaction were carried out in 
flame-dried glassware under an atmosphere of nitrogen. Thin-layer chromatography (TLC) was 
performed on Merck silica gel 60 F254 plates using UV light (254 or 366 nm), KMnO4 or CAM 
stain for visualization. Flash chromatography was performed using silica gel Silia Flash® 40-63 
micron (230-400 mesh) from Silicycle unless noted. 
Materials and Instrumentation. All chemicals were purchased from Sigma-Aldrich, Alfa Aesar, 
Acros Organics, Oakwood, TCI America, Frontier Scientific, Matrix Scientific, Ark Pharm, Strem, 
and Chem Impex International, and were used as received unless otherwise stated. THF, CH2Cl2, 
Et2O, MeOH, MeCN and DMF were dried by being passed through a column of activated alumina 
under argon using a JC-Meyer Solvent Systems. Triethylamine and diisopropylamine were freshly 
distilled prior to use over calcium hydride and potassium hydroxide, respectively. 
[Ir(dF(CF3)ppy)2(dtbbpy)]PF6 (2.59•PF6) was prepared according to the procedure described by 
Stephenson.170 2-Iodoxybenzoic acid (IBX) was prepared as described by Santagostino.171 Proton 
nuclear magnetic resonance (1H NMR) spectra were recorded on Varian MR400, Varian vnmrs 
500, Varian Inova 500, and Varian vnmrs 700 spectrometers and are referenced to residual protic 
NMR solvent (CDCl3: d 7.26 ppm, CD2Cl2: d 5.32 ppm). Data for 1H NMR are reported as 
follows: chemical shift (d ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, br = broad), coupling constant (Hz), integration. Carbon nuclear magnetic resonance 
(13C NMR) spectra were recorded on Varian vnmrs 500 and Varian vnmrs 700 spectrometers and 
are referenced to the carbon resonances of the NMR solvent (CDCl3: d 77.16 ppm, CD2Cl2: 
d 54.00 ppm). High-resolution mass spectroscopic (MS) data was recorded at the Mass 
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Spectrometry Facility at the Department of Chemistry of the University of Michigan in Ann Arbor, 
MI on an Agilent 6230 TOF HPLC-MS (ESI) or Micromass AutoSpec Ultima Magnetic Sector 
mass spectrometer (ESI, EI). Infrared (IR) spectra were obtained using a Thermo-Nicolet IS-50 
spectrometer. IR data are represented as frequency of absorption (cm-1). Stereochemistry indicators 
with asterisk (R*, S*) were used to indicate relative stereochemistry of diastereomers.  
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2.7.2. Reaction Optimization 
A test tube was charged with 2.68 (21 mg, 0.1 mmol, 1.0 equiv.), photocatalyst and solvent, 
then sealed with a rubber septum and placed in front of a 40 W PR160-427 nm Kessil light at a 
distance of approximately 5 cm, which was set to 100% intensity (reactions involving UV light 
were carried out in a Luzchem LZG-ORG photoreactor). After stirring for 0.5 h, the reaction 
mixture was transferred to a 50-mL round-bottom flask and the solvent removed in vacuo. The 
crude reaction mixture was analyzed by 1H NMR to determine the yield of 2.69 using mesitylene 
as the internal standard. 
Table 2.3: Reaction optimization of the intramolecular aza Paternò-Büchi reaction. 
 
entry catalyst (mol%) solvent conc. (M) yield 
1a,b – CH2Cl2 0.01 6% 
2b,c xanthone (30) MeCN 0.01 43% 
3 [Ru(bpy)3](PF6)2 (2.5) THF 0.01 – 
4 fac-[Ir(Fppy)3 (2.5) THF 0.01 30% 
5 fac-[Ir(ppy)3] (2.5) THF 0.01 39% 
6 fac-[Ir(dFppy)3 (2.5) THF 0.01 52% 
7 2.59•PF6 (2.5) THF 0.01 97% 
8 2.59•PF6 (2.5) CH2Cl2 0.025 72% 
9 2.59•PF6 (2.5) MeOH 0.025 87% 
10 2.59•PF6 (2.5) EtOAc 0.025 87% 
11 2.59•PF6 (2.5) acetone 0.025 86% 
12 2.59•PF6 (2.5) MeCN 0.025 88% 
13 2.59•PF6 (2.5) THF 0.025 93% 
14 2.59•PF6 (2.5) THF 0.05 88% 
15 2.59•PF6 (2.5) THF 0.10 90% 
16 2.59•PF6 (1.0) THF 0.01 96% 
17 2.59•PF6 (0.5) THF 0.01 98% 
18 – THF 0.01 – 
19d 2.59•PF6 (2.5) THF 0.01 – 














2.7.3. Mechanistic Experiments 
Electrochemical Measurements 
Cyclic voltammetry was performed on a CHI620E electrochemical analyzer (CH 
instruments) using a 3-mL five-necked electrochemical cell equipped with a carbon working 
electrode, a platinum counter or auxiliary electrode, an Ag/AgCl (3 M KCl) reference electrode 
and a scan rate of 100 mV/s. The experimental setup was calibrated using ferrocene (Fc+/Fc) prior 
to each experiment. Samples were prepared with 0.03 mmol substrate in 3 mL n-Bu4NPF6 
electrolyte (0.1 M in MeCN) and degassed by sparging with argon gas for 10 min prior to use. The 
potential (Ep/2) was determined and converted to SCE as described by Nicewicz.172 
 
Figure 2.25: Cyclic voltammogram of compound (E)-2.68. 
The cyclic voltammogram shows an irreversible oxidation process with Ep/2 = +1.82 V (vs. 
SCE). [Ir(dF(CF3)ppy)2(dtbbpy)]PF6 (E1/2III*/II = +1.21 V vs. SCE) does not possess an excited 
















Ep/2 = 1.85 V (vs. Ag/AgCl)
1.82 V (vs. SCE)
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UV/Vis Absorption Spectra 
UV/Vis absorption spectra were recorded on a Shimadzu UV-1601 UV/Vis spectrometer. Samples 
were prepared in THF with substrate (E)-2.68 (10 mM) and photocatalyst 2.59•PF6 (0.05 mM). 
The photocatalyst is the only species absorbing at 427 nm. 
 
Figure 2.26: UV/Vis spectra of a representative reaction mixture. 
  
 
















Stern-Volmer Quenching Studies 
All samples were prepared using stock solutions of 2.59•PF6 (0.11 mM), (E)-2.68 (102.9 mM), 
(E)-2.103 (144.8 mM) or 2.104 (102.4 mM) in dry MeCN. To a volumetric flask was added 
2.59•PF6 (190 µL) with the respective amount of quencher and the volume adjusted to 4 mL with 
dry MeCN. The solution was transferred to a 1-cm quartz cuvette and degassed by sparging with 
nitrogen gas for 15 min. Emission spectra were recorded using a PTI QuantaMaster fluorimeter 
(Horiba) with an excitation wavelength of 420 nm. The emission intensities for the Stern-Volmer 
analysis were observed at 471 nm. The ratio of I0/I was plotted as a function of the quencher 
concentration (I0: emission intensity of 2.59•PF6 without quencher; I: emission intensity of 
2.59•PF6 in the presence of quencher). The plotted data from the Stern-Volmer quenching studies 
is shown in Figure 2.19. 
 
Table 2.4: Quenching data from the Stern-Volmer quenching study. 
 0.0 mM 2.5 mM 5.0 mM 8.5 mM 12.5 mM 
I0 / I (2.68) 1.0 8.7 16.4 27.7 37.8 
I0 / I (2.103) 1.0 9.7 18.2 29.6 43.5 
I0 / I (2.104) 1.0 1.1 1.0 1.0 1.1 
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NMR Time Study 
A 1-dram vial was charged with (E)-2.68 (6.2 mg, 0.03 mmol, 1.0 equiv.), 2.59•PF6 (0.2 mg, 
0.5 mol%), dimethyl terephthalate (4.7 mg) and d3-MeCN (3 mL). From the resulting solution 
1 mL was transferred to a NMR tube, which was placed in front of a 40 W PR160-427 nm Kessil 
light (~5 cm distance) and the solution irradiated under ambient atmosphere at 50% light intensity. 
Conversion and yield were determined at several time points by quantitative 1H NMR using 
dimethyl terephthalate as the internal standard. The plots displaying the concentrations of all 
reagents and reaction intermediates during the course of the reaction are shown in Figure 2.21 and 
Figure 2.22. 










0.0 61 39 100 0 0 
0.5 58 41 95 3 1 
1.0 53 43 88 6 3 
2.0 41 44 71 14 12 
4.0 24 40 44 23 30 
6.0 13 35 27 25 44 
8.0 8 26 17 21 60 
10.0 5 18 9 15 72 
12.0 3 12 6 10 82 
17.0 1 3 0 0 91 








Reaction was carried out according to GP-2.6a on a 0.25 mmol scale. No formation of desired 
azetidine product was observed after 0.5 h, and only unreacted starting material was observed in 
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2.7.4. Experimental Procedures 
Synthesis of Starting Materials and Characterization 
General Procedure for Alkylation of Cinnamyl Alcohols (GP-2.1) 
 
A round-bottom flask equipped with a magnetic stir bar was charged with NaH (60% dispersion 
in mineral oil; 1.5 equiv.) and dry DMF (0.5 M). The mixture was cooled to 0 °C and the 
corresponding cinnamyl alcohol was added slowly and the reaction mixture stirred for 1 h. Next, 
2-bromo-1,1-dimethoxyethane (2.0 equiv.) was added and the reaction heated at 110 °C for 24 h. 
After cooling to rt, NH4Cl solution (aq., sat.) and water were sequentially added, and the mixture 
extracted with EtOAc (3x). The combined organic extracts were washed with water (2x) and brine 
(2x), dried over Na2SO4, filtered and concentrated in vacuo. The crude product was purified by 
flash column chromatography (EtOAc/hexane) to afford the corresponding pure alkylated 
cinnamyl alcohol. 
 
(E)-(3-(2,2-Dimethoxyethoxy)prop-1-en-1-yl)benzene (A2.1): Prepared according to GP-2.1 
from (E)-cinnamyl alcohol (37.3 mmol). Purification by flash column chromatography (5–15% 
EtOAc/hexanes) afforded the pure title compound as a yellow oil (2.90 g, 35%). 
1H NMR (700 MHz, CDCl3): d 7.39 (d, J = 7.4 Hz, 2H), 7.32 (t, J = 7.6 Hz, 2H), 7.24 (t, J = 
7.3 Hz, 1H), 6.61 (d, J = 15.9 Hz, 1H), 6.29 (dt, J = 15.9, 6.2 Hz, 1H), 4.56 (t, J = 5.2 Hz, 1H), 
4.21 (dd, J = 6.2, 1.2 Hz, 2H), 3.54 (d, J = 5.2 Hz, 2H), 3.41 (s, 6H); 13C NMR (176 MHz, CDCl3): 
d 136.7, 133.0, 128.7, 127.9, 126.7, 125.9, 102.9, 72.3, 69.8, 54.1; IR (cm-1): 2936, 2834, 1724, 
1450, 1366, 1312, 1194, 1111, 1067, 966, 841, 750, 697; HRMS: m/z calculated for C13H18O3Na+ 














(E)-1-Chloro-4-(3-(2,2-dimethoxyethoxy)prop-1-en-1-yl)benzene (A2.2): Prepared according 
to GP-2.1 from (E)-4-chlorocinnamyl alcohol173 (5.7 mmol). Purification by flash column 
chromatography (5–20% EtOAc/hexanes) afforded the pure title compound as a yellow oil 
(482 mg, 33%). 
1H NMR (500 MHz, CDCl3): d 7.31 (d, J = 8.7 Hz, 2H), 7.28 (d, J = 8.8 Hz, 2H), 6.56 (d, J = 
15.9 Hz, 1H), 6.26 (dt, J = 15.9, 6.0 Hz, 1H), 4.55 (t, J = 5.2 Hz, 1H), 4.19 (dd, J = 6.0, 1.3 Hz, 
2H), 3.54 (d, J = 5.2 Hz, 2H), 3.41 (s, 6H); 13C NMR (126 MHz, CDCl3): d 135.3, 133.5, 131.6, 
128.9, 127.8, 126.6, 102.9, 72.1, 70.0, 54.1; IR (cm-1): 2909, 2831, 1491, 1447, 1193, 1112, 1090, 
1012, 967, 849, 797; HRMS: m/z calculated for C13H17ClO3Na+ [M+Na]+: 279.0758; found: 
279.0760. 
 
(E)-1-Bromo-4-(3-(2,2-dimethoxyethoxy)prop-1-en-1-yl)benzene (A2.3): Prepared according 
to GP-2.1 from (E)-4-bromocinnamyl alcohol174 (4.7 mmol). Purification by flash column 
chromatography (5–20% EtOAc/hexanes) afforded the pure title compound as a yellow oil 
(433 mg, 31%). 
1H NMR (400 MHz, CDCl3): d 7.43 (d, J = 8.4 Hz, 2H), 7.24 (d, J = 8.5 Hz, 2H), 6.55 (d, J = 
15.9 Hz, 1H), 6.28 (dt, J = 15.9, 6.0 Hz, 1H), 4.55 (t, J = 5.2 Hz, 1H), 4.19 (dd, J = 6.0, 1.2 Hz, 
2H), 3.54 (d, J = 5.2 Hz, 2H), 3.41 (s, 6H); 13C NMR (176 MHz MHz, CDCl3): d 135.7, 131.8, 








1114, 1072, 1009, 969, 848; HRMS: m/z calculated for C13H17BrO3Na+ [M+Na]+: 323.0253; 
found: 323.0252. 
 
(E)-4-(3-(2,2-Dimethoxyethoxy)prop-1-en-1-yl)-1,1'-biphenyl (A2.4): Prepared according to 
GP-2.1 from (E)-4-phenylcinnamyl alcohol174 (5.6 mmol). Purification by flash column 
chromatography (5–20% EtOAc/hexanes) afforded the pure title compound as a pale-yellow foam 
(624 mg, 38%). 
1H NMR (700 MHz, CDCl3): d 7.60 (d, J = 7.3 Hz, 2H), 7.56 (d, J = 8.2 Hz, 2H), 7.48 – 7.42 (m, 
4H), 7.34 (t, J = 7.4 Hz, 1H), 6.65 (d, J = 15.9 Hz, 1H), 6.34 (dt, J = 15.9, 6.2 Hz, 1H), 4.57 (t, J = 
5.2 Hz, 1H), 4.23 (dd, J = 6.1, 1.0 Hz, 2H), 3.56 (d, J = 5.2 Hz, 2H), 3.42 (s, 6H); 13C NMR 
(176 MHz, CDCl3): d 140.7, 140.6, 135.7, 132.5, 128.9, 127.4, 127.4, 127.1, 127.0, 125.9, 102.9, 
72.3, 69.8, 54.1; IR (cm-1): 2915, 2832, 1487, 1449, 1408, 1364, 1193, 1109, 1077, 971, 911, 853, 
756, 731, 695; HRMS: m/z calculated for C19H22O3Na+ [M+Na]+: 321.1461; found: 321.1466. 
 
(E)-(3-(2,2-dimethoxyethoxy)-2-methylprop-1-en-1-yl)benzene (A2.5): Prepared according to 
GP-2.1 from (E)-2-methyl-3-phenylprop-2-en-1-ol (6.8 mmol). Purification by flash column 
chromatography (5–20% EtOAc/hexanes) afforded the pure title compound as a yellow oil 
(530 mg, 33%). 
1H NMR (500 MHz, CDCl3): d 7.33 (t, J = 7.6 Hz, 2H), 7.28 (d, J = 7.5 Hz, 2H), 7.22 (t, J = 
7.2 Hz, 1H), 6.50 (s, 1H), 4.56 (t, J = 5.2 Hz, 1H), 4.09 (s, 2H), 3.52 (d, J = 5.2 Hz, 2H), 3.42 (s, 









77.8, 69.5, 54.0, 15.5; IR (cm-1): 2911, 2831, 1445, 1358, 1110, 1072, 964, 918, 855, 746, 699; 
HRMS: m/z calculated for C14H20O3Na+ [M+Na]+: 259.1305; found: 259.1308.  
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General Procedure for Oxime Synthesis from Acetals (GP-2.2) 
 
A 100-mL round-bottom flask equipped with a magnetic stir bar was charged with the 
corresponding acetal (1.0 equiv.) and a 1:1 mixture (v/v) of water/acetone (0.1 M). p-TsOH 
(0.2 equiv.) was added and the reaction heated at 85 °C until complete as determined by TLC 
analysis (4–8 h). After cooling to rt, NaHCO3 solution (aq., sat.) was added and the resulting 
mixture extracted with EtOAc (3x). The combined organic extracts were dried over Na2SO4, 
filtered, concentrated in vacuo and dried using high-vac. 
The crude aldehyde was dissolved in CH2Cl2 (0.1 M), before adding NaOAc (4.0 equiv.) 
and the corresponding hydroxylamine hydrochloride (2.0 equiv.). The mixture was stirred at rt 
until complete as judged by TLC analysis (4–18 h). NaHCO3 solution (aq., sat.) was added, the 
organic layer separated, and the aqueous layer extracted with EtOAc (3x). The combined organic 
extracts were washed with brine, dried over Na2SO4, filtered and concentrated in vacuo. 
Purification by flash column chromatography (EtOAc/hexanes) afforded the corresponding pure 
oxime, typically as a mixture of E/Z oxime isomers. 
 
2-(Cinnamyloxy)acetaldehyde O-benzyl oxime (2.71): Prepared according to GP-2.2 from A2.1 
(500 mg, 2.3 mmol, 1.0 equiv.) and O-benzylhydroxylamine hydrochloride (718 mg, 4.5 mmol, 
2.0 equiv.). Purification by flash column chromatography (5–10% EtOAc/hexanes) afforded the 
pure title compound as a pale-yellow oil (444 mg, 70%; E/Z (oxime) = 1.3:1). 
1H NMR (700 MHz, CDCl3): d 7.56 (t, J = 5.7 Hz, 1.3H; major), 7.41 – 7.30 (m, 20.7H; 
major+minor), 7.28 – 7.24 (m, 2.3H; major+minor), 6.94 (t, J = 3.6 Hz, 1H; minor), 6.61 (dd, J = 
18.9, 16.1 Hz, 2.3H; major+minor), 6.27 (dq, J = 15.9, 6.1 Hz, 2.3H; major+minor), 5.12 (d, J = 
X
CH(OMe)2











3.3 Hz, 4.6H; major+minor), 4.37 (d, J = 3.6 Hz, 2H; minor), 4.17 (ddd, J = 12.0, 6.1, 1.3 Hz, 
4.6H; major+minor), 4.14 (d, J = 5.7 Hz, 2.6H; major); 13C NMR (176 MHz, CDCl3): d 150.9, 
147.7, 137.7, 137.5, 136.7, 136.6, 133.4, 133.3, 128.72, 128.70, 128.57, 128.56, 128.4, 128.2, 
128.10, 128.08, 127.99, 127.95, 126.68, 126.67, 125.3, 125.2, 76.4, 76.2, 71.9, 71.2, 66.8, 64.6; 
IR (cm-1): 3028, 2851, 1495, 1453, 1365, 1107, 1013, 966, 914, 842, 733, 691; HRMS: m/z 
calculated for C18H19NO2Na+ [M+Na]+: 304.1308; found: 304.1312. 
 
2-(Cinnamyloxy)acetaldehyde oxime (2.72): Prepared according to GP-2.2 from A2.1 (500 mg, 
2.3 mmol, 1.0 equiv.) and hydroxylamine hydrochloride (313 mg, 4.5 mmol, 2.0 equiv.). 
Purification by flash column chromatography (10–30% EtOAc/hexanes) afforded the pure title 
compound as a pale-yellow oil (287 mg, 67%; E/Z (oxime) = 1.1:1). 
1H NMR (700 MHz, CDCl3): d 8.13 (b, 1H; minor), 7.85 (b, 1.1H; major), 7.54 (t, J = 5.6 Hz, 
1.1H; major), 7.41 – 7.38 (m, 4.2H; major+minor), 7.34 – 7.30 (m, 4.2H; major+minor), 7.27 – 
7.23 (m, 2.1H; major+minor), 6.96 (t, J = 3.7 Hz, 1H; minor), 6.63 (dd, J = 15.9, 9.8 Hz, 2.1H; 
major+minor), 6.28 (dq, J = 15.9, 6.2 Hz, 2.1H; major+minor), 4.40 (d, J = 3.7 Hz, 2H; minor), 
4.19 (ddd, J = 9.7, 6.1, 1.3 Hz, 4.2H; major+minor), 4.15 (d, J = 5.6 Hz, 2.2H; major); 13C NMR 
(176 MHz MHz, CDCl3): d 151.5, 148.7, 136.61, 136.57, 133.5, 133.4, 128.73, 128.71, 128.02, 
127.99, 126.69, 126.68, 125.24, 125.15, 72.0, 71.3, 66.7, 64.0; IR (cm-1): 3203, 3027, 2868, 1448, 
1395, 1348, 1284, 1116, 967, 920, 829, 731, 689; HRMS: m/z calculated for C11H13NO2H+ 







2-(((E)-3-(4-Chlorophenyl)allyl)oxy)acetaldehyde O-methyl oxime (S2.79): Prepared 
according to GP-2.2 from A2.2 (438 mg, 1.7 mmol, 1.0 equiv.) and O-methylhydroxylamine 
hydrochloride (285 mg, 3.4 mmol, 2.0 equiv.). Purification by flash column chromatography (5–
10% EtOAc/hexanes) afforded the pure title compound as a colorless oil (312 mg, 76%; 
E/Z (oxime) = 1.5:1). 
1H NMR (500 MHz, CDCl3): d 7.46 (t, J = 5.7 Hz, 1.5H; major), 7.33 – 7.27 (m, 10H; 
major+minor), 6.86 (t, J = 3.9 Hz, 1H; minor), 6.58 (d, J = 15.9 Hz, 2.5H; major+minor), 6.25 (dt, 
J = 15.9, 6.0 Hz, 2.5H; major+minor), 4.31 (d, J = 3.7 Hz, 2H; minor), 4.16 (d, J = 6.0 Hz, 5H; 
major+minor), 4.12 (d, J = 5.7 Hz, 3H; major), 3.89 – 3.86 (m, 7.5H; major+minor); 13C NMR 
(126 MHz, CDCl3): d 150.0, 146.9, 135.13, 135.07, 133.6, 133.5, 131.82, 131.80, 128.9, 128.8, 
127.82, 127.81, 126.1, 126.0, 71.6, 71.0, 66.9, 64.5, 62.2, 61.8; IR (cm-1): 2938, 2899, 1491, 1464, 
1359, 1089, 1040, 1012, 967, 846, 796; HRMS: m/z calculated for C12H14ClNO2Na+ [M+Na]+: 
262.0605; found: 262.0603. 
 
2-(((E)-3-(4-Bromophenyl)allyl)oxy)acetaldehyde O-methyl oxime (S2.80): Prepared 
according to GP-2.2 from A2.3 (434 mg, 1.4 mmol, 1.0 equiv.) and O-methylhydroxylamine 
hydrochloride (241 mg, 2.9 mmol, 2.0 equiv.). Purification by flash column chromatography (5–
10% EtOAc/hexanes) afforded the pure title compound as a colorless foam (308 mg, 75%; 










1H NMR (700 MHz, CDCl3): d 7.46 (t, J = 5.7 Hz, 1.3H; major), 7.45 – 7.42 (m, 4.6H; 
major+minor), 7.27 – 7.23 (m, 4.6H; major+minor), 6.86 (t, J = 3.7 Hz, 1H; minor), 6.56 (dd, J = 
15.9, 3.8 Hz, 2.3H; major+minor), 6.26 (dt, J = 15.9, 6.0 Hz, 2.3H; major+minor), 4.31 (d, J = 
3.7 Hz, 2H; minor), 4.17 – 4.15 (m, 4.6H; major+minor), 4.12 (d, J = 5.7 Hz, 2.6H; major), 3.87 
(d, J = 0.7 Hz, 6.9H; major+minor); 13C NMR (176 MHz, CDCl3): d 150.0, 146.9, 135.6, 135.5, 
131.9, 131.83, 131.80, 131.79, 128.14, 128.13, 126.2, 126.1, 121.74, 121.70, 71.6, 71.0, 66.9, 64.5, 
62.2, 61.8; IR (cm-1): 2937, 2851, 1487, 1401, 1358, 1109, 1072, 1040, 1008, 966, 844, 793; 
HRMS: m/z calculated for C12H14BrNO2Na+ [M+Na]+: 306.0100; found: 306.0107. 
 
2-(((E)-3-([1,1'-Biphenyl]-4-yl)allyl)oxy)acetaldehyde O-methyl oxime (S2.81): Prepared 
according to GP-2.2 from A2.4 (497 mg, 1.7 mmol, 1.0 equiv.) and O-methylhydroxylamine 
hydrochloride (278 mg, 3.3 mmol, 2.0 equiv.). Purification by flash column chromatography (5–
10% EtOAc/hexanes) afforded the pure title compound as a colorless solid (364 mg, 78%; 
E/Z (oxime) = 1.1:1). 
1H NMR (700 MHz, CDCl3): d 7.60 (d, J = 7.4 Hz, 4.2H; major+minor), 7.57 (dd, J = 8.3, 2.8 Hz, 
4.2H; major+minor), 7.50 – 7.42 (m, 9.5H; major+minor), 7.36 – 7.33 (m, 2.1H; major+minor), 
6.88 (t, J = 3.7 Hz, 1H; minor), 6.69 – 6.64 (m, 2.1H; major+minor), 6.32 (dtd, J = 15.9, 6.1, 
1.4 Hz, 2.1H; major+minor), 4.33 (d, J = 3.7 Hz, 2H; minor), 4.22 – 4.19 (m, 4.2H; major+minor), 
4.14 (d, J = 5.7 Hz, 2.2H; major), 3.88 (d, J = 1.0 Hz, 6.3H; major+minor); 13C NMR (176 MHz, 
CDCl3): d 150.2, 147.0, 140.74 (2C), 140.72, 140.69, 135.7, 135.6, 132.84, 132.82, 128.9 (2C), 






62.2, 61.9; IR (cm-1): 2940, 2848, 1486, 1448, 1349, 1264, 1104, 1042, 967, 851, 754, 689; 
HRMS: m/z calculated for C18H19NO2Na+ [M+Na]+: 304.1308; found: 304.1301. 
 
2-(((E)-2-Methyl-3-phenylallyl)oxy)acetaldehyde O-methyl oxime (S2.85): Prepared according 
to GP-2.2 from A2.5 (499 mg, 2.1 mmol, 1.0 equiv.) and O-methylhydroxylamine hydrochloride 
(353 mg, 4.2 mmol, 2.0 equiv.). Purification by flash column chromatography (5–10% 
EtOAc/hexanes) afforded the pure title compound as a pale-yellow oil (407 mg, 88%; 
E/Z (oxime) = 1.4:1). 
1H NMR (500 MHz, CDCl3): d 7.48 (t, J = 5.7 Hz, 1.4H; major), 7.34 (td, J = 7.7, 2.0 Hz, 4.8H; 
major+minor), 7.28 (dd, J = 6.7, 3.8 Hz, 4.8H; major+minor), 7.23 (dt, J = 8.7, 3.8 Hz, 2.4H, 
major+minor), 6.88 (t, J = 3.6 Hz, 1H; minor), 6.52 (s, 2.4H; major+minor), 4.29 (d, J = 3.7 Hz, 
2H; minor), 4.11 (d, J = 5.7 Hz, 2.8H; major), 4.06 (s, 4.8H; major+minor), 3.88 (d, J = 1.6 Hz, 
7.2H; major+minor), 1.92 – 1.87 (m, 7.2H; major+minor); 13C NMR (176 MHz, CDCl3): d 150.2, 
147.1, 137.42, 137.36, 134.5, 134.4, 129.00, 128.99, 128.22, 128.20, 127.8, 127.7, 126.70, 126.65, 
77.4, 76.9, 66.6, 64.1, 62.1, 61.8, 15.6, 15.5; IR (cm-1): 2938, 2900, 144, 1351, 1091, 1039, 918, 






General Procedure for Oxime Synthesis from Alcohols (GP-2.3) 
 
A 25-mL round-bottom flask equipped with a magnetic stir bar was charged with the 
corresponding alcohol (1.0 equiv.) and DMSO (0.3 M). IBX (1.5 equiv.) was added and the 
mixture stirred at rt until complete as judged by TLC analysis (4–18 h). Water was added to the 
reaction mixture and precipitated solids removed by filtration through a pad of celite. After 
washing the filter cake with Et2O, the filtrate was collected, the organic layer separated and the 
aqueous layer extracted with Et2O (3x). The combined organic extracts were washed with water 
(2x) and brine (2x), dried over MgSO4, filtered, concentrated in vacuo and dried using high-vac. 
The crude aldehyde was dissolved in CH2Cl2 (0.1 M), before adding NaOAc (4.0 equiv.) 
and the respective hydroxylamine hydrochloride (2.0 equiv.). The mixture was stirred at rt until 
complete as judged by TLC analysis (4–18 h). NaHCO3 solution (aq., sat.) was added, the organic 
layer separated and the aqueous layer extracted with EtOAc (3x). The combined organic layers 
were washed with brine, dried over Na2SO4, filtered and concentrated in vacuo. Purification by 
flash column chromatography (EtOAc/hexanes) afforded the corresponding pure oxime, typically 
as a mixture of E/Z oxime isomers. 
 
2-(((Z)-3-Phenylallyl)oxy)acetaldehyde O-methyl oxime ((Z)-2.68): Prepared according to GP-
2.3 from A2.6 (207 mg, 1.2 mmol, 1.0 equiv.) and O-methylhydroxylamine hydrochloride 
(194 mg, 2.3 mmol, 2.0 equiv.). Purification by flash column chromatography (20–30% 
EtOAc/hexanes) afforded the pure title compound as a colorless oil (84 mg, 35%; 













1H NMR (700 MHz, CDCl3): d 7.43 (t, J = 5.7 Hz, 1.3H; major), 7.35 (t, J = 7.6 Hz, 4.6H; 
major+minor), 7.29 – 7.26 (m, 2.3H; major+minor), 7.20 (d, J = 7.4 Hz, 4.6H; major+minor), 6.84 
(t, J = 3.7 Hz, 1H; minor), 6.64 (dd, J = 11.8, 4.9 Hz, 2.3H; major+minor), 5.86 – 5.81 (m, 2.3H; 
major+minor), 4.29 – 4.27 (m, 6.6H; major+minor), 4.09 (d, J = 5.7 Hz, 2.6H; major), 3.86 (s, 3H; 
minor), 3.84 (s, 3.9H; major); 13C NMR (176 MHz, CDCl3): d 150.2, 147.0, 136.59, 136.55, 
132.5, 132.4, 128.89, 128.87, 128.41, 128.40, 128.3, 128.2, 127.5, 127.4, 68.0, 67.4, 67.1, 64.7, 
62.2, 61.8; IR (cm-1): 2938, 1494, 1447, 1340, 1098, 1041, 866, 851, 772, 698; HRMS: m/z 
calculated for C12H15NO2Na+ [M+Na]+: 228.0995; found: 228.0995. 
 
2-(((E)-3-(4-(Trifluoromethyl)phenyl)allyl)oxy)acetaldehyde O-methyl oxime (S2.82): 
Prepared according to GP-2.3 from A2.7 (437 mg, 1.8 mmol, 1.0 equiv.) and O-
methylhydroxylamine hydrochloride (296 mg, 3.6 mmol, 2.0 equiv.). Purification by flash column 
chromatography (5–10% EtOAc/hexanes) afforded the pure title compound as a colorless solid 
(343 mg, 71%; E/Z (oxime) = 1.4:1). 
1H NMR (700 MHz, CDCl3): d 7.57 (dd, J = 8.2, 2.8 Hz, 4.8H; major+minor), 7.49 – 7.45 (m, 
6.2H; major+minor), 6.87 (t, J = 3.7 Hz, 1H; minor), 6.66 (dd, J = 16.0, 4.1 Hz, 2.4H; 
major+minor), 6.36 (dt, J = 16.0, 5.8 Hz, 2.4H; major+minor), 4.32 (d, J = 3.7 Hz, 2H; minor), 
4.20 (d, J = 5.8 Hz, 4.8H; major+minor), 4.14 (d, J = 5.7 Hz, 2.8H; major), 3.88 (s, 7.2H; 
major+minor); 13C NMR (176 MHz, CDCl3): d 149.9, 146.8, 140.2, 140.1, 131.3, 131.2, 129.7 (q, 
J = 32.4 Hz), 129.6 (q, J = 32.4 Hz), 128.3, 128.1, 126.73, 126.72, 125.7 – 125.5 (m, 2C), 124.3 






1040, 1016, 967, 854, 821, 728, 651; HRMS: m/z calculated for C13H14F3NO2H+ [M+H]+: 
274.1049; found: 274.1044. 
 
N-Cinnamyl-N-(2-(methoxyimino)ethyl)-4-methylbenzenesulfonamide (S.84): Prepared 
according to GP-2.3 from N-cinnamyl-N-(2-hydroxyethyl)-4-methylbenzenesulfonamide175 
(700 mg, 2.1 mmol, 1.0 equiv.) and O-methylhydroxylamine hydrochloride (353 mg, 4.2 mmol, 
2.0 equiv.). Purification by flash column chromatography (10–30% EtOAc/hexanes) afforded the 
pure title compound as a colorless oil (371 mg, 49%; E/Z (oxime) = 1.2:1). 
1H NMR (700 MHz, CDCl3): d 7.73 (d, J = 7.6 Hz, 4.4H; major+minor), 7.34 – 7.28 (m, 8.8H; 
major+minor), 7.27 (d, J = 7.4 Hz, 4.4H; major+minor), 7.26 – 7.23 (m, 2.2H; major+minor), 7.21 
(t, J = 5.9 Hz, 1.2H; major), 6.65 (t, J = 4.3 Hz, 1H; minor), 6.45 (d, J = 15.7 Hz, 2.2H; 
major+minor), 6.01 – 5.93 (m, 2.2H; major+minor), 4.04 (d, J = 4.3 Hz, 2H; minor), 3.96 (dd, J = 
9.6, 7.0 Hz, 4.4H; major+minor), 3.93 (d, J = 5.9 Hz, 2.4H; major), 3.79 (s, 3H; minor), 3.77 (s, 
3.6H; major), 2.44 (s, 3H; minor), 2.43 (s, 3.6H; major); 13C NMR (176 MHz, CDCl3): d 147.9, 
145.6, 143.9, 143.8, 137.0, 136.5, 136.3, 136.1, 135.0, 134.9, 130.1, 130.0, 128.74, 128.69, 128.2, 
128.1, 127.43, 127.43, 126.7, 126.6, 123.3, 123.0, 62.2, 61.9, 51.5, 50.0, 45.9, 42.9, 21.7, 21.6; IR 
(cm-1): 2937, 1597, 1495, 1448, 1337, 1156, 1089, 1030, 968, 897, 814, 731, 654; HRMS: m/z 
calculated for C19H22N2O3SNa+ [M+Na]+: 381.1243; found: 381.1245. 
 
(5E)-6-Phenylhex-5-enal O-methyl oxime (S2.86): Prepared according to GP-2.3 from 6-
phenylhex-5-en-1-ol176 (763 mg, 4.3 mmol, 1.0 equiv.; E/Z = 2.6:1) and O-methylhydroxylamine 









10% EtOAc/hexanes) afforded the pure title compound as a colorless oil (797 mg, 91%; 
E/Z (styrene) = 2.6:1; E/Z (oxime) = 1.5:1). Characterization data is provided for the two major 
(E)-styrene isomers. 
1H NMR (700 MHz, CDCl3): d 7.39 (t, J = 6.2 Hz, 1.5H; major), 7.36 – 7.30 (m, 5H; 
major+minor), 7.31 – 7.27 (m, 5H; major+minor), 7.24 – 7.18 (m, 2.5H; major+minor), 6.66 (t, 
J = 5.5 Hz, 1H; minor), 6.40 (d, J = 15.8 Hz, 2.5H; major+minor), 6.19 (dtd, J = 15.6, 6.9, 1.5 Hz, 
2.5H; major+minor), 3.87 (s, 3H; minor), 3.82 (s, 4.5H; major), 2.41 – 2.32 (m, 4H; minor), 2.29 
– 2.19 (m, 6H; major), 1.71 – 1.60 (m, 5H; major+minor)17; 13C NMR (176 MHz, CDCl3): 
d 151.5, 151.4, 150.6, 150.5, 137.74, 137.73, 137.6 (2C), 131.9 (2C), 130.80, 130.79, 129.84 (2C), 
129.81, 129.76, 128.8 (2C), 128.62, 128.62, 128.3 (2C), 127.1 (2C), 126.74, 126.73, 126.1 (2C), 
61.71, 61.69, 61.4, 61.3, 32.7, 32.5, 29.2, 29.1, 28.4, 28.1, 27.1, 26.64, 26.56, 26.1, 25.4, 25.2; IR 
(cm-1): 3024, 2936, 1493, 1448, 1047, 964, 917, 883, 847, 803, 741, 692; HRMS: m/z calculated 
for C13H17NOH+ [M+H]+: 204.1383; found: 204.1376. 
 
N-Cinnamyl-N-((Z)-2-(methoxyimino)-2-(pyridin-2-yl)ethyl)-4-methylbenzenesulfonamide 
(S2.91): Prepared according to GP-2.3 from A2.8 (225 mg, 0.55 mmol, 1.0 equiv.) and O-
methylhydroxylamine hydrochloride (92 mg, 1.1 mmol, 2.0 equiv.). The oxime formation was 
carried out in methanol (5 mL) at reflux for 16 h. Purification by flash column chromatography 
(10–60% EtOAc/hexanes) afforded the pure title compound as a colorless oil (602 mg, 64%; 
E/Z (oxime) = 1:1.3). 
1H NMR (500 MHz, CDCl3): d 8.58 (d, J = 4.8 Hz, 1H; minor), 8.54 (d, J = 4.3 Hz, 1.3H; major), 








major+minor), 6.43 (d, J = 15.8 Hz, 1H; minor), 6.32 (d, J = 15.9 Hz, 1.3H; major), 5.94 (ddt, J = 
15.9, 11.2, 6.7 Hz, 2.3H; major+minor), 4.62 (s, 2.6H; major), 4.47 (s, 2H; minor), 3.99 – 3.96 (m, 
8.5H; major+minor), 3.83 (s, 3H; minor), 2.41 (s, 6.9H; major+minor); 13C NMR (176 MHz, 
CDCl3): d 154.2, 152.9, 151.7, 149.7, 149.2, 148.8, 143.3, 143.1, 137.05, 137.03, 136.53, 136.46, 
136.4, 135.7, 134.2, 133.7, 129.52, 129.51, 128.6, 128.5, 127.9, 127.8, 127.6, 127.5, 126.51, 
126.45, 126.21, 124.2, 124.1, 123.9, 123.8, 122.0, 62.7, 62.5, 51.4, 50.4, 49.1, 40.4, 21.6, 21.5; IR 
(cm-1): 2936, 2821, 1598, 1566, 1582, 1495, 1435, 1339, 1156, 1091, 1044, 994, 997, 906, 814, 
729, 692, 667, 650; HRMS: m/z calculated for C24H25N3O3SH+ [M+H]+: 436.1689; found: 
436.1687. 
 
(2-((2-Phenylcyclopent-1-en-1-yl)methoxy)acetaldehyde O-methyl oxime (S2.93): Prepared 
according to GP-2.3 from A2.9 (834 mg, 3.8 mmol, 1.0 equiv.) and O-methylhydroxylamine 
hydrochloride (638 mg, 7.6 mmol, 2.0 equiv.) Purification by flash column chromatography (0–
10% EtOAc/hexanes) afforded the pure title compound as a colorless oil (602 mg, 64%; 
E/Z (oxime) = 1:1.6). 
1H NMR (700 MHz, CDCl3): d 7.42 (t, J = 5.8 Hz, 1H; minor), 7.34 (t, J = 7.6 Hz, 5.2H; 
major+minor), 7.27 – 7.25 (m, 2.6H; major+minor), 7.24 – 7.21 (m, 5.2H; major+minor), 6.83 (t, 
J = 3.6 Hz, 1.6H; major), 4.22 (d, J = 3.6 Hz, 3.2H; major), 4.14 (d, J = 5.2 Hz, 5.2H; 
major+minor), 4.02 (d, J = 5.8 Hz, 2H; minor), 3.85 (s, 4.8H; major), 3.83 (s, 3H; minor), 2.81 – 
2.77 (m, 5.2H; major+minor), 2.66 – 2.61 (m, 5.2H; major+minor), 2.00 – 1.94 (m, 5.2H; 
major+minor); 13C NMR (176 MHz, CDCl3): d 150.5, 147.2, 141.51, 141.49, 137.64, 137.60, 
135.03, 134.96, 128.31, 128.29, 127.88, 127.86, 127.14, 127.09, 68.2, 67.6, 67.0, 64.6, 62.2, 61.8, 










(S2.100): Prepared according to GP-2.3 from A2.10 (500 mg, 1.8 mmol, 1.0 equiv.) and O-
methylhydroxylamine hydrochloride (297 mg, 3.6 mmol, 2.0 equiv.). Purification by flash column 
chromatography (20% EtOAc/hexanes) afforded the pure title compound as a colorless oil 
(337 mg, 62%; E/Z (oxime) = 1.3:1; E/Z (diene) = 8:1). 
1H NMR (700 MHz, CDCl3): d 7.69 (dd, J = 8.3, 2.2 Hz, 4.6H; major+minor), 7.31 (t, J = 8.4 Hz, 
4.6H; major+minor), 7.17 (t, J = 5.9 Hz, 1.3H; major), 6.61 (t, J = 4.3 Hz, 1H; minor), 6.29 – 6.22 
(m, 2.3H; major+minor), 6.10 (dd, J = 15.2, 10.7 Hz, 2.3H; major+minor), 5.54 – 5.43 (m, 2.3H; 
major+minor), 5.18 (d, J = 17.0 Hz, 2.3H; major+minor), 5.11 (dd, J = 10.0, 7.8 Hz, 2.3H; 
major+minor), 3.98 (d, J = 4.3 Hz, 2H; minor), 3.88 (d, J = 5.9 Hz, 2.6H; major), 3.84 – 3.81 (m, 
7.6H; major+minor), 3.79 (s, 3.9H; major+minor), 2.43 (d, J = 2.2 Hz, 6.9H; major+minor); 
13C NMR (176 MHz, CDCl3): d 147.9, 145.5, 143.9, 143.7, 136.8, 136.3, 135.8, 135.7, 135.64, 
135.56, 130.0, 129.9, 127.38, 127.37, 127.2, 127.0, 118.6, 118.4, 62.2, 61.9, 51.0, 49.9, 45.9, 42.8, 
21.64, 21.63; IR (cm-1): 2938, 1598, 1441, 1337, 1156, 1090, 1030, 1005, 911, 854, 814, 743, 658; 
HRMS: m/z calculated for C15H20N2O3SNa+ [M+Na]+: 331.1087; found: 331.1088. 
 
2-(3-Phenylpropoxy)acetaldehyde O-methyl oxime (2.104): Prepared according to GP-2.3 from 









10.3 mmol, 2.0 equiv.). Purification by flash column chromatography (2–10% EtOAc/hexanes) 
afforded the pure title compound as a colorless oil (338 mg, 32%; E/Z (oxime) = 1:1.1). 
1H NMR (700 MHz, CDCl3): d 7.44 (t, J = 5.8 Hz, 1H; minor), 7.28 (td, J = 7.9, 2.2 Hz, 4.2H; 
major+minor), 7.21 – 7.17 (m, 6.3H; major+minor), 6.83 (t, J = 3.7 Hz, 1.1H; major), 4.24 (d, J = 
3.7 Hz, 2.2H; major), 4.06 (d, J = 5.8 Hz, 2H; minor), 3.87 (s, 3.3H; major), 3.86 (s, 3H; minor), 
3.46 (q, J = 6.2 Hz, 4.2H; major+minor), 2.70 (q, J = 7.7 Hz, 4.2H; major+minor), 1.95 – 1.88 (m, 
4.2H; major+minor); 13C NMR (176 MHz, CDCl3): d 150.6, 147.3, 141.9, 141.8, 128.6 (2C), 
128.49, 128.47, 125.99, 125.96, 70.6, 70.0, 67.5, 65.1, 62.2, 61.8, 32.34, 32.33, 31.3, 31.2; IR (cm-
1): 2938, 2861, 1496, 1454, 1114, 1040, 911, 850, 744, 698; HRMS: m/z calculated for 
C12H17NO2H+ [M+H]+: 208.1332; found: 208.1328.  
 131 
General Procedure for Oxime Synthesis from Carbonyl Compounds (GP-2.4) 
 
A 50-mL round-bottom flask equipped with a magnetic stir bar was charged with the 
corresponding aldehyde (1.0 equiv.) and CH2Cl2 (0.1 M). Next, NaOAc (4.0 equiv.) and the 
corresponding hydroxylamine hydrochloride (2.0 equiv.) were added sequentially and the mixture 
stirred at rt until complete as judged by TLC analysis (4–18 h). Then, NaHCO3 solution (aq., sat.) 
was added and the organic layer separated. The aqueous layer was extracted with EtOAc (3x) and 
the combined organic extracts washed with brine, dried over Na2SO4, filtered and concentrated in 
vacuo. Purification by flash column chromatography (EtOAc/hexanes) afforded the pure oxime, 
typically as a mixture of E/Z oxime isomers. 
 
2-(Cinnamyloxy)acetaldehyde O-methyl oxime ((E)-2.68): Prepared according to GP-2.4 from 
2-(cinnamyloxy)acetaldehyde177 (1.33 g, 7.6 mmol, 1.0 equiv.) and O-methylhydroxylamine 
hydrochloride (1.26 g, 15.1 mmol, 2.0 equiv.). Purification by flash column chromatography (10–
20% EtOAc/hexanes) afforded the pure title compound as a colorless oil (1.05 g, 68%; 
E/Z (oxime) = 1.4:1). 
1H NMR (700 MHz, CDCl3): d 7.47 (t, J = 5.7 Hz, 1.4H; major), 7.41 – 7.37 (m, 4.8H; 
major+minor), 7.34 – 7.30 (m, 4.8H; major+minor), 7.27 – 7.23 (m, 2.4H; major+minor), 6.87 (t, 
J = 3.6 Hz, 1H; minor), 6.62 (d, J = 15.9 Hz, 2.4H; major+minor), 6.27 (dtd, J = 15.9, 6.1, 1.0 Hz, 
2.4H; major+minor), 4.31 (d, J = 3.7 Hz, 2H; minor), 4.20 – 4.16 (m, 4.8H; major+minor), 4.13 
(d, J = 5.7 Hz, 2.8H; major), 3.87 (s, 7.2H; major+minor); 13C NMR (176 MHz, CDCl3): d 150.2, 















71.9, 71.3, 66.8, 64.4, 62.2, 61.9; IR (cm-1): 2938, 2850, 1449, 1358, 1108, 1040, 965, 851, 735, 
691; HRMS: m/z calculated for C12H15NO2Na+ [M+Na]+: 228.0995; found: 228.0999. 
 
Diethyl 2-(2-(methoxyimino)ethyl)-2-((E)-3-(4-methoxyphenyl)allyl)malonate (S.83): 
Prepared according to GP-2.4 from A2.12 (190 mg, 0.6 mmol, 1.0 equiv.) and O-
methylhydroxylamine hydrochloride (91 mg, 1.1 mmol, 2.0 equiv.). Purification by flash column 
chromatography (2–20% EtOAc/hexanes) afforded the pure title compound as a yellow oil 
(150 mg, 73%; E/Z (oxime) = 2:1). 
1H NMR (500 MHz, CD2Cl2): d 7.38 – 7.31 (m, 2H; major), 7.26 (dd, J = 8.8, 3.0 Hz, 6H), 6.85 
– 6.81 (m, 6H), 6.70 (t, J = 5.4 Hz, 1H), 6.40 (dd, J = 15.7, 7.3 Hz, 3H), 5.91 (dt, J = 15.5, 7.6 Hz, 
3H), 4.19 (q, J = 7.1 Hz, 12H), 3.83 (s, 3H), 3.78 (s, 15H), 2.87 (d, J = 5.4 Hz, 2H), 2.77 (dd, J = 
7.5, 3.8 Hz, 6H), 2.73 (d, J = 6.4 Hz, 4H), 1.24 (t, J = 7.1 Hz, 18H); 13C NMR (126 MHz, CD2Cl2): 
d 170.9, 170.7, 159.8 (2C), 147.1, 147.0, 134.44 (2C), 134.3 (2C), 130.3, 127.9 (2C), 121.62, 
121.60, 114.4, 62.22, 62.15, 62.1, 61.9, 57.4, 56.5, 55.8 (2C), 38.0, 37.5, 33.4, 29.6, 14.5, 14.4; IR 
(cm-1): 2980, 2936, 1729, 1608, 1512, 1301, 1250, 1205, 1032, 971, 841; HRMS: m/z calculated 
for C20H27NO6H+ [M+H]+: 378.1911; found: 378.1910. 
 
Diethyl 2-cinnamyl-2-(2-(methoxyimino)ethyl)malonate (S2.87): Prepared according to GP-2.4 










2.2 mmol, 2.0 equiv.). Purification by flash column chromatography (20% EtOAc/hexanes) 
afforded the pure title compound as a pale-yellow oil (366 mg, 96%; E/Z (oxime) = 1.3:1). 
1H NMR (500 MHz, CDCl3): d 7.37 (t, J = 6.4 Hz, 1.3H; major), 7.33 – 7.27 (m, 9.2H; 
major+minor), 7.22 (t, J = 6.5 Hz, 2.3H; major+minor), 6.73 (t, J = 5.4 Hz, 1H; minor), 6.46 (dd, 
J = 15.7, 5.2 Hz, 2.3H; major+minor), 6.10 – 6.02 (m, 2.3H; major+minor), 4.22 (q, J = 7.1 Hz, 
9.2H; major+minor), 3.86 (s, 3H; minor), 3.81 (s, 3.9H; major), 2.93 (d, J = 5.4 Hz, 2H; minor), 
2.86 – 2.80 (m, 4.6H; major+minor), 2.78 (d, J = 6.4 Hz, 2.6H; major), 1.26 (t, J = 7.1 Hz, 13.8H; 
major+minor); 13C NMR (176 MHz, CDCl3): d 170.5, 170.3, 146.62, 146.57, 137.1 (2C), 134.74, 
134.73, 128.6 (2C), 127.6 (2C), 126.4 (2C), 123.5, 123.4, 61.84, 61.83, 61.76, 61.6, 56.9, 56.1, 
37.7, 37.3, 33.2, 29.4, 14.22, 14.21; IR (cm-1): 2981, 2938, 1727, 1445, 1367, 1185, 1095, 1041, 




yl)benzenesulfonamide (S2.88): Prepared according to GP-2.4 from crude A2.14 (343 mg, 
0.72 mmol, 1.0 equiv.) and O-methylhydroxylamine hydrochloride (121 mg, 1.45 mmol, 
2.0 equiv.). Purification by flash column chromatography (2–18% EtOAc/hexanes) afforded the 
pure title compound as a colorless oil (326 mg, 90%; E/Z (oxime) = 1.1:1). 
1H NMR (500 MHz, CDCl3): d 7.73 (dd, J = 10.2, 8.3 Hz, 4.2H; major+minor), 7.36 – 7.18 (m, 
15.8H; major+minor), 6.75 (d, J = 5.6 Hz, 1H; minor), 6.46 (dd, J = 20.2, 15.9 Hz, 2.1H; 
major+minor), 6.09 (ddt, J = 32.6, 15.9, 6.7 Hz, 2.1H; major+minor), 4.83 (q, J = 6.1 Hz, 1H; 








6.7, 1.7 Hz, 2.1H; major+minor), 3.74 (s, 3.3H; major), 3.67 (s, 3H; minor), 2.40 (s, 3H; minor), 
2.39 (s, 3.3H; major), 0.87 – 0.78 (m, 18.9H; major+minor), 0.00 (d, J = 3.2 Hz, 12.6H; 
major+minor); 13C NMR (176 MHz, CDCl3): d 147.5, 147.0, 143.32, 143.26, 138.1, 137.7, 136.5, 
136.4, 133.5, 133.0, 129.6, 129.5, 128.7, 128.6, 128.0, 127.9, 127.68, 127.65, 126.59, 126.57, 
126.3, 126.0, 63.4, 62.7, 62.0, 61.9, 58.6, 54.8, 49.3, 48.1, 25.9 (2C), 21.6 (2C), 18.34, 18.30, -
5.35 (3C), -5.41; IR (cm-1): 2928.4, 2855.9, 1462.9, 13339.7, 1253.1, 1156.5, 1090.2, 1043.9, 
967.1, 900.1, 834.0, 813.1, 776.5, 727.4, 691.6, 657.8.; HRMS: m/z calculated C26H38N2O4SSiH+ 
for [M+H]+: 503.2394; found: 503.2393. 
 
1-(Cinnamyloxy)propan-2-one O-methyl oxime (S2.89): Prepared according to GP-2.4 from 
A2.15 (295 mg, 1.6 mmol, 1.0 equiv.) and O-methylhydroxylamine hydrochloride (259 mg, 
3.1 mmol, 2.0 equiv.). Purification by flash column chromatography (5–15% EtOAc/hexanes) 
afforded the pure title compound as a colorless oil (316 mg, 93%; E/Z (oxime) = 1:3.3). 
1H NMR (700 MHz, CDCl3): d 7.41 – 7.37 (m, 8.6H; major+minor), 7.34 – 7.29 (m, 8.6H; 
major+minor), 7.24 (t, J = 7.3 Hz, 4.3H; major+minor), 6.62 (dd, J = 15.7, 3.7 Hz, 4.3H; 
major+minor), 6.31 – 6.25 (m, 4.3H; major+minor), 4.32 (s, 2H; minor), 4.14 (td, J = 6.5, 1.4 Hz, 
8.6H; major+minor), 4.04 (s, 6.6H; major), 3.88 (s, 9.9H; major), 3.81 (s, 3H; minor), 1.97 (s, 3H; 
minor), 1.91 (s, 9.9H; major); 13C NMR (176 MHz, CDCl3): d 157.2, 154.9, 136.72, 136.67, 
133.0, 132.9, 128.69, 128.67, 127.90, 127.86, 126.6 (2C), 125.59, 125.55, 71.9, 71.5, 70.9, 65.6, 
61.7, 61.6, 16.7, 12.2; IR (cm-1): 2937, 2852, 1495, 1448, 1366, 1115, 1045, 965, 888, 831, 735, 







(Z)-2-(Cinnamyloxy)-1-phenylethan-1-one O-methyl oxime (S2.90): Prepared according to GP-
2.4 from crude A2.16 (stoichiometry based on 2.9 mmol A2.17) and O-methylhydroxylamine 
hydrochloride (482 mg, 5.8 mmol, 2.0 equiv.). Purification by flash column chromatography (5–
15% EtOAc/hexanes) afforded the pure title compound as a colorless oil (255 mg, 31%; Z only). 
1H NMR (700 MHz, CDCl3): d 7.71 (dd, J = 6.5, 2.9 Hz, 2H), 7.39 – 7.34 (m, 5H), 7.31 (t, J = 
7.6 Hz, 2H), 7.24 (t, J = 7.3 Hz, 1H), 6.55 (d, J = 15.9 Hz, 1H), 6.22 (dt, J = 15.9, 6.1 Hz, 1H), 
4.69 (s, 2H), 4.13 (d, J = 6.1 Hz, 2H), 4.00 (s, 3H); 13C NMR (176 MHz, CDCl3): d 155.5, 136.7, 
134.4, 133.1, 129.3, 128.7, 128.4, 127.9, 127.2, 126.6, 125.6, 71.5, 62.4, 62.0; IR (cm-1): 2936, 
1724, 1494, 1445, 1327, 1184, 1115, 1041, 965, 885, 763, 743, 690; HRMS: m/z calculated for 
C18H19NO2H+ [M+H]+: 282.1489; found: 282.1494. 
 
(E)-2-(Cinnamyloxy)benzaldehyde O-methyl oxime (S2.94): Prepared according to GP-2.4 
from 2-(cinnamyloxy)benzaldehyde178 (508 mg, 2.1 mmol, 1.0 equiv.) and O-
methylhydroxylamine hydrochloride (356 mg, 4.3 mmol, 2.0 equiv.). Purification by flash column 
chromatography (10% EtOAc/hexanes) afforded the pure title compound as a colorless oil 
(459 mg, 81%; E only). 
1H NMR (700 MHz, CDCl3): d 8.53 (s, 1H), 7.81 (dd, J = 7.7, 1.6 Hz, 1H), 7.41 (d, J = 7.6 Hz, 
2H), 7.34 (t, J = 7.6 Hz, 3H), 7.29 – 7.26 (m, 1H), 6.96 (t, J = 7.5 Hz, 1H), 6.94 (d, J = 8.3 Hz, 
1H), 6.72 (d, J = 16.0 Hz, 1H), 6.40 (dt, J = 16.0, 5.7 Hz, 1H), 4.73 (dd, J = 5.7, 1.4 Hz, 2H), 3.98 
(s, 3H); 13C NMR (176 MHz, CDCl3): d 156.8, 145.0, 136.5, 133.2, 131.2, 128.8, 128.1, 126.7, 









1051, 1005, 963, 917, 743, 690; HRMS: m/z calculated for C17H17NO2Na+ [M+Na]+: 290.1151; 
found: 290.1147. 
 
Diethyl 2-cinnamyl-2-(3-(methoxyimino)propyl)malonate (S2.95): Prepared according to GP-
2.4 from A.18 (500 mg, 1.5 mmol, 1.0 equiv.) and O-methylhydroxylamine hydrochloride 
(251 mg, 3.0 , 2.0 equiv.). Purification by flash column chromatography (20% EtOAc/hexanes) 
afforded the pure title compound as a pale-yellow oil (476 mg, 88%; E/Z (oxime) = 1.2:1). 
1H NMR (500 MHz, CDCl3): d 7.35 – 7.27 (m, 10H; major+minor), 7.21 (t, J = 6.8 Hz, 2.2H; 
major+minor), 6.62 (t, J = 5.3 Hz, 1H; minor), 6.45 (d, J = 15.7 Hz, 2.2H; major+minor), 6.03 
(dtd, J = 15.4, 7.5, 2.6 Hz, 2.2H; major+minor), 4.25 – 4.17 (m, 8.8H; major+minor), 3.84 (s, 3H; 
minor), 3.80 (s, 3.6H; major), 2.82 (d, J = 7.5 Hz, 4.4H; major+minor), 2.34 – 2.27 (m, 2H; minor), 
2.24 – 2.17 (m, 2.4H; major), 2.14 – 2.06 (m, 4.4H; major+minor), 1.25 (t, J = 7.1 Hz, 13.2H; 
major+minor); 13C NMR (176 MHz, CDCl3): d 170.9 (2C), 150.2, 149.5, 137.12, 137.10, 134.2 
(2C), 128.6 (2C), 127.6 (2C), 126.34, 126.33, 123.81, 123.79, 61.8, 61.6 (2C), 61.4, 57.5, 57.4, 
36.8, 36.4, 29.7, 29.1, 24.8, 20.8, 14.2 (2C); IR (cm-1): 2980, 1725, 1446, 1367, 1263, 1180, 1094, 
1049, 1028, 967, 858, 741, 693; HRMS: m/z calculated for C20H27NO5Na+ [M+Na]+: 384.1781; 
found: 384.1783. 
 
3-(Buta-1,3-dien-1-yl)cyclopentane-1-carbaldehyde O-benzyl oxime (2.101): Prepared 
according to GP-2.4 from (1S*,3R*)-3-(buta-1,3-dien-1-yl)cyclopentane-1-carbaldehyde179 







(366 mg, 2.3 mmol, 2.0 equiv.). Purification by flash column chromatography (0–10% 
EtOAc/hexanes) afforded the pure title compound as a colorless oil (205 mg, 70%; E/Z (oxime) = 
2:1; E/Z (diene) = 10:1). .Characterization data is provided for the two major (E)-diene isomers. 
1H NMR (700 MHz, CDCl3): d 7.38 (d, J = 7.4 Hz, 2H; major), 7.37 – 7.33 (m, 12H; 
major+minor), 7.31 – 7.28 (m, 3H; major+minor), 6.65 (d, J = 6.9 Hz, 1H, minor), 6.29 (dt, J = 
17.2, 10.3 Hz, 3H; major+minor), 6.05 (dd, J = 15.2, 10.6 Hz, 3H; major+minor), 5.69 – 5.63 (m, 
3H; major+minor), 5.10 (d, J = 18.0 Hz, 5H; major+minor), 5.04 (s, 4H; major), 4.98 (d, J = 
10.1 Hz, 3H; major+minor), 3.38 – 3.31 (m, 1H; minor), 2.80 – 2.71 (m, 2H; major), 2.66 – 2.52 
(m, 3H; major+minor), 2.17 – 2.10 (m, 1H; minor), 2.06 – 2.00 (m, 2H; major), 1.99 – 1.83 (m, 
6H; major+minor), 1.69 – 1.60 (m, 3H; major+minor), 1.49 – 1.41 (m, 3H; major+minor), 1.33 
(dt, J = 12.6, 10.3 Hz, 2H; major), 1.21 (dt, J = 12.5, 10.3 Hz, 1H; minor); 13C NMR (176 MHz, 
CDCl3): d 156.9, 156.5, 154.9, 154.8, 138.7, 138.6, 137.24, 137.22, 129.89, 129.86, 128.53, 
128.50, 128.44, 128.43, 127.98, 127.98, 115.41, 115.39, 75.8, 75.7, 43.34, 43.33, 39.90, 39.90, 
38.28, 38.26, 32.3, 32.1, 30.0, 29.8; IR (cm-1): 2950, 2866, 1496, 1453, 1366, 1040, 1003, 899, 
732, 696; HRMS: m/z calculated for C17H21NOH+ [M+H]+: 256.1696; found: 256.1701. 
 
Diethyl 2-allyl-2-(2-(methoxyimino)ethyl)malonate (2.105): Prepared according to GP-2.4 from 
diethyl 2-allyl-2-(2-oxoethyl)malonate180 (271 mg, 1.0 mmol, 1.0 equiv.) and O-
methylhydroxylamine hydrochloride (167 mg, 2.0 mmol, 2.0 equiv.). Purification by flash column 
chromatography (10% EtOAc/hexanes) afforded the pure title compound as a colorless oil 






General Procedure for Hydrazone Synthesis (GP-2.5) 
 
A 100-mL round-bottom flask equipped with a magnetic stir bar was charged with acetal 
(1.0 equiv.) and a 1:1 mixture (v/v) of water/acetone (0.1 M). p-TsOH (0.2 equiv.) was added and 
the solution heated at 85 °C until complete as determined by TLC analysis (4–8 h). After cooling 
to rt, NaHCO3 solution (aq., sat.) was added and the mixture extracted with EtOAc (3x). The 
combined organic extracts were dried over Na2SO4, filtered, concentrated in vacuo and dried using 
high-vac. 
The crude aldehyde was dissolved in MeOH (0.1 M), the corresponding 
hydrazide/hydrazine (1.5 equiv.) added and the reaction stirred overnight at rt. Then, the solvent 
was removed in vacuo and the crude product purified by flash column chromatography 
(EtOAc/hexanes) to afford the corresponding pure hydrazone. 
 
Tert-butyl 2-(2-(cinnamyloxy)ethylidene)hydrazine-1-carboxylate (2.73): Prepared according 
to GP-2.5 from A2.1 (500 mg, 2.3 mmol, 1.0 equiv.) and tert-butyl carbazate (446 mg, 3.4 mmol, 
1.5 equiv.). Purification by flash column chromatography (20–40% EtOAc/hexanes) afforded the 
pure title compound as a pale-yellow solid (402 mg, 62%; E/Z (hydrazone) = 3.9:1). 
1H NMR (700 MHz, CDCl3): d 7.86 (s, 3.9H; major), 7.41 – 7.36 (m, 9.8H; major+minor), 7.35 
– 7.29 (m, 9.8H; major+minor), 7.24 (t, J = 7.3 Hz, 5.9H; major+minor), 6.65 (d, J = 7.8 Hz, 1H; 
minor), 6.61 (d, J = 15.8 Hz, 3.9H; major), 6.26 (dt, J = 15.9, 6.1 Hz, 4.9H; major+minor), 4.24 – 
4.19 (m, 9.8H; major+minor), 4.19 – 4.15 (m, 9.8H; major+minor), 1.50 (s, 44.1H; major+minor); 
13C NMR (176 MHz, CDCl3): d 152.8, 152.5, 143.1, 139.4, 136.6, 136.2, 134.2, 133.1, 128.7, 
O
CH(OMe)2











128.6, 128.2, 127.8, 126.7, 126.6, 125.4, 124.2, 81.4, 81.2, 71.8, 71.3, 69.3, 66.7, 28.3 (2C); IR 
(cm-1): 3232, 2978, 2931, 1706, 1533, 1449, 1366, 1269, 1247, 1164, 1133, 1042, 1015, 966, 859, 
723, 691; HRMS: m/z calculated for C16H22N2O3Na+ [M+Na]+: 313.1523; found: 313.1530. 
 
(E)-2-(2-(Cinnamyloxy)ethylidene)-1,1-dimethylhydrazine (2.74): Prepared according to GP-
2.5 from A2.1 (300 mg, 1.4 mmol, 1.0 equiv.) and N,N-dimethylhydrazine (0.15 mL, 2.0 mmol, 
1.5 equiv.). Purification by flash column chromatography (5–10% EtOAc/hexanes) afforded the 
pure title compound as a pale-yellow oil (116 mg, 39%; E only). 
1H NMR (700 MHz, CDCl3): d 7.38 (d, J = 8.0 Hz, 2H), 7.31 (t, J = 7.2 Hz, 2H), 7.23 (t, J = 
7.3 Hz, 1H), 6.65 – 6.59 (m, 2H), 6.31 (dt, J = 15.9, 6.1 Hz, 1H), 4.18 (d, J = 6.1 Hz, 2H), 4.15 (d, 
J = 5.3 Hz, 2H), 2.83 (s, 6H); 13C NMR (176 MHz, CDCl3): d 136.9, 132.9, 131.8, 128.7, 127.8, 
126.6, 126.1, 71.0, 70.7, 42.8; IR (cm-1): 2854, 1598, 1496, 1447, 1262, 1116, 1036, 968, 817, 








2-(Cinnamyloxy)acetonitrile (A2.17): A 100-mL round-bottom flask equipped with a stir bar 
was charged with NaH (60% dispersion in mineral oil; 1.79 g, 44.7 mmol, 1.2 equiv.) and THF 
(35 mL). The mixture was cooled to 0 °C and a solution of cinnamyl alcohol (5.00 g, 37.3 mmol, 
1.0 equiv.) in THF (5 mL) was added dropwise. After stirring for 30 min at 0 °C, bromoacetonitrile 
(3.1 mL, 44.7 mmol, 1.2 equiv.) was added and the reaction mixture allowed to warm up to rt and 
stirred overnight. Then, NH4Cl solution (aq., sat.) was added and the biphasic mixture diluted with 
water and EtOAc. The organic layer was separated and the aqueous layer extracted with EtOAc 
(3x). The combined organic extracts were washed with brine, dried over Na2SO4, filtered and 
concentrated in vacuo. Purification by flash column chromatography (5–10% EtOAc/hexanes) 
afforded the pure title compound as a pale-yellow oil (3.23 g, 50%). 
1H NMR (700 MHz, CDCl3): d 7.41 (d, J = 7.4 Hz, 2H), 7.34 (t, J = 7.6 Hz, 2H), 7.28 (t, J = 
7.3 Hz, 1H), 6.70 (d, J = 15.9 Hz, 1H), 6.23 (dt, J = 15.9, 6.4 Hz, 1H), 4.31 (dd, J = 6.5, 1.2 Hz, 
2H), 4.29 (s, 2H); 13C NMR (176 MHz, CDCl3): d 136.0, 135.4, 128.8, 128.4, 126.8, 123.2, 116.1, 
71.8, 54.8; IR (cm-1): 3027, 2861, 1494, 1450, 1352, 1091, 967, 883, 744, 692; HRMS: m/z 
calculated for C11H11NONa+ [M+Na]+: 196.0733; found: 196.0730. 
 
(Z)-2-((3-Phenylallyl)oxy)ethan-1-ol (A2.6): A 25-mL round-bottom flask equipped with a stir 
bar was charged with nickel(II) acetate tetrahydrate (71 mg, 0.28 mmol, 0.2 equiv.), sodium 
borohydride (11 mg, 0.28 mmol, 0.2 equiv.) and EtOH (4 mL). The mixture was sparged with 





















yn-1-yl)oxy)ethan-1-ol182 (250 mg, 1.4 mmol, 1.0 equiv.) and 1,2-diaminoethane (38 µL, 
0.57 mmol, 0.4 equiv.) in EtOH (1 mL) was added and the reaction stirred for 5.5 h at rt under an 
atmosphere of hydrogen. The mixture was filtered through celite and the filtrate concentrated in 
vacuo. Purification by flash column chromatography (30% EtOAc/hexanes) afforded the pure title 
compound as a colorless oil (207 mg, 82%). Spectroscopic data were consistent with those 
reported in the literature.176 
 
(E)-2-((3-(4-(Trifluoromethyl)phenyl)allyl)oxy)ethan-1-ol (A2.7): In a 25-mL round-bottom 
flask equipped with a magnetic stir bar, NaH (60% dispersion in mineral oil; 148 mg, 3.7 mmol, 
1.2 equiv.) was added to a solution of ethylene glycol (0.31 mL, 5.6 mmol, 1.9 equiv.) in THF 
(8 mL) at 0 °C and the resulting mixture stirred for 0.5 h at that temperature, before adding 4-
(trifluoromethyl)cinnamyl bromide183 (800 mg, 3.0 mmol, 1.0 equiv.) as solution in THF (2 mL) 
dropwise. Then, the reaction mixture was allowed to warm up to rt and heated at reflux overnight. 
After cooling down to rt, NH4Cl solution (aq., sat.) was added and the biphasic mixture diluted 
with water and EtOAc. The organic layer was separated and the aqueous layer extracted with 
EtOAc (3x). The combined organic extracts were washed with brine, dried over Na2SO4, filtered 
and concentrated in vacuo. Purification by flash column chromatography (5–50% EtOAc/hexanes) 
afforded the pure title compound as colorless oil (470 mg, 64%). 
1H NMR (700 MHz, CDCl3): d 7.57 (d, J = 8.2 Hz, 2H), 7.48 (d, J = 8.2 Hz, 2H), 6.66 (d, J = 
16.0 Hz, 1H), 6.39 (dt, J = 16.0, 5.8 Hz, 1H), 4.23 (dd, J = 5.8, 1.4 Hz, 2H), 3.80 (t, J = 4.6 Hz, 
2H), 3.64 (t, J = 4.6 Hz, 2H); 13C NMR (176 MHz, CDCl3): d 140.2, 131.0, 129.7 (q, J = 32.4 Hz), 









1615, 1322, 1162, 1106, 1065, 1016, 968, 852, 730; HRMS: m/z calculated for C12H13F3O2Na+ 
[M+Na]+: 269.0760; found: 269.0762. 
 
Diethyl (E)-2-(3-(4-methoxyphenyl)allyl)-2-(2-oxoethyl)malonate (A2.12): A 25-mL round-
bottom flask equipped with a magnetic stir bar was charged with diethyl 2-allyl-2-(2-
oxoethyl)malonate180 (300 mg, 1.2 mmol, 1.0 equiv.) and CH2Cl2 (2.5 mL). Hoveyda-Grubbs 
catalyst (2nd generation) (39 mg, 0.06 mmol, 5 mol%), 4-methoxystyrene (332 mg, 2.5 mmol, 
2.0 eq.), and benzoquinone (7 mg, 0.06 mmol, 5 mol%) were added sequentially and the reaction 
was heated at reflux for 16 h. After cooling to room temperature, the solvent was removed in vacuo 
and the crude product purified by flash column chromatography (2–30% EtOAc/hexanes) to afford 
the pure title compound as a yellow oil (220 mg, 55%). 
1H NMR (500 MHz, CD2Cl2): d 9.70 (s, 1H), 7.26 (d, J = 8.6 Hz, 2H), 6.83 (d, J = 8.7 Hz, 2H), 
6.37 (d, J = 15.7 Hz, 1H), 5.90 (dt, J = 15.5, 7.6 Hz, 1H), 4.27 – 4.12 (m, 4H), 3.78 (s, 3H), 2.96 
(s, 2H), 2.86 (d, J = 7.6 Hz, 2H), 1.25 (t, J = 7.1 Hz, 6H); 13C NMR (126 MHz, CD2Cl2): d 199.6, 
170.8, 159.9, 134.6, 130.2, 127.9, 121.8, 114.4, 62.5, 55.8, 55.7, 46.8, 38.2, 14.4; IR (cm-1): 2981, 
2839, 1723, 1607, 1511, 1247, 1190, 1176, 1094, 1031, 972, 843; HRMS: m/z calculated for 
C19H24O6Na+ [M+Na]+: 371.1465; found: 371.1465. 
 
Diethyl 2-cinnamyl-2-(2-oxoethyl)malonate (A2.13): A 25-mL round-bottom flask equipped 
with a magnetic stir bar was charged with NaH (60% dispersion in mineral oil; 193 mg, 4.8 mmol, 
EtO2C CO2Et
















1.2 equiv.) and THF (13 mL). After cooling the mixture to 0 °C, diethyl 2-(2,2-
dimethoxyethyl)malonate184 (1.00 g, 4.0 mmol, 1.0 equiv.) was added dropwise and the solution 
allowed to warm up to rt and stirred for 1 h. The solution was cooled to 0 °C, then, cinnamyl 
bromide (1.19 g, 6.0 mmol, 1.5 equiv.) was added subsequently and the solution allowed to warm 
up to rt and stirred overnight. Next, NH4Cl solution (aq., sat.) was added and the biphasic mixture 
diluted with water and Et2O. The organic layer was separated and the aqueous layer extracted with 
Et2O (3x). The combined organic extracts were dried over MgSO4, filtered, concentrated in vacuo 
and dried using high-vac. 
The crude acetal was dissolved in a 1:1 mixture (v/v) of water/acetone (40 mL). p-TsOH 
(153 mg, 0.8 mmol, 0.2 equiv.) was added and the reaction heated at 85 °C for 2 h. After cooling 
down to rt, NaHCO3 solution (aq., sat.) was added and the mixture extracted with EtOAc (3x). The 
combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. 
Purification by flash column chromatography (20% EtOAc/hexanes) afforded the pure title 
compound as colorless oil (950 mg, 74%). 
1H NMR (500 MHz, CDCl3): d 9.73 (s, 1H), 7.34 – 7.27 (m, 4H), 7.25 – 7.21 (m, 1H), 6.43 (d, 
J = 15.7 Hz, 1H), 6.05 (dt, J = 15.5, 7.6 Hz, 1H), 4.24 (q, J = 7.1 Hz, 4H), 3.01 (s, 2H), 2.92 (d, 
J = 7.6 Hz, 2H), 1.27 (t, J = 7.1 Hz, 6H); 13C NMR (176 MHz, CDCl3): d 199.0, 170.1, 136.8, 
134.9, 128.7, 127.8, 126.4, 123.6, 62.1, 55.2, 46.4, 37.7, 14.1; IR (cm-1): 2982, 1721, 1446, 1367, 
1188, 1093, 1020, 969, 860, 741, 693; HRMS: m/z calculated for C18H22O5Na+ [M+Na]+: 
341.1359; found: 341.1362. 
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Methyl N-cinnamyl-N-tosyl-D-serinate (A2.19): A 100-mL round-bottom flask equipped with a 
magnetic stir bar was charged with D-serine methyl ester hydrochloride (1.00 g, 6.43 mmol, 
1.0 equiv.) and CH2Cl2 (30 mL), before adding tosyl chloride (1.76 g, 9.23 mmol, 1.4 equiv.) and 
triethylamine (2.93 mL, 21.0 mmol, 3.3 equiv.). After stirring at rt for 16 h, NaHCO3 solution (aq., 
sat.) was added, the organic layer separated, and the aqueous layer extracted with CH2Cl2 (3x). 
The combined organic extracts were washed with brine, dried over Na2SO4, filtered and 
concentrated in vacuo, then dried using high-vac. 
The crude N-tosyl amine was dissolved in acetone (30 mL), before adding K2CO3 (1.74 g, 
12.6 mmol, 2.0 equiv.), cinnamyl bromide (2.49 g, 12.6 mmol, 2.0 equiv.), and KI (140 mg, 
0.84 mmol, 0.1 equiv.). The resulting mixture was stirred at 60 °C for 3 h. Next, NaHCO3 solution 
(aq., sat.) was added, the organic layer separated, and the aqueous layer extracted with Et2O (3x). 
The combined organic extracts were washed with brine, dried over MgSO4, filtered and 
concentrated in vacuo. Purification by flash column chromatography (5–65% EtOAc/hexanes) 
afforded the pure title compound as a pale-yellow oil (1.17 g, 47%). 
1H NMR (700 MHz, CDCl3): d 7.73 (d, J = 8.2 Hz, 2H), 7.26 (m, 6H), 7.21 (m, 1H), 6.48 – 6.43 
(m, 1H), 6.10 (dt, J = 15.9, 6.7 Hz, 1H), 4.62 (t, J = 6.4 Hz, 1H), 4.10 (dd, J = 16.1, 6.2 Hz, 1H), 
4.06 (dd, J = 11.8, 6.1 Hz, 1H), 3.94 (dd, J = 16.0, 7.2 Hz, 1H), 3.86 (dd, J = 11.8, 6.8 Hz, 1H), 
3.55 (s, 3H), 2.39 (s, 3H); 13C NMR (176 MHz, CDCl3): d 170.4, 143.8, 137.1, 136.1, 133.8, 
129.7, 128.7, 128.2, 127.7, 126.6, 125.2, 61.5, 60.9, 52.5, 49.1, 21.7; IR (cm-1): 3522, 2953, 
1739,1336, 1290, 1246, 1155, 1089, 1038, 970, 731, 660; HRMS: m/z calculated for 
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Methyl O-(tert-butyldimethylsilyl)-N-cinnamyl-N-tosyl-D-serinate (A2.20): A 100-mL round-
bottom flask equipped with a magnetic stir bar was charged with A2.19 (1.17 g, 3.00 mmol, 
1.0 equiv.), imidazole (205 mg, 3.00 mmol, 1.0 equiv.), TBSCl (543 mg, 3.60 mmol, 1.2 equiv.) 
and CH2Cl2 (30.0 mL). After stirring for 16 h at rt, the NaHCO3 solution (aq., sat.) was added and 
the organic layer separated. Then, the aqueous layer was extracted with CH2Cl2 (3x) and the 
combined organic extracts washed with brine, dried over Na2SO4, filtered and concentrated in 
vacuo. Purification by flash chromatography (2–20% EtOAc/hexanes) afforded the pure title 
compound as a colorless oil (1.30 g, 86%). 
1H NMR (400 MHz, CDCl3): d 7.72 (d, J = 8.2 Hz, 2H), 7.31 – 7.18 (m, 7H), 6.46 (d, J = 15.9 Hz, 
1H), 6.22 – 6.07 (m, 1H), 4.71 (t, J = 5.5 Hz, 1H), 4.23 – 4.08 (m, 2H), 4.04 (d, J = 5.5 Hz, 2H), 
3.57 (s, 3H), 2.37 (s, 3H), 0.82 (s, 9H), 0.00 (d, J = 3.9 Hz, 6H); 13C NMR (100 MHz, CD2Cl2): 
d 170.3, 144.1, 138.2, 137.3, 132.6, 130.0, 129.0, 128.1, 128.0, 127.5, 126.9, 63.2, 61.9, 52.5, 49.1, 
26.0, 21.8, 18.6, –5.3, –5.5; IR (cm-1): 2952, 2929, 2884, 2856, 1743, 1342, 1254, 1157, 1093, 
837, 813, 779, 753, 693, 657; HRMS: m/z calculated for C26H37NO5SSiNH4+ [M+NH4]+: 
521.2500; found: 521.2501. 
 
(R)-N-(1-((tert-butyldimethylsilyl)oxy)-3-oxopropan-2-yl)-N-cinnamyl-4-
methylbenzenesulfonamide (A2.14): A 100-mL round-bottom flask equipped with a magnetic 
stir bar was charged with A2.20 (1.17 g, 2.32 mmol, 1.0 equiv.) and CH2Cl2 (25 mL). After 
cooling the solution to –78 °C, a freshly prepared 1 M solution of DIBAL-H (0.91 mL, 5.11 mmol, 


























was transferred to an ice bath and allowed to warm to 0 °C. The mixture was diluted with diethyl 
ether (25 mL), then, water (0.2 mL) was added dropwise, followed by the addition of 15% NaOH 
(aq., 0.2 mL) and water (0.5 mL). The mixture was allowed to warm to rt and stirred for 15 min. 
Next, MgSO4 was added and the mixture stirred for an additional 15 min. Solids were removed by 
filtration and the filtrate concentrated in vacuo to afford the corresponding crude alcohol. 
The crude alcohol was dissolved in DMSO (20 mL) and IBX (971 mg, 3.47 mmol, 1.5 equiv.) was 
added sequentially. The mixture was stirred at rt for 12 h, after which Et2O (20 mL) and water 
(20 mL) were added. The mixture was filtered through celite, and the organic layer was separated 
from the biphasic filtrate. The aqueous layer was extracted with Et2O (3x), and the combined 
organic extracts were washed with brine, dried over MgSO4, filtered and concentrated in vacuo. 
Purification by flash chromatography (2–20% EtOAc/hexanes) afforded the pure title compound 
as a colorless oil (343 mg, 31%). 
1H NMR (500 MHz, CDCl3): d 9.68 (s, 1H), 7.77 (d, J = 8.3 Hz, 2H), 7.34 – 7.21 (m, 7H), 6.47 
(d, J = 15.9 Hz, 1H), 6.12 (dt, J = 15.8, 6.8 Hz, 1H), 4.34 (dd, J = 7.3, 5.0 Hz, 1H), 4.20 – 4.05 
(m, 3H), 4.02 (dd, J = 11.0, 7.4 Hz, 1H), 2.41 (s, 3H), 0.82 (s, 9H), 0.00 (d, J = 10.6 Hz, 6H); 
13C NMR (100 MHz, CDCl3): d 198.8, 143.7, 137.5, 136.1, 134.4, 129.8, 128.7, 128.2, 127.6, 
126.6, 125.0, 67.5, 61.0, 49.7, 25.8, 21.6, 18.2, –5.5, –5.6; IR (cm-1): 2954, 2928, 2856, 1734, 
1471, 1338, 1256, 1157, 1092, 837, 781, 751; HRMS: m/z calculated for C25H35NO4SSiNH4+ 
[M+NH4]+: 491.2394; found: 491.2400. 
 
1-(Cinnamyloxy)propan-2-one (A2.15): A 25-mL round-bottom flask equipped with a magnetic 
stir bar was charged with A2.17 (500 mg, 2.9 mmol, 1.0 equiv.) and THF (10 mL). After cooling 











added dropwise and the reaction mixture allowed to warm up to rt and stirred for 2 h. Then, a 2 M 
aqueous solution of HCl (5 mL) was added at 0 °C, the mixture allowed to warm up to rt and 
stirred vigorously for 0.5 h. The biphasic mixture was diluted with water and EtOAc, the organic 
layer separated and the aqueous layer extracted with EtOAc (3x). The combined organic extracts 
were washed with NaHCO3 solution (aq., sat.), brine, dried over MgSO4, filtered and concentrated 
in vacuo. Purification by flash column chromatography (5–15% EtOAc/hexanes) afforded the pure 
title compound as a colorless oil (328 mg, 60%). 
1H NMR (700 MHz, CDCl3): d 7.39 (d, J = 7.5 Hz, 2H), 7.33 (t, J = 7.6 Hz, 2H), 7.26 (t, J = 
7.8 Hz, 1H), 6.63 (d, J = 15.9 Hz, 1H), 6.29 (dt, J = 15.9, 6.2 Hz, 1H), 4.23 (dd, J = 6.2, 1.1 Hz, 
2H), 4.11 (s, 2H), 2.18 (s, 3H); 13C NMR (176 MHz, CDCl3): d 206.8, 136.5, 133.7, 128.8, 128.1, 
126.7, 125.1, 75.4, 72.1, 26.6; IR (cm-1): 3027, 2852, 1729, 1716, 1495, 1449, 1354, 1119, 966, 
733, 692; HRMS: m/z calculated for C12H14O2Na+ [M+Na]+: 213.0886; found: 213.0893. 
 
2-(Cinnamyloxy)-1-phenylethan-1-one (A2.16): A 50-mL round-bottom flask equipped with a 
magnetic stir bar was charged with freshly grinded magnesium turnings (105 mg, 4.3 mmol, 
1.5 equiv.). THF (4 mL) and bromobenzene (0.48 mL, 4.6 mmol, 1.6 equiv.) were added 
sequentially and the mixture brought to reflux with a heat gun, then allowed to stir at rt for 2 h. 
After diluting the solution with THF (4 mL), CuBr (8 mg, 0.06 mmol, 0.02 equiv.) and A2.17 
(500 mg, 2.9 mmol, 1.0 equiv.) were added and the reaction heated at reflux for 0.5 h. Then, the 
mixture was cooled to 0 °C and 2 M aqueous HCl solution (5 mL) was added followed by vigorous 
stirring for 0.5 h. The biphasic mixture was partitioned between water and Et2O, the organic layer 
separated and the aqueous layer extracted with Et2O (3x). The combined organic extracts were 











in vacuo, then dried using high-vac. The crude phenyl ketone was used for the synthesis of S2.90 
without further purification. 
 
N-Cinnamyl-N-(2-hydroxy-2-(pyridin-2-yl)ethyl)-4-methylbenzenesulfonamide (A2.8): A 
25-mL round-bottom flask with a magnetic stir bar was charged with 2-bromopyridine (0.16 mL, 
1.61 mmol, 1.0 equiv.) and THF (1 mL), and a 1 M solution of isopropylmagnesium bromide in 
THF (1.6 mL, 1.0 equiv.) was added over 5 minutes. After stirring for 2 h at rt, a solution of N-
cinnamyl-N-(2-hydroxyethyl)-4-methylbenzenesulfonamide175 (530 mg, 1.61 mmol, 1.0 equiv.) 
in THF (1 mL) was added dropwise. The mixture was stirred for 12 h at rt followed by addition of 
NH4Cl solution (aq., sat.). The organic layer was separated, and the aqueous layer extracted with 
diethyl ether (3x). The combined organic extracts were washed with brine, dried over MgSO4, 
filtered and concentrated in vacuo. Purification by flash column chromatography (10–70% 
EtOAc/hexanes) afforded the pure title compound as a yellow oil (225 mg, 34%). 
1H NMR (500 MHz, CDCl3): d 8.47 (d, J = 4.7 Hz, 1H), 7.74 (d, J = 8.3 Hz, 2H), 7.70 (td, J = 
7.7, 1.7 Hz, 1H), 7.48 (d, J = 7.8 Hz, 1H), 7.32 – 7.27 (m, 4H), 7.25 – 7.13 (m, 4H), 6.37 (d, J = 
15.9 Hz, 1H), 5.80 (dt, J = 15.8, 6.8 Hz, 1H), 5.02 (q, J = 5.0 Hz, 1H), 4.27 (d, J = 5.4 Hz, 1H), 
4.03 (dd, J = 15.5, 5.8 Hz, 1H), 3.92 (dd, J = 15.5, 7.3 Hz, 1H), 3.51 (dd, J = 14.7, 4.5 Hz, 1H), 
3.44 (dd, J = 14.8, 7.4 Hz, 1H), 2.41 (s, 3H); 13C NMR (126 MHz, CDCl3): d 159.5, 148.6, 143.7, 
136.9, 136.8, 136.3, 134.4, 129.9, 128.6, 128.0, 127.6, 126.6, 123.7, 123.0, 121.7, 72.4, 54.2, 52.0, 
21.6; IR (cm-1): 3026, 2924, 1596, 1438, 1335, 1305, 1155, 1089, 969, 925, 815, 732, 693, 662; 














(2-(Bromomethyl)cyclopent-1-en-1-yl)benzene (A2.21): A 25-mL round-bottom flask equipped 
with a magnetic stir bar was charged with (2-phenylcyclopent-1-en-1-yl)methanol185 (940 mg, 
5.4 mmol, 1.0 equiv.) and Et2O (6 mL). PBr3 (0.21 mL, 2.2 mmol, 0.4 equiv.) was added dropwise 
at 0 °C and the reaction stirred for 1 h at that temperature. Then, brine (1 mL) was added and the 
aqueous layer separated. The organic layer was washed sequentially with NaHCO3 solution (aq., 
sat., 3x) and brine, dried over MgSO4, filtered and concentrated in vacuo and dried using high-vac 
to afford the crude title compound as a colorless oil (1.18 g, 92%), which was directly used for the 
next step without further purification. 
 
2-((2-Phenylcyclopent-1-en-1-yl)methoxy)ethan-1-ol (A2.9): NaH (60% dispersion in mineral 
oil; 498 mg, 12.4 mmol, 2.5 equiv.) was carefully added to a solution of ethylene glycol (2.8 mL, 
49.8 mmol, 10.0 equiv.) in THF (10 mL) at 0 °C. After stirring for 15 min, the mixture was 
transferred to a 50-mL round-bottom flask equipped with a magnetic stir bar containing a solution 
of A2.21 (1.18 g, 5.0 mmol, 1.0 equiv.) in THF (10 mL) and the resulting mixture refluxed for 4 h. 
After cooling down to rt, NH4Cl solution (aq., sat.) was added and the mixture extracted with 
EtOAc (3x). The combined organic extracts were washed with brine, dried over Na2SO4, filtered 
and concentrated in vacuo. Purification by flash column chromatography (5–50% EtOAc/hexanes) 
afforded the pure title compound as a colorless oil (869 mg, 80%). 
1H NMR (700 MHz, CDCl3): d  7.34 (t, J = 7.6 Hz, 2H), 7.27 – 7.25 (m, 1H), 7.25 – 7.22 (m, 2H), 
4.17 (s, 2H), 3.74 – 3.70 (m, 2H), 3.52 – 3.48 (m, 2H), 2.79 (t, J = 7.5 Hz, 2H), 2.65 (t, J = 7.5 Hz, 
2H), 1.97 (p, J = 7.5 Hz, 2H), 1.91 (t, J = 6.2 Hz, 1H); 13C NMR (176 MHz, CDCl3): d 140.9, 















1442, 1355, 1253, 1207, 1105, 1054, 1035, 1005, 889, 760, 732, 698, 655; HRMS: m/z calculated 
for C14H18O2+ [M]+: 218.1307; found: 218.1312. 
 
Diethyl 2-cinnamyl-2-(3-oxopropyl)malonate (A2.18): A round-bottom flask equipped with a 
magnetic stir bar was charged with NaH (60% dispersion in mineral oil; 457 mg, 11.4 mmol, 
1.5 equiv.) and THF (15 mL). After cooling to 0 °C, diethyl malonate (1.7 mL, 11.4 mmol, 
1.5 equiv.) was added dropwise and the reaction mixture stirred for 1 h at that temperature. Next, 
a solution of cinnamyl bromide (1.50 g, 7.6 mmol, 1.0 equiv.) in THF (2 mL) was added and the 
reaction mixture allowed to warm up to rt and stirred overnight. NH4Cl solution (aq., sat.) and 
water were sequentially added, the organic layer separated and the aqueous layer extracted with 
EtOAc (3x). The combined organic extracts were dried over Na2SO4, filtered and concentrated in 
vacuo. Excess diethyl malonate was removed under high-vac at 70 °C, and the crude product was 
taken to the next step without further purification. 
A 100-mL round-bottom flask equipped with a magnetic stir bar was charged with crude 
diethyl 2-cinnamylmalonate, K2CO3 (1.16 g, 8.4 mmol, 1.1 equiv.), acrolein (0.85 mL, 
11.4 mmol, 1.5 equiv.) and CH2Cl2 (20 mL) and the mixture stirred at rt overnight. Water and 
EtOAc were added, the organic layer separated and the aqueous layer extracted with EtOAc (3x). 
The combined organic extracts were washed with brine, dried over Na2SO4, filtered and 
concentrated in vacuo. Purification by flash column chromatography (20% EtOAc/hexanes) 
afforded the pure title compound as a pale-yellow oil (914 mg, 36%). 
1H NMR (500 MHz, CDCl3): d 9.74 (s, 1H), 7.33 – 7.27 (m, 4H), 7.24 – 7.20 (m, 1H), 6.45 (d, 
J = 15.7 Hz, 1H), 6.04 (dt, J = 15.5, 7.5 Hz, 1H), 4.26 – 4.15 (m, 4H), 2.80 (d, J = 7.5 Hz, 2H), 
EtO2C CO2Et






2.53 (t, J = 7.8 Hz, 2H), 2.24 (t, J = 8.1 Hz, 2H), 1.26 (t, J = 7.1 Hz, 6H); 13C NMR (176 MHz, 
CDCl3): d 200.9, 170.9, 137.0, 134.3, 128.6, 127.6, 126.3, 123.6, 61.6, 57.0, 39.3, 37.5, 25.4, 14.2; 
IR (cm-1): 2981, 1721, 1446, 1367, 1233, 1184, 1095, 1025, 968, 858, 739, 693; HRMS: m/z 
calculated for C19H24O5Na+ [M+Na]+: 355.1516; found: 355.1518. 
 
(E)-N-(2-Hydroxyethyl)-4-methyl-N-(penta-2,4-dien-1-yl)benzenesulfonamide (A2.10): 
Ethanolamine (0.25 mL, 4.1 mmol, 1.0 equiv.) was converted to N-(2-hydroxyethyl)-4-
toluenesulfonamide following a literature procedure175 and the crude product used for the next step 
without further purification. 
A 25-mL round-bottom flask equipped with a magnetic stir bar was charged with crude N-
(2-hydroxyethyl)-4-toluenesulfonamide from the previous step and acetone (10 mL), followed by 
the sequential addition of K2CO3 (859 mg, 6.2 mmol, 1.5 equiv.), potassium iodide (69 mg, 
0.41 mmol, 0.1 equiv.) and freshly prepared (E)-5-bromopenta-1,3-diene186 (913 mg, 6.2 mmol, 
1.5 equiv.). Then, the reaction was heated to reflux overnight. After cooling to rt, the reaction 
mixture was diluted with water and EtOAc, the organic layer separated and the aqueous layer 
extracted with EtOAc (3x). The combined organic extracts were washed with brine, dried over 
Na2SO4, filtered and concentrated in vacuo. Purification by flash column chromatography (30–
50% EtOAc/hexanes) afforded the pure title compound as a pale-yellow oil (994 mg, 85%; 
E/Z (diene) = 15:1). 
1H NMR (700 MHz, CDCl3): d 7.71 (d, J = 8.3 Hz, 2H), 7.32 (d, J = 7.9 Hz, 2H), 6.25 (dt, J = 
17.0, 10.3 Hz, 1H), 6.11 (dd, J = 15.2, 10.5 Hz, 1H), 5.51 (dt, J = 15.0, 6.8 Hz, 1H), 5.18 (d, J = 









J = 5.3 Hz, 2H), 2.44 (s, 3H); 13C NMR (176 MHz, CDCl3): d 143.7, 136.4, 135.7, 135.1, 129.9, 
127.9, 127.4, 118.6, 61.2, 51.3, 49.8, 21.6; IR (cm-1): 3510, 2925, 1598, 1447, 1329, 1152, 1047, 
1003, 950, 909, 814, 752, 726, 657; HRMS: m/z calculated for C14H19NO3SNa+ [M+Na]+: 
304.0978; found: 304.0982. 
 
2-(3-Phenylpropoxy)ethan-1-ol (A2.11): A 100-mL round-bottom flask equipped with a 
magnetic stir bar was charged with 2-(cinnamyloxy)ethan-1-ol187 (1.00 g, 5.6 mmol, 1.0 equiv.), 
palladium on activated carbon (10 wt%; 299 mg, 5 mol%) and MeOH (30 mL). The mixture was 
sparged for 20 min with hydrogen gas from a balloon and stirred at rt for 2 h under a hydrogen 
atmosphere. Then, the reaction mixture was passed through a pad of celite. After washing the pad 
with EtOAc, the filtrate was concentrated in vacuo and dried using high-vac to obtain the pure title 
compound as a colorless oil (1.00 g, 99%). 
1H NMR (700 MHz, CDCl3): d 7.29 (t, J = 7.6 Hz, 2H), 7.21 – 7.18 (m, 3H), 3.73 (q, J = 5.4 Hz, 
2H), 3.53 (t, J = 4.5 Hz, 2H), 3.49 (t, J = 6.4 Hz, 2H), 2.70 (t, J= 7.8 Hz, 2H), 1.96 – 1.90 (m, 3H); 
13C NMR (176 MHz MHz, CDCl3): d 141.9, 128.54, 128.46, 125.9, 71.9, 70.5, 62.0, 32.4, 31.3; 
IR (cm-1): 3418, 2927, 2862, 1496, 1453, 1361, 1118, 1044, 891, 745, 698; HRMS: m/z calculated 
for C11H16O2Na+ [M+Na]+: 203.1043; found: 203.1037. 
 
(E)-(3-ethoxyprop-1-en-1-yl)benzene (2.103): A 50-mL round-bottom flask equipped with a 
magnetic stir bar was charged with NaH (60% dispersion in mineral oil; 507 mg, 12.7 mmol, 
2.5 equiv.) and THF (15 mL). After cooling to 0 ºC, EtOH (0.74 mL, 12.7 mmol, 2.5 equiv.) was 













5.1 mmol, 1.0 equiv.) in THF (2.5 mL) was added at 0 ºC, and the mixture heated at reflux for 2 h. 
After cooling down to rt, NH4Cl solution (aq., sat.) was added and the resulting mixture partitioned 
between water and EtOAc. The organic layer was separated and the aqueous layer extracted with 
EtOAc (3x). The combined organic extracts were washed with brine, dried over MgSO4, filtered 
and concentrated in vacuo. Purification by flash column chromatography (2.5% Et2O/pentane) 
provided the pure title compound as a colorless oil (452 mg, 52%). Spectroscopic data were 
consistent with those reported in the literature.188 
 
Cinnamyl 2-(methoxyimino)acetate (S2.92): A 25-mL round-bottom flask equipped with a 
magnetic stir bar was charged with dicinnamyl (2R,3R)-2,3-dihydroxysuccinate189 (1.00 g, 
2.6 mmol, 1.0 equiv.) and a 2:1 THF/water mixture. NaIO4 (1.12 g, 5.2 mmol, 2.0 equiv.) was 
added and the reaction stirred overnight at rt. Then, solids were removed by filtration through a 
pad of celite and NaHSO3 solution (aq., sat.) was added to the filtrate. The resulting mixture was 
extracted with Et2O (3x) and the combined organic extracts washed with brine, dried over MgSO4, 
filtered and concentrated in vacuo, then dried using high-vac. The crude oxoacetate was used for 
the next step without further purification. 
To a 50-mL round-bottom flask equipped with magnetic stir bar containing crude 
oxoacetate and CH2Cl2 (25 mL) was sequentially added NaOAc (1.72 g, 20.9 mmol, 8.0 equiv.) 
and O-methylhydroxylamine hydrochloride (874 mg, 10.5 mmol, 4.0 equiv.). After stirring the 
resulting mixture overnight at rt, NaHCO3 solution (aq., sat.) was added, the organic layer 
separated and the aqueous layer extracted with EtOAc (3x). The combined organic extracts were 













column chromatography (5–10% EtOAc/hexanes) afforded the pure title compound as a colorless 
oil (453 mg, 40%; E/Z (oxime) = 6.7:1). 
1H NMR (500 MHz, CDCl3): d 7.52 (s, 6.7H; major), 7.40 (d, J = 7.3 Hz, 15.4H; major+minor), 
7.33 (t, J = 7.4 Hz, 15.4H; major+minor), 7.29 – 7.25 (m, 7.7H; major+minor), 6.99 (s, 1H; minor), 
6.71 (d, J = 15.9 Hz, 7.7H; major+minor), 6.39 – 6.26 (m, 7.7H; major+minor), 4.92 (dd, J = 6.6, 
1.3 Hz, 13.4H; major), 4.86 (dd, J = 6.6, 1.3 Hz, 2H; minor), 4.07 (s, 20.1H; major), 4.05 (s, 3H; 
minor); 13C NMR (176 MHz, CDCl3): d 161.9, 158.8, 140.7, 136.9, 136.1 (2C), 135.5, 135.3, 
128.77, 128.75, 128.40, 128.39, 126.84, 126.82, 122.3, 122.2, 66.3, 65.9, 64.0, 63.7; IR (cm-1): 
2941, 1719, 1598, 1494, 1449, 1382, 1318, 1265, 1198, 1171, 1047, 962, 917, 735, 691; HRMS: 
m/z calculated for C12H13NO3Na+ [M+Na]+: 242.0788; found: 242.0794. 
 
3-((Cinnamyloxy)methyl)-5,5-diphenyl-4,5-dihydroisoxazole (2.97): A 25-mL round-bottom 
flask equipped with a magnetic stir bar was charged with NaH (60% dispersion in mineral oil; 
71 mg, 1.8 mmol, 1.5 equiv.) and THF (10 mL). Next, a solution of (5,5-diphenyl-4,5-
dihydroisoxazol-3-yl)methanol190 (300 mg, 1.2 mmol, 1.0 equiv.) in THF (2 mL) was added 
dropwise at 0 °C and then, after stirring for 15 min, a solution of cinnamyl bromide (257 mg, 
1.3 mmol, 1.1 equiv.) in THF (2 mL) and the reaction allowed to warm up to rt and stirred 
overnight. NH4Cl solution (aq., sat.) was added and the mixture extracted with EtOAc (3x). The 
combined organic extracts were washed with brine, dried over Na2SO4, filtered and concentrated 
in vacuo. Purification by flash column chromatography (2–10% EtOAc/hexanes) afforded the pure 
title compound as a pale-yellow oil (384 mg, 88%). 
1H NMR (700 MHz, CDCl3): d 7.44 – 7.41 (m, 4H), 7.36 – 7.30 (m, 8H), 7.29 – 7.26 (m, 2H), 












(dd, J = 6.2, 1.4 Hz, 2H), 3.70 (s, 2H); 13C NMR (176 MHz, CDCl3): d 156.7, 144.0, 136.5, 133.6, 
128.7, 128.5, 128.00, 127.8, 126.7, 126.2, 124.9, 91.8, 71.0, 64.7, 48.4; IR (cm-1): 3025, 2852, 
1598, 1492, 1447, 1363, 1328, 1221, 1109, 1058, 966, 894, 865, 747, 692; HRMS: m/z calculated 
for C25H23NO2Na+ [M+Na]+: 392.1621; found: 392.1619.  
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Synthesis of Azetidine Products and Characterization 
General Procedure for [2+2] Cycloaddition 
General Procedure for small-scale reactions (GP-2.6). An oven-dried test tube (25x150 mm) 
equipped with a magnetic stir bar was charged with substrate (0.25 mmol, 1.0 equiv.), 
[Ir(dF(CF3)ppy)2(dtbbpy)](PF6) (1.4 mg or 2.8 mg, 0.5 or 1 mol%) and THF (25 mL). When a 
substrate required extended reaction times (>2 h), the reaction mixture was degassed by sparging 
with nitrogen gas for 30 min prior to irradiation and the reaction conducted under a nitrogen 
atmosphere. The test tube was sealed with a rubber septum and placed in front of a 40 W PR160-
427 nm Kessil light at a distance of approximately 5 cm. The light was set to 100% intensity and 
the reaction stirred until complete as judged by TLC analysis (0.5–72 h). The internal temperature 
of the photoreactor was maintained below 45 °C by a fan. Upon completion, the reaction mixture 
was transferred to a 100-mL round-bottom flask and the solvent removed in vacuo. The 
diastereomeric ratio was determined by 1H NMR analysis from the crude mixture, before purifying 
the crude product by flash column chromatography (EtOAc/hexanes) to afford the corresponding 
pure azetidine. 
General Procedure for gram-scale reactions (GP-2.7). A 500-mL round-bottom flask equipped 
with a magnetic stir bar was charged with substrate (1.0 equiv.), [Ir(dF(CF3)ppy)2(dtbbpy)](PF6) 
(0.5 mol%) and THF (0.025 M). The flask was placed in between a 40 W PR160-427 nm Kessil 
light (100% intensity) and a 34 W H150-BLUE Kessil light at a distance of approximately 5 cm 
and the reaction stirred under ambient atmosphere until complete as judged by TLC analysis. 
Solvent was removed in vacuo and the diastereomeric ratio determined by 1H NMR analysis from 
the crude mixture. Purification of the crude product by flash column chromatography 
(EtOAc/hexanes) afforded the corresponding pure azetidine. 
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Figure 2.28: Reaction setup used for the [2+2] cycloaddition reactions. left: setup for small scale reactions (0.25 mmol). right: setup 
for gram-scale reactions. 
 
 
(1R*,5S*,7S*)-6-Methoxy-7-phenyl-3-oxa-6-azabicyclo[3.2.0]heptane (2.69): Prepared 
according to GP-2.6 using (E)-2.68 (51 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 (1.4 mg, 0.5 mol%) 
and THF (25 mL) with a reaction time of 0.5 h. The diastereomeric ratio was determined to be 
>20:1 by 1H NMR analysis of the crude mixture. Purification by flash column chromatography 
(10–20% EtOAc/hexanes) afforded the pure title compound as a colorless oil (49 mg, 96%; 
combined yield). 
1H NMR (500 MHz, CDCl3): d 7.43 (d, J = 7.5 Hz, 2H), 7.37 (t, J = 7.6 Hz, 2H), 7.29 (t, J = 
7.2 Hz, 1H), 4.76 (d, J = 10.6 Hz, 1H), 4.54 (t, J = 5.5 Hz, 1H), 4.42 (d, J = 5.8 Hz, 1H), 3.98 (d, 
J = 9.4 Hz, 1H), 3.58 (dd, J = 10.6, 5.3 Hz, 1H), 3.52 (dd, J = 9.4, 3.6 Hz, 1H), 3.45 (s, 3H), 2.72 
(td, J = 5.8, 3.9 Hz, 1H); 13C NMR (126 MHz, CDCl3): d 141.9, 128.6, 127.6, 126.4, 73.9, 70.8, 
67.5, 67.2, 60.6, 42.1; IR (cm-1): 2949, 2852, 1466, 1162, 1084, 1059, 1019, 909, 730, 697; 









(1R*,5S*,7S*)-6-Methoxy-7-phenyl-3-oxa-6-azabicyclo[3.2.0]heptane (2.69): Prepared 
according to GP-2.6 using (Z)-2.68 (51 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 (1.4 mg, 0.5 mol%) 
and THF (25 mL) with a reaction time of 0.5 h. The diastereomeric ratio was determined to be 
>20:1 by 1H NMR analysis of the crude mixture. Purification by flash column chromatography 
(10–20% EtOAc/hexanes) afforded the pure title compound as a colorless oil (50 mg, 97%; 
combined yield). Spectroscopic data was found consistent with those obtained when (E)-2.68 was 
used. 
 
(1R*,5S*,7S*)-6-Methoxy-7-phenyl-3-oxa-6-azabicyclo[3.2.0]heptane (2.69): Prepared 
according to GP-2.7 using (E)-2.68 (1.40 g, 6.8 mmol, 1.0 equiv.), 2.59•PF6 (38 mg, 0.5 mol%) 
and THF (300 mL) with a reaction time of 1 h. The diastereomeric ratio was determined to be 
>20:1 by 1H NMR analysis of the crude mixture. Purification by flash column chromatography 
(5–20% EtOAc/hexanes) afforded the pure title compound as a colorless oil (1.27 g, 91%; 
combined yield). Spectroscopic data was found consistent with those obtained when the reaction 
was conducted on 0.25 mmol scale. 
 
(1R*,5S*,7S*)-6-(Benzyloxy)-7-phenyl-3-oxa-6-azabicyclo[3.2.0]heptane (2.75): Prepared 
according to GP-2.6 using 2.71 (70 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 (1.4 mg, 0.5 mol%) and 














1H NMR analysis of the crude mixture. Purification by flash column chromatography (5–10% 
EtOAc/hexanes) afforded the pure title compound as a colorless oil (67 mg, 96%; combined yield). 
1H NMR (700 MHz, CDCl3): d 7.37 – 7.35 (m, 2H), 7.33 (t, J = 7.6 Hz, 2H), 7.29 – 7.23 (m, 6H), 
4.76 (d, J = 10.5 Hz, 1H), 4.62 (s, 2H), 4.48 (d, J = 5.8 Hz, 1H), 4.30 (t, J = 5.6 Hz, 1H), 3.95 (d, 
J = 9.4 Hz, 1H), 3.50 – 3.45 (m, 2H), 2.65 (td, J = 5.9, 3.6 Hz, 1H) 13C NMR (176 MHz, CDCl3): 
d 141.9, 138.4, 128.6, 128.5, 128.3, 127.7, 127.5, 126.5, 75.6, 74.1, 70.8, 68.5, 67.6, 42.6; IR (cm-
1): 2850, 1495, 1453, 1366, 1204, 1084, 1061, 977, 909, 742, 695; HRMS: m/z calculated for 
C18H19NO2H+ [M+H]+: 282.1489; found: 282.1491. 
 
(1R*,5S*,7S*)-6-(Benzyloxy)-7-phenyl-3-oxa-6-azabicyclo[3.2.0]heptane (2.75): Prepared 
according to GP-2.7 using 2.71 (1.20 g, 4.3 mmol, 1.0 equiv.), 2.59•PF6 (24 mg, 0.5 mol%) and 
THF (300 mL) with a reaction time of 1 h. The diastereomeric ratio was determined to be 20:1 by 
1H NMR analysis of the crude mixture. Purification by flash column chromatography (5–20% 
EtOAc/hexanes) afforded the pure title compound as a colorless oil (1.08 g, 90%; combined yield). 
Spectroscopic data was found consistent with those obtained when the reaction was conducted on 
0.25 mmol scale. 
 
(1R*,5S*,7S*)-7-Phenyl-3-oxa-6-azabicyclo[3.2.0]heptan-6-ol (2.76): Prepared according to 
GP-2.6 using 2.72 (48 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 (1.4 mg, 0.5 mol%) and THF (25 mL) 
with a reaction time of 0.5 h. The diastereomeric ratio was determined to be >20:1 by 1H NMR 










EtOAc/hexanes) afforded the pure title compound as an off-white solid (48 mg, 54%; combined 
yield). 
1H NMR (700 MHz, CDCl3): d 7.35 – 7.30 (m, 4H), 7.29 – 7.26 (m, 1H), 4.79 (d, J = 10.7 Hz, 
1H), 4.36 (d, J = 5.9 Hz, 1H), 4.32 (t, J = 5.6 Hz, 1H), 3.92 (d, J = 9.4 Hz, 1H), 3.51 – 3.45 (m, 
2H), 2.74 (td, J = 5.9, 3.6 Hz, 1H); 13C NMR (176 MHz, CDCl3): d 140.8, 128.6, 127.9, 126.9, 
75.5, 70.7, 69.1, 66.8, 41.8; IR (cm-1): 3243, 2853, 1454, 1353, 1266, 1162, 1084, 1055, 954, 815, 
741, 697; HRMS: m/z calculated for C11H13NO2Na+ [M+Na]+: 214.0838; found: 214.0838. 
 
Tert-butyl ((1R*,5S*,7S*)-7-phenyl-3-oxa-6-azabicyclo[3.2.0]heptan-6-yl)carbamate (2.77): 
Prepared according to GP-2.6 using 2.73 (73 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 (1.4 mg, 
0.5 mol%) and THF (25 mL) with a reaction time of 0.5 h. The diastereomeric ratio was 
determined to be 13:1 by 1H NMR analysis of the crude mixture. Purification by flash column 
chromatography (30–40% EtOAc/hexanes) afforded the pure title compound as a pale-yellow solid 
(45 mg, 62%; combined yield). 
1H NMR (700 MHz, CDCl3): d 7.50 (d, J = 7.4 Hz, 2H), 7.36 (t, J = 7.7 Hz, 2H), 7.26 (t, J = 
7.4 Hz, 1H), 5.91 (b, 1H), 4.60 (t, J = 4.8 Hz, 1H), 4.49 (d, J = 11.5 Hz, 1H), 4.22 (d, J = 4.8 Hz, 
1H), 4.03 (d, J = 9.5 Hz, 1H), 3.50 (dd, J = 9.5, 3.9 Hz, 1H), 3.47 (dd, J = 11.5, 4.1 Hz, 1H), 2.75 
(q, J = 4.9 Hz, 1H), 1.41 (s, 9H); 13C NMR (176 MHz, CDCl3): d 154.9, 141.6, 128.6, 127.5, 
126.0, 80.3, 77.2, 71.9, 68.7, 67.5, 43.2, 28.4; IR (cm-1): 3262, 2975, 2857, 1734, 1695, 1522, 
1455, 1366, 1247, 1161, 1049, 993, 906, 743, 670; HRMS: m/z calculated for C16H22N2O3Na+ 








Prepared according to GP-2.6 using S2.79 (62 mg, 0.26 mmol, 1.0 equiv.), 2.59•PF6 (1.4 mg, 
0.5 mol%) and THF (25 mL) with a reaction time of 0.5 h. The diastereomeric ratio was 
determined to be >20:1 by 1H NMR analysis of the crude mixture. Purification by flash column 
chromatography (2–20% EtOAc/hexanes) afforded the pure title compound as a colorless oil 
(61 mg, 98%; combined yield). 
1H NMR (500 MHz, CDCl3): d 7.35 (d, J = 8.6 Hz, 2H), 7.32 (d, J = 8.6 Hz, 2H), 4.73 (d, J = 
10.7 Hz, 1H), 4.52 (t, J = 5.6 Hz, 1H), 4.36 (d, J = 5.8 Hz, 1H), 3.94 (d, J = 9.5 Hz, 1H), 3.55 (dd, 
J = 10.7, 5.3 Hz, 1H), 3.49 (dd, J = 9.5, 3.6 Hz, 1H), 3.42 (s, 3H), 2.66 (td, J = 5.9, 3.5 Hz, 1H); 
13C NMR (100 MHz, CDCl3): d 140.4, 133.3, 128.7, 127.8, 73.1, 70.7, 67.5, 67.1, 60.6, 42.2; IR 
(cm-1): 2951, 2895, 2852, 1491, 1466, 1081, 1064, 1050, 1023, 1014, 979, 913, 820, 803, 725; 
HRMS: m/z calculated for C12H14ClNO2H+ [M+H]+: 240.0786; found: 240.0786. 
 
(1R*,5S*,7S*)-7-(4-Bromophenyl)-6-methoxy-3-oxa-6-azabicyclo[3.2.0]heptane (2.80): 
Prepared according to GP-2.6 using S2.80 (71 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 (1.4 mg, 
0.5 mol%) and THF (25 mL) with a reaction time of 0.5 h. The diastereomeric ratio was 
determined to be >20:1 by 1H NMR analysis of the crude mixture. Purification by flash column 
chromatography (10–20% EtOAc/hexanes) afforded the pure title compound as a white solid 












1H NMR (500 MHz, CDCl3): d 7.48 (d, J = 8.3 Hz, 2H), 7.29 (d, J = 8.3 Hz, 2H), 4.73 (d, J = 
10.7 Hz, 1H), 4.51 (t, J = 5.5 Hz, 1H), 4.34 (d, J = 5.8 Hz, 1H), 3.94 (d, J = 9.5 Hz, 1H), 3.55 (dd, 
J = 10.7, 5.3 Hz, 1H), 3.49 (dd, J = 9.5, 3.6 Hz, 1H), 3.41 (s, 3H), 2.65 (td, J = 5.8, 3.7 Hz, 1H); 
13C NMR (126 MHz, CDCl3): d 141.0, 131.7, 128.2, 121.4, 73.2, 70.7, 67.5, 67.1, 60.7, 42.2; IR 
(cm-1): 2929, 2843, 1485, 1161, 1059, 1007, 937, 903, 858, 814, 792, 718; HRMS: m/z calculated 
for C12H14BrNO2H+ [M+H]+: 284.0281; found: 284.0279. 
 
(1R*,5S*,7S*)-7-([1,1'-Biphenyl]-4-yl)-6-methoxy-3-oxa-6-azabicyclo[3.2.0]heptane (2.81): 
Prepared according to GP-2.6 using S2.81 (70 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 (1.4 mg, 
0.5 mol%) and THF (25 mL) with a reaction time of 0.5 h. The diastereomeric ratio was 
determined to be 16:1 by 1H NMR analysis of the crude mixture. Purification by flash column 
chromatography (10–20% EtOAc/hexanes) afforded the pure title compound as a colorless oil 
(70 mg, 99%; combined yield). 
1H NMR (500 MHz, CDCl3): d 7.60 (d, J = 8.1 Hz, 4H), 7.49 (d, J = 8.1 Hz, 2H), 7.44 (t, J = 
7.6 Hz, 2H), 7.35 (t, J = 7.4 Hz, 1H), 4.77 (d, J = 10.6 Hz, 1H), 4.56 (t, J = 5.5 Hz, 1H), 4.45 (d, 
J = 5.8 Hz, 1H), 3.99 (d, J = 9.4 Hz, 1H), 3.58 (dd, J = 10.6, 5.3 Hz, 1H), 3.53 (dd, J = 9.3, 3.6 Hz, 
1H), 3.46 (s, 3H), 2.75 (td, J = 5.8, 3.8 Hz, 1H); 13C NMR (126 MHz, CDCl3): d 141.1, 141.0, 
140.6, 128.9, 127.4 (2C), 127.2, 126.9, 73.7, 70.8, 67.5, 67.2, 60.7, 42.2; IR (cm-1): 2930, 2849, 
1486, 1098, 1079, 1008, 978, 911, 832, 760, 734, 695; HRMS: m/z calculated for C18H19NO2Na+ 









(2.82): Prepared according to GP-2.6 using S2.82 (68 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 
(1.4 mg, 0.5 mol%) and THF (25 mL) with a reaction time of 0.5 h. The diastereomeric ratio was 
determined to be >20:1 by 1H NMR analysis of the crude mixture. Purification by flash column 
chromatography (5–20% EtOAc/hexanes) afforded the pure title compound as a colorless oil 
(66 mg, 97%; combined yield). 
1H NMR (700 MHz, CDCl3): d 7.61 (d, J = 8.1 Hz, 2H), 7.53 (d, J = 8.1 Hz, 2H), 4.75 (d, J = 
10.6 Hz, 1H), 4.54 (t, J = 5.5 Hz, 1H), 4.45 (d, J = 5.7 Hz, 1H), 3.97 (d, J = 9.5 Hz, 1H), 3.57 (dd, 
J = 10.6, 5.2 Hz, 1H), 3.52 (dd, J = 9.5, 3.5 Hz, 1H), 3.44 (s, 3H), 2.68 (td, J = 5.8, 3.6 Hz, 1H); 
13C NMR (176 MHz, CDCl3): d 145.9, 129.8 (q, J = 32.3 Hz), 126.6, 125.5 (q, J = 3.8 Hz), 124.3 
(q, J = 272 Hz), 73.1, 70.7, 67.6, 67.1, 60.6, 42.2; IR (cm-1): 2940, 2854, 1620, 1417, 1322, 1161, 
1118, 1064, 1017, 913, 832, 807, 712, 639; HRMS: m/z calculated for C13H14F3NO2H+ [M+H]+: 
274.1049; found: 274.1044. 
 
Diethyl (1S*,5R*,7S*)-6-methoxy-7-(4-methoxyphenyl)-6-azabicyclo[3.2.0]heptane-3,3-
dicarboxylate (2.83): Prepared according to GP-2.6 using S2.83 (94 mg, 0.25 mmol, 1.0 equiv.), 
2.59•PF6 (1.4 mg, 0.5 mol%) and THF (25 mL) with a reaction time of 1.5 h. The diastereomeric 
ratio was determined to be 20:1 by 1H NMR analysis of the crude mixture. Purification by flash 
column chromatography (2–30% EtOAc/hexanes) afforded the pure title compound as a colorless 












1H NMR (400 MHz, C6D6): d 7.37 (d, J = 8.6 Hz, 2H), 6.83 (d, J = 8.6 Hz, 2H), 4.57 (d, J = 
6.0 Hz, 1H), 4.52 (q, J = 6.9 Hz, 1H), 4.13 – 4.02 (m, 2H), 3.98 – 3.87 (m, 2H), 3.41 (dd, J = 14.7, 
4.6 Hz, 1H), 3.32 (s, 3H), 3.31 (s, 3H), 2.89 – 2.79 (m, 2H), 2.39 (qd, J = 7.1, 6.2, 1.8 Hz, 1H), 
2.29 (dd, J = 14.0, 7.9 Hz, 1H), 0.99 (t, J = 7.1 Hz, 3H), 0.89 (t, J = 7.1 Hz, 3H); 13C NMR 
(126 MHz, C6D6): d 172.3, 171.7, 159.8, 134.2, 128.5, 114.2, 76.6, 69.9, 63.9, 61.52, 61.49, 60.5, 
54.8, 42.6, 38.5, 34.7, 14.1, 14.0; IR (cm-1): 2937, 1725, 1611, 1513, 1464, 1443, 1300, 1244, 
1206, 1178, 1094, 1062, 1034, 859, 809; HRMS: m/z calculated for C20H27NO6H+ [M+H]+: 
378.1911; found: 378.1917. 
 
(1R*,5S*,7S*)-6-Methoxy-7-phenyl-3-tosyl-3,6-diazabicyclo[3.2.0]heptane (2.84): Prepared 
according to GP-2.6 using S2.84 (90 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 (1.4 mg, 0.5 mol%) 
and THF (25 mL) with a reaction time of 0.5 h. The diastereomeric ratio was determined to be 
12:1 by 1H NMR analysis of the crude mixture. Purification by flash column chromatography (10–
30% EtOAc/hexanes) afforded the pure title compound as a white solid (83 mg, 92%; combined 
yield). 
1H NMR (700 MHz, CDCl3): d 7.77 (d, J = 8.2 Hz, 2H), 7.39 – 7.32 (m, 6H), 7.30 – 7.26 (m, 1H), 
4.51 (d, J = 6.0 Hz, 1H), 4.40 – 4.33 (m, 2H), 3.61 (d, J = 10.0 Hz, 1H), 3.40 (s, 3H), 2.82 – 2.75 
(m, 2H), 2.57 (q, J = 5.8 Hz, 1H), 2.45 (s, 3H); 13C NMR (176 MHz, CDCl3): d 143.9, 141.3, 
132.5, 129.8, 128.6, 128.1, 127.8, 126.5, 73.8, 66.2, 60.8, 51.5, 46.4, 40.5, 21.7; IR (cm-1): 2936, 
1597, 1466, 1343, 1158, 1093, 1055, 1023, 813, 735, 699, 665; HRMS: m/z calculated for 









Prepared according to GP-2.6 using S2.85 (55 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 (1.4 mg, 
0.5 mol%) and THF (25 mL) with a reaction time of 1.5 h. The diastereomeric ratio was 
determined to be 1.6:1 by 1H NMR analysis of the crude mixture. Purification by flash column 
chromatography (1–5% EtOAc/hexanes) afforded the pure title compound as a colorless oil 
(51 mg, 93%; combined yield). 
(1R*,5S*,7S*) Diastereomer (major): 1H NMR (700 MHz, CDCl3): d 7.41 (d, J = 7.5 Hz, 2H), 
7.36 (t, J = 7.6 Hz, 2H), 7.27 (t, J = 7.4 Hz, 1H), 4.48 (s, 1H), 4.12 (d, J = 9.8 Hz, 1H), 3.83 (d, 
J = 2.8 Hz, 1H), 3.54 – 3.50 (m, 5H), 2.98 (d, J = 9.8 Hz, 1H), 1.44 (s, 3H); 13C NMR (176 MHz, 
CDCl3): d 138.7, 128.5, 127.5, 126.8, 77.6, 77.2, 73.0, 72.5, 61.8, 45.0, 22.7; IR (cm-1): 2952, 
2894, 2844, 1495, 1466, 1452, 1062, 1032, 1023, 911, 744, 721; HRMS: m/z calculated for 
C13H17NO2H+ [M+H]+: 220.1332; found: 220.1333; (1R*,5S*,7R*) Diastereomer (minor): 
1H NMR (500 MHz, CDCl3): d 7.39 (d, J = 7.1 Hz, 2H), 7.35 (t, J = 7.6 Hz, 2H), 7.27 (t, J = 
7.1 Hz, 1H), 4.72 (d, J = 10.7 Hz, 1H), 4.58 (s, 1H), 4.05 (d, J = 5.1 Hz, 1H), 3.83 (d, J = 9.1 Hz, 
1H), 3.68 (dd, J = 10.7, 5.1 Hz, 1H), 3.48 (s, 3H), 3.29 (d, J = 9.1 Hz, 1H), 0.86 (s, 3H); 13C NMR 
(176 MHz, CDCl3): d 139.5, 128.3, 127.3, 126.8, 76.8, 75.3, 72.3, 67.8, 60.8, 46.2, 14.3; IR (cm-
1): 2935, 2849, 1495, 1467, 1451, 1056, 1032, 1008, 943, 911, 734, 701; HRMS: m/z calculated 
for C13H17NO2H+ [M+H]+: 220.1332; found: 220.1331. 
 
(1S*,5R*,7S*)-6-Methoxy-7-phenyl-6-azabicyclo[3.2.0]heptane (2.86): Prepared according to 









(250 mL) with a reaction time of 4 h. The diastereomeric ratio was determined to be >20:1 by 1H 
NMR analysis of the crude mixture. Purification by flash column chromatography (1–5% 
EtOAc/hexanes) afforded the pure title compound as a pale-yellow oil (0.49 g, 98%; combined 
yield). 
1H NMR (700 MHz, CDCl3): d 7.39 (d, J = 7.3 Hz, 2H), 7.34 (t, J = 7.7 Hz, 2H), 7.25 (t, J = 
7.3 Hz, 1H), 4.40 (t, J = 6.5 Hz, 1H), 4.15 (d, J = 5.8 Hz, 1H), 3.44 (s, 3H), 2.54 (q, J = 5.8 Hz, 
1H), 2.48 – 2.43 (m, 1H), 2.00 – 1.93 (m, 2H), 1.82 – 1.77 (m, 1H), 1.62 – 1.50 (m, 2H); 13C NMR 
(176 MHz, CDCl3): d 143.1, 128.4, 127.1, 126.2, 74.0, 68.4, 60.5, 42.5, 30.8, 25.99, 25.95; IR 
(cm-1): 2934, 1853, 1494, 1465, 1451, 1325, 1267, 1179, 1058, 1022, 970, 944, 907, 833, 751, 
734, 697; HRMS: m/z calculated for C13H17NOH+ [M+H]+: 204.1383; found: 204.1376. 
 
Diethyl (1S*,5R*,7S*)-6-Methoxy-7-phenyl-6-azabicyclo[3.2.0]heptane-3,3-dicarboxylate 
(2.87): Prepared according to GP-2.6 using S2.87 (87 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 
(1.4 mg, 0.5 mol%) and THF (25 mL) with a reaction time of 0.5 h. The diastereomeric ratio was 
determined to be 13:1 by 1H NMR analysis of the crude mixture. Purification by flash column 
chromatography (5–10% EtOAc/hexanes) afforded the pure title compound as a colorless oil 
(84 mg, 97%; combined yield). 
1H NMR (500 MHz, CDCl3): d 7.39 (d, J = 7.5 Hz, 2H), 7.34 (t, J = 7.5 Hz, 2H), 7.29 – 7.24 (m, 
1H), 4.50 (q, J = 6.6 Hz, 1H), 4.34 (d, J = 6.0 Hz, 1H), 4.30 – 4.23 (m, 2H), 4.23 – 4.14 (m, 2H), 
3.38 (s, 3H), 3.04 (dd, J = 14.7, 4.8 Hz, 1H), 2.62 (d, J = 14.4 Hz, 1H), 2.55 (q, J = 7.4 Hz, 2H), 
2.33 (dd, J = 14.2, 7.9 Hz, 1H), 1.30 (t, J = 7.1 Hz, 3H), 1.25 (t, J = 7.1 Hz, 3H); 13C NMR 







41.5, 38.8, 34.2, 14.3, 14.2; IR (cm-1): 2980, 2938, 1726, 1445, 1366, 1252, 1180, 1094, 1061, 




3,6-diazabicyclo[3.2.0]heptane (2.88): Prepared according to GP-2.6 using S2.88 (126 mg, 
0.25 mmol, 1.0 equiv.), 2.59•PF6 (1.4 mg, 0.5 mol%) and THF (25 mL) with a reaction time of 
0.5 h. The diastereomeric ratio was determined to be 2.5:1 by 1H NMR analysis of the crude 
mixture. Purification by flash column chromatography (2–20% diethyl ether/pentane) afforded the 
pure title compound as a colorless oil (120 mg, 95%; combined yield). 
1H NMR (500 MHz, CDCl3): d 7.87 (d, J = 8.2 Hz, 2H), 7.35 (d, J = 8.2 Hz, 2H), 7.28 (m, 2H), 
7.24 (m, 1H), 7.06 (d, J = 7.0 Hz, 2H), 4.79 (t, J = 4.0 Hz, 1H), 4.46 (d, J = 6.1 Hz, 1H), 3.85 (d, 
J = 4.0 Hz, 2H), 3.53 – 3.44 (m, 3H), 3.33 (s, 3H), 2.50 (tt, J = 6.0, 2.4 Hz, 1H), 2.43 (s, 3H), 0.86 
(s, 9H), 0.06 (d, J = 15.9 Hz, 6H); 13C NMR (176 MHz, CDCl3): d 143.5, 140.8, 137.5, 129.9, 
128.5, 127.8, 127.6, 126.5, 73.1, 71.2, 66.2, 60.4, 58.8, 51.8, 41.2, 25.9, 21.7, 18.2, -5.36, -5.43; 
IR (cm-1): 2929, 2883, 2856, 1463, 1345, 1251, 1187, 1156, 1091, 1033, 1005, 956, 869, 831, 813, 




Prepared according to GP-2.6 using S2.89 (55 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 (2.8 mg, 













determined to be 17:1 by 1H NMR analysis of the crude mixture. Purification by flash column 
chromatography (5–15% EtOAc/hexanes) afforded the pure title compound as a colorless oil 
(50 mg, 91%; combined yield). 
1H NMR (700 MHz, CDCl3): d 7.43 (d, J = 7.3 Hz, 2H), 7.36 (t, J = 7.6 Hz, 2H), 7.28 (t, J = 
7.3 Hz, 1H), 4.73 (d, J = 10.1 Hz, 1H), 4.28 (d, J = 5.8 Hz, 1H), 3.93 (d, J = 9.4 Hz, 1H), 3.63 (dd, 
J = 9.4, 3.5 Hz, 1H), 3.49 (s, 3H), 3.37 (d, J = 10.1 Hz, 1H), 2.23 (dd, J = 5.7, 3.5 Hz, 1H), 1.51 
(s, 3H); 13C NMR (126 MHz, CDCl3): d 142.4, 128.5, 127.4, 126.6, 74.3, 71.8, 70.9, 70.7, 62.2, 
48.4, 23.5; IR (cm-1): 2935, 2851, 1452, 1375, 1192, 1130, 1061, 1045, 939, 913, 792, 746, 697; 
HRMS: m/z calculated for C13H17NO2H+ [M+H]+: 220.1332; found: 220.1329. 
 
(1R*,5R*,7S*)-6-Methoxy-5,7-diphenyl-3-oxa-6-azabicyclo[3.2.0]heptane (2.90): Prepared 
according to GP-2.6 using S2.90 (70 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 (2.8 mg, 1 mol%) and 
degassed THF (25 mL) with a reaction time of 18 h. The diastereomeric ratio was determined to 
be 12:1 by 1H NMR analysis of the crude mixture. Purification by flash column chromatography 
(1–10% EtOAc/hexanes) afforded the pure title compound as a colorless oil (68 mg, 97%; 
combined yield). 
1H NMR (700 MHz, CDCl3): d 7.51 (d, J = 7.1 Hz, 2H), 7.42 – 7.38 (m, 4H), 7.33 (t, J = 7.6 Hz, 
2H), 7.29 (t, J = 7.4 Hz, 1H), 7.28 – 7.24 (m, 1H), 5.03 (d, J = 10.5 Hz, 1H), 4.47 (d, J = 5.7 Hz, 
1H), 4.12 (d, J = 9.6 Hz, 1H), 3.91 (dd, J = 9.6, 3.5 Hz, 1H), 3.79 (d, J = 10.5 Hz, 1H), 3.59 (s, 
3H), 2.60 (dd, J = 5.6, 3.5 Hz, 1H); 13C NMR (176 MHz, CDCl3): d 143.0, 142.2, 128.56, 128.55, 






1446, 1262, 1059, 1043, 1022, 964, 914, 840, 748, 696; HRMS: m/z calculated for C18H19NO2H+ 
[M+H]+: 282.1489; found: 282.1491. 
 
(1R*,5S*,7S*)-6-Methoxy-7-phenyl-5-(pyridin-2-yl)-3-tosyl-3,6-diazabicyclo[3.2.0]heptane 
(2.91): Prepared according to GP-2.6 using S2.91 (109 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 
(1.4 mg, 0.5 mol%) and degassed THF (25 mL) with a reaction time of 17 h. The diastereomeric 
ratio was determined to be >20:1 by 1H NMR analysis of the crude mixture. Purification by flash 
column chromatography (10–60% EtOAc/hexanes) afforded the pure title compound as a colorless 
oil (80 mg, 74%; combined yield). 
1H NMR (500 MHz, CDCl3): d 8.39 (d, J = 4.7 Hz, 1H), 7.81 (d, J = 7.9 Hz, 3H), 7.70 (t, J = 
7.7 Hz, 1H), 7.35 (dt, J = 15.5, 7.5 Hz, 6H), 7.31 – 7.23 (m, 1H), 7.17 – 7.10 (m, 1H), 4.61 (d, J = 
10.8 Hz, 1H), 4.56 (d, J = 6.0 Hz, 1H), 3.73 (d, J = 10.0 Hz, 1H), 3.58 (d, J = 10.8 Hz, 1H), 3.54 
(s, 3H), 3.20 (dd, J = 10.0, 4.5 Hz, 1H), 2.55 – 2.49 (m, 1H), 2.46 (s, 3H); 13C NMR (176 MHz, 
CDCl3): d 161.6, 149.2, 143.7, 141.5, 136.7, 133.4, 129.8, 128.6, 128.1, 127.8, 126.9, 122.2, 120.8, 
79.3, 71.2, 61.8, 52.0, 50.9, 48.4, 21.7; IR (cm-1): 2934, 1590, 1465, 1161, 1091, 1027, 1012, 911, 
815, 784, 749, 731, 698, 666; HRMS: m/z calculated for C24H25N3O3SNa+ [M+Na]+: 458.1509; 
found: 458.1507. 
 
(1R*,5S*,7S*)-6-methoxy-7-phenyl-3-oxa-6-azabicyclo[3.2.0]heptan-4-one (2.92): Prepared 
according to GP-2.6, the reaction was conducted in a sealed 30-mL microwave vial using S2.92 
(55 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 (2.8 mg, 1 mol%) and degassed MeCN (25 mL) at 82 °C 














analysis of the crude mixture. Purification by flash column chromatography (5–40% 
EtOAc/hexanes) afforded the pure title compound as a yellow oil (33 mg, 60%; combined yield; 
75% brsm). 
1H NMR (500 MHz, CDCl3): d 7.43 – 7.37 (m, 4H), 7.36 – 7.32 (m, 1H), 4.57 (ddd, J = 12.8, 6.1, 
1.2 Hz, 2H), 4.40 (d, J = 9.7 Hz, 1H), 4.34 (dd, J = 9.8, 5.0 Hz, 1H), 3.54 (s, 3H), 2.87 (q, J = 
5.7 Hz, 1H); 13C NMR (126 MHz, CDCl3): d 171.9, 139.3, 128.9, 128.6, 126.7, 75.6, 70.5, 63.2, 
61.2, 37.1; IR (cm-1): 2934, 1774, 1456, 1371, 1266, 1160, 1046, 993, 974, 943, 731, 698; HRMS: 
m/z calculated for C12H13NO3Na+ [M+Na]+: 242.0788; found: 242.0787. 
 
(3aS*,4aS*,7aS*)-4-methoxy-4a-phenylhexahydro-1H,3H-cyclopenta[b]furo[3,4-c]azete 
(2.93): Prepared according to GP-2.6 using S2.93 (61 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 
(2.8 mg, 1 mol%) and degassed THF (25 mL) with a reaction time of 15 h. The diastereomeric 
ratio was determined to be >20:1 by 1H NMR analysis of the crude mixture. Purification by flash 
column chromatography (2–10% EtOAc/hexanes) afforded the pure title compound as a white 
solid (60 mg, 98%; combined yield). 
1H NMR (700 MHz, CDCl3): d 7.43 (dd, J = 8.2, 1.1 Hz, 2H), 7.35 (t, J = 7.8 Hz, 2H), 7.20 (tt, 
J = 7.2, 1.3 Hz, 1H), 4.02 (d, J = 10.0 Hz, 1H), 3.76 (d, J = 3.7 Hz, 1H), 3.61 (s, 3H), 3.48 (d, J = 
10.0 Hz, 1H), 3.36 (dd, J = 10.0, 3.7 Hz, 1H), 3.18 (d, J = 10.0 Hz, 1H), 2.82 (dd, J = 14.8, 6.8 Hz, 
1H), 2.11 – 2.02 (m, 2H), 1.94 – 1.87 (m, 1H), 1.87 – 1.81 (m, 2H); 13C NMR (176 MHz, CDCl3): 
d 144.2, 128.2, 126.3, 126.2, 80.9, 73.5, 72.8, 69.3, 61.4, 59.0, 35.6, 32.6, 25.7; IR (cm-1): 2959, 
2941, 2841, 1492, 1461, 1446, 1061, 1043, 992, 902, 786, 757, 736, 717, 704, 653; HRMS: m/z 








(2.94): Prepared according to GP-2.6 using S2.94 (67 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 
(2.8 mg, 1 mol%) and degassed THF (25 mL) with a reaction time of 72 h. The diastereomeric 
ratio was determined to be 7:1 by 1H NMR analysis of the crude mixture. Purification by flash 
column chromatography (1–10% EtOAc/hexanes) afforded the pure title compound as a colorless 
oil (28 mg, 42%). 
1H NMR (700 MHz, CDCl3): d 7.51 (d, J = 7.3 Hz, 2H), 7.39 (t, J = 7.6 Hz, 2H), 7.34 – 7.27 (m, 
2H), 7.24 (dd, J = 7.8, 1.4 Hz, 1H), 7.06 – 7.02 (m, 2H), 4.97 (d, J = 7.6 Hz, 1H), 4.61 (d, J = 
8.4 Hz, 1H), 4.17 (dd, J = 11.9, 1.5 Hz, 1H), 3.90 (dd, J = 11.9, 1.9 Hz, 1H), 3.48 (s, 3H), 2.68 – 
2.63 (m, 1H); 13C NMR (176 MHz, CDCl3): d 155.4, 141.0, 133.4, 129.4, 128.6, 127.8, 126.9, 
121.2, 118.9, 117.8, 70.5, 63.4, 61.2, 59.9, 36.8; IR (cm-1): 2823, 1581, 1486, 1447, 1220, 1209, 
1079, 1051, 1030, 1001, 940, 929, 747, 699; HRMS: m/z calculated for C17H17NO2Na+ [M+Na]+: 
290.1151; found: 290.1150. 
 
Diethyl (1S*,6R*,8S*)-7-Methoxy-8-phenyl-7-azabicyclo[4.2.0]octane-3,3-dicarboxylate 
(2.95): Prepared according to GP-2.6 using S2.95 (90 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 
(2.8 mg, 1 mol%) and degassed THF (25 mL) with a reaction time of 72 h. The diastereomeric 
ratio was determined to be 3.5:1 by 1H NMR analysis of the crude mixture. Purification by flash 
column chromatography (5–10% EtOAc/hexanes) afforded the pure title compound as a colorless 
oil (84 mg, 93%; combined yield). Characterization data was obtained for a 5:1 mixture of 












1H NMR (700 MHz, CDCl3): d 7.48 (d, J = 6.1 Hz, 9H; major+minor), 7.39 – 7.31 (m, 15H; 
major+minor), 7.29 – 7.24 (m, 6H; major+minor), 4.47 (d, J = 8.0 Hz, 5H; major), 4.29 (q, J = 
7.2 Hz, 10H; major), 4.21 – 4.11 (m, 15H; major), 4.04 (d, J = 9.4 Hz, 1H; minor), 3.98 (q, J = 
7.6 Hz, 5H; minor), 3.49 (s, 3H; minor), 3.44 (s, 15H; major), 2.80 (td, J = 11.2, 3.2 Hz, 1H; 
minor), 2.64 (dd, J = 12.5, 3.1 Hz, 1H; minor), 2.59 – 2.54 (m, 1H; minor), 2.52 – 2.34 (m, 10H; 
major+minor), 2.21 – 2.01 (m, 13H; major+minor), 1.97 – 1.73 (m, 15H; major+minor), 1.44 – 
1.36 (m, 1H minor), 1.30 (t, J = 7.1 Hz, 16H; major+minor), 1.23 (td, J = 7.1, 1.6 Hz, 20H; 
major+minor); 13C NMR (176 MHz, CDCl3): d 172.5, 172.0, 171.7, 170.9, 141.6, 140.1, 128.5, 
128.4, 127.7, 127.4, 126.9, 126.5, 78.8, 74.0, 72.8, 61.73, 61.66, 61.59, 61.56, 60.9, 60.8 (2C), 
56.0, 53.4, 36.5, 34.9, 32.9, 30.7, 28.6, 27.6, 26.2, 17.8, 14.21, 14.15, 14.13, 14.11; IR (cm-1): 
2938, 1726, 1449, 1367, 1228, 1175, 1111, 1024, 952, 860, 733, 699; HRMS: m/z calculated for 
C20H27NO5Na+ [M+Na]+: 384.1781; found: 384.1784. 
 
(3aR*,4S*,8aS*)-4,7,7-Triphenyltetrahydro-1H,3H-furo[3',4':2,3]azeto[1,2-b]isoxazole 
(2.98): Prepared according to GP-2.6 using 2.97 (94 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 (2.8 mg, 
1 mol%) and degassed THF (25 mL) with a reaction time of 14.5 h. The diastereomeric ratio was 
determined to be 4:1 by 1H NMR analysis of the crude mixture. Purification by flash column 
chromatography (10–60% EtOAc/hexanes) afforded the pure title compound as an off-white solid 
(82 mg, 87%; combined yield). 
1H NMR (700 MHz, CDCl3): d 7.45 – 7.42 (m, 4H), 7.39 – 7.33 (m, 3H), 7.30 (t, J = 7.8 Hz, 2H), 
7.21 (t, J = 7.3 Hz, 1H), 7.14 – 7.10 (m, 3H), 7.02 – 6.99 (m, 2H), 4.84 (d, J = 6.4 Hz, 1H), 4.04 







1H), 3.37 (d, J = 10.2 Hz, 1H), 3.18 (s, 2H); 13C NMR (176 MHz, CDCl3): d 144.3, 143.2, 135.7, 
129.6, 128.5, 128.14, 128.10, 127.9, 127.3, 127.2, 126.06, 126.06, 89.4, 78.3, 74.7, 71.5, 68.2, 
48.0, 47.8; IR (cm-1): 3058, 2968, 2850, 1598, 1492, 1448, 1265, 1189, 1125, 1043, 1032, 985, 
912, 866, 731, 694; HRMS: m/z calculated for C25H23NO2H+ [M+H]+: 370.1802; found: 370.1799. 
 
(1S*,2R*,4R*,5R*,6R*)-3-(Benzyloxy)-4-vinyl-3-azatricyclo[4.2.1.02,5]nonane (2.102): 
Prepared according to GP-2.6 using 2.101 (64 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 (2.8 mg, 
1 mol%) and degassed THF (25 mL) with a reaction time of 24 h. The diastereomeric ratio was 
determined to be 4:1 (exo/endo >20:1) by 1H NMR analysis of the crude mixture. Purification by 
flash column chromatography (0–10% EtOAc/hexanes) afforded the pure title compound as a 
colorless oil (25 mg, 39%; combined yield). Characterization data was obtained for the 
(1S*,2R*,4R*,5R*,6R*) diastereomer (major). 
1H NMR (700 MHz, CDCl3): d 7.34 – 7.30 (m, 4H), 7.28 – 7.24 (m, 1H), 5.96 (ddd, J = 17.1, 
10.2, 6.8 Hz, 1H), 5.11 (d, J = 17.1 Hz, 1H), 5.01 (d, J = 10.3 Hz, 1H), 4.60 (d, J = 11.7 Hz, 1H), 
4.56 (d, J = 11.7 Hz, 1H), 3.90 (t, J = 5.4 Hz, 1H), 3.70 (d, J = 5.6 Hz, 1H), 2.46 (s, 1H), 2.17 (d, 
J = 10.6 Hz, 2H), 1.98 (t, J = 4.9 Hz, 1H), 1.49 – 1.42 (m, 2H), 1.30 (d, J = 10.5 Hz, 1H), 1.02 – 
0.91 (m, 2H); 13C NMR (176 MHz, CDCl3): d 139.1, 138.8, 128.4, 128.3, 127.6, 114.6, 75.8, 73.4, 
71.5, 43.2, 37.9, 37.8, 34.1, 27.6, 25.2; IR (cm-1): 2952, 1871, 1453, 1364, 1023, 987, 916, 846, 







(1R*,5S*,7R*)-6-Methoxy-3-tosyl-7-vinyl-3,6-diazabicyclo[3.2.0]heptane (2.100): Prepared 
according to GP-2.6 using 2.99 (77 mg, 0.25 mmol, 1.0 equiv.), 2.59•PF6 (1.4 mg, 0.5 mol%) and 
THF (25 mL) with a reaction time of 0.5 h. The diastereomeric ratio was determined to be 2:1 by 
1H NMR analysis of the crude mixture. Purification by flash column chromatography (25% 
EtOAc/hexanes) afforded the pure title compound as a pale-yellow solid (76 mg, 99%; combined 
yield). 
(1R*,5S*,7R*) Diastereomer (major): 1H NMR (500 MHz, CDCl3): d 7.73 (d, J = 8.2 Hz, 2H), 
7.34 (d, J = 8.0 Hz, 2H), 5.94 (ddd, J = 17.3, 10.3, 7.0 Hz, 1H), 5.23 (d, J = 17.2 Hz, 1H), 5.12 (d, 
J = 10.3 Hz, 1H), 4.29 – 4.21 (m, 2H), 3.97 (t, J = 6.4 Hz, 1H), 3.49 (d, J = 10.0 Hz, 1H), 3.42 (s, 
3H), 2.72 (td, J = 11.6, 10.6, 5.8 Hz, 2H), 2.48 (q, J = 5.7 Hz, 1H), 2.44 (s, 3H); 13C NMR 
(126 MHz, CDCl3): d 143.9, 137.8, 132.6, 129.8, 128.1, 116.8, 73.2, 66.7, 60.8, 51.2, 46.6, 38.2, 
21.7; IR (cm-1): 2936, 2890, 1598, 1472, 1338, 1156, 1125, 1053, 1013, 928, 809, 708, 667; 
HRMS: m/z calculated for C15H20N2O3SNa+ [M+Na]+: 331.1087; found: 331.1089; 
(1R*,5S*,7S*) Diastereomer (minor): 1H NMR (500 MHz, CDCl3): d 7.73 (d, J = 8.2 Hz, 2H), 
7.32 (d, J = 8.0 Hz, 2H), 5.76 (ddd, J = 16.9, 10.5, 6.1 Hz, 1H), 5.31 (d, J = 17.2 Hz, 1H), 5.23 (d, 
J = 10.5 Hz, 1H), 4.02 – 3.93 (m, 2H), 3.66 (d, J = 10.6 Hz, 1H), 3.51 (dd, J = 10.6, 2.5 Hz, 1H), 
3.43 (s, 3H), 2.99 (qd, J = 8.7, 2.3 Hz, 1H), 2.89 – 2.82 (m, 2H), 2.43 (s, 3H); 13C NMR (126 MHz, 
CDCl3): d 143.6, 133.9, 133.6, 129.6, 128.0, 118.8, 70.1, 69.0, 61.9, 53.8, 46.9, 35.6, 21.8; IR (cm-
1): 2939, 2889, 1464, 1334, 1176, 1155, 1093, 1045, 1030, 988, 923, 812, 737, 665; HRMS: m/z 







Synthetic Modifications of Azetidine Products 
 
(1R*,5S*,7S*)-7-Phenyl-3-oxa-6-azabicyclo[3.2.0]heptane (2.111): A 25-mL round-bottom 
flask equipped with a magnetic stir bar was charged with azetidine 2.69 (51 mg, 0.25 mmol, 
1.0 equiv.). Then, 2 M aqueous HCl solution (5 mL) and zinc powder (82 mg, 1.25 mmol, 
5 equiv.) were added sequentially and the resulting mixture stirred at 80 °C for 1 h. The reaction 
was cooled to 0 °C and 2 M aqueous NaOH solution was added dropwise until pH 10-12 was 
reached. The mixture was subsequently extracted with CH2Cl2 (3x) and the combined organic 
layers dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash column 
chromatography (1–10% MeOH/CH2Cl2) afforded the pure title compound as a yellow oil (38 mg, 
87%). 
1H NMR (500 MHz, CDCl3): d 7.43 (d, J = 7.3 Hz, 2H), 7.37 (t, J = 7.6 Hz, 2H), 7.28 – 7.24 (m, 
1H), 4.60 (d, J = 4.5 Hz, 1H), 4.38 (dd, J = 6.3, 3.6 Hz, 1H), 4.16 (d, J = 9.7 Hz, 1H), 4.08 (d, J = 
10.4 Hz, 1H), 3.57 (dd, J = 10.4, 3.6 Hz, 1H), 3.54 (dd, J = 9.7, 4.6 Hz, 1H), 3.07 (dt, J = 6.3, 
4.6 Hz, 1H); 13C NMR (126 MHz, CDCl3): d 145.1, 128.7, 127.2, 125.9, 76.0, 72.9, 64.0, 60.4, 
48.1; IR (cm-1): 3314, 3025, 2929, 2844, 1603, 1491, 1452, 1338, 1165, 1094, 1070, 977, 909, 
881, 735, 697; HRMS: m/z calculated for C11H13NOH+ [M+H]+: 176.1070; found: 176.1067. 
 
(1S*,5R*,7S*)-7-Phenyl-6-tosyl-6-azabicyclo[3.2.0]heptane (2.112): A 100-mL round-bottom 
flask equipped with a magnetic stir bar was charged with 2.86 (178 mg, 0.88 mmol, 1.0 equiv.) 
and a 9:1 mixture (v/v) of 2 M HCl solution (aq.) and THF (20 mL). The mixture was heated at 
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added and the mixture continued to reflux for 1.5 h. After cooling to 0 °C, 2 M NaOH solution 
(aq.) was added until pH 12 and the mixture sequentially extracted with CH2Cl2 (3x) and EtOAc 
(3x). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo, 
then dried using high-vac to afford the crude azetidine (quant. yield), which was used in the next 
step without further purification. 
The crude azetidine was dissolved in CH2Cl2 (10 mL) and the solution cooled to 0 °C. Et3N 
(0.13 mL, 0.96 mmol, 1.1 equiv.) and p-TsCl (184 mg, 0.96 mmol, 1.1 equiv.) were added 
sequentially and the solution allowed to warm up to rt and stirred for 1.5 h. Then, water was added, 
the organic layer separated and the aqueous layer extracted with CH2Cl2 (3x). The combined 
organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash 
column chromatography (5–15% EtOAc/hexanes) afforded the pure title compound as a white 
solid (200 mg, 70%). 
1H NMR (700 MHz, CDCl3): d 7.43 (d, J = 8.2 Hz, 2H), 7.22 (s, 5H), 7.10 (d, J = 8.0 Hz, 2H), 
4.85 (t, J = 5.5 Hz, 1H), 4.65 (d, J = 4.1 Hz, 1H), 2.76 (q, J = 6.3 Hz, 1H), 2.57 (dd, J = 14.1, 
5.6 Hz, 1H), 2.36 (s, 3H), 1.89 – 1.79 (m, 2H), 1.80 – 1.71 (m, 1H), 1.52 – 1.39 (m, 2H); 13C NMR 
(176 MHz, CDCl3): d 142.8, 140.2, 137.9, 129.3, 128.5, 127.9, 127.2, 126.9, 70.9, 68.9, 44.6, 32.2, 
30.7, 24.1, 21.6; IR (cm-1): 3030, 2952, 1598, 1495, 1455, 1338, 1186, 1152, 1121, 1090, 1059, 
1028, 997, 951, 815, 754, 698, 665; HRMS: m/z calculated for C19H21NO2SNa+ [M+Na]+: 
350.1185; found: 350.1185. 
 
(1S*,5R*,7S*)-6-Tosyl-6-azabicyclo[3.2.0]heptane-7-carboxylic acid (2.113): Adapted from a 













magnetic stir bar was charged with 2.112 (100 mg, 0.31 mmol, 1.0 equiv.). CCl4 (0.7 mL), MeCN 
(0.7 mL) and water (1.0 mL) were added and the mixture stirred until all solids were dissolved. 
Then, periodic acid (879 mg, 4.6 mmol, 15.0 equiv.) and RuCl3 hydrate (3.4 mg, 0.015 mmol, 
0.05 equiv.) were added sequentially and the vial sealed with a rubber septa pierced with a needle 
to maintain an open atmosphere. The biphasic mixture was vigorously stirred for 24 h, before 
adding additional periodic acid (879 mg, 4.6 mmol, 15.0 equiv.) and RuCl3 hydrate (3.4 mg, 
0.015 mmol, 0.05 equiv.), and the reaction was continued to stir for 12 h. Et2O was added and the 
mixture stirred for 0.5 h, before the addition of water. The organic layer was separated and the 
aqueous layer sequentially extracted with Et2O (3x) and EtOAc (3x). The combined organic layers 
were dried over MgSO4, filtered and concentrated in vacuo. Purification by flash column 
chromatography (94:5:1 CH2Cl2/MeOH/AcOH) afforded the pure title compound as a pale-yellow 
oil (34 mg, 38%). 
1H NMR (700 MHz, CDCl3): d 7.75 (d, J = 8.0 Hz, 2H), 7.35 (d, J = 7.9 Hz, 2H), 4.74 (t, J = 
5.4 Hz, 1H), 4.19 (d, J = 4.1 Hz, 1H), 3.06 (q, J = 5.6 Hz, 1H), 2.46 (s, 3H), 2.31 (dd, J = 14.7, 
5.9 Hz, 1H), 1.81 (dd, J = 13.7, 6.3 Hz, 1H), 1.71 (dt, J = 13.1, 6.6 Hz, 1H), 1.50 (h, J = 13.5, 
6.8 Hz, 1H), 1.33 (h, J = 19.6, 12.5, 5.7 Hz, 1H), 1.20 – 1.11 (m, 1H); 13C NMR (176 MHz, 
CDCl3): d 174.2, 144.2, 136.5, 129.9, 127.5, 69.5, 65.7, 39.9, 31.2, 30.6, 23.6, 21.8; IR (cm-1): 
2960, 1716, 1598, 1434, 1335, 1289, 1241, 1150, 1090, 1060, 1001, 907, 815, 727, 708, 674, 648; 
HRMS: m/z calculated for C14H17NO4SNa+ [M+Na]+: 318.0770; found: 318.0769. 
 
((2S*,3R*,4S*)-1-Methoxy-4-phenylazetidine-2,3-diyl)dimethanol (2.114): A 10-mL round-
bottom flask equipped with a magnetic stir bar was charged with LiAlH4 (12 mg, 0.32 mmol, 












1.0 equiv.) in THF (0.5 mL) was added dropwise. Then, the reaction mixture was allowed to warm 
up to rt and stirred for 3.5 h. Water was carefully added at 0 °C, followed by Rochelle salt solution 
(aq., sat.), and the resulting mixture was allowed to gradually warm up to rt and stirred for 3 h. 
The resulting clear biphasic mixture was extracted with Et2O (3x) and the combined organic layers 
dried over MgSO4, filtered and concentrated in vacuo. Purification by flash column 
chromatography (30–95% EtOAc/hexanes) afforded the pure title compound as a white solid 
(23 mg, 84%). 
1H NMR (700 MHz, CDCl3): d 7.43 (d, J = 7.3 Hz, 2H), 7.36 (t, J = 7.6 Hz, 2H), 7.28 (t, J = 
7.3 Hz, 1H), 4.76 (d, J = 9.0 Hz, 1H), 4.31 – 4.24 (m, 1H), 4.17 – 4.10 (m, 2H), 3.91 – 3.83 (m, 
2H), 3.52 (s, 3H), 3.03 (t, J = 5.2 Hz, 1H), 2.90 (dd, J = 7.6, 4.4 Hz, 1H), 2.50 (bs, 1H); 13C NMR 
(176 MHz, CDCl3): d 141.2, 128.6, 127.7, 126.6, 73.4, 66.6, 62.1, 59.8, 59.6, 40.7; IR (cm-1): 
3319, 2935, 1596, 1495, 1453, 1370, 1266, 1155, 1091, 1020, 736, 698; HRMS: m/z calculated 
for C12H17NO3Na+ [M+Na]+: 246.1101; found: 246.1105.  
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Representative NOE Data 
 






























































































































































































X-Ray Crystallographic Data 
 
CCDC 1873931 
Colorless blocks of tert-butyl ((1R*,5S*,7S*)-7-phenyl-3-oxa-6-azabicyclo[3.2.0]heptan-6-
yl)carbamate (2.77) were grown via vapor diffusion (pentane/ethyl acetate) of the compound at 
ambient temperature. A crystal of dimensions 0.18 x 0.14 x 0.10 mm was mounted on a Rigaku 
AFC10K Saturn 944+ CCD-based X-ray diffractometer equipped with a low temperature device 
and Micromax-007HF Cu-target micro-focus rotating anode (l = 1.54187 A) operated at 1.2 kW 
power (40 kV, 30 mA). The X-ray intensities were measured at 85(1) K with the detector placed 
at a distance 42.00 mm from the crystal. A total of 2028 images were collected with an oscillation 
width of 1.0° in w.  The exposure times were 1 sec. for the low angle images, 2 sec. for high angle. 
Rigaku d*trek images were exported to CrysAlisPro for processing and corrected for absorption. 
The integration of the data yielded a total of 23789 reflections to a maximum 2q value of 138.67° 
of which 2901 were independent and 2802 were greater than 2s(I). The final cell constants (Table 
2) were based on the xyz centroids of 17770 reflections above 10s(I). Analysis of the data showed 
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negligible decay during data collection. The structure was solved and refined with the Bruker 
SHELXTL (version 2016/6) software package, using the space group P2(1)/c with Z = 4 for the 
formula C16H22N2O3. All non-hydrogen atoms were refined anisotropically with the hydrogen 
atoms placed in a combination of idealized and refined positions. Full matrix least-squares 
refinement based on F2 converged at R1 = 0.0505 and wR2 = 0.1183 [based on I > 2sigma(I)], R1 
= 0.0512 and wR2 = 0.1191 for all data. Acknowledgement is made for funding from NSF grant 
CHE-0840456 for X-ray instrumentation. 
 
G.M. Sheldrick (2015) "Crystal structure refinement with SHELXL", Acta Cryst., C71, 3-8 (Open 
Access). 
 
CrystalClear Expert 2.0 r16, Rigaku Americas and Rigaku Corporation (2014), Rigaku Americas, 
9009, TX, USA 77381-5209, Rigaku Tokyo, 196-8666, Japan. 
 
CrysAlisPro 1.171.38.41 (Rigaku Oxford Diffraction, 2015). 
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Empirical formula C16 H22 N2 O3 
Formula weight 290.35 
Temperature 85(2) K 
Wavelength 1.54184 A 
Crystal system, space group Monoclinic,  P2(1)/c 
Unit cell dimensions a = 9.81308(10) A   alpha = 90 deg. 
 b = 16.02162(18) A    beta = 96.5969(9) deg. 
 c = 10.02249(9) A   gamma = 90 deg. 
Volume 1565.32(3) A^3 
Z, Calculated density 4,  1.232 Mg/m^3 
Absorption coefficient 0.693 mm^-1 
F(000) 624 
Crystal size 0.180 x 0.140 x 0.100 mm 
Theta range for data collection 4.536 to 69.335 deg. 
Limiting indices -11<=h<=11, -19<=k<=18, -11<=l<=12 
Reflections collected / unique 23789 / 2901 [R(int) = 0.0747] 
Completeness to theta = 67.684 99.70% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.76509 
Refinement method Full-matrix least-squares on F^2 
Data / restraints / parameters 2901 / 0 / 198 
Goodness-of-fit on F^2 1.105 
Final R indices [I>2sigma(I)] R1 = 0.0505, wR2 = 0.1183 
R indices (all data) R1 = 0.0512, wR2 = 0.1191 
Extinction coefficient 0.041(2) 




Chapter 3: Synthesis of Azetidines via Intermolecular Visible Light-Mediated [2+2] 
Cycloaddition Reactions 
Portions of this chapter have been published in Becker, M.R.; Wearing, E.R.; Schindler, 
C.S. Synthesis of azetidines via visible light-mediated intermolecular [2+2] photocycloadditions. 
Nat. Chem. 2020, 12, 898–905.  
3.1. Introduction 
3.1.1. Photochemistry of Oximes 
Oximes can undergo a wide variety of different transformation from their excited state, 
which has been extensively summarized by Roth and Sivaguru.191,192 Similar to the reactivity of 
excited state imines, acyclic excited oximes readily undergo E/Z isomerization upon irradiation 
with UV light (typically 254 nm)193,194 or in the presence of a triplet sensitizer.195,196 Padwa and 
Albrecht studied the photoisomerization of O-methyl acetophenone oxime (3.1) by measuring the 
photostationary state in the presence of a range of triplet sensitizers (Figure 3.1). 
 
Figure 3.1: Photosensitized isomerization of oxime O-methyl acetophenone oxime. 
Evaluation of photosensitizers ranging in triplet energies between 53.7–74.6 kcal mol-1 
revealed drastic differences in the photostationary state of 3.1. The highest E/Z ratios were 
observed with triplet sensitizers with ET ≈ 59 kcal mol-1 (E/Z = 1:13), while a stark decrease in E/Z 
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rationalized based on photosensitization of the oxime, generating a twisted excited state (3.2) 
(Figure 3.1). Based on the observed isomerization efficiencies, the triplet energies of (E)-3.1 and 
(Z)-3.1 were estimated to be approximately 59 and 72 kcal mol-1. 
 
Figure 3.2: Photo-Beckmann rearrangement and ketone formation as photoproducts via irradiation of an oxime. 
While the photochemical E/Z isomerization represents one of the most common relaxation 
pathways of excited oximes, these compounds can exhibit additional reactivity from their excited 
state. The Beckmann rearrangement is the acid-catalyzed conversion of an oxime to a 
corresponding amide. Albeit less general, the same transformation can be achieved through 
irradiation of an oxime with UV light, known as the photo-Beckmann rearrangement. This reaction 
was first discovered by Amin and de Mayo in 1963, who reported the conversion of benzaldoxime 
to benzamide under UV light irradiation in up to 41% yield.197 The authors proposed an oxaziridine 
as key intermediate of the rearrangement, a hypothesis that was later supported via spectroscopic 
studies by Mukai.198 Specifically, Mukai and coworkers were able to form 3.4 in approximately 
50% yield through irradiation of oxime 3.3 (Figure 3.2). Interestingly, this intermediate either 
decomposed to the corresponding photo-Beckmann rearrangement product 3.5 or ketone 3.6 
depending on the solvent used in the reaction. With acetic acid as the solvent amide 3.5 was 
isolated in 56% yield, while performing the reaction in MeOH provided ketone 3.6 in 30% yield, 

























Beckmann-rearrangement, the synthetic utility of the photo-Beckmann rearrangement is limited 
due to its narrow scope and generally poor yields.191 
 
Figure 3.3: Nitrogen-oxygen bond cleavage as relaxation pathway for the alkylation and arylation of (hetero)aromatics. 
Similar to E/Z isomerization, homolytic nitrogen–oxygen bond scission represents a 
common photoreaction of excited state oximes for the generation of iminyl radicals. This reactivity 
has been reported for both aliphatic and aromatic oximes under UV light irradiation, while both 
the unsubstituted as well as O-alkylated oximes are tolerated.191 While in most examples reported 
in the literature, an iminyl radical was generated to undergo intramolecular radical addition to an 
adjacent aromatic ring, Hasebe and Tsuchiya developed a decarboxylative variant, in which alkyl 
and aryl radicals are generated and added to aromatic substrates. (Figure 3.3).199,200 Irradiation of 
benzophenone oxime ester 3.7 resulted in N–O bond homolysis affording iminyl radical 3.9 and 
acyloxy radical 3.8. Upon decarboxylation of 3.8, the resulting carbon-centered radical can 
subsequently react with the benzene or pyridine solvent. Importantly, the homolysis step is 
proposed to occur from the triplet excited state. Besides the desired product 3.12, dimer 3.10 and 
benzophenone (3.11) were observed in 70–85% and 8–18% yield, respectively. Using solvent-
quantities of either benzene or pyridine, arylation and alkylation was achieved with a series of 
different oxime ester precursor in generally good yields (3.13–3.18). The reaction with pyridine 





















































the photoreactions of excited state oximes discussed above, these excited state intermediates have 
also been reported to undergo other reactions such as nitrile formation or the generation of 
iminoxyl radicals.191 
There exist only a small number of examples in which excited state oximes have 
participated in [2+2] cycloaddition reactions, likely a direct a result of the high number of 
alternative relaxation pathways accessible upon excitation. The first example of an oxime reacting 
in a photocycloaddition reaction was reported by Mukai and coworkers relying on 3-aryl-2-
isoxazolines (3.19) featuring an electron-withdrawing substituent as substrates (Figure 3.4).149 
 
Figure 3.4: Photochemical [2+2] cycloaddition reactions of oximes. 
Upon irradiation with UV light these compounds underwent photocycloaddition with an 
alkene in modest to good yields. The authors propose the reaction to occur via a singlet state 
exciplex (3.21), which likely explains the overall narrow substrate scope of this transformation. 
Typically, aromatic substrates such as thiophene (3.23), furan (3.24) indene (3.20) and benzene 
(3.25) are required for successful cycloaddition.147,148 In contrast, no reaction was observed for 
alkenes lacking an additional unit of unsaturation, for example enamines, vinyl ethers or 
cycloalkenes. The reaction generally favors the formation of the exo-diastereomer in which the 
alkene substituents and the isoxazolidine ring point to opposite sides of the azetidine ring. These 
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reaction of 3-aryl-2-isoxazolines both experimentally as well as computationally.150,151 The 
computations did not provide any evidence for the involvement of triplet excited state 
intermediates, thus supporting the mechanism proposed by Mukai. Interestingly, the electron-
withdrawing substituent of the 3-aryl-2-isoxazolines (3.19) was found crucial for reactivity as it 
prevents rapid deactivation back to the ground state. Furthermore, the authors observed a strong 
dependence of the regioselectivity of the cycloaddition process on the electronic properties of the 
alkene substrate, particularly when comparing furans (3.24) and acrylates (3.26). This was 
attributed to a match of partial charges between the alkene and oxime reaction partners 
(Figure 3.4). 
3.1.2. Triplet State Oximes via Visible Light Energy Transfer Catalysis 
Although the photochemistry of oximes has been studied for over a century, examples in 
which photoexcited oximes are successfully utilized in synthetic organic transformations remain 
limited.201 In general, most examples have a narrow scope and only provide low yields of the 
desired product. Additionally, UV light is required to achieve efficient excitation of the oxime 
chromophore, thus providing limited selectivity issues as other organic functional group can also 
adsorb UV light. In recent years, visible light triplet energy transfer catalysis has emerged as an 
attractive tool to access the triplet excited state of organic molecules under mild conditions. Glorius 
and coworkers recognized that benzophenone oximes, similar to those originally used by Hasebe 
and Tsuchiya, can be sensitized with a commercially available iridium photosensitizer for the 
decarboxylative functionalization of carboxylic acids.199,200,202 Aryl (3.27) or aliphatic carboxylic 
acids (3.28) were functionalized with benzophenone derived oxime 3.29 to obtain the 
corresponding oxime ester 3.30 or 3.31, respectively (Figure 3.5). Under blue LED irradiation and 
in the presence of photocatalyst 2.59•PF6 these compounds underwent decarboxylation to generate 
a carbon-centered aryl or alkyl radical intermediate that could subsequently be functionalized with 
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various electrophiles. The authors successfully demonstrated the utility of this reaction protocol 
for deuteration (3.34), trifluoromethylthiolation (3.35), iodination (3.36), chlorination (3.37), 
borylation (3.38) and arylation (3.39) in 47–83% yield (Figure 3.5). 
 
Figure 3.5: Visible light-sensitized decarboxylative functionalization reactions. 
A series of mechanistic experiments were carried out that provided strong support for a 
mechanism proceeding via triplet energy transfer. Computational analysis revealed that oxime 3.40 
possesses a triplet energy of ET = 46.4 kcal mol-1, supporting an exergonic energy transfer process 
from photocatalyst 2.59•PF6 (ET = 60.1 kcal mol-1). Interestingly, analysis of the mechanistic 
profile of the reaction via DFT calculations suggested a concerted N–O bond 
cleavage/decarboxylation, rather than a stepwise process proceeding via a carboxyl radical as 
proposed by Hasebe and Tsuchiya. 
Glorius and coworkers further expanded the utility of activating oxime esters via triplet 
energy transfer for the carboimination of alkenes.203 Under very similar conditions to their 
previous work, energy transfer to the oxime ester results in decarboxylative N–O bond cleavage, 
providing a carbon-centered radical and an iminyl radical. The transient carbon-centered radical 
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stabilized radical subsequently undergoes radical–radical combination with the iminyl radical to 
the desired product (Figure 3.6). 
 
Figure 3.6: Photosensitized intermolecular carboimination of alkenes. 
In contrast to the decarboxylative functionalization discussed above, the carboimination 
reaction protocol was unsuccessful with aromatic carboxylic acids. Nevertheless, the authors 
demonstrated the utility of the reaction protocol on a variety of primary, secondary and tertiary 
aliphatic carboxylic acids in 36–85% yield (3.41, 3.43–3.46) (Figure 3.6). Notably, the 
benzophenone imine motif can be readily hydrolyzed to reveal the corresponding free amine 3.42 
in 89% yield. This protocol was recently expanded to achieve the oxyimination of unactivated 
alkenes by utilizing oxime carbonates as bifunctional reagents.204 
 
Figure 3.7: Radical-radical cross coupling via photocatalytic energy transfer. 
You and Cho utilized a similar reaction design for the synthesis of functionalized imine 
building blocks via radical–radical cross-coupling in which triplet energy transfer to oxime esters 















































































conditions that resulted in selective hetero-coupling between the carbon-centered and the iminyl 
radical to provide imine 3.49. The use of ethyl acetate as solvent at a low reaction concentration 
was found crucial for achieving high selectivity. The reaction scope was demonstrated on a series 
of primary, secondary and tertiary alkyl carboxylic acids in 30–75% yield. 
 
Figure 3.8: Synthesis of sterically hindered primary amines via tandem energy transfer and photoredox catalysis. 
Rovis and Lehnherr reported a tandem energy transfer/photoredox-based method for the 
synthesis of sterically hindered primary amines, which represent important motifs in active 
pharmaceutical ingredients.206 The reaction protocol reductively couples aromatic O-benzoyl 
oximes and cyanoarenes relying on 2.58•PF6 as the photocatalyst (Figure 3.8). High-throughput 
experimentation identified diisopropylamine as the optimal stoichiometric reductant and DMSO 
as the optimal solvent for the developed transformation. These conditions were amenable to a 




















































































































products (3.53–3.55) in 10–95% yield. Although the authors initially hypothesized a cleavage of 
the oxime N–O bond via a single-electron reduction, collected reaction data was not in support of 
such a mechanism. Instead, mechanistic experiments were in favor of an initial triplet energy 
transfer process of the iridium photocatalyst to the aromatic oxime resulting in N–O bond cleavage. 
Based on DFT calculation, the triplet energy of 3.56 was determined as ET = 54.2 kcal mol-1. Next, 
hydrogen atom abstraction of the iminyl radical (3.57) from diisopropylamine was proposed to 
occur, providing iminium salt 3.60 after protonation with benzoic acid. This intermediate can be 
reduced via single electron transfer from a strongly reducing iridium(II) intermediate regenerating 
catalyst 2.58, or alternatively from the a-amino radical of i-Pr2NH (3.59). Intermediate 3.61 can 
subsequently undergo heterocoupling with persistent radical 3.63, which is generated through 
proton-coupled electron transfer by an iridium(II) intermediate and the cyanoarene (3.51). Net loss 
of a proton and cyanide leads to the formation of the final product 3.53. 
 
Figure 3.9: Enantioselective radical C–H amination via triplet energy transfer for the synthesis of chiral b-amino alcohols. 
Over the last years, Nagib and coworkers have pioneered the synthesis of medicinally 
valuable b-amino alcohols via b-functionalization of alcohols utilizing C–H abstraction of in situ 
generated nitrogen centered radicals, typically derived from imidates.207–210,210,211 While these 




























































































enantioselective variant of this reaction through the merger of triplet energy transfer and chiral 
copper catalysis.212 This report relies on the use of aryl oxime imidates (3.65) that are converted 
to chiral oxazolines with catalytic amounts of 2.59•BArF4, CuBArF4, camphoric acid, and chiral 
bisoxazoline ligand 3.67 in typically high yields and 79–99% e.e. (Figure 3.9). The majority of 
substrates contained an activating group in the b-position, thus C–H functionalization occurred at 
benzylic, allylic or propargylic C–H bonds (3.68–3.71). Nevertheless, the authors demonstrated 
that the C–H functionalization could also be successfully carried out on unactivated C–H bonds, 
although adjacent sterically demanding substituents were required to achieve high 
enantioselectivities. The desired chiral b-amino alcohols could be obtained through hydrolysis of 
the oxazoline to provide products such as 3.72 in 77% yield and 98% enantiospecificity. Based on 
Stern-Volmer quenching studies the authors proposed that the triplet energy transfer occurs from 
the iridium photocatalyst to a copper-bound imidate (3.73) resulting in subsequent  N–O bond 
fission. The resulting nitrogen-centered radical can undergo enantio- and regioselective hydrogen 
atom transfer (HAT) to generate a carbon–centered radical (3.75), which is rapidly trapped by the 
copper catalyst. Based on radical trap experiments, the rate of alkyl radical trapping was estimated 
to be between 108–1011 s-1. Finally, stereoselective amination provides the desired chiral oxazoline 
product (Figure 3.9). 
3.2. Reaction Design and Optimization 
Towards the development of an intermolecular aza Paternò-Büchi reaction, we envisioned 
a reaction design relying on activation via triplet energy transfer from a visible light photocatalyst. 
Based on our previous work on intramolecular aza Paternò-Büchi reactions that showed that 
styrenes are readily activated via triplet sensitization, initial efforts were focused on styrene 
substrates such as b-methylstyrene (3.76).213 Towards that goal, 3.76 was reacted with hexanal O-
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methyl oxime (3.77) in the presence of 2.59•PF6 under blue LEDs irradiation (Figure 3.10). No 
azetidine product arising from a cycloaddition reaction was observed, although isomerization of 
3.76 from >20:1 to 1:4 E/Z indicated that triplet sensitization of the styrene likely occurred. 
Similarly, no reaction was observed with benzaldehyde O-methyl oxime (3.78) under otherwise 
identical conditions, indicating that styrene isomerization is outcompeting the desired 
cycloaddition process. Interestingly, we also observed isomerization of oxime 3.78 under these 
reaction conditions (20:1 to 1:4 E/Z), which suggested that photocatalyst 2.59•PF6 is capable of 
sensitizing the aromatic oxime moiety of 3.78. 
 
Figure 3.10: Probing the feasibility of an intermolecular aza Paternò-Büchi reaction relying on styrene sensitization. 
This observation is in agreement with reports that determined the triplet energies of similar 
aromatic oximes to be approximately 54–59 kcal mol-1.196,206 Therefore, we next evaluated the 
feasibility of an intermolecular aza Paternò-Büchi reaction via activation of the oxime component 
by triplet energy transfer. For the development of this reaction, we envisioned a reaction design 
relying on a cyclic oxime to prevent competitive oxime isomerization (Figure 3.11). Changes to 
the functional group adjacent to the oxime was expected to allow for control of the triplet energy 
of the oxime moiety. Photocycloaddition with an unactivated alkene would provide the desired 
bicyclic azetidine product containing an isoxazoline ring, which could be converted to the 
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1-hexene as an unactivated reaction partner that is unable to interact with the iridium photocatalyst 
2.59•PF6. Considering that triplet energies are only known for a limited number of oximes, we 
measured the quenching fraction for each substrate to inform about their quenching ability.214 
 F = 100 • !
!!
 Equation 3.1 
The quenching fraction (F) was calculated based on the ratio of luminescence intensity in 
the presence of a substrate (I0) and without (I) (Equation 3.1). Two distinct scenarios can be 
distinguished through this hypothesis-driven approach. Specifically, substrates that lack quenching 
(F < 25%) are likely unable to interact with the photocatalyst, for example due to a mismatch in 
triplet energies. Thus, no reactivity would be expected, which was confirmed with aliphatic oxime 
2.104 (F = 24%) (Figure 3.11). 
 
Figure 3.11: Development of an intermolecular aza Paternò-Büchi reaction. 
In contrast, some substrates might possess a matching triplet energy, thus quenching would 
be expected (F > 25%), but are not reactive towards [2+2] photocycloaddition reactions. Aromatic 
oxime 3.79 was identified as a strong quencher of 2.59•PF6 (F = 97%), however, no azetidine 
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cycloaddition reactions by Sampedro and Mukai. However, it is important to note that those 
reactions were performed with activated alkenes and occurred from the singlet state. Interestingly, 
isoxazolone 3.80 showed high reactivity (>95% conversion) under the reaction conditions, but 
only provided a complex mixture of products, which could be a result of cleavage of the relatively 
weak N–O bond. Similarly, N-tosyl hydrazone 3.81 showed high conversion to a complex mixture 
of products while N-benzoyl hydrazone 3.82 did not provide any reactivity. Although all of these 
aromatic oximes and hydrazones were quenchers of 2.59•PF6 (F > 0.25), the lack of reactivity 
indicates that their triplet state is not reactive in intermolecular [2+2] cycloaddition reactions. 
Thus, substrates with alternative conjugating groups adjacent to the oxime were evaluated. When 
isoxazoline carboxylate 3.83 (F = 54%) was reacted under the reaction conditions, the desired 
azetidine (3.84) was isolated in 60% yield as the sole product of the reaction. 
Table 3.1: Photocatalyst evaluation of the developed intermolecular aza Paternò-Büchi reaction. Yields were determined by 1H 
NMR from the crude reaction mixture using an internal standard. 
 
Having identified a suitable substrate for an intermolecular aza Paternò-Büchi reaction, we 
next focused on optimizing relevant reaction parameters. Although photocatalyst 
[Ir(dF(Me)ppy)2(dtbbpy)]PF6 (2.58•PF6) provided 3.84 in similar yield (54%), a drastic difference 



































































































difference in stereoselectivity originated from different amounts of minor diastereomer (endo-
3.84) present in the crude reaction mixture, while similar quantities of the major diastereomer (exo-
3.84) were detected. This observation led us to perform a control reaction, in which both 
diastereomers were independently irradiated with blue LEDs in the presence of photocatalyst 
2.59•PF6. While exo-3.84 could be fully recovered after 16 h, we observed an intriguing 41% 
conversion of endo-3.84 to unidentifiable degradation products, indicating that the decomposition 
of the minor diastereomer caused the observed difference in yield and stereoselectivity 
(Figure 3.12). 
 
Figure 3.12: Control reactions probing the stability of both azetidine diastereomers. 
Considering that 2.58•PF6 and 2.59•PF6 are both relatively strong oxidants, we carried out 
cyclic voltammetry experiments of azetidine products. These experiments revealed that the endo-
diastereomer is amenable to single-electron oxidation with an oxidation process at Ep/2 = +1.33 V 
(vs. SCE), while the exo-diastereomer is oxidized at a more positive potential of Ep/2 = +1.51 V 
(vs. SCE) (Figure 3.26). In addition, the concave structure of the endo-diastereomer is more 
accessible for the photocatalyst to engage with the substrate through undesired single-electron 
transfer. Thus, less oxidizing photocatalysts were evaluated, which identified fac-[Ir(dFppy)3] 
(2.51) as optimal, providing the desired product in 94% yield (Table 3.1, entry 3). Other 
photocatalysts with lower triplet energies but similar redox properties did not facilitate the 
reaction, indicating that the reaction indeed occurs via energy transfer as opposed to a photoredox-
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+
no conversion of exo-3.84 (< 5%)
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Figure 3.13: Scope of the oxime component in the developed intermolecular aza Paternò-Büchi reaction (major diastereomer is 
shown). EWG = electron-withdrawing group. 
3.3. Substrate Scope 
With optimized conditions identified, we next evaluated the scope of the oxime component 
in the developed reaction. Thus, a series of 2-isoxazolines bearing various substitution patterns 
were tested (Figure 3.13, top). Importantly, azetidine 3.84 could be readily synthesized on larger 
scale in 90% yield providing gram-quantities of 3.84. Substitution in the 5-position of the 
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95% yield (3.85), albeit in diminished stereoselectivity of 1.3:3. The reaction allowed 
incorporation of various synthetic motifs into the 2-isoxazoline ring, including aromatic 
substituents (3.86 and 3.88), nitrogen spirocycles (3.87), ethers (3.89) and esters (3.90) in 72–99% 
yield. Notably, in the case of mono-substituted substrates such as 3.88 and 3.90, the cycloaddition 
preferentially occurs at the less substituted face, which highlights how 2-isoxazoline substitution 
can control the cycloaddition process. Variations of the ester moiety allowed the integration of 
synthetic handles such as alkynes (3.91) in 60% yield, while sterically bulky and electron-rich 
substituents were similarly tolerated, affording azetidines 3.92 and 3.93 in 98% and 88% yield, 
respectively. In contrast, alkene-containing esters (3.94) preferentially undergo intramolecular 
cycloaddition resulting in intriguing scaffolds such as tricyclic azetidine 3.95 in 87% yield. Finally, 
we were able to convert 2-isoxazolines containing other electron-withdrawing substituents than 
ester in the title reaction. While functional groups such as carboxylic acids (3.97) or amides did 
not provide any desired reactivity (Figure 3.13, bottom), we identified nitriles as a compatible 
group, affording azetidine 3.96 in 88% yield. 
Subsequent efforts were directed at evaluating the alkene scope of the developed reaction 
(Figure 3.14). Notably, feedstock reagents such as ethylene gas can be directly used in the 
cycloaddition reaction, allowing access to azetidines such as 3.105 in 70% yield. Furthermore, 
primary alkenes were found to be competent substrates in the cycloaddition and allowed 
incorporation of various functional groups including nitriles, amides, alcohols, sulfonamides as 
well as aromatic functional groups in 67–98% yield (3.106–3.113). Notably, the successful 
formation of azetidines 3.111 and 3.112 highlights that pharmaceutical scaffolds can be readily 




Figure 3.14: Alkene scope of the developed intermolecular aza Paternò-Büchi reaction. 
1,1-Disubstituted alkenes as well as internal alkenes readily underwent the cycloaddition 
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and 8-membered alkenes were well tolerated, smaller 5-membered alkenes (3.139) were found 
unreactive under the reaction conditions (Figure 3.14, bottom). Quaternary alkenes can be used in 
the developed reaction, which subsequently afford fully substituted azetidine products such as 
3.118. Given the interest in azetidine spirocycles for medicinal chemistry application, we 
hypothesized utilizing exocyclic alkenes as the substrates that would afford the corresponding 
spirocyclic azetidines products in a single synthetic transformation from readily available starting 
materials.215 Indeed, we were able to isolate bis-azetidine spirocycle 3.119 in 99% yield using the 
developed reaction protocol, and the structure of this compound was further confirmed by X-ray 
crystallographic analysis. Similarly, this method allows for the incorporation of sulfur or nitrogen 
heterocycles, as well as cyclobutanes, yielding the corresponding spirocycles 3.120–3.125 in 
generally good yields. Even though 3.123–3.125 were derived from trisubstituted alkenes, the 
azetidine product were obtained in only slightly diminished regioselectivity of 8:1 to 13:1. Finally, 
we investigated functionalized alkenes as substrates with which functional groups could be 
incorporated directly at the azetidine ring. Vinyl ethers, vinyl acetates as well as acrylates readily 
participated in the cycloaddition reaction and provided the desired products 3.126–3.129 in 46–
99% yield. The enhanced diastereoselectivity of 3.126 is likely a result of decomposition of the 
minor diastereomer via undesired single-electron oxidation under the reaction conditions, which 
could be attributed to the additional electron-rich vinyl ether substituent. Similarly, silane 3.130 
was afforded as a single diastereomer, but in a diminished yield of 53%. Finally, the reaction 
protocol enables incorporation of valuable synthetic handles such as boronic esters (3.131) or 
trifluoromethyl substituents (3.132) in very good yields. Our extensive investigations into the 
scope of the cycloaddition reaction also revealed functional groups that were not tolerated, 
including enamines (3.133, 3.135), tertiary amines (3.134), vinyl chlorides (3.136) and 
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phthalimides (3.137). These scaffolds represent challenging substrates in energy transfer-mediated 
transformations, as they likely interact with the photocatalyst via oxidative or reductive quenching. 
Additionally, we found that styrene (3.138) did not participate in the cycloaddition reaction, likely 
due to competitive quenching of the iridium photocatalyst via energy transfer. 
3.4. Synthetic Applications 
To further demonstrate the synthetic utility of the developed intermolecular cycloaddition 
reaction, we next focused on converting the obtained cycloadducts to the corresponding free 
azetidines via cleavage of the nitrogen–oxygen (N–O) bond. Towards that goal, we evaluated a 
series of heterogeneous catalyst to achieve N–O bond cleavage via hydrogenolysis. Utilizing 3.84 
as a model substrate for the transformation, we observed only poor conversion of < 25% with a 
series of catalysts, including palladium on carbon, platinum(IV) oxide, ruthenium on carbon or 
palladium(II) hydroxide (Table 3.2, entries 1, 3–5). 
Table 3.2: Catalyst evaluation for the N–O bond cleavage reaction. 
 
In contrast, Raney nickel provided higher conversion, however, this result was 
unfortunately challenging to reproduce, likely due to difficulties to accurately measure consistent 
amounts of the slurry (Table 3.2, entry 2). Interestingly, the product formed in these reaction was 
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lactonization. The poor conversion can likely be attributed to catalyst inhibition by the basic amine 
moiety in the product 3.140. Therefore, other reaction parameters were evaluated with 
palladium(II) hydroxide as the catalyst. Increasing the catalyst loading to 50 mol% only led to a 
subtle increase in conversion, while increasing the reaction temperature substantially improved 
conversion, however, it did not provide increased yields (Table 3.2, entries 6+7). Similarly, 
performing the hydrogenolysis at elevated pressure was not successful, and only resulted in 
increased decomposition (Table 3.2, entry 8). 
Table 3.3: Reaction optimization of the palladium-mediated N–O bond cleavage reaction. 
 
Next, different solvents were evaluated in the N–O bond cleavage reaction. While addition 
of water or acetic acid resulted in trace amounts of the desired product (Table 3.3, entries 1+2), a 
1:1:1 mixture of ethanol, water and acetic acid provided >95% conversion and 76% yield of 3.140, 
indicating that acidic conditions can prevent catalyst inhibition through protonation of the free 
amine moiety in the product (Table 3.3, entry 3). However, subtle changes to the composition of 
the solvent system resulted in substantial decomposition of the product, which made it challenging 
to reproduce as well as to scale up these conditions (Table 3.3, entries 4+5). As a result, other 
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protonation. While oxalic acid or trifluoroacetic acid resulted in slightly increased conversions 
(Table 3.3, entries 9+11), utilizing hydrochloric acid and p-toluenesulfonic acid provided the 
desired product in 79% and 85% yield, respectively (Table 3.3, entries 8+10). 
 
Figure 3.15: Synthesis of free azetidines via N–O bond cleavage through palladium-mediated hydrogenolysis reactions. (a) Boc2O, 
DMAP, CH2Cl2, rt (for 3.141) (b) p-TsCl, K2CO3, MeCN, 80 ºC (for 3.142). 
Importantly, 2.5 equivalents of p-toluenesulfonic acid were found optimal and afforded the 
desired product in 68% yield on a 50-mg scale (Figure 3.15). The structure of 3.140 was further 
confirmed via X-ray crystallographic analysis. In contrast, reacting azetidine 3.143 containing an 
unsubstituted isoxazolidine ring afforded the uncyclized amino alcohol 3.144 in 45% yield. 
Interestingly, stopping the reaction at shorter reaction times allowed to isolate mixtures containing 
both the cyclized lactone and the amino alcohol, which indicates that lactonization initially occurs, 
however, the lactone is ultimately opened under the reaction conditions. When the isoxazolidine 
ring contains a phenyl substituent, such as in 3.145, hydrogenolysis of the N–O bond as well as 
the benzylic C–O bond takes place, giving rise to free azetidine 3.146 in 84% yield. 
 
Figure 3.16: Synthesis modification of the obtained azetidine products. (a) LiOH, H2O, MeOH, rt (b) LiAlH4, Et2O, 0 ºC (c) LiOH, 
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These building blocks are amenable to further functionalization of the free amino moiety, 
for example 3.141 and 3.142 were readily obtained via Boc-protection or tosylation in 78% and 
99% yield, respectively. 
While the N–O bond in the azetidine products can be readily cleaved through 
hydrogenolysis, it also functions as a nitrogen protecting group that enables various synthetic 
manipulations of these compounds in high yields. For example, 3.84 readily underwent hydrolysis 
(3.147), reduction (3.148), amide formation (3.149) and Grignard addition reactions (3.150) in 93–
97% yield (Figure 3.16). At the outset of our investigations, we also investigated single-electron 
reductants for the cleavage of the N–O bond. Interestingly, utilizing samarium(II) iodide, a 
common reagent used for N–O bond reduction, resulted in the formation of oxazepane 3.151 in 
42% yield.216 This product likely originates from single-electron reduction of the ester moiety to 
the corresponding a-alkoxy radical rather than the N–O bond, which subsequently induces 
fragmentation of the internal C–N bond.217,218 In contrast, utilizing zinc as the stoichiometric 
reductant under acidic conditions afforded g-lactam 3.152 in 58% yield as a 3:1 mixture of 
diastereomers. Under these conditions, the internal C–N bond as well as the N–O bond is cleaved, 
resulting in an amino alcohol intermediate that subsequently undergoes lactam formation. These 
results highlight that the developed intermolecular cycloaddition reaction not only allows for 
access to novel azetidine products, but that these building blocks can also function as precursor for 
the synthesis of other heterocycles. 
3.5. Mechanistic Studies 
The next step of this study aimed at corroborating the postulated triplet energy transfer 
mechanism and to gain further insights into the previously unexplored triplet reactivity of 
glyoxylate-derived oximes such as 3.83. In agreement with the initially outlined mechanism, Stern-
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Volmer studies confirmed oxime 3.83 as the only species in solution that is quenching the iridium 
photocatalyst fac-[Ir(dF(ppy)3], while the alkene component does not interact with the catalyst 
(Figure 3.17). The quenching process is unlikely to result from an electron transfer interaction as 
the redox potentials for 3.83 (Ered = +2.01 V versus SCE) are out of range for fac-[Ir(dF(ppy)3] 
(IrIII*/II = +0.36 V versus SCE; IrIV/III* = –1.28 V versus SCE) (Figure 3.25).165 
 
Figure 3.17: Stern-Volmer quenching studies with iridium catalyst fac-[Ir(dF(ppy)3]. 
In contrast, the reaction can be carried out with xanthone, an established organic 
photosensitizer. Utilizing 20 mol% of the catalyst, the desired product 3.84 was obtained in 54% 
yield relying on irradiation with UV light (Figure 3.18). Further control reactions revealed that a 
photocatalyst is essential to harvest the triplet reactivity of glyoxylate-derived oximes as direct 
irradiation 3.83 with various light sources in the absence of a catalyst did not lead to any product 
formation. Thus, it can be concluded that the singlet state of 3.83 is not reactive towards [2+2] 
cycloaddition reactions. This reactivity is in stark contrast to the 3-aryl-2-isoxazolines utilized by 
Mukai and Sampedro, which participated in cycloaddition reactions, although exclusively from 
the singlet excited state.147–150 Furthermore, the lack of reactivity of 3.83 further highlights that 
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direct irradiation does not result in sufficient population of the excited triplet state, indicating that 
intersystem crossing of 3.83 is likely inefficient. 
 
Figure 3.18: Control reactions using an organic photosensitizer (top) and different light sources without a catalyst (bottom). 
We next investigated the structural features that are necessary for desired reactivity. 
Reacting alcohol 3.153 lacking the ester moiety under standard conditions did not result in product 
formation (Figure 3.19). This result is in agreement with previously made observations that 
aliphatic oximes have relatively high triplet energy that are not accessible for visible light 
photocatalysts. Next, we tested acyclic oxime 3.154 as substrate under our reaction conditions. 
Interestingly, no reaction with the alkene was observed, however, we detected a drastic change in 
the oxime isomer ratio from 20:1 to 1:1.2 E/Z. Based on this observation we postulate that triplet 
energy transfer to the acyclic oxime occurs. However, as a result of the lacking cyclic backbone, 
E/Z isomerization outcompetes the desired cycloaddition process. 
 











































































Figure 3.20: Probing the impact of alkene properties in the intermolecular cycloaddition reaction. 
Considering that biradicals would be likely intermediates in a mechanism proceeding via 
the triplet state, we designed an intramolecular probe (3.155) containing either an (E)- or (Z)-
alkene (Figure 3.20). Next, (E)- and (Z)-3.155 were independently irradiated with visible light in 
the presence of catalytic amounts of 2.51. Both reactions produced an almost identical mixture of 
diastereomers (3.156) in similar yields, indicative of a biradical intermediate that allows for free 
rotation of the alkene substituent. In contrast, irradiation of 3.103 containing a terminal alkene 
under our standard reaction conditions resulted in a complex mixture of inter- and intramolecular 
cycloaddition products. 
 
Figure 3.21: Proposed mechanism for the developed intermolecular aza Paternò-Büchi reaction. 
This stark difference in reactivity can be attributed to the lack of stabilization of the 
biradical intermediate, and further shows that the first step of the cycloaddition process is likely 
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Based on the conducted mechanistic investigations we propose a mechanism that 
commences with efficient triplet energy transfer from the excited state photocatalyst (*IrIII) to the 
oxime 3.83 (Figure 3.21). The triplet state oxime (3.158) subsequently undergoes stepwise 
cycloaddition with the alkene (3.159), proceeding via an initial carbon–carbon bond formation. 
The resulting biradical intermediate can either adapt a preferred conformation exo-3.160 in which 
the alkene residue is pointing away from the isoxazolidine ring, or, alternatively, a disfavored 
conformation endo-3.160 with the alkene residue positioned underneath the isoxazolidine ring. 
The equilibrium between these two conformation, which ultimately determines the 
diastereoselectivity of the reaction, is dependent on the substitution of the isoxazolidine ring. 
While no substituents provide negligible stereoselectivity (1.3:1 d.r.), the geminal dimethyl 
substituents in 3.83 result in an increased stereoselectivity (2.5:1 d.r.). Finally, the desired azetidine 
product 3.161 is formed via radical recombination upon intersystem crossing. 
 
Figure 3.22: Stereochemical model developed based on the observed stereoselectivity preferences of the evaluated substrates. 
The stereochemical model developed based on the conformational analysis of the biradical 
intermediates exo-3.160 and endo-3.160 is in agreement with the stereochemical outcome of all 
substrates investigated throughout this work, which is summarized in Figure 3.22. In general, for 
terminal and 1,1-disubstituted alkenes with two different substituents the larger alkene residue is 
placed exo in the final product. Interestingly, for trisubstituted alkenes the substituent in the 3-








































































selectivity likely arises from the fact that this stereocenter is set during the first step of the 
cycloaddition process, and that this position does not contain any biradical character. 
3.6. Conclusion and Outlook 
In summary, we have developed an intermolecular aza Paternò-Büchi reaction that relies 
on activation of cyclic glyoxylate-derived oximes via triplet energy transfer from a visible light 
photocatalyst. This method provides a highly versatile approach for the synthesis of azetidines that 
avoids limitations of previously reported procedures such as the need of direct irradiation via UV 
light, or the use of activated alkenes. The glyoxylate-derived oximes used in the developed 
transformation display distinct differences to the reactivity of the previously reported 3-aryl-2-
isoxazolines, as they react from the triplet excited state that is exclusively accessible via triplet 
energy transfer. In addition, the investigated triplet state oximes tolerate a broad scope of 
unactivated alkene substrates. Finally, the obtained azetidine products are readily converted to a 
range of valuable building blocks, including free azetidine accessed via N–O bond cleavage. 
Although the aza Paternò-Büchi reactions discussed herein represent highly efficient 
protocols to access complex azetidine scaffolds, some challenges remain that will require further 
investigations in the future. For example, these reactions, specifically those proceeding via triplet 
sensitization of oximes, are currently limited to cyclic imines due to the competing 
photoisomerization of acyclic substrates. Consequently, the successful design of novel, acyclic 
imine reagents that could engage in intermolecular [2+2] cycloaddition reactions would 
substantially expand the scope and the utility of current aza Paternò-Büchi reaction protocols, and 
enable access to additional types of novel azetidines products. Furthermore, the aza Paternò-Büchi 
reactions developed herein typically rely on the use of iridium photocatalysts. However, the 
prohibitively high cost of these catalysts provides challenges for conducting these reactions on 
large scale. Therefore, the development of cycloaddition reactions that proceed without any 
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catalyst or, alternatively, can be mediated by cheaper organic photocatalysts would represent a 
valuable improvement in this regard. Finally, advancing our understanding of the unprecedented 
excited state reactivity of the isoxazoline carboxylates discussed in this dissertation will likely 
accelerate the process of addressing current limitations, as well as hold the potential to utilize this 
reactivity for the development of other novel, photochemical transformations.  
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3.7. Experimental Section 
3.7.1. General Information 
General Laboratory Procedures. All air- or moisture-sensitive reaction were carried out in 
flame-dried glassware under an atmosphere of nitrogen. Thin-layer chromatography (TLC) was 
performed on Merck silica gel 60 F254 plates using UV light (254 or 366 nm), KMnO4 or CAM 
stain for visualization. Flash chromatography was performed using silica gel Silia Flash® 40-63 
micron (230-400 mesh) from Silicycle unless noted. 
Materials and Instrumentation. All chemicals were purchased from Sigma-Aldrich, Alfa Aesar, 
Acros Organics, Oakwood, TCI America, Frontier Scientific, Matrix Scientific, Ark Pharm, and 
Chem Impex International, and were used as received unless otherwise stated. THF, CH2Cl2, Et2O, 
MeOH, MeCN and DMF were dried by being passed through a column of activated alumina under 
argon using a JC-Meyer Solvent Systems. [Ir(dF(CF3)ppy)2(dtbbpy)]PF6 was prepared according 
to a literature procedure.170 All other photocatalysts including fac-[Ir(dFppy)3] were purchased 
from Sigma-Aldrich and used as received. 2-(3-phenylpropoxy)acetaldehyde O-methyl oxime 
(2.104),213 3-phenylisoxazol-5(4H)-one (3.80),219 5,5-dimethyl-3-phenyl-1-tosyl-4,5-dihydro-1H-
pyrazole (3.81)220 and (5,5-dimethyl-4,5-dihydroisoxazol-3-yl)methanol (3.153)190 were prepared 
according to literature procedures. Proton nuclear magnetic resonance (1H NMR) spectra were 
recorded on Varian MR400, Varian vnmrs 500, Varian Inova 500, and Varian vnmrs 700 
spectrometers and are referenced to residual protic NMR solvent (CDCl3: d 7.26 ppm). Data for 
1H NMR are reported as follows: chemical shift (d ppm), multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet, b = broad), coupling constant (Hz), integration. Carbon nuclear 
magnetic resonance (13C NMR) spectra were recorded on Varian vnmrs 500 and Varian vnmrs 700 
spectrometers and are referenced to the carbon resonances of the NMR solvent (CDCl3: 
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d 77.16 ppm). High-resolution mass spectrometry (MS) data was recorded at the Mass 
Spectrometry Facility at the Department of Chemistry of the University of Michigan in Ann Arbor, 
MI on an Agilent 6230 TOF HPLC-MS (ESI) or Micromass AutoSpec Ultima Magnetic Sector 
mass spectrometer (ESI, EI). Infrared (IR) spectra were obtained using a Thermo-Nicolet IS-50 
spectrometer. IR data are represented as frequency of absorption (cm-1). Stereochemistry indicators 
with asterisk (R*, S*) were used to indicate relative stereochemistry of diastereomers. 
Photochemical Setup. 
Visible light-mediated reactions were carried out using two 40 W PR160-427 Kessil lights (100% 
intensity) that were placed at both sides of the reaction vessel at a distance of approximately 10 cm. 
The reactor temperature was monitored throughout the reaction with a temperature probe placed 
adjacent to the reaction vessel and maintained at 35 ºC by cooling with a fan positioned above the 
reaction (Figure 3.23). 
 
Figure 3.23: Photochemical setup used for intermolecular [2+2] photocycloaddition. 
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3.7.2. Reaction Optimization 
Evaluations of Substrates 
A 1-dram vial was charged with the corresponding substrate (0.1 mmol, 1.0 equiv.), 
[Ir(dF(CF3)ppy)2(dtbbpy)]PF6 (3 mg, 2.5 mol%) and MeCN (0.5 mL). The vial was subsequently 
sealed with a septum-equipped cap and the reaction mixture degassed by sparging with nitrogen 
gas for 5 min. Then, 1-hexene (67 µL, 0.54 mmol, 5.0 equiv.) was added via syringe, the vial 
sealed with electrical tape and the reaction stirred under irradiation with blue LED lights (427 nm) 
at ambient temperature (fan cooling) for 4–20 h. The solvent was removed in vacuo and crude 
reaction mixture purified by flash column chromatography. 
Table 3.4: Evaluation of substrates for photochemical [2+2] photocycloaddition. 
 
entry substrate  reaction time (h) quenching percentage (%) yield (%) 
1 
 
2.104 18 24 0a 
2 
 
3.79 18 97 0a 
3 
 
3.80 4 59 0b 
4 
 
3.81 4 88 0b 
5 
 
3.82 18 96 0a 
6 
 
3.83 18 54 60 
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The quenching percentage was calculated using the following equation: 100(1-I/I0) (I: 
luminescence of [Ir(dF(CF3)ppy)2(dtbbpy)]PF6 in the absence of quencher; I0: luminescence of 
[Ir(dF(CF3)ppy)2(dtbbpy)]PF6 in the presence of 2500 equiv. of substrate).214 190 µL of a 0.11 mM 
stock solution of catalyst in MeCN and the respective amount of a 50–60 mM stock solution of 
substrate (2500 equiv.) were added to a 4-mL volumetric flask and the volume adjusted with 
MeCN. The solution was transferred to a 1-cm cuvette, which was sealed with a septum-equipped 
cap and the solution degassed by sparging for 15 min with argon gas, before measuring the 
luminescence using a PTI quantaMaster fluorimeter (Horiba) (excitation at 420 nm; luminescence 
was observed at 427 nm).  
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Reaction Optimization of Photochemical [2+2] Cycloaddition 
A 1-dram vial was charged with 3.83 (17 mg, 0.1 mmol, 1.0 equiv.), photocatalyst and solvent. 
The vial was subsequently sealed with a septum-equipped cap and the reaction mixture degassed 
by sparging with nitrogen gas for 5 min. Then, 1-hexene was added via syringe, the vial sealed 
with electrical tape and the reaction stirred under irradiation with blue LED lights (427 nm) at 
ambient temperature (fan cooling) for 16 h. The solvent was removed in vacuo and the crude 
reaction mixture analyzed by 1H NMR using mesitylene as the internal standard. 
 
Table 3.5: Photocatalyst evaluation. 
entry photocatalyst yield (%) d.r. r.r. conversion (%) 
1 xanthonea 54 4:1 16:1 70 
2 [Ir(dF(Me)ppy)2(dtbbpy)]PF6 54 >20:1 9:1 >95 
3 [Ir(dF(CF3)ppy)2(dtbbpy)]PF6 69 9:1 13:1 >95 
4 fac-[Ir(dFppy)3] 94 3:1 >20:1 >95 
5 fac-[Ir(4’-CF3-ppy)3] 8 3:1 >20:1 9 
6 fac-[Ir(ppy)3] 0 – – <5 
7 [Ir(ppy)2(dtbbpy)]PF6 0 – – <5 
8 [Ru(bpz)3](PF6)2 0 – – <5 
9 [Ru(phen)3](PF6)2 0 – – <5 
10 [Ru(bpy)3](PF6)2 0 – – <5 
Conditions: Reactions performed with 0.5 mmol 1-hexene (5.0 equiv.) and 2.5 mol% photocatalyst in MeCN (1 mL) for 16 h. 
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Table 3.6: Solvent evaluation. 
entry solvent yield (%) d.r. r.r. conversion (%) 
1 acetonitrile 94 3:1 >20:1 >95 
2 CH2Cl2 >95 3:1 >20:1 >95 
3 1,2-dichloroethane >95 3:1 19:1 >95 
4 THF 50 3:1 11:1 >95 
5 ethyl acetate 89 3:1 16:1 >95 
6 methanol 89 2:1 17:1 94 
7 toluene 91 4:1 16:1 >95 
8 acetone 92 3:1 18:1 >95 
9 1,4-dioxane 94 3:1 >20:1 >95 
10 DMF 94 3:1 >20:1 >95 
11 DMSO 84 2:1 19:1 >95 
Conditions: Reactions performed with 0.5 mmol 1-hexene (5.0 equiv.) and 2.5 mol% fac-[Ir(dFppy)3] in the corresponding 
solvents (1 mL) for 16 h. d.r. = diastereomer ratio; r.r. = regioisomer ratio. 
Table 3.7: Reaction concentration evaluation. 
entry concentration (M) yield (%) d.r. r.r. conversion (%) 
1 0.05 94 3:1 >20:1 >95 
2 0.10 94 3:1 >20:1 >95 
3 0.25 93 3:1 >20:1 >95 
4 0.50 90 3:1 19:1 >95 
5 no solvent (neat) 10 – – 12 
Conditions: Reactions performed with 0.5 mmol 1-hexene (5.0 equiv.) and 2.5 mol% fac-[Ir(dFppy)3] in MeCN (x mL) for 16 h. 
d.r. = diastereomer ratio; r.r. = regioisomer ratio. 
Table 3.8: Alkene equivalents evaluation. 
entry equivalents (alkene) yield (%) d.r. r.r. conversion (%) 
1 1.1 75 3:1 18:1 79 
2 1.5 93 3:1 >20:1 >95 
3 2.0 92 3:1 19:1 >95 
4 5.0 94 3:1 >20:1 >95 
Conditions: Reactions performed with x mmol 1-hexene (x equiv.) and 2.5 mol% fac-[Ir(dFppy)3] in MeCN (1 mL) for 16 h. d.r. = 
diastereomer ratio; r.r. = regioisomer ratio. 
Table 3.9: Catalyst loading evaluation. 
entry catalyst loading (mol%) yield (%) d.r. r.r. conversion (%) 
1 0.1 88 3:1 19:1 >95 
2 0.5 86 3:1 17:1 >95 
3 1.0 91 3:1 19:1 >95 
4 2.5 93 3:1 >20:1 >95 
Conditions: Reactions performed with 0.15 mmol 1-hexene (1.5 equiv.) and x mol% fac-[Ir(dFppy)3] in MeCN (1 mL) for 16 h. 
d.r. = diastereomer ratio; r.r. = regioisomer ratio.  
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Reaction Optimization of N–O Bond Cleavage of Azetidine Products 
A 1-dram vial was charged with exo-3.84 (10 mg, 0.04 mmol, 1.0 equiv.), reagents and solvent 
(1 mL). The vial was subsequently sealed with a septum-equipped cap and reaction mixture 
sparged with hydrogen gas for 5–10 min, before being stirred at the corresponding temperature for 
24 h under a hydrogen atmosphere (ballon, 1 atm). The reaction mixture was filtered through 
celite, the filter cake washed with CH2Cl2 and the filtrate concentrated in vacuo. The residue was 
taken up in CH2Cl2 and water and the aqueous layer brought to pH 10–11 with 2 M NaOH solution 
(aq.). Next, the organic layer was separated and the aqueous layer extracted with CH2Cl2 (2x). The 
combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. The crude 
reaction mixture was analyzed by 1H NMR to determine yield and conversion using mesitylene as 
the internal standard.  
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Table 3.10: Reaction optimization of N–O bond cleavage reaction. 
 





1 Zn (xs) HCl (aq.)/THF 80 0 >95 
2 Zn (xs) AcOH 60 38 53 
3 Pd/C (20) EtOH 40 12 11 
4 Pd(OH)2 (20), H2 (1 atm) EtOH 40 23 16 
5 Raney-Ni, H2 (1 atm) EtOH 40 58 67 
6 PtO2 (20), H2 (1 atm) EtOH 40 0 <5 
7 Ru/C (20), H2 (1 atm) EtOH 40 12 17 
8 Pd(OH)2 (50), H2 (1 atm) EtOH 40 27 39 
9 Pd(OH)2 (20), H2 (4 atm) EtOH 60 16 46 
10 Pd(OH)2 (20), H2 (1 atm) EtOH 78 14 >95 
11 Pd(OH)2 (20), H2 (1 atm) EtOH/H2O (1:1) 40 4 28 
12 Pd(OH)2 (20), H2 (1 atm) DMF 40 0 <5 
13 Pd(OH)2 (20), H2 (1 atm) acetone 40 0 51 
14 Pd(OH)2 (20), H2 (1 atm) H2O/AcOH (1:1) 40 0 >95 
15 Pd(OH)2 (20), H2 (1 atm) EtOH/H2O/AcOH 40 61 >95 
16 Pd(OH)2 (20), H2 (1 atm) p-TsOH (2.0 equiv.) EtOH 40 85 87 
17 Pd(OH)2 (20), H2 (1 atm) oxalic acid (2.0 equiv.) EtOH 40 14 40 
18 Pd(OH)2 (20), H2 (1 atm) TFA (3.4 equiv.) EtOH 40 33 61 


















3.7.3. Mechanistic Investigations 
UV/Vis Absorption Spectra 
UV/Vis absorption specta were recorded on a Varian Cary 50 UV/Vis spectrophotometer. Samples 
were prepared in MeCN with 3.83 (2.5 mM) and fac-[Ir(dFppy)3] (0.025 mM). The photocatalyst 
is the only species absorbing at 427 nm. 
 
Figure 3.24: UV/Vis absorption spectra of fac-[Ir(dFppy)3] and compound 3.83.  
 














Cyclic voltammetry was performed on a CHI620E electrochemical analyzer (CH instruments) 
using a 3-mL five-neck electrochemical cell equipped with a glassy carbon working electrode, a 
platinum counter or auxiliary electrode and an Ag/AgCl (3 M KCl) reference electrode. The 
experimental setup was calibrated using ferrocene (Fc+/Fc) prior to each experiment. Samples were 
prepared with 0.03 mmol substrate in 3 mL n-Bu4NPF6 electrolyte (0.1 M in MeCN) and degassed 
prior to use by sparging with argon gas for 10 min. Data acquisition was performed at a scan rate 
of 100 mV/s and the potential (Ep/2) determined according to literature procedures.172 All potentials 
are reported versus the saturated calomel electrode (SCE). The cyclic voltamogram for 2-




Figure 3.25: Cyclic voltammogram of compound 3.83. 
 
Figure 3.26: Cyclic voltammograms of azetidines exo-3.85, 3.115 and endo-3.85. The compounds show an irreversible oxidation 




































Stern-Volmer Quenching Study 
Samples for the quenching study were prepared using stock solutions of 3.83 (103 mM), 1-hexene 
(103 mM) and fac-[Ir(dFppy)3] (0.05 mM) in dry MeCN. To a 4-mL volumetric flask was added 
fac-[Ir(dFppy)3] (572 µL) and the respective amount of quencher (for 3.83: 0 µL, 100 µL, 195 µL, 
332 µL, 488 µL; for 1-hexene: 0 µL; 100 µL, 280 µL, 485 µL) and the volume adjusted to 4 mL 
with dry MeCN. The solution was transferred to a 1-cm quartz cuvette, which was sealed with a 
septum-equipped cap and degassed by sparging with nitrogen gas for 15 min. Emission spectra 
were recorded using a PTI quantaMaster fluorimeter (Horiba) with an excitation wavelength of 
420 nm. Emissions were observed at 480 nm and the ratio of I0/I plotted as a function of the 
quencher concentration (I0: emission intensity without quencher; I: emission intensity with 
quencher). The Stern-Volmer analysis shows that 2-isoxazoline 3.83 is a quencher of the 
photocatalyst fac-[Ir(dFppy)3], while 1-hexene does not interact with the photocatalyst. The plotted 
data from the Stern-Volmer quenching study can be found in Figure 3.17. 
Table 3.11: Stern-Volmer quenching data. 













In Situ 1H NMR Experiment 
 
A 1-dram vial was charged with 3.83 (34 mg, 0.2 mmol, 1.0 equiv.), fac-[Ir(dFppy)3] (2 mg, 
1 mol%) and d3-MeCN (2 mL). The mixture was homogenized by sonicating for 1 min. Then, 
mesitylene (~5 µL) and 1-hexene (37 µL, 0.3 mmol, 1.5 equiv.) were added. The reaction was 
carried out with a LED NMR setup by Goldstone Scientific (Mic-LED-NMR). A volume of 
600 µL of the prepared solution was transferred to a 5 mm thin-wall NMR tube, which was fitted 
with a coaxial glass insert containing a fiber-optic cable and the tube sealed with a cap and 
parafilm. The sample was inserted into a Varian vnmrs 500 and the reaction mixture irradiated 
through the fiber-optic cable with a LED light (390 nm) at ambient temperature. Concentrations 
of all reactants and products were monitored by 1H NMR in 15 min increments in reference to 
mesitylene as the internal standard. After a reaction time of 11.5 h the reaction reached 84% 
conversion with 81% yield of product. The product diastereomer ratio was found to be constant 


























Figure 3.27: NMR time study. (A) Stacked NMR data of the NMR experiment (B) Plot of the NMR time study.  
A. Stacked NMR data of the kinetic experiment 
 
B. 1H NMR time study of title reaction 
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Table 3.12: Data from the NMR time study. 
time [h] 3.83 (%) 1-hexene (%) exo-3.84 (%) endo-3.84 (%) 
0.00 76 142 0 0 
0.25 83 139 0 0 
0.50 100 145 0 0 
0.75 98 143 2 0 
1.00 95 140 4 1 
1.25 92 137 6 2 
1.50 88 133 8 3 
1.75 85 130 11 3 
2.00 82 127 13 4 
2.25 78 124 16 5 
2.50 75 121 18 6 
2.75 72 118 20 7 
3.00 69 115 22 7 
3.25 66 113 24 8 
3.50 64 110 26 9 
3.75 61 107 28 10 
4.00 58 105 30 10 
4.25 56 103 32 11 
4.50 54 101 33 12 
4.75 51 99 35 12 
5.00 49 96 37 13 
5.25 47 94 38 13 
5.50 45 93 39 14 
5.75 43 91 41 14 
6.00 41 89 42 15 
6.25 40 88 43 15 
6.50 38 86 45 16 
6.75 36 85 46 16 
7.00 35 83 47 16 
7.25 33 82 48 17 
7.50 32 80 49 17 
7.75 30 79 50 17 
8.00 29 78 51 18 
8.25 28 77 52 18 
8.50 26 76 53 18 
8.75 25 74 54 19 
9.00 24 73 54 19 
9.25 23 72 55 19 
9.50 22 71 56 20 
9.75 21 70 57 20 
10.00 20 70 58 20 
10.25 19 69 58 20 
10.50 18 68 59 21 
10.75 17 67 59 21 
11.00 17 67 60 21 




A 1-dram vial was charged with substrate (0.1 mmol, 1.0 equiv.), photocatalyst (1.0–2.5 mol%) 
and MeCN (1 mL). The vial was subsequently sealed with a septum-equipped cap and the reaction 
mixture degassed by sparging with nitrogen gas for 5 min. Then, 1-hexene was added via syringe, 
the vial sealed with electrical tape and the reaction stirred under irradiation with blue LED lights 
(427 nm) at ambient temperature (fan cooling) for 16–18 h. The solvent was removed in vacuo 
and the crude reaction mixture analyzed by 1H NMR using mesitylene as the internal standard. 
 
Figure 3.28: Control reactions testing the requirements of light and a catalyst for the cycloaddition reaction. 
 
 
Figure 3.29: Control reaction to demonstrate the stability of the 2-isoxazoline substrates under the reaction conditions. 
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(427 nm), 16 h
+
no conversion of exo-diastereomer (< 5%)
41% conversion of exo-diastereomer
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Figure 3.31: Control reaction demonstrating the requirement of a cyclic backbone. 
 
Figure 3.32: Control reaction demonstrating the requirement of an electron-withdrawing group. 
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Other Evaluated Substrates in the Photochemical [2+2] Cycloaddition 
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3.7.4. Experimental Procedures 
General Procedure for Synthesis of 2-Isoxazolines via (3+2) Cycloaddition (GP-3.1) 
 
A round-bottom flask equipped with a magnetic stir bar was charged with ethyl 2-
(hydroxyimino)acetate221 (1.0 equiv.) and DMF (0.5 M). N-chlorosuccinimide (1.0 equiv.) was 
added and the resulting mixture stirred at 60 ºC for 2 h. After cooling to rt, the reaction mixture 
was partitioned between water and EtOAc. The organic layer was separated, and the aqueous layer 
extracted with EtOAc (2x). The combined organic extracts were washed with water (2x) and brine, 
then dried over Na2SO4, filtered and concentrated in vacuo to afford ethyl 2-chloro-2-
(hydroxyimino)acetate as a colorless solid, which was used for the next step without further 
purification. 
A round-bottom flask containing ethyl 2-chloro-2-(hydroxyimino)acetate was equipped 
with a magnetic stir bar, charged with the corresponding alkene (1.5–33.4 equiv.) and CH2Cl2 
(0.3 M), and subsequently sealed with a rubber septum. Next, Et3N (1.0 equiv.) was added 
dropwise over 2-4 h using a syringe pump, and, after completion of addition, the reaction stirred 
for additional 0.5–12 h. The resulting reaction mixture was washed with 0.5 M HCl solution (aq.) 
and the aqueous layer extracted with CH2Cl2 (2x). The combined organic extracts were washed 
with brine, dried over Na2SO4, filtered and concentrated in vacuo. The crude mixture was purified 
by flash column chromatography to afford the pure title compound. 
Note: For cyclic 2-isoxazolines 3.83 and S3.85, the alkene was added by sparging the solution 
with the corresponding gaseous alkene after sealing the flask with a rubber septum, and the reaction 
carried out under an atmosphere of the alkene. The amount of added alkene was determined by 
















Ethyl 5,5-dimethyl-4,5-dihydroisoxazole-3-carboxylate (3.83): Prepared according to GP-3.1 
using ethyl 2-(hydroxyimino)acetate221 (5.00 g, 42.7 mmol, 1.0 equiv.), N-chlorosuccinimide 
(5.70 g, 42.7 mmol, 1.0 equiv.), Et3N (6.0 mL, 42.7 mmol, 1.0 equiv.) and 2-methylpropene 
(24.0 g, 427 mmol, 10.0 equiv.). Purification by flash column chromatography (5–20% 
EtOAc/hexanes) afforded the pure title compound as a colorless low-melting solid (4.62 g, 63%). 
Spectroscopic data were consistent with those reported in the literature.190 
1H NMR (400 MHz, CDCl3): d 4.34 (q, J = 7.1 Hz, 2H), 2.96 (s, 2H), 1.46 (s, 6H), 1.37 (t, J = 
7.1 Hz, 3H). 
 
Ethyl 4,5-dihydroisoxazole-3-carboxylate (S3.85): Prepared according to GP-3.1 using ethyl 2-
(hydroxyimino)acetate221 (750 mg, 6.4 mmol, 1.0 equiv.), N-chlorosuccinimide (855 mg, 
6.4 mmol, 1.0 equiv.), Et3N (0.89 mL, 6.4 mmol, 1.0 equiv.) and ethylene (6.00 g, 214 mmol, 
33.4 equiv.). Purification by flash column chromatography (5–35% EtOAc/hexanes) afforded the 
pure title compound as a colorless oil (600 mg, 65%). 
1H NMR (700 MHz, CDCl3): d 4.54 (t, J = 10.7 Hz, 2H), 4.36 (q, J = 7.1 Hz, 2H), 3.21 (t, J = 
10.7 Hz, 2H), 1.37 (t, J = 7.1 Hz, 3H).; 13C NMR (176 MHz, CDCl3): d 160.8, 151.9, 71.4, 62.2, 
33.9, 14.2; IR (cm-1): 2984, 2361, 2338, 1715, 1685, 1587, 1404, 1333, 1254, 1118, 1017, 916, 
858, 818, 748; HRMS: m/z calculated for C6H10NO3+ [M+H]+: 144.0655; found: 144.0656. 
 
Ethyl 5-ethoxy-4,5-dihydroisoxazole-3-carboxylate (S3.89): Prepared according to GP-3.1 















(334 mg, 2.5 mmol, 1.0 equiv.), Et3N (0.35 mL, 2.5 mmol, 1.0 equiv.) and ethyl vinyl ether 
(1.2 mL, 12.5 mmol, 5.0 equiv.). Purification by flash column chromatography (2–15% 
EtOAc/hexanes) afforded the pure title compound as a colorless oil (328 mg, 70%). 
1H NMR (500 MHz, CDCl3): d 5.70 (d, J = 6.9 Hz, 1H), 4.36 (q, J = 6.7 Hz, 2H), 3.90 (p, J = 
7.4 Hz, 1H), 3.61 (p, J = 7.5 Hz, 1H), 3.23 (dd, J = 18.4, 6.9 Hz, 1H), 3.08 (d, J = 18.4 Hz, 1H), 
1.37 (t, J = 7.1 Hz, 3H), 1.22 (t, J = 7.0 Hz, 3H); 13C NMR (126 MHz, CDCl3): d 160.4, 152.0, 
105.0, 64.5, 62.2, 40.3, 15.1, 14.2; IR (cm-1): 2981, 2361, 2338, 1718, 1589, 1374, 1339, 1260, 
1190, 1130, 1090, 1017, 904, 850, 761, 741; HRMS: m/z calculated for C8H14NO4+ [M+H]+: 
188.0917; found: 188.0916.  
 
8-(Tert-butyl) 3-ethyl 1-oxa-2,8-diazaspiro[4.5]dec-2-ene-3,8-dicarboxylate (S3.87): Prepared 
according to GP-3.1 using ethyl 2-(hydroxyimino)acetate221 (293 mg, 2.5 mmol, 1.0 equiv.), N-
chlorosuccinimide (334 mg, 2.5 mmol, 1.0 equiv.), Et3N (0.35 mL, 2.5 mmol, 1.0 equiv.) and tert-
butyl 4-methylenepiperidine-1-carboxylate222 (740 mg, 3.8 mmol, 1.5 equiv.). Purification by 
flash column chromatography (7–40% EtOAc/hexanes) afforded the pure title compound as a 
colorless solid (463 mg, 59%). 
1H NMR (700 MHz, CDCl3): d 4.35 (q, J = 7.1 Hz, 2H), 3.65 (b, 2H), 3.49 – 3.39 (m, 2H), 2.96 
(s, 2H), 1.88 (d, J = 13.3 Hz, 2H), 1.70 (t, J = 9.0 Hz, 2H), 1.46 (s, 9H), 1.37 (t, J = 7.1 Hz, 3H); 
13C NMR (176 MHz, CDCl3): d 160.9, 154.7, 151.2, 88.0, 79.9, 62.2, 43.8, 40.7, 35.8, 28.5, 14.2; 
IR (cm-1): 2979, 2927, 2361, 2338, 1734, 1695, 1429, 1366, 1152, 1110, 1077, 949, 855, 749; 







Ethyl 5-phenyl-4,5-dihydroisoxazole-3-carboxylate (S3.88): Prepared according to GP-3.1 
using ethyl 2-(hydroxyimino)acetate221 (293 mg, 2.5 mmol, 1.0 equiv.), N-chlorosuccinimide 
(334 mg, 2.5 mmol, 1.0 equiv.), Et3N (0.35 mL, 2.5 mmol, 1.0 equiv.) and styrene (0.57 mL, 
5.0 mmol, 2.0 equiv.). Purification by flash column chromatography (7–40% EtOAc/hexanes) 
afforded the pure title compound as a colorless oil (413 mg, 75%). 
1H NMR (700 MHz, CDCl3): d  7.42 – 7.37 (m, 2H), 7.37 – 7.31 (m, 3H), 5.79 (dd, J = 11.6, 
8.9 Hz, 1H), 4.37 (q, J = 7.1 Hz, 2H), 3.64 (dd, J = 17.8, 11.6 Hz, 1H), 3.22 (dd, J = 17.8, 8.9 Hz, 
1H), 1.38 (t, J = 7.1 Hz, 3H); 13C NMR (176 MHz, CDCl3): d 160.7, 151.3, 139.6, 129.0, 128.8, 
126.0, 85.1, 62.3, 41.6, 14.2; IR (cm-1): 2983, 2361, 2338, 1717, 1588, 1379, 1333, 1243, 1119, 
1016, 921, 860, 745, 698; HRMS: m/z calculated for C12H14NO3+ [M+H]+: 220.0968; found: 
220.0970. 
 
Diethyl 2-((3-(ethoxycarbonyl)-4,5-dihydroisoxazol-5-yl)methyl)malonate (S3.90): Prepared 
according to GP-3.1 using ethyl 2-(hydroxyimino)acetate221 (293 mg, 2.5 mmol, 1.0 equiv.), N-
chlorosuccinimide (334 mg, 2.5 mmol, 1.0 equiv.), Et3N (0.35 mL, 2.5 mmol, 1.0 equiv.) and 
diethyl allylmalonate (0.99 mL, 5.0 mmol, 2.0 equiv.). Purification by flash column 
chromatography (5–40% EtOAc/hexanes) afforded the pure title compound as a colorless oil 
(571 mg, 72%). 
1H NMR (700 MHz, CDCl3): d 4.90 – 4.83 (m, 1H), 4.35 (qd, J = 7.1, 1.4 Hz, 2H), 4.28 – 4.17 
(m, 4H), 3.63 (dd, J = 8.8, 5.8 Hz, 1H), 3.33 (dd, J = 17.6, 10.9 Hz, 1H), 2.89 (dd, J = 17.6, 7.4 Hz, 









(176 MHz, CDCl3): d 168.9, 168.8, 160.6, 151.6, 81.1, 62.3, 61.9 (2C), 48.4, 39.2, 34.3, 14.23, 
14.15, 14.1; IR (cm-1): 2983, 1721, 1590, 1446, 1370, 1239, 1175, 1149, 1018, 924, 859, 793, 748; 
HRMS: m/z calculated for C14H21NNaO7+ [M+Na]+: 338.1210; found: 338.1214.  
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Procedure for Gram-Scale Synthesis of 3.83 
 
To a 250-mL round-bottom flask equipped with a magnetic stir bar containing ethyl 2-
(hydroxyimino)acetate221 (10.00 g, 85.4 mmol, 1.0 equiv.) and DMF (100 mL) was added N-
chlorosuccinimide, and the resulting mixture heated at 60 ºC for 3.5 h. After cooling to rt, the 
reaction mixture was diluted with water (300 mL) and extracted with Et2O (3x 200 mL). The 
combined organic extracts were washed with water (200 mL) and brine (200 mL), then dried over 
MgSO4, filtered and concentrated in vacuo to afford ethyl 2-chloro-2-(hydroxyimino)acetate as a 
white solid, which was used for the next step without further purification. 
Next, a 1-L three-neck round-bottom flask was equipped with a magnetic stir bar, nitrogen 
gas inlet and a condenser, which was cooled to –78 ºC and connected to a lecture bottle containing 
2-methylpropene. The three-neck flask was cooled to approximately –20 ºC and 2-methylpropene 
gas (56 g, 998 mmol, 11.7 equiv.) was condensed into the flask. Ethyl 2-chloro-2-
(hydroxyimino)acetate was added as a solution in CH2Cl2 (300 mL) and the resulting mixture 
warmed up to 0 ºC with an ice bath. The ice bath was removed and Et3N (12.0 mL, 85.4 mmol, 
1.0 equiv.) was subsequently added dropwise using a syringe pump over 6 h. After stirring for 10 h 
at rt, water (100 mL) was added, the organic layer separated and the aqueous layer extracted with 
CH2Cl2 (2x 50 mL). The combined organic layers were washed with brine (100 mL), dried over 
Na2SO4, filtered and concentrated in vacuo. Purification by flash column chromatography (0–10% 
EtOAc/hexanes) afforded the pure title compound as a colorless, low-melting solid (9.89 g, 68%). 
Spectroscopic data were consistent with those reported in the literature.190 
1H NMR (400 MHz, CDCl3): d 4.34 (q, J = 7.1 Hz, 2H), 2.96 (s, 2H), 1.46 (s, 6H), 1.37 (t, J = 

















General Procedure for Synthesis of 2-Isoxazolines via Steglich Esterification (GP-3.2) 
 
To a round-bottom flask equipped with a magnetic stir bar containing 3.97 (1.0 equiv.) and CH2Cl2 
(0.1 M) were added the corresponding alcohol (1.0–2.0 equiv.) EDC • HCl (1.2 equiv.) and 
DMAP (0.2 equiv.). The resulting reaction mixture was stirred at rt until complete as judged by 
TLC analysis (6–24 h). Then, 1 M HCl solution (aq.) was added, the organic layer separated, and 
the aqueous layer extracted with CH2Cl2 (3x). The combined organic layers were washed with 
brine, dried over Na2SO4, filtered and concentrated in vacuo. The crude product was purified by 
flash column chromatography to afford the pure title compound. 
 
Prop-2-yn-1-yl 5,5-dimethyl-4,5-dihydroisoxazole-3-carboxylate (S3.91): Prepared according 
to GP-3.2 using 3.97 (150 mg, 1.1 mmol, 1.0 equiv.), propargyl alcohol (0.12 mL, 2.1 mmol, 
2.0 equiv.), EDC • HCl (241 mg, 1.3 mmol, 1.2 equiv.) and DMAP (26 mg, 0.2 mmol, 0.2 equiv.) 
with a reaction time of 6 h. Purification by flash column chromatography (5–30% EtOAc/hexanes) 
afforded the pure title compound as a colorless oil (167 mg, 88%) 
1H NMR (700 MHz, CDCl3): d 4.87 (d, J = 2.5 Hz, 2H), 2.98 (s, 2H), 2.52 (t, J = 2.5 Hz, 1H), 
1.47 (s, 6H); 13C NMR (176 MHz, CDCl3): d 160.4, 150.4, 89.1, 76.9, 75.9, 53.1, 45.1, 27.3; IR 
(cm-1): 3279, 2977, 2362, 2337, 1723, 1581, 1437, 1380, 1338, 1285, 1230, 1118, 942, 742, 668; 























Adamantan-1-yl 5,5-dimethyl-4,5-dihydroisoxazole-3-carboxylate (S3.92): Prepared 
according to GP-3.2 using 3.97 (150 mg, 1.1 mmol, 1.0 equiv.), 1-adamantanol (191 mg, 
1.3 mmol, 1.2 equiv.), EDC • HCl (241 mg, 1.3 mmol, 1.2 equiv.) and DMAP (26 mg, 0.2 mmol, 
0.2 equiv.) with a reaction time of 24 h. Purification by flash column chromatography (1–10% 
EtOAc/hexanes) afforded the pure title compound as a white solid (143 mg, 49%). 
1H NMR (700 MHz, CDCl3): d 2.92 (s, 2H), 2.20 (s, 9H), 1.73 – 1.64 (m, 6H), 1.44 (s, 6H); 
13C NMR (176 MHz, CDCl3): d 160.0, 152.4, 88.2, 83.4, 45.6, 41.4, 36.2, 31.1, 27.4; IR (cm-1): 
2912, 2856, 2362, 2337, 1724, 1577, 1457, 1344, 1279, 1235, 1054, 954, 741; HRMS: m/z 
calculated for C16H23NNaO3+ [M+Na]+: 300.1570; found: 300.1571. 
 
4-Methoxybenzyl 5,5-dimethyl-4,5-dihydroisoxazole-3-carboxylate (S3.93): Prepared 
according to GP-3.2 using 3.97 (100 mg, 0.7 mmol, 1.0 equiv.), 4-methoxybenzyl alcohol (97 mg, 
0.7 mmol, 1.0 equiv.), EDC • HCl (148 mg, 0.8 mmol, 1.1 equiv.) and DMAP (17 mg, 0.1 mmol, 
0.2 equiv.) with a reaction time of 24 h. Purification by flash column chromatography (5–30% 
EtOAc/hexanes) afforded the pure title compound as a colorless oil (135 mg, 73%). 
1H NMR (700 MHz, CDCl3): d 7.36 (d, J = 8.6 Hz, 2H), 6.89 (d, J = 8.7 Hz, 2H), 5.24 (s, 2H), 
3.81 (s, 3H), 2.95 (s, 2H), 1.44 (s, 6H); 13C NMR (176 MHz, CDCl3): d 161.0, 159.9, 151.0, 130.6, 
127.2, 114.0, 88.6, 67.3, 55.3, 45.2, 27.3; IR (cm-1): 2959, 2836, 2361, 2338, 1712, 1513, 1298, 
1234, 1179, 1121, 1092, 1033, 925, 851, 832, 768, 759; HRMS: m/z calculated for C14H17NO4+ 














3-Methylbut-2-en-1-yl 5,5-dimethyl-4,5-dihydroisoxazole-3-carboxylate (3.94): Prepared 
according to GP-3.2 using 3.97 (143 mg, 1.0 mmol, 1.0 equiv.), 3-methyl-2-buten-1-ol (0.20 mL, 
2.0 mmol, 2.0 equiv.), EDC • HCl (230 mg, 1.2 mmol, 1.2 equiv.) and DMAP (24 mg, 0.2 mmol, 
0.2 equiv.) with a reaction time of 6 h. Purification by flash column chromatography (2–15% 
EtOAc/hexanes) afforded the pure title compound as a colorless oil (198 mg, 94%). 
1H NMR (700 MHz, CDCl3): d 5.39 (t, J = 7.3 Hz, 1H), 4.75 (d, J = 7.4 Hz, 2H), 2.94 (d, J = 
1.0 Hz, 2H), 1.74 (d, J = 16.9 Hz, 6H), 1.44 (s, 6H); 13C NMR (176 MHz, CDCl3): d 161.2, 151.2, 
140.3, 117.9, 88.5, 62.8, 45.3, 27.3, 25.9, 18.2; IR (cm-1): 2975, 2934, 1713, 1583, 1440, 1400, 
1286, 1231, 1123, 940, 731; HRMS: m/z calculated for C11H17NNaO3+ [M+Na]+: 234.1101; 
found: 234.1101. 
 
(E)-Pent-2-en-1-yl 5,5-dimethyl-4,5-dihydroisoxazole-3-carboxylate ((E)-3.155): Prepared 
according to GP-3.2 using 3.97 (143 mg, 1.0 mmol, 1.0 equiv.), trans-2-penten-1-ol (0.20 mL, 
2.0 mmol, 2.0 equiv.), EDC • HCl (230 mg, 1.2 mmol, 1.2 equiv.) and DMAP (24 mg, 0.2 mmol, 
0.2 equiv.) with a reaction time of 18 h. Purification by flash column chromatography (2–15% 
EtOAc/hexanes) afforded the pure title compound as a colorless oil (184 mg, 87%). 
1H NMR (400 MHz, CDCl3): d 5.94 – 5.85 (m, 1H), 5.67 – 5.56 (m, 1H), 4.71 (d, J = 6.6 Hz, 2H), 
2.96 (s, 2H), 2.08 (p, J = 7.1 Hz, 2H), 1.46 (s, 6H), 1.00 (t, J = 7.5 Hz, 3H); 13C NMR (176 MHz, 
CDCl3): d 161.0, 151.1, 139.5, 122.0, 88.6, 66.7, 45.3, 27.3, 25.4, 13.1; IR (cm-1): 2969, 2935, 
1714, 1583, 1440, 1372, 1285, 1231, 1121, 938, 765, 745; HRMS: m/z calculated for 
















(Z)-Pent-2-en-1-yl 5,5-dimethyl-4,5-dihydroisoxazole-3-carboxylate ((Z)-3.155): Prepared 
according to GP-3.2 using 3.97 (143 mg, 1.0 mmol, 1.0 equiv.), cis-2-penten-1-ol (0.20 mL, 
2.0 mmol, 2.0 equiv.), EDC • HCl (230 mg, 1.2 mmol, 1.2 equiv.) and DMAP (24 mg, 0.2 mmol, 
0.2 equiv.) with a reaction time of 18 h. Purification by flash column chromatography (2–15% 
EtOAc/hexanes) afforded the pure title compound as a colorless oil (195 mg, 92%). 
1H NMR (400 MHz, CDCl3): d 5.74 – 5.65 (m, 1H), 5.61 – 5.52 (m, 1H), 4.82 (d, J = 6.9 Hz, 2H), 
2.96 (s, 2H), 2.15 (p, J = 7.3 Hz, 2H), 1.46 (s, 6H), 1.00 (t, J = 7.5 Hz, 3H); 13C NMR (176 MHz, 
CDCl3): d 161.1, 151.0, 138.0, 121.9, 88.6, 61.6, 45.3, 27.3, 21.0, 14.1; IR (cm-1): 2971, 2876, 
1715, 1583, 1390, 1371, 1336, 1286, 1230, 1120, 939, 765, 745; HRMS: m/z calculated for 
C11H17NNaO3+ [M+Na]+: 234.1101; found: 234.1103. 
Miscellaneous Procedures 
 
Methyl (E)-4-((hydroxyimino)methyl)benzoate (A3.1): A 50-mL round-bottom flask equipped 
with a magnetic stir bar was charged with methyl 4-formylbenzoate (1.00 g, 6.1 mmol, 1.0 equiv.) 
and MeOH (20 mL). Sodium acetate (1.50 g, 18.3 mmol, 3.0 equiv.) and hydroxylamine 
hydrochloride (466 mg, 6.7 mmol, 1.1 equiv.) were added sequentially and the resulting mixture 
stirred at rt for 18 h. NaHCO3 solution (aq., sat.) was added and the organic solvent removed in 
vacuo. The residue was diluted with water and extracted with EtOAc (3x). The combined organic 
extracts were dried over Na2SO4, filtered and concentrated in vacuo, then dried using high-vac to 
afford the pure title compound as a white solid. Spectroscopic data were consistent with those 















1H NMR (400 MHz, CDCl3): d 8.17 (s, 1H), 8.05 (d, J = 8.0 Hz, 2H), 7.65 (d, J = 8.1 Hz, 2H), 
7.51 (s, 1H), 3.93 (d, J = 2.1 Hz, 3H). 
	
(5,5-Dimethyl-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl)(phenyl)methanone (3.82): A 25-mL 
round-bottom flask was charged with 3-methyl-1-phenylbut-2-en-1-one224 (500 mg, 3.1 mmol, 
1.0 equiv.) and EtOH (12 mL). Hydrazine hydrate (1.4 mL, 15.6 mmol, 5.0 equiv.) was added and 
the resulting reaction mixture heated at 70 ºC for 6 h. After cooling to rt, the solvent was removed 
in vacuo and the resulting residue taken up in EtOAc. The organic layer was washed with NH4Cl 
solution (aq., sat.) and brine, dried over Na2SO4, filtered and concentrated in vacuo to afford 5,5-
dimethyl-3-phenyl-4,5-dihydro-1H-pyrazole. 
The crude compound was dissolved in CH2Cl2 (15 mL), and benzoyl chloride (0.54 mL, 
4.7 mmol, 1.5 equiv.), Et3N (0.65 mL, 4.7 mmol, 1.5 equiv.) and DMAP (76 mg, 0.6 mmol, 
0.2 equiv.) were sequentially added. After stirring the reaction mixture for 18 h at rt, the mixture 
was diluted with CH2Cl2 and washed with 1 M HCl solution (aq.) and brine, dried over Na2SO4, 
filtered and concentrated in vacuo. Purification by flash column chromatography (2–20% 
EtOAc/hexanes) afforded the pure title compound as an off-white solid (235 mg, 27%). 
Spectroscopic data were found consistent with those reported in the literature.225 
 
Methyl 4-(5,5-dimethyl-4,5-dihydroisoxazol-3-yl)benzoate (3.79): To a 25-mL round-bottom 
flask equipped with a magnetic stir bar containing A3.1 (544 mg, 3.0 mmol, 1.0 equiv.) and DMF 
(10 mL) was added N-chlorosuccinimide (405 mg, 3.0 mmol, 1.0 equiv.). After heating for 2 h at 


























filtration to afford methyl (Z)-4-(chloro(hydroxyimino)methyl)benzoate, which was subsequently 
transferred to a 100-mL round-bottom flask and dissolved in CH2Cl2 (30 mL). The flask was sealed 
with a rubber septum and the solution sparged with 2-methylpropene for 20 min. Next, Et3N 
(0.47 mL, 3.3 mmol, 1.1 equiv.) was added dropwise over 2 h using a syringe pump and the 
reaction stirred for additional 0.5 h at rt under an atmosphere of 2-methylpropene. The reaction 
mixture was diluted with CH2Cl2 and washed with 0.2 M HCl solution (aq.) and brine, dried over 
Na2SO4, filtered and concentrated in vacuo. Purification by flash column chromatography (5–30% 
EtOAc/hexanes) afforded the pure title compound as a white solid (448 mg, 63%). 
1H NMR (400 MHz, CDCl3): d 8.06 (d, J = 8.5 Hz, 2H), 7.71 (d, J = 8.5 Hz, 2H), 3.93 (s, 3H), 
3.12 (s, 2H), 1.51 (s, 6H); 13C NMR (126 MHz, CDCl3): d 166.7, 155.7, 134.7, 131.1, 130.0, 
126.4, 85.9, 52.4, 46.6, 27.5; IR (cm-1): 2972, 1709, 1609, 1588, 1436, 1370, 1274, 1101, 960, 
904, 860, 770, 693; HRMS: m/z calculated for C13H16NO3+ [M+H]+: 234.1125; found: 234.1125. 
 
5,5-Dimethyl-4,5-dihydroisoxazole-3-carboxylic acid (3.97): To a 50-mL round-bottom flask 
equipped with a magnetic stir bar was added 3.83 (1.00 g, 5.8 mmol, 1.0 equiv.) and a 3:1 mixture 
of methanol/H2O (20 mL). Lithium hydroxide monohydrate (270 mg, 6.4 mmol, 1.1 equiv.) was 
added and the reaction mixture stirred for 12 h at rt. Next, the solution was acidified with 1 M HCl 
solution (aq.) and subsequently extracted with CH2Cl2 (10x). The combined organic extracts were 
dried over Na2SO4, filtered and concentrated in vacuo, then dried using high-vac to afford the pure 
title compound as a white solid (773 mg, 92%). 
1H NMR (700 MHz, CDCl3): d 2.98 (s, 2H), 1.49 (s, 6H); 13C NMR (176 MHz, CDCl3): d 164.2, 
150.7, 90.2, 44.5, 27.4; IR (cm-1): 3381, 2978, 1704, 1587, 1439, 1289, 1240, 1139, 1020, 949, 














5,5-Dimethyl-4,5-dihydroisoxazole-3-carbaldehyde oxime (A3.2): A 25-mL round-bottom 
flask equipped with a magnetic stir bar was charged with 5,5-dimethyl-4,5-dihydroisoxazole-3-
carbaldehyde225 (160 mg, 1.3 mmol, 1.0 equiv.). MeOH (10 mL) was added, followed by 
sequential addition of hydroxylamine hydrochloride (175 mg, 2.5 mmol, 2.0 equiv.) and sodium 
acetate (413 mg, 5.0 mmol, 4.0 equiv.). After stirring for 16 h at rt, the reaction mixture was 
concentrated in vacuo. The residue was diluted with NaHCO3 solution (aq., sat.) and extracted 
with EtOAc (3x). The combined organic extracts were washed with brine, dried over Na2SO4, 
filtered and concentrated in vacuo, then dried using high-vac to afford the pure title compound as 
a white solid (123 mg, 69%; 4:1 mixture of oxime isomers). 
1H NMR (500 MHz, CDCl3): d 8.48 (s, 1H; minor), 8.07 (s, 4H; major), 8.04 (s, 4H; major), 7.40 
(s, 1H; minor), 3.25 (s, 2H; minor), 2.91 (s, 8H; major), 1.44 (d, J = 1.7 Hz, 30H; major+minor); 
13C NMR (126 MHz, CDCl3): d 154.0, 143.8 (2C), 139.6, 87.1, 86.5, 48.5, 44.5, 27.2, 27.1; IR 
(cm-1): 3245, 3179, 3089, 2999, 2982, 2937, 2859, 1467, 1432, 1369, 1292, 1154, 907, 855, 760, 
730; HRMS: m/z calculated for C6H11N2O2+ [M+H]+: 143.0815; found: 143.0815. 
 
5,5-Dimethyl-4,5-dihydroisoxazole-3-carbonitrile (S3.96): Adapted from a literature procedure 
with minor modifications.226 To a 10-mL round-bottom flask equipped with a magnetic stir bar 
containing a solution of triphenylphosphine (22 mg, 0.08 mmol, 0.1 equiv.) in EtOAc (2 mL) was 
added oxalyl chloride (0.1 mL, 1.2 mmol, 1.5 equiv.) dropwise. After stirring for 5 min at rt, a 
solution of A3.2 (110 mg, 0.8 mmol, 1.0 equiv.) in EtOAc (1 mL) was added dropwise over 0.5 h. 




























mixture was purified by flash column chromatography (10–20% Et2O/pentane) to afford the pure 
title compound as a colorless oil (77 mg, 80%). 
1H NMR (500 MHz, CDCl3): d 2.93 (s, 2H), 1.49 (s, 6H); 13C NMR (126 MHz, CDCl3): d 133.9, 
111.6, 89.6, 46.9, 27.1; IR (cm-1): 2982, 2236, 1555, 1462, 1374, 1324, 1263, 1150, 964, 827, 782, 
663; HRMS: m/z calculated for C6H8N2O+ [M]+: 124.0637; found: 124.0642. 
 
Ethyl 2-((benzyloxy)imino)propanoate ((E)-3.154): To a 25-mL round-bottom flask equipped 
with a magnetic stir bar was added ethyl pyruvate (0.20 mL, 1.8 mmol, 1.0 equiv.) and EtOH 
(10 mL). After sequential addition of sodium acetate (591 mg, 7.2 mmol, 4.0 equiv.) and O-
benzylhydroxylamine hydrochloride (575 mg, 3.6 mmol, 2.0 equiv.), the reaction was stirred for 
14 h at rt. Next, NaHCO3 solution (aq., sat.) was added and the organic solvent removed in vacuo. 
Water was added to the remaining residue and the mixture extracted with EtOAc (3x). The 
combined organic extracts were washed with brine, dried over Na2SO4, filtered and concentrated 
in vacuo. Purification by flash column chromatography (2–10% EtOAc/hexanes) afforded the pure 
title compound as a colorless oil (338 mg, 85%; 20:1 mixture of oxime isomers). 
1H NMR (500 MHz, CDCl3): d 7.40 – 7.31 (m, 5H), 5.31 (s, 2H), 4.32 (q, J = 7.1 Hz, 2H), 2.09 
(s, 3H), 1.35 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3): d 163.9, 149.6, 136.8, 128.6, 128.4, 
128.3, 77.7, 61.9, 14.3, 11.8; IR (cm-1): 2982, 1715, 1613, 1497, 1454, 1366, 1317, 1148, 1009, 








Synthesis of Alkene Starting Materials 
 
N-(But-3-en-1-yl)-N-cyclopropyl-4-methylbenzenesulfonamide (S3.109): A 10-mL round-
bottom flask equipped with a magnetic stir bar was charged with cyclopropylamine (0.21 mL, 
3.0 mmol, 1.0 equiv.) and water (3 mL). Pyridine (0.29 mL, 3.6 mmol, 1.2 equiv.) and 4-
toluenesulfonyl chloride (636 mg, 3.3 mmol, 1.1 equiv.) were added sequentially and the reaction 
stirred for 1 h at rt. The resulting precipitate was collected by filtration and washed with water to 
afford N-cyclopropyl-4-methylbenzenesulfonamide as an orange solid. 
The compound was dissolved in DMF (10 mL) followed by the addition of K2CO3 (1.26 g, 
9.1 mmol, 3.0 equiv.) and 4-bromo-1-butene (0.46 mL, 4.6 mmol, 1.5 equiv.). After stirring the 
reaction for 6 h at 80 ºC, the mixture was allowed to cool down to rt and diluted with water. After 
extracting with EtOAc (3x) the combined organic extracts were washed with water (2x) and brine, 
dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash column 
chromatography (2–20% EtOAc/hexanes) afforded the product as a colorless oil (150 mg, 19%). 
1H NMR (700 MHz, CDCl3): d 7.74 (d, J = 8.2 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 5.74 (ddt, J = 
17.1, 10.2, 6.8 Hz, 1H), 5.07 – 5.01 (m, 2H), 3.26 – 3.22 (m, 2H), 2.43 (s, 3H), 2.35 (q, J = 7.0 Hz, 
2H), 2.04 (h, J = 6.9, 3.7 Hz, 1H), 0.87 – 0.83 (m, 2H), 0.71 – 0.67 (m, 2H); 13C NMR (176 MHz, 
CDCl3): d 143.4, 135.8, 135.2, 129.6, 127.7, 116.9, 50.7, 33.1, 30.5, 21.6, 7.5; IR (cm-1): 2924, 
2361, 2338, 1457, 1341, 1160, 1090, 1028, 992, 916, 862, 814, 711, 691, 654; HRMS: m/z 









Benzyl 4-ethylidenepiperidine-1-carboxylate (S3.123): Benzyl 4-oxopiperidine-1-carboxylate 
was synthesized from piperidine-4-one hydrochloride (400 mg, 2.6 mmol, 1.0 equiv.) according 
to a literature procedure227 and used for the next step without further purification. To a 25-mL 
round-bottom flask equipped with a magnetic stir bar containing a suspension of 
ethyltriphenylphosphonium bromide (1.45 g. 3.9 mmol, 1.5 equiv.) in Et2O (10 mL) was added 
KOt-Bu (438 mg, 3.9 mmol, 1.5 equiv.) at 0 ºC. After stirring the mixture for 0.5 h, a solution of 
crude benzyl 4-oxopiperidine-1-carboxylate in Et2O (2 mL) was slowly added and the reaction 
allowed to warm up to rt. After stirring for 2.5 h at rt, NH4Cl solution (aq., sat.) and water were 
added, the organic layer separated, and the aqueous layer extracted with Et2O (3x). The combined 
organic extracts were washed with brine, dried over MgSO4, filtered and concentrated in vacuo. 
Purification by flash column chromatography (1–10% EtOAc/hexanes) afforded the pure title 
compound as a colorless oil (455 mg, 71%). 
1H NMR (700 MHz, CDCl3): d 7.39 – 7.29 (m, 5H), 5.29 (q, J = 6.5 Hz, 1H), 5.14 (s, 2H), 3.49 – 
3.45 (m, 4H), 2.19 (d, J = 56.5 Hz, 4H), 1.60 (d, J = 6.7 Hz, 3H); 13C NMR (176 MHz, CDCl3): 
d 155.4, 137.1, 135.1, 128.6, 128.1, 128.0, 118.4, 67.2, 45.9, 44.9, 35.8, 27.9, 12.8; IR (cm-1): 
2861, 2362, 2337, 1695, 1425, 1363, 1014, 963, 824, 734, 696 ; HRMS: m/z calculated for 
C15H19NNaO2+ [M+Na]+: 268.1308; found: 268;1308. 
 
2-(But-3-en-1-yloxy)-1,4-difluorobenzene (S3.113): A 25-mL round-bottom flask equipped with 
a magnetic stir bar was charged with 2,5-difluorophenol (325 mg, 2.5 mmol, 1.0 equiv.) and DMF 
























1.5 equiv.) were added and the resulting heterogeneous mixture stirred for 20 h at 80 ºC. After 
cooling to rt, the mixture was diluted with water and extracted with EtOAc (3x). The combined 
organic extracts were washed with water (2x) and brine, dried over Na2SO4, filtered and 
concentrated in vacuo. Purification by flash column chromatography (1–5% EtOAc/hexanes) 
afforded the pure title compound as a colorless, volatile oil (173 mg, 38%). 
1H NMR (500 MHz, CDCl3): d 7.05 – 6.96 (m, 1H), 6.73 – 6.65 (m, 1H), 6.61 – 6.53 (m, 1H), 
5.90 (ddt, J = 17.1, 10.3, 6.7 Hz, 1H), 5.22 – 5.10 (m, 2H), 4.05 (t, J = 6.8 Hz, 2H), 2.58 (q, J = 
6.7 Hz, 2H); 13C NMR (176 MHz, CDCl3): d 158.9 (dd, J = 241.8, 2.5 Hz), 149.1 (dd, J = 241.1, 
3.3 Hz), 147.7 (dd, J = 12.5, 10.5 Hz), 133.9, 117.7, 116.3 (dd, J = 20.7, 10.2 Hz), 106.7 (dd, J = 
23.8, 6.9 Hz), 102.9 (dd, J = 27.4, 2.0 Hz), 68.9, 33.5; IR (cm-1): 2934, 1626, 1510, 1472, 1432, 
1387, 1323, 1286, 1248, 1204, 1157, 1099, 1025, 990, 918, 834, 791, 726; HRMS: m/z calculated 
for C10H10F2O+ [M]+: 184.0694; found: 184.0697. 
 
3-(But-3-en-1-yloxy)pyridine (S3.110): A 25-mL round-bottom flask equipped with a magnetic 
stir bar was charged with 3-hydroxypyridine (238 mg, 2.5 mmol, 1.0 equiv.) and DMF (5 mL). 
K2CO3 (1.04 g, 7.5 mmol, 3.0 equiv.) and 4-bromo-1-butene (0.38 mL, 3.8 mmol, 1.5 equiv.) were 
added and the resulting heterogeneous mixture stirred for 20 h at 80 ºC. After cooling to rt, the 
mixture was diluted with water and extracted with EtOAc (3x). The combined organic extracts 
were washed with water (2x) and brine, dried over Na2SO4, filtered and concentrated in vacuo. 
Purification by flash column chromatography (10–40% EtOAc/hexanes) afforded the pure title 
compound as an orange, volatile oil (70 mg, 19%). 
1H NMR (500 MHz, CDCl3): d 8.32 (dd, J = 2.7, 1.1 Hz, 1H), 8.21 (dd, J = 4.3, 1.8 Hz, 1H), 7.24 








1H), 4.06 (t, J = 6.7 Hz, 2H), 2.59 – 2.53 (m, 2H); 13C NMR (176 MHz, CDCl3): d 155.2, 142.2, 
138.2, 134.1, 123.9, 121.3, 117.5, 67.6, 33.6; IR (cm-1): 2925, 1643, 1586, 1426, 1387, 1231, 1050, 
1023, 991, 920, 798, 707; HRMS: m/z calculated for C9H12NO+ [M+H]+: 150.0913; found: 
150.0908. 
 
But-3-en-1-yl 4-(N,N-dipropylsulfamoyl)benzoate (S3.111): A 25-mL round-bottom flask 
equipped with a magnetic stir bar was charged with probenecid (713 mg, 2.5 mmol, 1.0 equiv.) 
and DMF (5 mL). K2CO3 (1.04 g, 7.5 mmol, 3.0 equiv.) and 4-bromo-1-butene (0.38 mL, 
3.8 mmol, 1.5 equiv.) were added and the resulting heterogeneous mixture stirred for 2 h at 80 ºC. 
After cooling to rt, the mixture was diluted with water and extracted with EtOAc (3x). The 
combined organic extracts were washed with water (2x) and brine, dried over Na2SO4, filtered and 
concentrated in vacuo. Purification by flash column chromatography (2–10% EtOAc/hexanes) 
afforded the pure title compound as colorless oil (0.85 g, quant.). 
1H NMR (400 MHz, CDCl3): d 8.14 (d, J = 8.3 Hz, 2H), 7.87 (d, J = 8.3 Hz, 2H), 5.86 (ddt, J = 
17.0, 10.3, 6.8 Hz, 1H), 5.15 (dd, J = 22.6, 13.7 Hz, 2H), 4.41 (t, J = 6.6 Hz, 2H), 3.12 – 3.06 (m, 
4H), 2.54 (q, J = 6.6 Hz, 2H), 1.54 (dq, J = 14.9, 7.3 Hz, 4H), 0.86 (t, J = 7.4 Hz, 6H); 13C NMR 
(176 MHz, CDCl3): d 165.3, 144.3, 133.9, 133.7, 130.3, 127.1, 117.7, 64.8, 50.0, 33.2, 22.1, 11.3; 
IR (cm-1): 2966, 2876, 1721, 1478, 1342, 1269, 1157, 1105, 1087, 990, 916, 862, 778, 738, 693; 
HRMS: m/z calculated for C17H26NO4S+ [M+H]+: 340.1577; found: 340.1581. 
 
3-(2-(4-Fluorophenyl)ethylidene)oxetane (S3.124): To a 100-mL round bottom flask equipped 
























phosphane222 (5.88 g, 12.6 mmol, 1.5 equiv.) in Et2O (40 mL) was added KOt-Bu (1.42 g, 
12.6 mmol, 1.5 equiv.) at 0 ºC and the reaction mixture stirred for 0.5 h at that temperature. 
Oxetan-3-one (0.54 mL, 8.4 mmol, 1.0 equiv.) was added dropwise and the resulting mixture 
allowed to warm up to rt and stirred for 16 h. NH4Cl solution (aq., sat.) and water were added, the 
organic layer separated and the aqueous layer extracted with Et2O (3x). The combined organic 
extracts were washed with brine, dried over MgSO4, filtered and concentrated in vacuo. 
Purification by flash column chromatography (5–20% Et2O/pentane) afforded the pure title 
compound as a pale-yellow oil (688 mg, 46%). 
1H NMR (400 MHz, CDCl3): d 7.16 – 7.10 (m, 2H), 7.01 – 6.94 (m, 2H), 5.35 – 5.25 (m, 1H), 
5.25 – 5.17 (m, 2H), 5.18 – 5.12 (m, 2H), 3.18 (d, J = 7.1 Hz, 2H); 13C NMR (126 MHz, CDCl3): 
d 161.6 (d, J = 243.9 Hz), 135.7, 135.4 (d, J = 3.4 Hz), 129.9 (d, J = 7.7 Hz), 118.1, 115.4 (d, J = 
21.1 Hz), 79.5, 78.8, 33.8; IR (cm-1): 2862, 1689, 1600, 1508, 1219, 1157, 1094, 1015, 946, 852, 
822, 742; HRMS: m/z calculated for C11H11FO+ [M]+: 178.0794; found: 178.0799.  
 248 
General Procedure for Photochemical [2+2] Cycloaddition (GP-3.3) 
 
A 3-dram vial equipped with a magnetic stir bar was charged with 2-isoxazoline (0.25 mmol, 
1.0 equiv.), alkene (if solid, 1.5 equiv.), fac-[Ir(dFppy)3] (0.2-2 mol%) and MeCN (2.5 mL). The 
vial was sealed with a septum-equipped cap and the reaction mixture degassed by sparging with 
nitrogen gas for 10 min. Then, alkene (if liquid, 1.5 equiv.) was added, the vial sealed with 
electrical tape and the reaction mixture homogenized by sonicating for approximately 30 seconds. 
Then, the reaction mixture was stirred at ambient temperature (fan cooling) under irradiation with 
blue LED lights (427 nm). After the indicated time (12–42 h), the reaction mixture was 
concentrated in vacuo and the crude reaction mixture analyzed by 1H NMR to determine the 
diastereomer (d.r.) and regioisomer (r.r.) ratio, before purification by flash column 
chromatography to afford the corresponding pure azetidine product (major diastereomer is drawn). 
Note: For 3.105, 3.115, 3.143 and 3.145 the alkene was added by sparging the solution with the 
corresponding gaseous alkene after sealing the vial, and the reaction carried out under an 









































Ethyl 7-butyl-3,3-dimethyl-2-oxa-1-azabicyclo[3.2.0]heptane-5-carboxylate (3.84): Prepared 
according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), 1-hexene (47 µL, 0.38 mmol, 
1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) with a reaction time of 19 h. 
1H NMR analysis of the crude reaction mixture revealed a diastereomer ratio of 3:1 and a 
regioisomer ratio of >20:1. Purification by flash column chromatography (5–40% EtOAc/hexanes) 
afforded the pure title compound as a pale-yellow oil (54 mg, 84% combined yield; d.r. = 3:1). 
Characterization data for both diastereomers was obtained after separation by flash column 
chromatography (5–40% EtOAc/hexanes).  
exo-Diastereomer (major): 1H NMR (700 MHz, CDCl3): d 4.24 (q, J = 7.1 Hz, 2H), 3.46 (p, J = 
8.4 Hz, 1H), 2.85 (d, J = 12.9 Hz, 1H), 2.47 (d, J = 12.9 Hz, 1H), 2.35 (dd, J = 11.1, 8.7 Hz, 1H), 
1.98 (dd, J = 11.1, 8.5 Hz, 1H), 1.75 – 1.67 (m, 1H), 1.55 – 1.50 (m, 1H), 1.51 (s, 3H), 1.39 – 1.21 
(m, 4H), 1.30 (t, J = 7.1 Hz, 3H), 1.20 (s, 3H), 0.88 (t, J = 7.2 Hz, 3H); 13C NMR (176 MHz, 
CDCl3): d 173.0, 87.2, 73.1, 67.4, 61.6, 51.1, 35.2, 30.4, 29.7, 28.5, 27.6, 22.8, 14.3, 14.2; IR (cm-
1): 2958, 2930, 2872, 1727, 1456, 1367, 1308, 1256, 1215, 1179, 1148, 1045, 864, 779, 733; 
HRMS: m/z calculated for C14H26NO3+ [M+H]+: 256.1907; found: 256.1901. 
endo-Diastereomer (minor): 1H NMR (700 MHz, CDCl3): d 4.27 (qd, J = 7.1, 1.4 Hz, 2H), 3.88 
(p, J = 7.8 Hz, 1H), 2.80 (dd, J = 11.6, 7.9 Hz, 1H), 2.72 (d, J = 12.4 Hz, 1H), 2.23 – 2.19 (m, 2H), 
1.97 – 1.90 (m, 1H), 1.55 – 1.47 (m, 1H), 1.45 (s, 3H), 1.34 – 1.27 (m, 6H), 1.24 – 1.18 (m, 1H), 
1.20 (s, 3H), 0.89 (t, J = 7.1 Hz, 3H); 13C NMR (176 MHz, CDCl3): d 173.1, 83.6, 72.7, 61.7, 
60.6, 52.9, 36.8, 31.3, 28.1, 27.1, 26.0, 22.8, 14.3, 14.1; IR (cm-1): 2955, 2930, 2872, 1729, 1457, 
1367, 1301, 1254, 1184, 1152, 1020, 924, 863, 785, 730; HRMS: m/z calculated for C14H26NO3+ 








Minor Regioisomer (2:1 mixture of diastereomers A/B): 1H NMR (700 MHz, CDCl3): d 4.34 – 
4.22 (m, 6H; A+B), 3.86 (dd, J = 9.0, 7.7 Hz, 2H; A), 3.54 – 3.47 (m, 2H; B), 3.01 (t, J = 9.2 Hz, 
2H; A), 2.84 (d, J = 12.8 Hz, 1H; B), 2.63 (d, J = 12.9 Hz, 2H; A), 2.59 – 2.50 (m, 6H; A+B), 1.59 
– 1.45 (m, 15H; A+B), 1.36 – 1.08 (m, 21H; A+B), 1.17 (s, 6H; A), 1.12 (s, 3H; B), 0.90 – 0.85 
(m, 9H; A+B); 13C NMR (176 MHz, CDCl3): d 173.3, 172.0, 86.2, 86.0, 80.0, 79.1, 62.7, 61.6, 
61.4, 60.0, 52.5, 43.9, 39.2, 33.8, 30.6, 30.1, 29.4, 29.1, 29.0, 28.8, 28.4, 28.1, 22.7, 22.6, 14.5, 
14.3, 14.10, 14.06; IR (cm-1): 2959, 2928, 2859, 1724, 1466, 1368, 1302, 1254, 1183, 1143, 1046, 
866, 779, 708; HRMS: m/z calculated for C14H26NO3+ [M+H]+: 256.1907; found: 256.1901. 
 
Ethyl 7-butyl-3,3-dimethyl-2-oxa-1-azabicyclo[3.2.0]heptane-5-carboxylate (3.84): Prepared 
according to GP-3.3 in a test tube (25x150 mm) using 3.83 (856 mg, 5.0 mmol, 1.0 equiv.), 1-
hexene (0.93 mL, 7.5 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (7.6 mg, 0.2 mol%) and MeCN (15 mL) 
with a reaction time of 24 h. 1H NMR analysis of the crude reaction mixture revealed a 
diastereomer ratio of 3:1 and a regioisomer ratio of >20:1. Purification by flash column 
chromatography (1–10% EtOAc/CH2Cl2) afforded the pure title compound as a pale-yellow oil 
(1.14 g, 90% combined yield; d.r. = 3:1). Spectroscopic data was found consistent with that 
obtained, when conducting the reaction on 0.25 mmol scale. 
 
Ethyl 7-hexyl-2-oxa-1-azabicyclo[3.2.0]heptane-5-carboxylate (3.85): Prepared according to 
GP-3.3 using S3.85 (36 mg, 0.25 mmol, 1.0 equiv.), 1-octene (59 µL, 0.38 mmol, 1.5 equiv.), fac-
[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) with a reaction time of 18 h. 1H NMR analysis 













>20:1. Purification by flash column chromatography (5–30% EtOAc/hexanes) afforded the pure 
exo-diastereomer as a pale-yellow oil (34 mg, 53%) and the endo-diastereomer as pale-yellow oil 
(27 mg, 42%). 
exo-Diastereomer (major): 1H NMR (700 MHz, CDCl3): d 4.34 – 4.17 (m, 4H), 3.37 (p, J = 
8.4 Hz, 1H), 2.59 (dt, J = 12.6, 8.8 Hz, 1H), 2.37 (ddd, J = 12.7, 6.8, 3.0 Hz, 1H), 2.27 (d, J = 
9.1 Hz, 2H), 1.75 – 1.68 (m, 1H), 1.58 – 1.51 (m, 1H), 1.40 – 1.33 (m, 1H), 1.32 – 1.22 (m, 10H), 
0.87 (t, J = 7.0 Hz, 3H); 13C NMR (176 MHz, CDCl3): d 173.2, 71.6, 67.8, 61.7, 61.6, 39.1, 35.6, 
31.9, 29.6, 29.2, 25.3, 22.7, 14.23, 14.16; IR (cm-1): 2956, 2927, 2856, 1729, 1454, 1368, 1317, 
1268, 1175, 1144, 1029, 907, 862, 725, 671; HRMS: m/z calculated for C14H26NO3+ [M+H]+: 
256.1907; found: 256.1904. 
endo-Diastereomer (minor): 1H NMR (700 MHz, CDCl3): d 4.32 – 4.17 (m, 4H), 4.00 (p, J = 
8.4 Hz, 1H), 2.94 (dd, J = 12.1, 8.4 Hz, 1H), 2.54 (ddd, J = 12.3, 9.5, 7.5 Hz, 1H), 2.26 (ddd, J = 
12.3, 5.9, 2.8 Hz, 1H), 2.00 (dd, J = 12.1, 8.9 Hz, 1H), 1.88 – 1.82 (m, 1H), 1.45 – 1.39 (m, 12H), 
0.87 (t, J = 7.0 Hz, 3H); 13C NMR (176 MHz, CDCl3): d 172.8, 73.0, 71.1, 62.7, 61.8, 39.8, 34.3, 
31.8, 30.0, 29.3, 26.0, 22.7, 14.24, 14.18; IR (cm-1): 2926, 2857, 1729, 1445, 1369, 1320, 1271, 
1176, 1140, 1096, 1025, 997, 917, 862, 720; HRMS: m/z calculated for C14H26NO3+ [M+H]+: 
256.1907; found: 256.1905. 
 
Ethyl 7-hexyl-3,3-diphenyl-2-oxa-1-azabicyclo[3.2.0]heptane-5-carboxylate (3.86): Prepared 
according to GP-3.3 using isoxadifen-ethyl (74 mg, 0.25 mmol, 1.0 equiv.), 1-octene (59 µL, 
0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (3.8 mg, 2 mol%) and MeCN (2.5 mL) with a reaction 









and a regioisomer ratio of 17:1. Purification by flash column chromatography (50–100% 
CH2Cl2/hexanes) afforded the pure title compound as a yellow oil (73 mg, 72% combined yield; 
d.r. = 2:1). Characterization data for both diastereomers was obtained after separation by flash 
column chromatography (5–40% EtOAc/hexanes). 
exo-Diastereomer (major): 1H NMR (700 MHz, CDCl3): d 7.44 (ddd, J = 15.3, 8.4, 1.3 Hz, 4H), 
7.32 (t, J = 7.7 Hz, 2H), 7.27 – 7.22 (m, 3H), 7.18 – 7.13 (m, 1H), 3.88 (qd, J = 7.1, 2.1 Hz, 2H), 
3.75 (d, J = 12.9 Hz, 1H), 3.58 (p, J = 8.0, 7.5 Hz, 1H), 3.24 (d, J = 12.9 Hz, 1H), 2.41 (dd, J = 
11.1, 8.7 Hz, 1H), 1.93 (dd, J = 11.1, 8.5 Hz, 1H), 1.86 – 1.78 (m, 1H), 1.58 – 1.51 (m, 1H), 1.45 
– 1.37 (m, 1H), 1.31 – 1.23 (m, 7H), 0.99 (t, J = 7.1 Hz, 3H), 0.87 (t, J = 7.0 Hz, 3H); 13C NMR 
(176 MHz, CDCl3): d 172.0, 144.7, 144.6, 128.4, 128.1, 127.5, 127.1, 126.4, 126.2, 93.4, 72.8, 
66.8, 61.4, 50.7, 35.5, 31.9, 30.1, 29.2, 25.4, 22.7, 14.2, 14.0; IR (cm-1): 2954, 2926, 2855, 1725, 
1492, 1447, 1368, 1312, 1222, 1180, 1081, 1031, 911, 862, 778, 749, 697; HRMS: m/z calculated 
for C26H34NO3+ [M+H]+: 408.2533; found: 408.2528. 
endo-Diastereomer (minor): 1H NMR (700 MHz, CDCl3): d 7.49 (d, J = 7.3 Hz, 2H), 7.43 (d, 
J = 8.0 Hz, 2H), 7.30 (t, J = 7.7 Hz, 2H), 7.27 – 7.20 (m, 3H), 7.14 (t, J = 7.3 Hz, 1H), 4.02 (p, J = 
7.4 Hz, 1H), 3.92 – 3.81 (m, 3H), 2.98 (d, J = 12.5 Hz, 1H), 2.66 (dd, J = 11.8, 8.3 Hz, 1H), 2.22 
(dd, J = 11.8, 6.6 Hz, 1H), 2.07 – 1.99 (m, 1H), 1.52 – 1.40 (m, 2H), 1.31 – 1.17 (m, 7H), 0.95 (t, 
J = 7.1 Hz, 3H), 0.86 (t, J = 7.1 Hz, 3H); 13C NMR (176 MHz, CDCl3): d 172.3, 144.2, 143.3, 
128.4, 128.2, 127.4, 127.1, 126.0, 126.0, 90.4, 72.6, 61.7, 61.5, 52.2, 34.7, 32.4, 31.8, 29.3, 26.4, 
22.7, 14.2, 14.0; IR (cm-1): 2926, 2855, 1724, 1492, 1448, 1368, 1314, 1225, 1180, 1085, 1030, 





dicarboxylate (3.87): Prepared according to GP-3.3 using S3.87 (78 mg, 0.25 mmol, 1.0 equiv.), 
1-octene (59 mg, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) 
with a reaction time of 19.5 h. 1H NMR analysis of the crude reaction mixture revealed a 
diastereomer ratio of 3:1 and a regioisomer ratio of 18:1. Purification by flash column 
chromatography (5–40% EtOAc/hexanes) afforded the pure exo-diastereomer as a colorless oil 
(74 mg, 70%) and the endo-diastereomer as a colorless oil (28 mg, 26%). 
exo-Diastereomer (major): 1H NMR (700 MHz, CDCl3): d 4.28 – 4.19 (m, 2H), 3.68 (b, 1H), 
3.56 (b, 1H), 3.45 (p, J = 8.0 Hz, 1H), 3.31 (m, 2H), 2.89 (d, J = 13.1 Hz, 1H), 2.43 (d, J = 13.1 Hz, 
1H), 2.34 (dd, J = 11.1, 8.6 Hz, 1H), 2.02 (dd, J = 11.2, 8.5 Hz, 1H), 1.93 – 1.86 (b, 1H), 1.86 – 
1.79 (b, 1H), 1.76 – 1.65 (m, 2H), 1.55 – 1.50 (m, 1H), 1.48 – 1.44 (m, 1H), 1.44 (s, 9H), 1.40 – 
1.33 (m, 1H), 1.32 – 1.24 (m, 10H), 0.87 (t, J = 7.0 Hz, 3H); 13C NMR (176 MHz, CDCl3): 
d 172.7, 154.8, 87.1, 79.6, 72.5, 67.6, 61.7, 49.6, 41.5 (2C), 38.9, 36.7, 35.4, 31.9, 30.1, 29.3, 28.6, 
25.3, 22.7, 14.3, 14.2; IR (cm-1): 2927, 2856, 1729, 1690, 1451, 1419, 1365, 1306, 1277, 1239, 
1177, 1146, 1095, 967, 862, 825, 767; HRMS: m/z calculated for C23H41N2O5+ [M+H]+: 425.3010; 
found: 425.3004. 
endo-Diastereomer (minor): 1H NMR (700 MHz, CDCl3): d 4.26 (q, J = 7.1 Hz, 2H), 3.90 (p, 
J = 7.7 Hz, 1H), 3.66 (b, 2H), 3.33 – 3.22 (m, 2H), 2.84 (dd, J = 11.7, 7.9 Hz, 1H), 2.74 (d, J = 
12.6 Hz, 1H), 2.22 (dd, J = 11.7, 8.0 Hz, 1H), 2.15 (d, J = 12.7 Hz, 1H), 1.97 – 1.91 (m, 1H), 1.86 
– 1.72 (m, 3H), 1.51 – 1.42 (m, 10H), 1.42 – 1.21 (m, 12H), 0.88 (t, J = 7.1 Hz, 3H); 13C NMR 








31.82, 31.77, 29.3, 28.6, 25.9, 22.7, 14.3, 14.2; IR (cm-1): 2927, 2858, 1730, 1691, 1452, 1419, 
1365, 1276, 1240, 1177, 1145, 1050, 967, 864, 828, 767; HRMS: m/z calculated for C23H41N2O5+ 
[M+H]+: 425.3010; found: 425.3001. 
 
Ethyl 3-phenyl-4-oxa-5-azadispiro[bicyclo[3.2.0]heptane-6,1'-cyclohexane-4',2''-
[1,3]dioxolane]-1-carboxylate (3.88): Prepared according to GP-3.3 using S3.88 (55 mg, 
0.25 mmol, 1.0 equiv.), 8-methylene-1,4-dioxaspiro[4.5]decane228 (58 mg, 0.38 mmol, 
1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) with a reaction time of 19.5 h. 
1H NMR analysis of the crude reaction mixture revealed a diastereomer ratio of 4:1 and a 
regioisomer ratio of 18:1. Purification by flash column chromatography (5–30% EtOAc/hexanes) 
afforded the pure title compound as a yellow oil (94 mg, 99% combined yield; d.r. = 4:1). 
Characterization data was obtained for a 3.8:1 mixture of exo/endo diastereomers. 
1H NMR (700 MHz, CDCl3): d 7.45 (d, J = 7.2 Hz, 7.6H; major), 7.40 (d, J = 7.7 Hz, 2H; minor), 
7.36 (t, J = 7.5 Hz, 9.6H: major+minor), 7.31 (t, J = 7.3 Hz, 4.8H; major+minor), 5.50 (dd, J = 
10.2, 5.5 Hz, 3.8H; major), 5.19 (dd, J = 11.3, 4.9 Hz, 1H; minor), 4.35 – 4.19 (m, 9.6H; 
major+minor), 3.98 – 3.87 (m, 19.2H; major+minor), 3.08 (dd, J = 12.4, 4.9 Hz, 1H; minor), 2.70 
(d, J = 12.3 Hz, 3.8H: major), 2.65 (dd, J = 12.7, 5.5 Hz, 3.8H; major), 2.58 (d, J = 12.0 Hz, 1H; 
minor), 2.50 (dd, J = 12.7, 10.2 Hz, 3.8H; major), 2.40 (dd, J = 12.4, 11.3 Hz, 1H; minor), 2.31 (d, 
J = 12.3 Hz, 3.8H; major), 2.30 – 2.26 (m, 1H; minor), 2.20 (d, J = 12.0 Hz, 1H; minor), 2.15 – 
2.08 (m, 3.8H; major+minor), 2.02 – 1.74 (m, 24H; major+minor) 1.62 – 1.53 (m, 9.6H; 
major+minor), 1.35 (t, J = 7.1 Hz, 3H; minor), 1.30 (t, J = 7.1 Hz, 11.4H; major); 13C NMR 
(176 MHz, CDCl3): d 173.2, 173.0, 138.4, 137.9, 128.7, 128.6, 128.4, 128.1, 126.8, 126.3, 108.2, 









36.9, 36.3, 35.8, 31.39, 31.35, 31.3, 30.8, 30.6, 29.6, 14.3, 14.2; IR (cm-1): 2951, 1723, 1445, 1375, 
1300, 1241, 1180, 1156, 1102, 1032, 946, 926, 885, 751, 730, 699; HRMS: m/z calculated for 
C21H27NNaO5+ [M+Na]+: 396.1781; found: 396.1771. 
 
Ethyl 3-ethoxy-4-oxa-5-azadispiro[bicyclo[3.2.0]heptane-6,1'-cyclohexane-4',2''-
[1,3]dioxolane]-1-carboxylate (3.89): Prepared according to GP-3.3 using S3.89 (47 mg, 
0.25 mmol, 1.0 equiv.), 8-methylene-1,4-dioxaspiro[4.5]decane228 (58 mg, 0.38 mmol, 
1.5 equiv.), fac-[Ir(dFppy)3] (3.8 mg, 2 mol%) and MeCN (2.5 mL) with a reaction time of 36 h. 
1H NMR analysis of the crude reaction mixture revealed a diastereomer ratio of 1.2:1 and a 
regioisomer ratio of >20:1. Purification by flash column chromatography (10–40% 
EtOAc/CH2Cl2) afforded the pure title compound as a pale-yellow oil (63 mg, 74% combined 
yield; d.r. = 1.2:1). Characterization data for both diastereomers was obtained after separation by 
flash column chromatography (20–30% EtOAc/CH2Cl2). Characterization data was obtained for a 
1.1:1 mixture of exo/endo diastereomers. 
1H NMR (700 MHz, CDCl3): d 5.44 (dd, J = 5.8, 2.0 Hz, 2.1H; major+minor), 4.31 – 4.18 (m, 
4.2H; major+minor), 3.96 – 3.88 (m, 8.4H; major+minor), 3.84 – 3.73 (m, 2.1H; major+minor), 
3.51 (dq, J = 9.6, 7.1 Hz, 1.1H; major), 3.37 (dq, J = 9.5, 7.0 Hz, 1H; minor), 3.02 (d, J = 13.1 Hz, 
1H; minor), 2.84 (dd, J = 13.6, 6.2 Hz, 1.1H; major), 2.55 – 2.50 (m, 2.2H; major), 2.48 (dd, J = 
13.2, 4.9 Hz, 1H; minor), 2.45 (dd, J = 13.6, 1.9 Hz, 1.1H; major), 2.27 – 2.19 (m, 2.1H; 
major+minor), 2.14 (d, J = 11.6 Hz, 1H; minor), 2.05 – 1.99 (m, 2H; minor), 1.96 – 1.72 (m, 8.5H; 
major+minor), 1.67 – 1.60 (m, 1H; minor), 1.59 – 1.45 (m, 4.2H; major+minor), 1.30 (td, J = 7.1, 
2.4 Hz, 6.3H; major+minor), 1.22 (t, J = 7.1 Hz, 3.3H; major), 1.11 (t, J = 7.0 Hz, 3H; minor); 










64.40, 64.37, 64.35, 64.3, 64.0, 62.6, 61.8, 61.6, 46.8, 46.5, 38.1, 37.4, 36.4, 35.8, 31.4, 30.9 (2C), 
30.69, 30.68, 30.1, 15.0, 14.9, 14.24, 14.18; IR (cm-1): 2944, 1726, 1444, 1374, 1267, 1225, 1143, 
1101, 1033, 993, 945, 925, 882, 771, 713, 662; HRMS: m/z calculated for C17H27NNaO6+ 
[M+Na]+: 364.1731; found: 364.1725. 
 
1-(Tert-butyl) 1'-ethyl 3'-(3-ethoxy-2-(ethoxycarbonyl)-3-oxopropyl)-4'-oxa-5'-
azaspiro[azetidine-3,6'-bicyclo[3.2.0]heptane]-1,1'-dicarboxylate (3.90): Prepared according 
to GP-3.3 using S3.90 (79 mg, 0.25 mmol, 1.0 equiv.), tert-butyl 3-methyleneazetidine-1-
carboxylate229 (64 mg, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN 
(2.5 mL) with a reaction time of 24 h. 1H NMR analysis of the crude reaction mixture revealed a 
diastereomer ratio of 3:1 and a regioisomer ratio of >20:1. Purification by flash column 
chromatography (3–50% EtOAc/CH2Cl2) afforded the pure title compound as a colorless oil 
(117 mg, 96% combined yield; d.r. = 3:1). Characterization data for both diastereomers was 
obtained after separation by flash column chromatography (30–50% EtOAc/hexanes). 
exo-Diastereomer (major): 1H NMR (700 MHz, CDCl3): d 4.31 (d, J = 9.5 Hz, 1H), 4.28 – 4.15 
(m, 6H), 4.11 (d, J = 9.6 Hz, 1H), 4.00 – 3.94 (m, 1H), 3.88 (d, J = 9.6 Hz, 1H), 3.69 (d, J = 9.2 Hz, 
1H), 3.63 (dd, J = 10.1, 4.9 Hz, 1H), 2.94 (d, J = 13.2 Hz, 1H), 2.40 (d, J = 13.2 Hz, 1H), 2.39 – 
2.34 (m, 1H), 2.30 (dd, J = 12.7, 5.3 Hz, 1H), 2.21 – 2.11 (m, 2H), 1.40 (s, 9H), 1.28 (q, J = 7.2 Hz, 
6H), 1.24 (t, J = 7.1 Hz, 3H); 13C NMR (176 MHz, CDCl3): d 171.8, 169.2, 169.0, 156.1, 79.9, 
79.3, 72.1, 62.5, 62.0, 61.93, 61.86, 61.8, 55.7, 49.1, 43.6, 37.3, 31.7, 28.4, 14.2, 14.14, 14.10; IR 
(cm-1): 2979, 1729, 1700, 1447, 1392, 1367, 1304, 1247, 1203, 1159, 1091, 1025, 961, 930, 860, 









endo-Diastereomer (minor): 1H NMR (700 MHz, CDCl3): d 4.63 (d, J = 9.3 Hz, 1H), 4.31 – 4.13 
(m, 7H), 4.05 (d, J = 9.9 Hz, 1H), 3.90 (d, J = 9.9 Hz, 1H), 3.72 (d, J = 9.4 Hz, 1H), 3.56 (dd, J = 
9.0, 5.8 Hz, 1H), 2.78 (dd, J = 12.6, 4.7 Hz, 1H), 2.73 (d, J = 12.2 Hz, 1H), 2.45 (d, J = 12.2 Hz, 
1H), 2.37 (ddd, J = 14.1, 9.0, 4.2 Hz, 1H), 2.25 – 2.17 (m, 1H), 1.77 (dd, J = 12.7, 11.2 Hz, 1H), 
1.43 (s, 9H), 1.30 – 1.25 (m, 9H); 13C NMR (176 MHz, CDCl3): d 171.4, 169.0, 168.9, 156.2, 
81.3, 78.0, 71.1, 63.1, 62.0, 61.89, 61.85, 61.0, 56.0, 49.7, 45.3, 34.11, 31.9, 28.5, 14.20, 14.17, 
14.15; IR (cm-1): 2979, 1730, 1699, 1447, 1392, 1367, 1329, 1302, 1159, 1093, 1055, 1022, 962, 




Prepared according to GP-3.3 using S3.91 (45 mg, 0.25 mmol, 1.0 equiv.), 1-octene (59 µL, 
0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) with a reaction 
time of 20 h. 1H NMR analysis of the crude reaction mixture revealed a diastereomer ratio of 3:1 
and a regioisomer ratio of 19:1. Purification by flash column chromatography (5–30% 
EtOAc/hexanes) afforded the pure exo-diastereomer as pale-yellow oil (31 mg, 43%) and the pure 
endo-diastereomer as a colorless oil (13 mg, 18%). 
exo-Diastereomer (major): 1H NMR (700 MHz, CDCl3): d 4.76 (m, 2H), 3.47 (p, J = 8.4 Hz, 
1H), 2.87 (d, J = 13.0 Hz, 1H), 2.49 (d, J = 13.0 Hz, 1H), 2.45 (t, J = 2.5 Hz, 1H), 2.37 (dd, J = 
11.1, 8.6 Hz, 1H), 2.00 (dd, J = 11.1, 8.4 Hz, 1H), 1.76 – 1.67 (m, 1H), 1.55 – 1.48 (m, 4H), 1.40 
– 1.32 (m, 1H), 1.30 – 1.21 (m, 7H), 1.20 (s, 3H), 0.85 (t, J = 7.0 Hz, 3H); 13C NMR (176 MHz, 










22.7, 14.2; IR (cm-1): ;HRMS: m/z calculated for C17H28NO3+ [M+H]+: 294.2064; found: 
294.2063. 
endo-Diastereomer (minor): 1H NMR (700 MHz, CDCl3): d 4.85 – 4.72 (m, 2H), 3.91 (p, J = 
7.8 Hz, 1H), 2.83 (dd, J = 11.7, 8.0 Hz, 1H), 2.75 (d, J = 12.5 Hz, 1H), 2.47 (t, J = 2.5 Hz, 1H), 
2.28 – 2.18 (m, 2H), 1.98 – 1.90 (m, 1H), 1.53 – 1.47 (m, 1H), 1.45 (s, 3H), 1.32 – 1.22 (m, 8H), 
1.20 (s, 3H), 0.87 (t, J = 7.0 Hz, 3H); 13C NMR (176 MHz, CDCl3): d 172.3, 83.7, 77.4, 75.3, 
72.5, 60.8, 53.0, 52.7, 36.6, 31.8, 31.6, 29.4, 27.1, 25.92, 25.86, 22.7, 14.2; IR (cm-1): 2926, 2857, 
1738, 1634, 1457, 1368, 1302, 1253, 1173, 1147, 1044, 993, 932, 786, 723, 666; HRMS: m/z 
calculated for C17H28NO3+ [M+H]+: 294.2064; found: 294.2062. 
 
Adamantan-1-yl-7-hexyl-3,3-dimethyl-2-oxa-1-azabicyclo[3.2.0]heptane-5-carboxylate 
(3.92): Prepared according to GP-3.3 using S3.92 (69 mg, 0.25 mmol, 1.0 equiv.), 1-octene 
(59 µL, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) with a 
reaction time of 18 h. 1H NMR analysis of the crude reaction mixture revealed a diastereomer ratio 
of 2:1 and a regioisomer ratio of 19:1. Purification by flash column chromatography (5–15% 
EtOAc/hexanes) afforded the pure title compound as a colorless oil (95 mg, 98% combined yield; 
d.r. = 2:1). Characterization data for both diastereomers was obtained after separation by flash 
column chromatography (1–20% EtOAc/hexanes). 
exo-Diastereomer (major): 1H NMR (500 MHz, CDCl3): d 3.42 (p, J = 7.6 Hz, 1H), 2.82 (d, J = 
12.7 Hz, 1H), 2.40 (d, J = 12.8 Hz, 1H), 2.29 (t, J = 9.8 Hz, 1H), 2.16 (d, J = 7.9 Hz, 9H), 1.97 (t, 
J = 9.6 Hz, 1H), 1.75 – 1.61 (m, 7H), 1.54 – 1.46 (m, 4H), 1.39 – 1.19 (m, 11H), 0.87 (t, J = 6.2 Hz, 










31.0, 30.4, 29.6, 29.3, 28.4, 25.3, 22.7, 14.2; IR (cm-1): 2911, 2853, 1720, 1456, 1366, 1326, 1298, 
1255, 1186, 1151, 1103, 1055, 967, 872, 778; HRMS: m/z calculated for C24H39NNaO3+ [M+Na]+: 
412.2822; found: 412.2824. 
endo-Diastereomer (minor): 1H NMR (500 MHz, CDCl3): d 3.84 (p, J = 7.9 Hz, 1H), 2.79 (dd, 
J = 11.5, 7.8 Hz, 1H), 2.67 (d, J = 12.3 Hz, 1H), 2.21 – 2.08 (m, 11H), 1.95 – 1.85 (m, 1H), 1.72 
– 1.63 (m, 6H), 1.55 – 1.46 (m, 1H), 1.43 (s, 3H), 1.31 – 1.24 (m, 8H), 1.22 (s, 3H), 0.87 (t, J = 
6.3 Hz, 3H); 13C NMR (126 MHz, CDCl3): d 171.9, 83.4, 81.8, 73.3, 60.5, 53.0, 41.2, 37.0, 36.3, 
31.9, 31.5, 31.0, 29.4, 27.0, 26.1, 25.8, 22.7, 14.2; IR (cm-1): 2911. 2852, 1723, 1456, 1366, 1328, 
1299, 1253, 1184, 1103, 1055, 967, 875, 729; HRMS: m/z calculated for C24H40NO3+ [M+H]+: 
390.3003; found: 390.3003. 
 
1-(Tert-butyl) 1'-(4-methoxybenzyl) 3',3'-dimethyl-4'-oxa-5'-azaspiro[azetidine-3,6'-
bicyclo[3.2.0]heptane]-1,1'-dicarboxylate (3.93): Prepared according to GP-3.3 using S3.93 
(66 mg, 0.25 mmol, 1.0 equiv.), tert-butyl 3-methyleneazetidine-1-carboxylate229 (64 mg, 
0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) with a reaction 
time of 20 h. 1H NMR analysis of the crude reaction mixture revealed a regioisomer ratio of >20:1. 
Purification by flash column chromatography (5–20% EtOAc/CH2Cl2) afforded the pure title 
compound as a colorless oil (95 mg, 88%). 
1H NMR (700 MHz, CDCl3): d 7.31 (d, J = 8.6 Hz, 2H), 6.87 (d, J = 8.6 Hz, 2H), 5.20 (d, J = 
11.8 Hz, 1H), 5.13 (d, J = 11.9 Hz, 1H), 4.65 (d, J = 9.4 Hz, 1H), 4.12 (d, J = 9.9 Hz, 1H), 3.87 
(d, J = 9.9 Hz, 1H), 3.81 (s, 3H), 3.71 (d, J = 9.4 Hz, 1H), 2.81 (d, J = 12.8 Hz, 1H), 2.60 (d, J = 








(s, 3H); 13C NMR (176 MHz, CDCl3): d 171.7, 159.9, 156.2, 130.4, 127.5, 114.0, 86.8, 79.7, 71.9, 
67.2, 63.0, 61.3, 56.0, 55.3, 50.2, 37.0, 28.4, 27.7, 26.4; IR (cm-1): 2976, 2937, 2875, 1740, 1689, 
1615, 1586, 1514, 1456, 1410, 1367, 1244, 1214, 1166, 1139, 1096, 1030, 963, 817, 798, 709; 
HRMS: m/z calculated for C23H33N2O6+ [M+H]+: 433.2333; found: 433.2325. 
 
4,4,7,7-Tetramethyltetrahydro-1H,3H-furo[3',4':2,3]azeto[1,2-b]isoxazol-1-one (3.95): 
Prepared according to GP-3.3 using 3.94 (53 mg, 0.25 mmol, 1.0 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 
1 mol%) and MeCN (2.5 mL) with a reaction time of 12 h. 1H NMR analysis of the crude reaction 
mixture revealed a diastereomer ratio of >10:1. Purification by flash column chromatography (2–
30% EtOAc/CH2Cl2) afforded the pure title compound as a white solid (46 mg, 87%). 
1H NMR (700 MHz, CDCl3): d 4.48 (d, J = 10.5 Hz, 1H), 4.34 (dd, J = 10.4, 8.0 Hz, 1H), 2.91 (d, 
J = 7.8 Hz, 1H), 2.54 (d, J = 12.5 Hz, 1H), 2.34 (d, J = 12.5 Hz, 1H), 1.50 (s, 3H), 1.42 (s, 3H), 
1.38 (s, 3H), 1.35 (s, 3H); 13C NMR (176 MHz, CDCl3): d 176.7, 86.3, 69.1, 66.8, 63.8, 48.0, 45.3, 
27.0, 26.0, 24.58, 24.55; IR (cm-1): 2974, 2930, 1771, 1457, 1367, 1288, 1207, 1157, 1131, 1095, 
1060, 992, 948, 927, 866, 832, 785, 730, 710, 679; HRMS: m/z calculated for C11H18NO3+ 
[M+H]+: 212.1281; found: 212.1277. 
 
7-Hexyl-3,3-dimethyl-2-oxa-1-azabicyclo[3.2.0]heptane-5-carbonitrile (3.96): Prepared 
according to GP-3.3 using S3.96 (31 mg, 0.25 mmol, 1.0 equiv.), 1-octene (59 µL, 0.38 mmol, 
1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) with a reaction time of 20 h. 


















regioisomer ratio of >20:1. Purification by flash column chromatography (2–15% EtOAc/hexanes) 
afforded the pure title compound as a colorless oil (52 mg, 88% combined yield; d.r. = 2:1). 
Characterization data was obtained for a 2.2:1 mixture of diastereomers. 
1H NMR (500 MHz, CDCl3): d 3.99 (p, J = 7.7 Hz, 1H; minor), 3.46 (p, J = 8.4 Hz, 2.2H; major), 
2.93 (dd, J = 11.9, 8.1 Hz, 1H; minor), 2.74 (d, J = 12.9 Hz, 2.2H; major), 2.65 (d, J = 12.6 Hz, 
1H; minor), 2.56 (d, J = 13.0 Hz, 2.2H; major), 2.50 (dd, J = 11.3, 8.7 Hz, 2.2H; major), 2.34 (d, 
J = 12.7 Hz, 1H; minor), 2.29 (dd, J = 12.1, 7.3 Hz, 1H; minor), 2.20 (dd, J = 11.3, 8.6 Hz, 2.2H; 
major), 1.95 – 1.87 (m, 1H; minor), 1.76 – 1.65 (m, 2.2H; major), 1.59 – 1.17 (m, 48H; 
major+minor), 0.86 (t, J = 6.7 Hz, 9.6H; major+minor); 13C NMR (126 MHz, CDCl3): d 121.0, 
120.7, 88.1, 84.8, 69.3, 61.9, 61.3, 61.2, 54.3, 52.4, 36.7, 35.4, 31.8, 31.7, 31.7, 31.3, 29.23, 29.15, 
28.4 (2C), 27.1, 25.7, 25.2, 25.1, 22.7 (2C), 14.1 (2C); IR (cm-1): 2955, 2925, 2853, 2235, 1468, 
1459, 1382, 1368, 1307, 1275, 1226, 1153, 1102, 1006, 970, 858, 824, 804, 722, 685, 646; HRMS: 
m/z calculated for C14H25N2O+ [M+H]+: 237.1961; found: 237.1960. 
 
Ethyl 3,3-dimethyl-2-oxa-1-azabicyclo[3.2.0]heptane-5-carboxylate (3.105): Prepared 
according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), fac-[Ir(dFppy)3] (3.8 mg, 2 mol%) 
and 1,2-dichloroethane (2.5 mL) with a reaction time of 44 h under an atmosphere of ethylene gas. 
Purification by flash column chromatography (2–35% EtOAc/CH2Cl2) afforded the pure title 
compound as a yellow oil (35 mg, 70%). 
1H NMR (400 MHz, CDCl3): d 4.26 (qd, J = 7.1, 2.5 Hz, 2H), 3.78 (ddd, J = 9.7, 8.4, 4.1 Hz, 1H), 
3.46 (q, J = 9.5 Hz, 1H), 2.85 (d, J = 12.9 Hz, 1H), 2.55 (d, J = 12.9 Hz, 1H), 2.47 (dt, J = 11.3, 
8.7 Hz, 1H), 2.29 (ddd, J = 11.3, 9.7, 4.1 Hz, 1H), 1.55 (s, 3H), 1.32 (t, J = 7.1 Hz, 3H), 1.20 (s, 







(cm-1): 2973, 1725, 1448, 1383, 1313, 1256, 1221, 1179, 1144, 1024, 921, 864, 821, 782, 705, 
672; HRMS: m/z calculated for C10H17NNaO3+ [M+Na]+: 222.1101; found: 222.1099. 
 
Ethyl 7-(3-cyanopropyl)-3,3-dimethyl-2-oxa-1-azabicyclo[3.2.0]heptane-5-carboxylate 
(3.106): Prepared according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), 5-hexenenitrile 
(43 µL, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (3.8 mg, 2 mol%) and MeCN (2.5 mL) with a 
reaction time of 36 h. 1H NMR analysis of the crude reaction mixture revealed a diastereomer ratio 
of 2:1 and a regioisomer ratio of 16:1. Purification by flash column chromatography (20–80% 
EtOAc/hexanes) afforded the pure exo-diastereomer as a pale-yellow oil (33 mg, 49%) and the 
pure endo-diastereomer as a colorless oil (15 mg, 22%). 
exo-Diastereomer (major): 1H NMR (700 MHz, CDCl3): d 4.26 (q, J = 7.0 Hz, 2H), 3.54 – 3.47 
(m, 1H), 2.88 (d, J = 13.0 Hz, 1H), 2.49 (d, J = 13.0 Hz, 1H), 2.47 – 2.35 (m, 3H), 2.04 (dd, J = 
11.2, 8.5 Hz, 1H), 1.90 – 1.82 (m, 1H), 1.81 – 1.71 (m, 3H), 1.52 (s, 3H), 1.31 (t, J = 7.1 Hz, 3H), 
1.21 (s, 3H); 13C NMR (176 MHz, CDCl3): d 172.6, 119.7, 87.7, 73.2, 66.2, 61.7, 51.0, 33.9, 30.0, 
29.8, 28.5, 21.6, 17.1, 14.3; IR (cm-1): 2973, 2936, 2245, 1725, 1456, 1384, 1368, 1309, 1256, 
1220, 1185, 1148, 1108, 1054, 1022, 861, 779, 729, 676; HRMS: m/z calculated for C14H23N2O3+ 
[M+H]+: 267.1703; found: 267.1703. 
endo-Diastereomer (minor): 1H NMR (700 MHz, CDCl3): d 4.28 (q, J = 7.0 Hz, 2H), 3.92 (qd, 
J = 8.0, 5.3 Hz, 1H), 2.87 (dd, J = 11.8, 7.9 Hz, 1H), 2.74 (d, J = 12.4 Hz, 1H), 2.38 (q, J = 6.8 Hz, 
2H), 2.27 (dd, J = 11.8, 8.1 Hz, 1H), 2.21 (d, J = 12.5 Hz, 1H), 2.16 – 2.10 (m, 1H), 1.85 – 1.78 
(m, 1H), 1.68 – 1.60 (m, 2H), 1.47 (s, 3H), 1.33 (t, J = 7.1 Hz, 3H), 1.21 (s, 3H); 13C NMR 









14.3; IR (cm-1): 2975, 2245, 1726, 1457, 1367, 1303, 1254, 1185, 1152, 1023, 894, 862, 786, 726, 
665; HRMS: m/z calculated for for C14H23N2O3+ [M+H]+: 267.1703; found: 267.1710. 
 
Ethyl 7-(3-(diisopropylamino)-3-oxopropyl)-3,3-dimethyl-2-oxa-1-azabicyclo[3.2.0]heptane-
5-carboxylate (3.107): Prepared according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), 
N,N-diisopropylpent-4-enamide229 (69 mg, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 
1 mol%) and MeCN (2.5 mL) with a reaction time of 24 h. 1H NMR analysis of the crude reaction 
mixture revealed a diastereomer ratio of 4:1 and a regioisomer ratio of >20:1. Purification by flash 
column chromatography (30–95% EtOAc/hexanes) afforded the pure exo-diastereomer as a pale-
yellow oil (65 mg, 73%) and the pure endo-diastereomer as a pale-yellow oil (22 mg, 25%). 
Characterization data is provided for the exo-diastereomer. 
exo-Diastereomer (major): 1H NMR (700 MHz, CDCl3): d 4.24 (qd, J = 7.1, 2.5 Hz, 2H), 4.05 
(p, J = 6.8 Hz, 1H), 3.58 (qd, J = 8.8, 4.1 Hz, 1H), 3.42 (b, 1H), 2.83 (d, J = 12.9 Hz, 1H), 2.52 – 
2.46 (m, 2H), 2.44 – 2.35 (m, 2H), 2.05 – 1.98 (m, 2H), 1.83 – 1.77 (m, 1H), 1.49 (s, 3H), 1.38 (d, 
J = 6.8 Hz, 6H), 1.30 (t, J = 7.1 Hz, 3H), 1.20 (s, 3H), 1.18 (d, J = 6.7 Hz, 6H); 13C NMR 
(176 MHz, CDCl3): d 172.9, 171.1, 87.5, 73.3, 66.6, 61.5, 51.1, 48.4, 45.7, 30.4, 30.1, 29.9, 28.7, 
21.0, 20.9, 20.8, 14.3; IR (cm-1): 2967, 2932, 1727, 1635, 1442, 1368, 1300, 1256, 1214, 1184, 
1149, 1107, 1044, 888, 862, 779, 728, 677; HRMS: m/z calculated for C19H35N2O4+ [M+H]+: 
355.2591; found: 355.2584. 
 
Ethyl 7-(4-hydroxybutyl)-3,3-dimethyl-2-oxa-1-azabicyclo[3.2.0]heptane-5-carboxylate 



















(45 µL, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) with a 
reaction time of 20 h. 1H NMR analysis of the crude reaction mixture revealed a diastereomer ratio 
of 3:1 and a regioisomer ratio of >20:1. Purification by flash column chromatography (30–99% 
EtOAc/CH2Cl2) afforded the pure exo-diastereomer as a pale-yellow oil (40 mg, 62%) and the pure 
endo-diastereomer as a pale-yellow oil (17 mg, 26%). 
exo-Diastereomer (major): 1H NMR (700 MHz, CDCl3): d 4.25 (q, J = 7.1 Hz, 2H), 3.65 (td, J = 
6.5, 2.0 Hz, 2H), 3.49 (qd, J = 8.4, 6.1 Hz, 1H), 2.86 (d, J = 12.9 Hz, 1H), 2.48 (d, J = 12.9 Hz, 
1H), 2.37 (dd, J = 11.1, 8.7 Hz, 1H), 2.00 (dd, J = 11.1, 8.5 Hz, 1H), 1.78 – 1.70 (m, 1H), 1.63 – 
1.54 (m, 3H), 1.52 (s, 3H), 1.51 – 1.45 (m, 1H), 1.44 – 1.37 (m, 1H), 1.31 (t, J = 7.1 Hz, 3H), 1.20 
(s, 3H); 13C NMR (176 MHz, CDCl3): d 172.8, 87.3, 73.0, 67.3, 62.4, 61.6, 51.0, 34.7, 32.5, 30.3, 
29.5, 28.4, 21.5, 14.2; IR (cm-1): 3388, 2973, 2933, 2862, 1727, 1456, 1383, 1368, 1310, 1257, 
1218, 1186, 1149, 1111, 1057, 1035, 863, 839, 779, 737, 674; HRMS: m/z calculated for 
C14H26NO4+ [M+H]+: 272.1856; found: 272.1854. 
 
Ethyl 7-(2-((N-cyclopropyl-4-methylphenyl)sulfonamido)ethyl)-3,3-dimethyl-2-oxa-1-
azabicyclo[3.2.0]heptane-5-carboxylate (3.109): Prepared according to GP-3.3 using 3.83 
(43 mg, 0.25 mmol, 1.0 equiv.), S3.109 (100 mg, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] 
(1.9 mg, 1 mol%) and MeCN (2.5 mL) with a reaction time of 20 h. 1H NMR analysis of the crude 
reaction mixture revealed a diastereomer ratio of 2:1 and a regioisomer ratio of >20:1. Purification 
by flash column chromatography (1–35% EtOAc/CH2Cl2) afforded the pure exo-diastereomer as 










exo-Diastereomer (major): 1H NMR (700 MHz, CDCl3): d 7.71 (d, J = 8.2 Hz, 2H), 7.30 (d, J = 
8.0 Hz, 2H), 4.25 (q, J = 7.1 Hz, 2H), 3.60 – 3.53 (m, 1H), 3.23 (ddd, J = 8.0, 6.5, 2.6 Hz, 2H), 
2.85 (d, J = 12.9 Hz, 1H), 2.50 (d, J = 13.0 Hz, 1H), 2.47 – 2.39 (m, 4H), 2.10 – 2.01 (m, 2H), 
1.99 – 1.95 (m, 1H), 1.94 – 1.88 (m, 1H), 1.53 (s, 3H), 1.31 (t, J = 7.1 Hz, 3H), 1.21 (s, 3H), 0.94 
– 0.89 (m, 1H), 0.89 – 0.85 (m, 1H), 0.72 – 0.64 (m, 2H); 13C NMR (176 MHz, CDCl3): d 172.6, 
143.5, 135.2, 129.6, 127.7, 87.6, 73.5, 64.9, 61.5, 50.9, 47.8, 34.4, 31.0, 30.1, 29.7, 28.5, 21.6, 
14.2, 7.6, 7.2; IR (cm-1): 2973, 1726, 1598, 1455, 1367, 1341, 1306, 1256, 1160, 1091, 1053, 1027, 
860, 815, 775, 712, 690, 648; HRMS: m/z calculated for C22H33N2O5S+ [M+H]+: 437.2105; found: 
437.2102. 
endo-Diastereomer (minor): 1H NMR (500 MHz, CDCl3): d 7.71 (d, J = 7.7 Hz, 2H), 7.29 (d, 
J = 7.8 Hz, 2H), 4.27 (q, J = 7.1 Hz, 2H), 3.89 (p, J = 7.7 Hz, 1H), 3.25 – 3.10 (m, 2H), 2.83 (dd, 
J = 11.5, 8.3 Hz, 1H), 2.75 (d, J = 12.5 Hz, 1H), 2.42 (s, 3H), 2.39 – 2.28 (m, 1H), 2.25 (dd, J = 
11.6, 7.9 Hz, 1H), 2.20 (d, J = 12.5 Hz, 1H), 2.07 – 1.98 (m, 1H), 1.87 – 1.76 (m, 1H), 1.44 (s, 
3H), 1.32 (t, J = 6.9 Hz, 3H), 1.17 (s, 3H), 0.84 (q, J = 9.8, 9.3 Hz, 2H), 0.67 (d, J = 6.8 Hz, 2H); 
13C NMR (176 MHz, CDCl3): d 172.8, 143.47, 135.5, 129.7, 127.8, 83.8, 72.8, 61.8, 58.4, 52.8, 
48.6, 36.3, 31.7, 31.0, 27.0, 25.9, 21.6, 14.3, 7.6, 7.3; IR (cm-1): 2977, 1727, 1456, 1368, 1342, 
1266, 1184, 1161, 1092, 1027, 979, 932, 860, 815, 732, 714, 700, 642; HRMS: m/z calculated for 
C22H33N2O5S+ [M+H]+: 437.2105; found: 437.2101. 
 
Ethyl 3,3-dimethyl-7-(2-(pyridin-3-yloxy)ethyl)-2-oxa-1-azabicyclo[3.2.0]heptane-5-
carboxylate (3.110): Prepared according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), 
S3.110 (56 mg, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) 










diastereomer ratio of 2:1 and a regioisomer ratio of >20:1. Purification by flash column 
chromatography (20–100% EtOAc/hexanes) afforded the pure title compound as a yellow oil 
(54 mg, 67% combined yield; d.r. = 2:1). Characterization data was obtained for the exo-
diastereomer after purification by flash column chromatography (50–100% EtOAc/hexanes). 
1H NMR (400 MHz, CDCl3): d 8.29 (s, 1H), 8.19 (t, J = 3.1 Hz, 1H), 7.19 (dd, J = 3.3, 1.6 Hz, 
2H), 4.24 (q, J = 7.1 Hz, 2H), 4.18 – 4.07 (m, 2H), 3.82 – 3.70 (m, 1H), 2.87 (d, J = 13.0 Hz, 1H), 
2.51 (d, J = 13.0 Hz, 1H), 2.44 (dd, J = 11.2, 8.7 Hz, 1H), 2.21 – 2.03 (m, 3H), 1.50 (s, 3H), 1.29 
(t, J = 7.1 Hz, 3H), 1.20 (s, 3H); 13C NMR (176 MHz, CDCl3): d 172.7, 155.2, 142.1, 138.4, 123.9, 
121.1, 87.7, 73.5, 64.8, 64.0, 61.7, 50.9, 34.6, 30.1, 29.7, 28.5, 14.2; IR (cm-1): 2973, 1725, 1574, 
1471, 1426, 1384, 1310, 1260, 1231, 1186, 1148, 1111, 1053, 1014, 925, 861, 800, 707, 678; 
HRMS: m/z calculated for C17H25N2O4+ [M+H]+: 321.1809; found: 321.1812. 
 
Ethyl 7-(2-((4-(N,N-dipropylsulfamoyl)benzoyl)oxy)ethyl)-3,3-dimethyl-2-oxa-1-
azabicyclo[3.2.0]heptane-5-carboxylate (3.111): Prepared according to GP-3.3 using 3.83 
(43 mg, 0.25 mmol, 1.0 equiv.), S3.111 (128 mg, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] 
(1.9 mg, 1 mol%) and MeCN (2.5 mL) with a reaction time of 23 h. 1H NMR analysis of the crude 
reaction mixture revealed a diastereomer ratio of 2:1 and a regioisomer ratio of >20:1. Purification 
by flash column chromatography (2–40% EtOAc/CH2Cl2) afforded the pure title compound as a 
yellow oil (118 mg, 92% combined yield; d.r. = 2:1). Characterization data for both diastereomers 
was obtained after separation by flash column chromatography (5–40% EtOAc/CH2Cl2). 
exo-Diastereomer (major): 1H NMR (500 MHz, CDCl3): d 8.12 (d, J = 8.4 Hz, 2H), 7.84 (d, J = 













(m, 4H), 2.86 (d, J = 13.0 Hz, 1H), 2.49 (d, J = 13.0 Hz, 1H), 2.43 (dd, J = 11.2, 8.7 Hz, 1H), 2.21 
– 2.01 (m, 3H), 1.56 – 1.49 (m, 4H), 1.49 (s, 3H), 1.29 (t, J = 7.1 Hz, 3H), 1.20 (s, 3H), 0.84 (t, 
J = 7.4 Hz, 6H); 13C NMR (176 MHz, CDCl3): d 172.6, 165.2, 144.3, 133.6, 130.3, 127.1, 87.7, 
73.5, 64.2, 62.4, 61.7, 50.9, 50.0, 34.2, 30.2, 29.7, 28.4, 22.0, 14.2, 11.2; IR (cm-1): 2968, 2876, 
1721, 1458, 1342, 1271, 1217, 1177, 1157, 1105, 1087, 1052, 991, 863, 778, 740, 693; HRMS: 
m/z calculated for C25H39N2O7S+ [M+H]+: 511.2472; found: 511.2471. 
endo- Diastereomer (minor): 1H NMR (500 MHz, CDCl3): d 8.14 (d, J = 8.3 Hz, 2H), 7.86 (d, 
J = 8.3 Hz, 2H), 4.48 – 4.20 (m, 4H), 4.15 (p, J = 7.9 Hz, 1H), 3.14 – 3.08 (m, 4H), 2.94 (dd, J = 
11.8, 7.9 Hz, 1H), 2.75 (d, J = 12.4 Hz, 1H), 2.47 (td, J = 14.1, 6.0 Hz, 1H), 2.37 (dd, J = 11.8, 
8.1 Hz, 1H), 2.23 (d, J = 12.5 Hz, 1H), 2.05 – 1.96 (m, 1H), 1.57 – 1.50 (m, 4H), 1.47 (s, 3H), 1.32 
(t, J = 7.1 Hz, 3H), 1.22 (s, 3H), 0.87 (t, J = 7.4 Hz, 6H); 13C NMR (176 MHz, CDCl3): d 172.7, 
165.3, 144.3, 133.7, 130.4, 127.1, 83.9, 72.7, 63.2, 61.9, 57.4, 52.9, 50.0, 36.9, 31.0, 26.9, 26.1, 
22.0, 14.3, 11.3; IR (cm-1): 2970, 2876, 1722, 1458, 1368, 1271, 1157, 1106, 1087, 992, 862, 734, 
695; HRMS: m/z calculated for C25H39N2O7S+ [M+H]+: 511.2472; found: 511.2468. 
 
Ethyl 7-(((2-acetoxybenzoyl)oxy)methyl)-3,3-dimethyl-2-oxa-1-azabicyclo[3.2.0]heptane-5-
carboxylate (3.112): Prepared according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), 
allyl 2-acetoxybenzoate230 (83 mg, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and 
MeCN (2.5 mL) with a reaction time of 23 h. 1H NMR analysis of the crude reaction mixture 
revealed a diastereomer ratio of 2:1 and a regioisomer ratio of >20:1. Purification by flash column 











(92 mg, 94% combined yield; d.r. = 2:1). Characterization data for both diastereomers was 
obtained after separation by flash column chromatography (5–40% EtOAc/CH2Cl2). 
exo-Diastereomer (major): 1H NMR (500 MHz, CDCl3): d 8.07 (dd, J = 7.9, 1.7 Hz, 1H), 7.54 
(td, J = 7.7, 1.7 Hz, 1H), 7.28 (td, J = 7.6, 1.2 Hz, 1H), 7.08 (dd, J = 8.1, 1.2 Hz, 1H), 4.45 – 4.35 
(m, 2H), 4.25 (q, J = 7.1 Hz, 2H), 3.84 (tt, J = 8.7, 5.2 Hz, 1H), 2.90 (d, J = 13.0 Hz, 1H), 2.48 (d, 
J = 13.0 Hz, 1H), 2.42 (dd, J = 11.5, 9.0 Hz, 1H), 2.34 (s, 3H), 2.31 (dd, J = 11.5, 8.4 Hz, 1H), 
1.53 (s, 3H), 1.28 (t, J = 7.1 Hz, 3H), 1.22 (s, 3H); 13C NMR (176 MHz, CDCl3): d 172.4, 169.9, 
164.2, 151.0, 134.1, 132.1, 126.0, 123.8, 123.0, 87.8, 73.3, 66.1, 64.7, 61.8, 50.8, 29.5, 28.4, 27.5, 
21.2, 14.2; IR (cm-1): 2974, 2934, 1769, 1720, 1607, 1578, 1452, 1366, 1256, 1186, 1136, 1087, 
1012, 917, 866, 817, 784, 755, 701, 671; HRMS: m/z calculated for C20H25NNaO7+ [M+Na]+: 
414.1523; found: 414.1527. 
endo-Diastereomer (minor): 1H NMR (500 MHz, CDCl3): d 8.03 (dd, J = 7.8, 1.5 Hz, 1H), 7.55 
(td, J = 8.0, 1.6 Hz, 1H), 7.29 (td, J = 7.7, 1.0 Hz, 1H), 7.09 (dd, J = 8.1, 1.2 Hz, 1H), 4.70 (dd, 
J = 11.7, 8.1 Hz, 1H), 4.44 (dd, J = 11.8, 5.1 Hz, 1H), 4.34 – 4.24 (m, 3H), 2.89 (dd, J = 12.1, 
8.3 Hz, 1H), 2.79 (d, J = 12.6 Hz, 1H), 2.41 (dd, J = 12.2, 8.0 Hz, 1H), 2.36 (s, 3H), 2.24 (d, J = 
12.6 Hz, 1H), 1.45 (s, 3H), 1.33 (t, J = 7.1 Hz, 3H), 1.20 (s, 3H); 13C NMR (176 MHz, CDCl3): 
d 172.4, 169.9, 164.4, 150.9, 134.1, 132.1, 126.1, 123.9, 123.1, 84.3, 72.7, 63.9, 62.0, 57.7, 52.5, 
33.5, 26.8, 25.9, 21.2, 14.3; IR (cm-1): 2971, 1766, 1722, 1608, 1490, 1448, 1367, 1307, 1263, 
1195, 1134, 1083, 1018, 969, 918, 840, 761, 711, 647; HRMS: m/z calculated for C20H26NO7+ 
[M+H]+: 392.1704; found: 392.1707. 
 
Ethyl 7-(2-(2,5-difluorophenoxy)ethyl)-3,3-dimethyl-2-oxa-1-azabicyclo[3.2.0]heptane-5-











S3.113 (69 mg, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) 
with a reaction time of 20 h. 1H NMR analysis of the crude reaction mixture revealed a 
diastereomer ratio of 2:1 and a regioisomer ratio of >20:1. Purification by flash column 
chromatography (1–20% EtOAc/CH2Cl2) afforded the pure title compound as a pale-yellow oil 
(83 mg, 93% combined yield; d.r. = 2:1). Characterization data for both diastereomers was 
obtained after separation by flash column chromatography (2–25% EtOAc/CH2Cl2). 
exo-Diastereomer (major): 1H NMR (500 MHz, CDCl3): d 7.01 – 6.93 (m, 1H), 6.74 – 6.67 (m, 
1H), 6.57 – 6.50 (m, 1H), 4.23 (q, J = 7.1 Hz, 2H), 4.18 – 4.07 (m, 2H), 3.77 (p, J = 8.4 Hz, 1H), 
2.86 (d, J = 12.9 Hz, 1H), 2.51 (d, J = 13.0 Hz, 1H), 2.44 (dd, J = 11.2, 8.8 Hz, 1H), 2.21 – 2.05 
(m, 3H), 1.49 (s, 3H), 1.28 (t, J = 7.2 Hz, 3H), 1.20 (s, 3H); 13C NMR (126 MHz, CDCl3): d 172.7, 
158.9 (dd, J = 241.9, 2.6 Hz), 149.0 (dd, J = 240.9, 3.2 Hz), 147.7 (dd, J = 12.4, 10.5 Hz), 116.1 
(dd, J = 20.8, 10.2 Hz), 106.6 (dd, J = 23.9, 7.0 Hz), 103.0 (dd, J = 27.6, 1.9 Hz), 87.7, 73.6, 66.1, 
64.0, 61.6, 51.0, 34.5, 30.1, 29.7, 28.6, 14.2; IR (cm-1): 2974, 1726, 1625, 1512, 1469, 1432, 1368, 
1309, 1249, 1186, 1156, 1099, 1053, 1019, 987, 836, 790, 721; HRMS: m/z calculated for 
C18H24F2NO4+ [M+H]+: 356.1668; found: 356.1665. 
endo-Diastereomer (minor): 1H NMR (500 MHz, CDCl3): d 6.98 (ddd, J = 10.8, 8.9, 5.3 Hz, 
1H), 6.71 (ddd, J = 9.9, 6.8, 3.0 Hz, 1H), 6.59 – 6.50 (m, 1H), 4.28 (q, J = 7.1 Hz, 2H), 4.22 – 4.11 
(m, 2H), 4.05 – 3.97 (m, 1H), 2.93 (dd, J = 11.9, 8.0 Hz, 1H), 2.75 (d, J = 12.4 Hz, 1H), 2.56 – 
2.45 (m, 1H), 2.40 (dd, J = 11.9, 8.2 Hz, 1H), 2.23 (d, J = 12.4 Hz, 1H), 2.08 – 1.97 (m, 1H), 1.48 
(s, 3H), 1.33 (t, J = 7.1 Hz, 3H), 1.22 (s, 3H); 13C NMR (126 MHz, CDCl3): d 172.7, 158.9 (dd, 
J = 241.9, 2.5 Hz), 149.0 (dd, J = 240.9, 3.2 Hz), 147.6 (dd, J = 12.7, 10.5 Hz), 116.1 (dd, J = 20.6, 
10.1 Hz), 106.4 (dd, J = 23.9, 6.9 Hz), 102.6 (dd, J = 27.7, 2.0 Hz), 83.9, 72.7, 66.8, 61.9, 57.3, 
53.0, 37.1, 31.3, 26.9, 26.0, 14.3; IR (cm-1): 2975, 1727, 1625, 1512, 1473, 1433, 1368, 1314, 
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1250, 1187, 1153, 1099, 1025, 988, 836, 790, 721; HRMS: m/z calculated for C18H24F2NO4+ 
[M+H]+: 356.1668; found: 356.1667. 
 
Ethyl 7-(2-((tert-butyldimethylsilyl)oxy)ethyl)-3,3,7-trimethyl-2-oxa-1-
azabicyclo[3.2.0]heptane-5-carboxylate (3.114): Prepared according to GP-3.3 using 3.83 
(43 mg, 0.25 mmol, 1.0 equiv.), tert-butyldimethyl((3-methylbut-3-en-1-yl)oxy)silane222 (76 mg, 
0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) with a reaction 
time of 24 h. 1H NMR analysis of the crude reaction mixture revealed a diastereomer ratio of 1.3:1 
and a regioisomer ratio of >20:1. Purification by flash column chromatography (2–35% 
EtOAc/CH2Cl2) afforded the pure title compound as a pale-yellow oil (82 mg, 88% combined 
yield; d.r. = 1.3:1). Characterization data for both diastereomers was obtained after separation by 
flash column chromatography (5–40% EtOAc/hexanes). 
exo (C7-Me)-Diastereomer (major): 1H NMR (500 MHz, CDCl3): d 4.33 – 4.21 (m, 2H), 3.77 
(ddd, J = 10.2, 7.4, 5.4 Hz, 1H), 3.64 (dt, J = 10.2, 7.4 Hz, 1H), 2.81 (d, J = 12.5 Hz, 1H), 2.44 (d, 
J = 11.9 Hz, 1H), 2.29 (dd, J = 12.2, 10.5 Hz, 2H), 2.03 – 1.90 (m, 2H), 1.45 (s, 3H), 1.37 (s, 3H), 
1.32 (t, J = 7.1 Hz, 3H), 1.17 (s, 3H), 0.88 (s, 9H), 0.04 (d, J = 3.1 Hz, 6H); 13C NMR (126 MHz, 
CDCl3): d 173.7, 84.2, 69.6, 63.1, 61.7, 59.7, 52.5, 42.1, 39.8, 27.5, 26.8, 26.1, 25.8, 18.4, 14.3, -
5.2, -5.3; IR (cm-1): 2956, 2929, 2857, 1727, 1462, 1367, 1308, 1253, 1183, 1086, 1031, 1006, 
939, 834, 774, 727, 665; HRMS: m/z calculated for C19H38NO4Si+ [M+H]+: 372.2565; found: 
272.2560. 
endo (C7-Me)-Diastereomer (minor): 1H NMR (500 MHz, CDCl3): d 4.33 – 4.18 (m, 2H), 3.76 
(ddd, J = 10.5, 6.6, 5.4 Hz, 1H), 3.67 (ddd, J = 10.5, 7.6, 6.1 Hz, 1H), 2.86 (d, J = 12.7 Hz, 1H), 








7.6, 6.6 Hz, 1H), 1.81 (dt, J = 13.9, 5.7 Hz, 1H), 1.45 (s, 3H), 1.35 – 1.28 (m, 6H), 1.15 (s, 3H), 
0.86 (s, 9H), 0.02 (d, J = 1.7 Hz, 6H); 13C NMR (126 MHz, CDCl3): d 173.6, 84.5, 70.8, 64.1, 
61.6, 59.5, 52.0, 45.1, 40.1, 28.0, 26.0, 25.6, 22.1, 18.3, 14.3, -5.2, -5.3; IR (cm-1): 2954, 2929, 
2857, 1726, 1463, 1368, 1301, 1253, 1182, 1140, 1089, 1039, 1006, 938, 833, 774, 729, 663; 
HRMS: m/z calculated for C19H38NO4Si+ [M+H]+: 372.2565; found: 272.2562. 
 
Ethyl 3,3,7,7-tetramethyl-2-oxa-1-azabicyclo[3.2.0]heptane-5-carboxylate (3.115): Prepared 
according to GP-3.3 using 3.83 (200 mg, 1.2 mmol, 1.0 equiv.), fac-[Ir(dFppy)3] (1.8 mg, 
0.2 mol%) and 1,2-dichloroethane (5 mL) with a reaction time of 24 h under an atmosphere of 2-
methylpropene. Purification by flash column chromatography (1–10% EtOAc/CH2Cl2) afforded 
the pure title compound as a yellow oil (244 mg, 92%). 
1H NMR (500 MHz, CDCl3): d 4.37 – 4.16 (m, 2H), 2.84 (d, J = 12.6 Hz, 1H), 2.40 – 2.16 (m, 
3H), 1.45 (s, 3H), 1.36 (s, 3H), 1.34 – 1.28 (m, 6H), 1.17 (s, 3H); 13C NMR (126 MHz, CDCl3): 
d 173.5, 84.3, 69.4, 61.9, 61.6, 52.0, 41.6, 30.1, 27.6, 25.7, 24.4, 14.2; IR (cm-1): ; HRMS: m/z 
calculated for C12H22NO3+ [M+H]+: 228.1594; found: 228.1595. 
 
Ethyl 7,7-dimethyl-2-oxa-1-azabicyclo[3.2.0]heptane-5-carboxylate (3.143): Prepared 
according to GP-3.3 using S3.85 (250 mg, 1.8 mmol, 1.0 equiv.), fac-[Ir(dFppy)3] (2.7 mg, 
0.2 mol%) and 1,2-dichloroethane (5 mL) with a reaction time of 24 h under an atmosphere of 2-
methylpropene. Purification by flash column chromatography (1–10% EtOAc/CH2Cl2) afforded 












1H NMR (500 MHz, CDCl3): d 4.30 – 4.06 (m, 4H), 2.63 – 2.49 (m, 2H), 2.33 – 2.26 (m, 1H), 
2.11 (d, J = 12.0 Hz, 1H), 1.31 (s, 3H), 1.28 (t, J = 7.1 Hz, 3H), 1.22 (s, 3H); 13C NMR (126 MHz, 
CDCl3): d 173.4, 70.8, 69.4, 62.9, 61.7, 40.1, 39.8, 30.5, 22.7, 14.2; IR (cm-1): 2967, 2872, 1727, 
1446, 1367, 1318, 1281, 1215, 1175, 1135, 1096, 1027, 938, 877, 860, 782, 748, 703, 658; HRMS: 
m/z calculated for C10H18NO3+ [M+H]+: 200.1281; found: 200.1277. 
 
Ethyl 2,2-dimethyldecahydro-3aH-cycloocta[3,4]azeto[1,2-b]isoxazole-3a-carboxylate 
(3.116): Prepared according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), cyclooctene 
(49 µL, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) with a 
reaction time of 20 h. 1H NMR analysis of the crude reaction mixture revealed a diastereomer ratio 
of 1.3:1. Purification by flash column chromatography (5–30% EtOAc/hexanes) afforded the pure 
title compound as a pale-yellow oil (67 mg, 95% combined yield; d.r. = 1.3:1). Characterization 
data for the endo-diastereomer was obtained after separation by flash column chromatography (5–
30% EtOAc/hexanes). 
endo-Diastereomer (minor): 1H NMR (400 MHz, CDCl3): d 4.26 (qd, J = 7.1, 3.1 Hz, 2H), 3.19 
(ddd, J = 11.1, 8.7, 3.8 Hz, 1H), 2.61 – 2.46 (m, 2H), 2.21 – 2.05 (m, 2H), 1.92 – 1.68 (m, 5H), 
1.68 – 1.44 (m, 5H), 1.37 – 1.21 (m, 5H), 1.21 – 0.96 (m, 5H); 13C NMR (176 MHz, CDCl3): 
d 173.4, 86.1, 77.5, 75.2, 61.4, 44.6, 40.1, 35.8, 30.3, 29.2, 28.6, 28.5, 28.2, 27.7, 26.6, 14.3; IR 
(cm-1): 2972, 2923, 2853, 1745, 1721, 1454, 1366, 1300, 1250, 1210, 1180, 1148, 1123, 1041, 







Ethyl 2,2-dimethyloctahydro-3aH-benzo[3,4]azeto[1,2-b]isoxazole-3a-carboxylate (3.117): 
Prepared according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), cyclohexene (38 µL, 
0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) with a reaction 
time of 20 h. 1H NMR analysis of the crude reaction mixture revealed a diastereomer ratio of 1.2:1. 
Purification by flash column chromatography (5–30% EtOAc/CH2Cl2) afforded the pure title 
compound as a yellow oil (58 mg, 91% combined yield; d.r. = 1.2:1). Characterization data for the 
exo-diastereomer was obtained after separation by flash column chromatography (5–30% 
EtOAc/CH2Cl2). 
exo-Diastereomer (major): 1H NMR (700 MHz, CDCl3): d 4.36 – 4.23 (m, 2H), 3.57 (ddd, J = 
8.4, 5.5, 1.7 Hz, 1H), 2.71 (d, J = 13.1 Hz, 1H), 2.63 (d, J = 13.1 Hz, 1H), 2.53 (q, J = 9.0 Hz, 1H), 
2.03 – 1.96 (m, 1H), 1.91 – 1.83 (m, 1H), 1.65 – 1.59 (m, 1H), 1.55 – 1.51 (m, 2H), 1.51 (s, 3H), 
1.47 – 1.39 (m, 1H), 1.34 – 1.27 (m, 4H), 1.18 (s, 3H), 1.03 – 0.92 (m, 1H); 13C NMR (176 MHz, 
CDCl3): d 172.6, 87.5, 78.2, 63.4, 61.2, 51.7, 33.8, 30.2, 29.0, 27.0, 25.3, 22.4, 20.9, 14.6; IR (cm-
1): 2966, 2935, 2861, 1737, 1464, 1366, 1289, 1252, 1178, 1139, 1045, 1015, 947, 861, 777, 728, 
716; HRMS: m/z calculated for C14H24NO3+ [M+H]+: 254.1751; found: 254.1750. 
 
Ethyl 3,3,6,6,7,7-hexamethyl-2-oxa-1-azabicyclo[3.2.0]heptane-5-carboxylate (3.118): 
Prepared according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), 2,3-dimethyl-2-butene 
(45 µL, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) with a 
reaction time of 22 h. Purification by flash column chromatography (3–30% EtOAc/CH2Cl2) 













1H NMR (500 MHz, CDCl3): d 4.35 – 4.21 (m, 2H), 2.53 (d, J = 13.1 Hz, 1H), 2.45 (d, J = 
13.1 Hz, 1H), 1.43 (s, 3H), 1.31 (t, J = 7.1 Hz, 3H), 1.20 (s, 3H), 1.18 (s, 3H), 1.16 (s, 3H), 1.12 
(s, 3H), 1.08 (s, 3H); 13C NMR (126 MHz, CDCl3): d 173.3, 84.0, 79.7, 68.0, 61.1, 47.6, 39.2, 
28.4, 26.0, 25.7, 22.8, 21.7, 20.4, 14.5; IR (cm-1): 2974, 2932, 1743, 1717, 1464, 1370, 1294, 1233, 
1172, 1124, 1047, 1014, 937, 862, 837, 766, 726, 641; HRMS: m/z calculated for C14H26NO3+ 
[M+H]+: 256.1907; found: 256.1908. 
 
1-(Tert-butyl) 1'-ethyl 3',3'-dimethyl-4'-oxa-5'-azaspiro[azetidine-3,6'-
bicyclo[3.2.0]heptane]-1,1'-dicarboxylate (3.119): Prepared according to GP-3.3 using 3.83 
(43 mg, 0.25 mmol, 1.0 equiv.), tert-butyl 3-methyleneazetidine-1-carboxylate229 (64 mg, 
0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) with a reaction 
time of 24 h. 1H NMR analysis of the crude reaction mixture revealed a regioisomer ratio of >20:1. 
Purification by flash column chromatography (5–30% EtOAc/CH2Cl2) afforded the pure title 
compound as a pale-yellow oil (85 mg, 99%). 
1H NMR (700 MHz, CDCl3): d 4.68 (d, J = 9.4 Hz, 1H), 4.26 (qd, J = 7.1, 1.4 Hz, 2H), 4.14 (d, 
J = 9.9 Hz, 1H), 3.91 (d, J = 9.9 Hz, 1H), 3.74 (d, J = 9.4 Hz, 1H), 2.85 (d, J = 12.8 Hz, 1H), 2.63 
(d, J = 12.1 Hz, 1H), 2.57 (d, J = 12.0 Hz, 1H), 2.00 (d, J = 12.9 Hz, 1H), 1.46 (s, 3H), 1.42 (s, 
9H), 1.31 (t, J = 7.1 Hz, 3H), 1.20 (s, 3H); 13C NMR (176 MHz, CDCl3): d 171.9, 156.2, 86.8, 
79.8, 71.9, 63.0, 61.8, 61.3, 56.2, 50.3, 37.1, 28.4, 27.9, 26.4, 14.2; IR (cm-1): 2977, 2873, 2248, 
1733, 1697, 1452, 1394, 1367, 1304, 1252, 1220, 1165, 1142, 1091, 1045, 916, 859, 772, 729, 










carboxylate (3.120): Prepared according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), 4-
methylenetetrahydro-2H-thiopyran222 (43 mg, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 
1 mol%) and MeCN (2.5 mL) with a reaction time of 20 h. 1H NMR analysis of the crude reaction 
mixture revealed a regioisomer ratio of >20:1. Purification by flash column chromatography (3–
50% EtOAc/CH2Cl2) afforded the pure title compound as a pale-yellow oil (53 mg, 74%). 
1H NMR (700 MHz, CDCl3): d 4.33 – 4.20 (m, 2H), 2.89 (d, J = 12.6 Hz, 1H), 2.85 – 2.75 (m, 
2H), 2.54 – 2.45 (m, 2H), 2.27 – 2.16 (m, 4H), 2.10 (ddd, J = 12.4, 8.9, 3.0 Hz, 1H), 2.02 (ddd, 
J = 13.1, 7.4, 2.7 Hz, 1H), 1.98 (ddd, J = 13.8, 7.8, 2.9 Hz, 1H), 1.43 (s, 3H), 1.32 (t, J = 7.1 Hz, 
3H), 1.17 (s, 3H); 13C NMR (176 MHz, CDCl3): d 173.2, 84.4, 69.9, 63.1, 61.7, 52.3, 39.9, 39.7, 
35.0, 27.4, 25.5, 25.11, 25.06, 14.2; IR (cm-1): 2976. 2933, 2212, 1726, 1456, 1429, 1368, 1304, 
1232, 1187, 1148, 1098, 1031, 912, 863, 827, 785, 725, 643; HRMS: m/z calculated for 
C14H24NO3S+ [M+H]+: 286.1471; found: 286.1470. 
 
8'-(Tert-butyl) 1-ethyl 3,3-dimethyl-4-oxa-5,8'-diazaspiro[bicyclo[3.2.0]heptane-6,3'-
bicyclo[3.2.1]octane]-1,8'-dicarboxylate (3.121): Prepared according to GP-3.3 using 3.83 
(43 mg, 0.25 mmol, 1.0 equiv.), tert-butyl 3-methylene-8-azabicyclo[3.2.1]octane-8-
carboxylate231 (84 mg, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN 
(2.5 mL) with a reaction time of 24 h. 1H NMR analysis of the crude reaction mixture revealed a 
diastereomer ratio of 5:1 and a regioisomer ratio of >20:1. Purification by flash column 














(77 mg, 78%) and the pure minor diastereomer as a pale-yellow oil (14 mg, 14%). Characterization 
is provided for the major (1S*,1'R*,5'S*,6r*)-diastereomer. 
(1S*,1'R*,5'S*,6r*)-Diastereomer (major): 1H NMR (700 MHz, CDCl3): d 4.34 – 4.25 (m, 1H), 
4.24 – 4.18 (m, 1H), 4.10 (b, 2H), 2.79 (d, J = 12.5 Hz, 1H), 2.53 (b, 1H), 2.27 (m, 2H), 2.20 (b, 
2H), 2.12 (d, J = 12.3 Hz, 2H), 1.93 – 1.54 (m, 4H), 1.48 (s, 3H) 1.45 (s, 9H), 1.31 (t, J = 7.1 Hz, 
3H), 1.18 (s, 3H); 13C NMR (176 MHz, CDCl3): d 173.4, 153.4, 84.6, 79.1, 70.0, 62.0, 61.6, 52.7 
(dd, J = 144.5, 18.4 Hz, 3C), 43.4 (d, J = 148.1 Hz), 43.0, 37.1 (d, J = 157.1 Hz), 28.6, 27.6, 27.1 
(d, J = 103.1 Hz), 26.0, 25.9 (d, J = 121.2 Hz), 14.2; IR (cm-1): 2974, 1726, 1686, 1452, 1413, 
1363, 1329, 1307, 1257, 1169, 1095, 1075, 1010, 971, 879, 846, 735; HRMS: m/z calculated for 
C21H35N2O5+ [M+H]+: 395.2540; found: 395.2535. 
 
Ethyl 3'-cyano-3,3-dimethyl-4-oxa-5-azaspiro[bicyclo[3.2.0]heptane-6,1'-cyclobutane]-1-
carboxylate (3.122): Prepared according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), 3-
methylenecyclobutane-1-carbonitrile (35 mg, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 
1 mol%) and MeCN (2.5 mL) with a reaction time of 20 h. 1H NMR analysis of the crude reaction 
mixture revealed a diastereomer ratio of 1:1 and a regioisomer ratio of >20:1. Purification by flash 
column chromatography (3–50% EtOAc/CH2Cl2) afforded the pure title compound as a pale-
yellow oil (45 mg, 68% combined yield; d.r. = 1:1). Characterization data was obtained for a 1:1 
mixture of diastereomers. 
1H NMR (700 MHz, CDCl3): d 4.26 (q, J = 7.1 Hz, 4H), 3.30 – 3.24 (m, 2H), 3.01 (tt, J = 9.3, 
5.5 Hz, 1H), 2.87 – 2.81 (m, 2H), 2.83 – 2.79 (m, 1H), 2.75 (ddd, J = 11.9, 9.4, 1.8 Hz, 1H), 2.68 
(dd, J = 12.2, 10.1 Hz, 1H), 2.61 – 2.53 (m, 2H), 2.53 – 2.42 (m, 4H), 2.31 – 2.25 (m, 2H), 2.08 









6H); 13C NMR (176 MHz, CDCl3): d 172.1, 172.0, 122.5, 121.2, 86.7, 86.6, 71.89, 71.87, 66.7, 
65.3, 61.8 (2C), 50.61, 50.55, 39.6, 39.4, 38.4, 37.4, 35.6, 34.7, 28.0, 27.9, 26.4, 26.2, 16.2, 14.4, 
14.2 (2C); IR (cm-1): 2977, 2237, 1724, 1456, 1369, 1281, 1221, 1185, 1127, 1050, 1022, 957, 
856, 779, 718; HRMS: m/z calculated for C14H21N2O3+ [M+H]+: 265.1547; found: 265.1551. 
 
1'-Benzyl 1-ethyl 3,3,7-trimethyl-4-oxa-5-azaspiro[bicyclo[3.2.0]heptane-6,4'-piperidine]-
1,1'-dicarboxylate (3.123): Prepared according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 
1.0 equiv.), S3.123 (92 mg, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN 
(2.5 mL) with a reaction time of 24 h. 1H NMR analysis of the crude reaction mixture revealed a 
diastereomer ratio of 3:1 and a regioisomer ratio of 8:1. Purification by flash column 
chromatography (5–50% EtOAc/CH2Cl2) afforded the pure title compound as a pale-yellow oil 
(82 mg, 78% combined yield; d.r. = 2.4:1). Characterization data was obtained for a 2.4:1 mixture 
of exo/endo diastereomers. 
1H NMR (700 MHz, CDCl3): d 7.37 – 7.29 (m, 17H; major+minor), 5.17 – 5.03 (m, 6.8H), 4.37 
– 4.15 (m, 6.8H; major+minor), 3.82 (b, 6.8H; major+minor), 3.35 (b, 6.8H), 2.87 (d, J = 12.7 Hz, 
1H; minor), 2.54 (d, J = 12.8 Hz, 2.4H; major), 2.45 (q, J = 7.5 Hz, 1H; minor), 2.30 (b, 5.8H; 
major+minor), 2.13 (b, 1H; minor), 1.90 (b, 5.8H; major+minor), 1.67 – 1.37 (m, 17H; 
major+minor), 1.34 – 1.28 (m, 10.2H; major+minor), 1.17 (s, 7.2H; major), 1.13 (s, 3H; minor), 
1.03 (d, J = 7.3 Hz, 7.2H; major), 1.00 (d, J = 7.5 Hz, 3H; minor); 13C NMR (176 MHz, CDCl3): 
d 173.6, 172.0, 155.3 (2C), 136.93, 136.91, 128.5 (2C), 128.0, 127.9, 127.9, 127.8, 84.1, 83.9, 
74.8, 74.6, 67.00, 66.98, 66.0, 63.3, 61.5, 61.4, 54.0, 45.3, 44.4, 41.5 (2C), 40.4, 40.04, 40.02, 38.6 










25.3, 14.5, 14.2, 10.8, 10.7; IR (cm-1): 2976, 2248, 1690, 1432, 1368, 1282, 1235, 1212, 1144, 




1-carboxylate (3.124): Prepared according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), 
S3.124 (67 mg, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) 
with a reaction time of 22 h. 1H NMR analysis of the crude reaction mixture revealed a 
diastereomer ratio of 1:1 and a regioisomer ratio of 8:1. Purification by flash column 
chromatography (2–40% EtOAc/CH2Cl2) afforded the pure title compound as a pale-yellow oil 
(46 mg, 52% combined yield; d.r. = 1:1). Characterization data was obtained for a 1:1 mixture of 
diastereomers (A/B). 
1H NMR (500 MHz, CDCl3): d 7.19 – 7.09 (m, 4H), 6.97 (t, J = 8.2 Hz, 4H), 5.32 (d, J = 7.1 Hz, 
1H), 5.26 (d, J = 7.3 Hz, 1H), 4.84 (d, J = 7.7 Hz, 1H), 4.78 (d, J = 7.8 Hz, 1H), 4.67 (d, J = 7.5 Hz, 
2H), 4.44 (d, J = 7.1 Hz, 1H), 4.41 (d, J = 7.7 Hz, 1H), 4.21 – 4.08 (m, 2H), 4.06 – 3.92 (m, 2H), 
3.17 (t, J = 8.1 Hz, 1H), 3.09 – 2.93 (m, 2H), 2.89 – 2.78 (m, 4H), 2.68 (d, J = 12.9 Hz, 1H), 1.90 
(d, J = 12.9 Hz, 1H), 1.84 (d, J = 12.9 Hz, 1H), 1.41 (d, J = 10.8 Hz, 6H), 1.19 (t, J = 7.1 Hz, 3H), 
1.16 – 1.09 (m, 9H); 13C NMR (126 MHz, CDCl3): d 171.7, 170.4, 161.8 (d, J = 245.0 Hz), 161.7 
(d, J = 245.2 Hz), 133.7 (d, J = 3.4 Hz), 133.3 (d, J = 3.5 Hz), 130.2 (d, J = 7.7 Hz), 129.7 (d, J = 
8.0 Hz), 115.7 (d, J = 10.8 Hz), 115,5 (d, J = 10.9 Hz), 86.6, 85.9, 81.8, 78.3, 77.7, 75.9, 75.6, 
72.9, 71.8, 70.2, 61.7, 61.7, 51.7, 48.0, 43.8, 42.7, 33.1, 31.7, 28.1, 27.8, 26.3, 26.1, 14.1, 14.0; IR 













azaspiro[bicyclo[3.2.0]heptane-6,4'-pyran]-1-carboxylate (3.125): Prepared according to GP-
3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), ethyl 4-(tetrahydro-4H-pyran-4-
ylidene)butanoate232 (75 mg, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and 
MeCN (2.5 mL) with a reaction time of 24 h. 1H NMR analysis of the crude reaction mixture 
revealed a diastereomer ratio of 4:1 and a regioisomer ratio of 13:1. Purification by flash column 
chromatography (5–85% EtOAc/CH2Cl2) afforded the pure title compound as a pale-yellow oil 
(72 mg, 78% combined yield; d.r. = 4:1). Characterization data was obtained for the exo-
diastereomer after purification by flash column chromatography (40–60% EtOAc/hexanes). 
exo-Diastereomer (major): 1H NMR (700 MHz, CDCl3): d 4.30 (dq, J = 10.8, 7.1 Hz, 1H), 4.20 
(dq, J = 10.8, 7.1 Hz, 1H), 4.12 (q, J = 7.1 Hz, 2H), 3.81 (td, J = 11.4, 2.4 Hz, 1H), 3.78 – 3.70 
(m, 3H), 2.63 (d, J = 12.7 Hz, 1H), 2.32 – 2.22 (m, 2H), 2.21 – 2.13 (m, 2H), 1.91 (dq, J = 13.7, 
2.7 Hz, 1H), 1.86 – 1.78 (m, 3H), 1.78 – 1.72 (m, 1H), 1.69 – 1.62 (m, 1H), 1.40 (s, 3H), 1.29 (t, 
J = 7.1 Hz, 3H), 1.25 (t, J = 7.1 Hz, 3H), 1.16 (s, 3H); 13C NMR (176 MHz, CDCl3): d 173.7, 
172.8, 84.1, 74.3, 65.4 (2C), 64.2, 61.8, 60.7, 45.1, 44.5, 39.8, 31.5, 29.7, 27.9, 25.7, 20.8, 14.3, 
14.2; IR (cm-1): 2972, 2874, 1729, 1463, 1368, 1301, 1231, 1179, 1117, 1101, 1040, 1024, 954, 










Ethyl 7-butoxy-3,3-dimethyl-2-oxa-1-azabicyclo[3.2.0]heptane-5-carboxylate (3.126): 
Prepared according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), n-butyl vinyl ether 
(49 µL, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) with a 
reaction time of 22 h. 1H NMR analysis of the crude reaction mixture revealed a diastereomer ratio 
of >10:1 and a regioisomer ratio of >20:1. Purification by flash column chromatography (2–30% 
EtOAc/hexanes) afforded the pure title compound as a colorless oil (31 mg, 46%). 
1H NMR (700 MHz, CDCl3): d 4.57 (t, J = 7.1 Hz, 1H), 4.24 (q, J = 7.1 Hz, 2H), 3.79 (dt, J = 9.3, 
6.8 Hz, 1H), 3.41 (dt, J = 9.3, 6.9 Hz, 1H), 2.85 (d, J = 13.0 Hz, 1H), 2.52 (dd, J = 11.8, 7.4 Hz, 
1H), 2.32 (dd, J = 11.8, 6.8 Hz, 1H), 2.25 (d, J = 13.0 Hz, 1H), 1.57 (p, J = 7.0 Hz, 2H), 1.49 (s, 
3H), 1.35 (hd, J = 7.3, 2.2 Hz, 2H), 1.29 (t, J = 7.1 Hz, 3H), 1.22 (s, 3H), 0.89 (t, J = 7.4 Hz, 3H); 
13C NMR (176 MHz, CDCl3): d 172.4, 94.8, 88.9, 68.0, 67.6, 61.8, 50.9, 31.6, 31.3, 29.6, 28.4, 
19.3, 14.2, 14.0; IR (cm-1): 2962, 2934, 2873, 1727, 1456, 1368, 1298, 1256, 1191, 1157, 1110, 
1025, 984, 913, 866, 788, 746, 679; HRMS: m/z calculated for C14H26NO4+ [M+H]+: 272.1856; 
found: 272.1851. 
 
Ethyl 7-acetoxy-3,3-dimethyl-2-oxa-1-azabicyclo[3.2.0]heptane-5-carboxylate (3.127): 
Prepared according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), vinyl acetate (35 µL, 
0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) with a reaction 
time of 22 h. 1H NMR analysis of the crude reaction mixture revealed a diastereomer ratio of 1.4:1 
and a regioisomer ratio of >20:1. Purification by flash column chromatography (1–30% 

















yield; d.r. = 1.4:1). Characterization data was obtained for a 1.4:1 mixture of endo/exo 
diastereomers. 
1H NMR (500 MHz, CDCl3): d 5.85 (dd, J = 5.8, 2.3 Hz, 1.4H; major), 5.71 (t, J = 7.1 Hz, 1H; 
minor), 4.28 – 4.20 (m, 4.8H; major+minor), 2.88 – 2.75 (m, 3.8H; major+minor), 2.67 (dd, J = 
12.0, 7.5 Hz, 1H; minor), 2.45 (d, J = 12.7 Hz, 1.4H; major), 2.35 (dd, J = 12.1, 6.7 Hz, 1H; 
minor), 2.33 – 2.26 (m, 2.4H; major+minor), 2.14 (s, 4.2H; major), 2.05 (s, 3H; minor), 1.51 (s, 
3H; minor), 1.44 (s, 4.2H; major), 1.28 (t, J = 7.1 Hz, 7.2H; major+minor), 1.20 (s, 3H; minor), 
1.16 (s, 4.2H; major); 13C NMR (126 MHz, CDCl3): d 172.3, 171.6, 169.6, 169.1, 89.5, 88.1, 87.7, 
84.0, 74.9, 68.9, 62.0, 61.8, 50.4, 50.3, 33.0, 31.4, 29.3, 28.2 (2C), 26.4, 21.01, 20.97, 14.2, 14.1; 
IR (cm-1): 2976, 2931, 1748, 1727, 1455, 1368, 1315, 1217, 1179, 1148, 1118, 1087, 1039, 1016, 
913, 865, 828, 777, 692; HRMS: m/z calculated for C12H19NNaO5+ [M+Na]+: 280.1155; found: 
280.1153. 
 
5-Ethyl 7-methyl 3,3,7-trimethyl-2-oxa-1-azabicyclo[3.2.0]heptane-5,7-dicarboxylate 
(3.128): Prepared according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), methyl 
methacrylate (40 µL, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN 
(2.5 mL) with a reaction time of 24 h. 1H NMR analysis of the crude reaction mixture revealed a 
diastereomer ratio of 5:1 and a regioisomer ratio of >20:1. Purification by flash column 
chromatography (5–50% EtOAc/hexanes) afforded the pure major diastereomer as a pale-yellow 
oil (56 mg, 82%) and the pure minor diastereomer as a pale-yellow oil (13 mg, 19%). 
exo(C7-Me)-Diastereomer (major): 1H NMR (700 MHz, CDCl3): d 4.31 – 4.18 (m, 2H), 3.72 (s, 
3H), 3.19 (d, J = 12.0 Hz, 1H), 2.72 (d, J = 12.4 Hz, 1H), 2.54 (d, J = 12.4 Hz, 1H), 2.27 (d, J = 








d 172.8, 171.8, 85.5, 70.2, 68.0, 61.8, 52.4, 50.0, 36.5, 27.0, 26.0, 24.2, 14.2; IR (cm-1): 2976, 
2361, 2338, 1729, 1451, 1368, 1297, 1255, 1188, 1141, 1094, 1027, 959, 863, 784, 685; HRMS: 
m/z calculated for C13H22NO5+ [M+H]+: 272.1492; found: 272.1493. 
endo(C7-Me)-Diastereomer (minor): 1H NMR (700 MHz, CDCl3): d 4.31 – 4.19 (m, 2H), 3.77 
(s, 3H), 3.04 (d, J = 12.1 Hz, 1H), 2.88 (d, J = 12.8 Hz, 1H), 2.31 (d, J = 12.9 Hz, 1H), 2.27 (d, 
J = 12.1 Hz, 1H), 1.54 (s, 3H), 1.48 (s, 3H), 1.29 (t, J = 7.1 Hz, 3H), 1.20 (s, 3H); 13C NMR 
(176 MHz, CDCl3): d 174.3, 172.5, 86.0, 70.9, 66.4, 61.9, 52.8, 51.2, 37.0, 28.1, 25.6, 20.6, 14.2; 
IR (cm-1): 2977, 2361, 2338, 1733, 1457, 1369, 1295, 1252, 1185, 1138, 1105, 1024, 994, 857, 
771, 728, 682; HRMS: m/z calculated for C13H22NO5+ [M+H]+: 272.1492; found: 272.1493. 
 
7-(Tert-butyl) 5-ethyl 3,3-dimethyl-2-oxa-1-azabicyclo[3.2.0]heptane-5,7-dicarboxylate 
(3.129): Prepared according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), tert-butyl 
acrylate (55 µL, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) 
with a reaction time of 42 h. 1H NMR analysis of the crude reaction mixture revealed a 
diastereomer ratio of 1:1 and a regioisomer ratio of >20:1. Purification by flash column 
chromatography (5–35% EtOAc/hexanes) afforded the pure endo-diastereomer as a colorless oil 
(34 mg, 45%) and the pure exo-diastereomer as a white solid (37 mg, 49%). 
exo-Diastereomer: 1H NMR (700 MHz, CDCl3): d 4.26 (qd, J = 7.1, 1.1 Hz, 2H), 3.97 (dd, J = 
9.6, 8.6 Hz, 1H), 2.88 (d, J = 13.0 Hz, 1H), 2.60 (dd, J = 11.5, 8.6 Hz, 1H), 2.51 – 2.42 (m, 2H), 
1.56 (s, 3H), 1.48 (s, 9H), 1.31 (t, J = 7.1 Hz, 3H), 1.26 (s, 3H); 13C NMR (176 MHz, CDCl3): 










1727, 1455, 1365, 1314, 1225, 1144, 1021, 944, 911, 844, 754, 671; HRMS: m/z calculated for 
C15H25NNaO5+ [M+H]+: 322.1625; found: 322.1624. 
endo-Diastereomer: 1H NMR (700 MHz, CDCl3): d 4.42 (dd, J = 8.2, 6.5 Hz, 1H), 4.31 – 4.23 
(m, 2H), 2.88 (dd, J = 12.2, 6.5 Hz, 1H), 2.73 (d, J = 12.3 Hz, 1H), 2.64 – 2.56 (m, 2H), 1.48 (s, 
9H), 1.38 (s, 3H), 1.32 (t, J = 7.1 Hz, 3H), 1.13 (s, 3H); 13C NMR (176 MHz, CDCl3): d 172.7, 
168.4, 85.0, 82.0, 73.7, 62.6, 61.8, 50.8, 29.7, 28.2, 26.9, 25.7, 14.2; IR (cm-1): 2974, 2933, 1718, 
1452, 1367, 1308, 1247, 1186, 1147, 1116, 1055, 1015, 950, 908, 847, 776, 725, 680; HRMS: m/z 
calculated for C15H25NNaO5+ [M+H]+: 322.1625; found: 322.1625. 
 
Ethyl 3,3-dimethyl-7-(trimethylsilyl)-2-oxa-1-azabicyclo[3.2.0]heptane-5-carboxylate 
(3.130): Prepared according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), 
vinyltrimethylsilane (55 µL, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and 
MeCN (2.5 mL) with a reaction time of 23 h. 1H NMR analysis of the crude reaction mixture 
revealed a diastereomer ratio of >10:1 and a regioisomer ratio of >20:1. Purification by flash 
column chromatography (2–20% EtOAc/hexanes) afforded the pure title compound as a pale-
yellow oil (36 mg, 53%). 
1H NMR (700 MHz, CDCl3): d 4.27 – 4.15 (m, 2H), 3.27 (t, J = 10.2 Hz, 1H), 2.85 (d, J = 12.8 Hz, 
1H), 2.62 (d, J = 12.8 Hz, 1H), 2.26 (dd, J = 10.3, 2.0 Hz, 2H), 1.55 (s, 3H), 1.29 (t, J = 7.1 Hz, 
3H), 1.20 (s, 3H), 0.06 (s, 9H); 13C NMR (176 MHz, CDCl3): d 173.0, 86.6, 77.9, 61.4, 59.4, 51.5, 
30.2, 28.8, 26.2, 14.2, -4.1; IR (cm-1): 2973, 1727, 1454, 1367, 1313, 1247, 1215, 1181, 1144, 














azabicyclo[3.2.0]heptane-5-carboxylate (3.131): Prepared according to GP-3.3 using 3.83 
(43 mg, 0.25 mmol, 1.0 equiv.), isopropenylboronic acid pinacol ester (71 µL, 0.38 mmol, 
1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 1 mol%) and MeCN (2.5 mL) with a reaction time of 18 h. 
1H NMR analysis of the crude reaction mixture revealed a diastereomer ratio of 5:1 and a 
regioisomer ratio of 17:1. The yield was determined to be 77% by 1H NMR analysis of the crude 
reaction mixture using mesitylene as the internal standard. Characterization data for the exo(C7-
Me)-diastereomer was obtained after purification by flash column chromatography (florisil; 0–
30% EtOAc/hexanes). 
exo(C7-Me)-Diastereomer (major): 1H NMR (700 MHz, CDCl3): d 4.33 – 4.17 (m, 2H), 2.81 
(d, J = 11.3 Hz, 1H), 2.75 (d, J = 12.1 Hz, 1H), 2.54 (d, J = 12.1 Hz, 1H), 2.08 (d, J = 11.3 Hz, 
1H), 1.42 (s, 6H), 1.32 (t, J = 7.1 Hz, 3H), 1.28 (s, 6H), 1.24 (s, 6H), 1.08 (s, 3H); 13C NMR 
(176 MHz, CDCl3): d 173.7, 84.3, 84.1, 70.4, 61.6, 51.3, 37.2, 26.4, 25.7, 25.5, 24.5, 14.3; IR (cm-
1): 2978, 1724, 1474, 1453, 1367, 1321, 1270, 1141, 983, 968, 926, 852, 733, 700, 674; HRMS: 
m/z calculated for C17H31BNO5+ [M+H]+: 340.2290; found: 340.2295. The boron bearing 
quaternary carbon was not observed by 13C NMR. 
 
Ethyl 3,3-dimethyl-7-octyl-7-(trifluoromethyl)-2-oxa-1-azabicyclo[3.2.0]heptane-5-
carboxylate (3.132): Prepared according to GP-3.3 using 3.83 (43 mg, 0.25 mmol, 1.0 equiv.), 2-
(trifluoromethyl)undec-1-ene233 (84 mg, 0.38 mmol, 1.5 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 




















mixture revealed a diastereomer ratio of 4:1 and a regioisomer ratio of >20:1. Purification by flash 
column chromatography (2–15% EtOAc/hexanes) afforded the pure endo(C7-CF3)-diastereomer 
as a colorless oil (68 mg, 69%) and the pure exo(C7-CF3)-diastereomer as a colorless oil (19 mg, 
19%). 
endo(CF3)-Diastereomer (major): 1H NMR (700 MHz, CDCl3): d 4.33 – 4.21 (m, 2H), 2.77 (d, 
J = 12.5 Hz, 1H), 2.73 (d, J = 12.8 Hz, 1H), 2.49 (dd, J = 12.8, 2.9 Hz, 2H), 1.94 – 1.81 (m, 2H), 
1.55 – 1.47 (b, 2H), 1.44 (s, 3H), 1.33 (t, J = 7.1 Hz, 3H), 1.32 – 1.21 (m, 12H), 1.18 (s, 3H), 0.87 
(t, J = 7.0 Hz, 3H); 13C NMR (176 MHz, CDCl3): d 172.6, 125.5 (q, J = 283.4 Hz), 85.7, 69.7, 
66.4 (q, J = 25.6 Hz), 62.0, 50.6, 35.9, 34.3 (d, J = 2.5 Hz), 32.0, 30.3, 29.7, 29.6, 29.4, 27.2, 25.5, 
23.1, 22.8, 14.2 (2C); IR (cm-1): 2925, 2855, 1731, 1459, 1369, 1306, 1252, 1190, 1173, 1141, 
1114, 1096, 1055, 943, 882, 784, 722, 678; HRMS: m/z calculated for C20H35F3NO3+ [M+H]+: 
394.2564; found: 394.2561. 
exo(CF3)-Diastereomer (minor): 1H NMR (700 MHz, CDCl3): d 4.34 – 4.21 (m, 2H), 2.83 (d, 
J = 12.9 Hz, 1H), 2.75 (d, J = 12.6 Hz, 1H), 2.32 (d, J = 12.9 Hz, 1H), 2.28 (d, J = 12.6 Hz, 1H), 
1.96 (t, J = 11.0 Hz, 1H), 1.79 (t, J = 13.9 Hz, 1H), 1.54 – 1.50 (m, 1H), 1.48 (s, 3H), 1.35 – 1.20 
(m, 19H), 0.87 (t, J = 7.0 Hz, 3H); 13C NMR (176 MHz, CDCl3): d 172.4, 126.1 (q, J = 281 Hz), 
85.7, 70.8, 66.6 (q, J = 27.9 Hz), 62.0, 52.5, 33.87 (d, J = 2.1 Hz), 32.0, 31.5, 30.6, 29.6, 29.4, 
29.4, 27.9, 25.9, 23.4, 22.8, 14.3, 14.2; IR (cm-1): 2925, 2855, 1729, 1461, 1370, 1305, 1253, 1148, 
1122, 1094, 1020, 956, 933, 861, 783, 737; HRMS: m/z calculated for C20H35F3NO3+ [M+H]+: 
394.2564; found: 394.2560. 
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4,7,7-Trimethyltetrahydro-1H,3H-furo[3',4':2,3]azeto[1,2-b]isoxazol-1-one (3.156): Prepared 
according to GP-3.3 using (E)-3.155 (53 mg, 0.25 mmol, 1.0 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 
1 mol%) and MeCN (2.5 mL) with a reaction time of 19 h. 1H NMR analysis of the crude reaction 
mixture revealed a diastereomer ratio of 1.2:1. Purification by flash column chromatography (2–
30% EtOAc/CH2Cl2) afforded the pure (3aS*,4R*,8aR*)-diastereomer as a white solid (22 mg, 
42%) and the pure (3aS*,4S*,8aR*)-diastereomer as a pale-yellow oil (18 mg, 34%). 
(3aS*,4R*,8aR*)-Diastereomer (major): 1H NMR (700 MHz, CDCl3): d 4.51 (d, J = 10.3 Hz, 
1H), 4.39 (t, J = 9.4 Hz, 1H), 3.68 (q, J = 7.9 Hz, 1H), 3.30 (t, J = 8.6 Hz, 1H), 2.60 (d, J = 12.8 Hz, 
1H), 2.45 (d, J = 12.8 Hz, 1H), 1.78 (dp, J = 14.9, 7.4 Hz, 1H), 1.62 – 1.51 (m, 4H), 1.40 (s, 3H), 
0.91 (t, J = 7.2 Hz, 3H); 13C NMR (176 MHz, CDCl3): d 175.9, 88.5, 72.4, 70.8, 66.0, 46.6, 35.8, 
28.3, 27.7, 23.5, 9.7; IR (cm-1): 2960, 2939, 2361, 2337, 1770, 1457, 1368, 1264, 1233, 1211, 
1155, 1100, 1048, 970, 949, 858, 824, 733, 706; HRMS: m/z calculated for C11H18NO3+ [M+H]+: 
212.1281; found: 212.1286. 
(3aS*,4S*,8aR*)-Diastereomer (minor): 1H NMR (700 MHz, CDCl3): d 4.41 (t, J = 8.4 Hz, 
1H), 4.35 (d, J = 9.8 Hz, 1H), 3.66 (q, J = 6.5 Hz, 1H), 3.00 (t, J = 6.4 Hz, 1H), 2.49 (d, J = 
12.4 Hz, 1H), 2.27 (d, J = 12.4 Hz, 1H), 2.02 (dp, J = 14.2, 7.1 Hz, 1H), 1.66 (dp, J = 14.8, 7.4 Hz, 
1H), 1.48 (s, 3H), 1.38 (s, 3H), 0.91 (t, J = 7.3 Hz, 3H); 13C NMR (176 MHz, CDCl3): d 176.1, 
85.3, 71.6, 70.6, 68.9, 48.5, 43.8, 26.8, 26.0, 23.3, 10.1; IR (cm-1): 2963, 2932, 2873, 2361, 2338, 
1759, 1457, 1366, 1218, 1170, 1133, 1050, 969, 885, 869, 827, 806, 723, 662; HRMS: m/z 










4,7,7-Trimethyltetrahydro-1H,3H-furo[3',4':2,3]azeto[1,2-b]isoxazol-1-one (3.156): Prepared 
according to GP-3.3 using (Z)-3.155 (53 mg, 0.25 mmol, 1.0 equiv.), fac-[Ir(dFppy)3] (1.9 mg, 
1 mol%) and MeCN (2.5 mL) with a reaction time of 19 h. 1H NMR analysis of the crude reaction 
mixture revealed a diastereomer ratio of 1.1:1. Purification by flash column chromatography (2–
30% EtOAc/CH2Cl2) afforded the pure title compound as a pale-yellow oil (36 mg, 68% combined 
yield; 1.1:1 d.r.). Spectroscopic data was found consistent with that obtained, when conducting the 
reaction with (E)-3.155. 
N–O Bond Cleavage of Azetidine Products 
 
2-Butyl-7,7-dimethyl-6-oxa-1-azaspiro[3.4]octan-5-one (cis-3.140): A 3-dram vial equipped 
with a magnetic stir bar was charged with exo-3.84 (50 mg, 0.2 mmol, 1.0 equiv.), Pd(OH)2 
(20wt%; 34 mg, 0.05 mmol, 0.25 equiv.) and p-TsOH (93 mg, 0.5 mmol, 2.5 equiv.). EtOH 
(5 mL) was added, the vial subsequently sealed with a septum-equipped cap and the reaction 
mixture sparged with hydrogen gas for 10 min. Then, the heterogenous reaction mixture was 
stirred vigorously at 45 ºC for 30 h under a hydrogen atmosphere (balloon). After cooling to rt, the 
reaction mixture was passed through celite, the filter cake washed with CH2Cl2 and the filtrate 
concentrated in vacuo. The residue was taken up in CH2Cl2 and water and the aqueous layer 
brought to pH 10-11 with 2 M NaOH solution (aq.). The organic layer was separated and the 
aqueous layer extracted with CH2Cl2 (2x). The combined organic extracts were dried over MgSO4, 
filtered and concentrated in vacuo. Purification by flash column chromatography (70–100% 






















EtOH, 45 ºC, 30 h
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1H NMR (400 MHz, CDCl3): d 3.70 (p, J = 7.2 Hz, 1H), 2.55 – 2.32 (m, 4H), 2.22 (d, J = 13.2 Hz, 
1H), 1.89 – 1.66 (m, 2H), 1.42 (s, 3H), 1.37 – 1.14 (m, 7H), 0.89 (t, J = 7.2 Hz, 3H); 13C NMR 
(176 MHz, CDCl3): d 179.4, 81.6, 62.9, 54.5, 50.1, 38.4, 37.3, 29.1, 28.0, 27.7, 22.6, 14.2; IR (cm-
1): 3318, 1957, 2928, 2857, 1761, 1456, 1387, 1374, 1273, 1243, 1204, 1154, 1075, 1027, 946, 
923, 876, 810, 730, 677; HRMS: m/z calculated for C12H22NO2+ [M+H]+: 212.1645; found: 
212.1645. 
 
2-Butyl-7,7-dimethyl-6-oxa-1-azaspiro[3.4]octan-5-one (trans-3.140): A 3-dram vial equipped 
with a magnetic stir bar was charged with endo-3.84 (100 mg, 0.4 mmol, 1.0 equiv.) and Pd(OH)2 
(20wt%; 55 mg, 0.08 mmol, 0.20 equiv.). A 1:1:1 mixture of EtOH, water and acetic acid (10 mL) 
was added, the vial subsequently sealed with a septum-equipped cap and the reaction mixture 
sparged with hydrogen gas for 12 min. Then, the heterogenous reaction mixture was stirred 
vigorously at 35 ºC for 24 h under a hydrogen atmosphere (balloon). After cooling to rt, the 
reaction mixture was passed through celite, the filter cake washed with MeOH and the filtrate 
concentrated in vacuo. The residue was taken up in CH2Cl2 and water and the aqueous layer 
brought to pH 10-11 with 2 M NaOH solution (aq.). The organic layer was separated and the 
aqueous layer extracted with CH2Cl2 (2x). The combined organic extracts were dried over Na2SO4, 
filtered and concentrated in vacuo. Purification by flash column chromatography (20–100% 
EtOAc/hexanes) afforded the pure title compound as a white solid (53 mg, 64%) 
1H NMR (700 MHz, CDCl3): d 4.09 (p, J = 6.8 Hz, 1H), 2.92 (b, 1H), 2.71 (t, J = 9.3 Hz, 1H), 
2.27 (d, J = 13.4 Hz, 1H), 2.12 (d, J = 13.4 Hz, 1H), 2.07 (t, J = 9.4 Hz, 1H), 1.58 – 1.44 (m, 2H), 
















35 ºC, 24 h
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81.8, 62.8, 54.0, 50.6, 39.1, 38.79, 3.12, 28.1, 27.4, 22.7, 14.2; IR (cm-1): 3299, 2920, 2855, 1753, 
1466, 1451, 1370, 1289, 1250, 1168, 1148, 1028, 933, 860, 799, 719, 695, 676; HRMS: m/z 
calculated for C12H22NO2+ [M+H]+: 212.1645; found: 212.1650. 
 
Ethyl 2-(2-hydroxyethyl)-4,4-dimethylazetidine-2-carboxylate (3.144): A 3-dram vial 
equipped with a magnetic stir bar was charged with 3.143 (40 mg, 0.2 mmol, 1.0 equiv.), Pd(OH)2 
(20wt%; 35 mg, 0.05 mmol, 0.25 equiv.) and p-TsOH (96 mg, 0.5 mmol, 2.5 equiv.). EtOH 
(5 mL) was added, the vial subsequently sealed with a septum-equipped cap and the reaction 
mixture sparged with hydrogen gas for 10 min. Then, the heterogenous reaction mixture was 
stirred vigorously at 45 ºC for 27 h under a hydrogen atmosphere (balloon). After cooling to rt, the 
reaction mixture was passed through celite, the filter cake washed with CH2Cl2 and the filtrate 
concentrated in vacuo. The residue was taken up in CH2Cl2 and water and the aqueous layer 
brought to pH 10-11 with 2 M NaOH solution (aq.). The organic layer was separated and the 
aqueous layer extracted with CH2Cl2 (2x). The combined organic extracts were dried over MgSO4, 
filtered and concentrated in vacuo. Purification by flash column chromatography (1–10% 
MeOH/CH2Cl2) afforded the pure title compound as a pale-yellow oil (18 mg, 45%). 
1H NMR (700 MHz, CDCl3): d 4.24 (q, J = 7.1 Hz, 2H), 4.08 (t, J = 10.7 Hz, 1H), 3.82 – 3.73 (m, 
1H), 2.40 (d, J = 12.0 Hz, 1H), 2.25 (d, J = 12.1 Hz, 1H), 1.91 (t, J = 12.2 Hz, 1H), 1.79 (dd, J = 
14.6, 4.8 Hz, 1H), 1.30 (t, J = 7.9 Hz, 9H); 13C NMR (176 MHz, CDCl3): d 180.8, 81.8, 62.8, 54.0, 
50.6, 39.1, 38.8, 29.1, 28.1, 27.4, 22.7, 14.2; IR (cm-1): 3301, 2958, 2868, 1724, 1447, 1376, 1279, 
1263, 1208, 1149, 1086, 1054, 1023, 855, 808, 746; HRMS: m/z calculated for C10H20NO3+ 

















Ethyl 4,4-dimethyl-2-phenethylazetidine-2-carboxylate (3.146): A 3-dram vial equipped with 
a magnetic stir bar was charged with 3.145 (30 mg, 0.1 mmol, 1.0 equiv.), Pd(OH)2 (20wt%; 
19 mg, 0.25 mmol, 0.25 equiv.) and p-TsOH (52 mg, 0.25 mmol, 2.5 equiv.). EtOH (3 mL) was 
added, the vial subsequently sealed with a septum-equipped cap and the reaction mixture sparged 
with hydrogen gas for 15 min. Then, the heterogenous reaction mixture was stirred vigorously at 
45 ºC for 22.5 h under a hydrogen atmosphere (balloon). After cooling to rt, the reaction mixture 
was passed through celite, the filter cake washed with CH2Cl2 and the filtrate concentrated in 
vacuo. The residue was taken up in CH2Cl2 and water and the aqueous layer brought to pH 10-11 
with 2 M NaOH solution (aq.). The organic layer was separated and the aqueous layer extracted 
with CH2Cl2 (2x). The combined organic extracts were dried over Na2SO4, filtered and 
concentrated in vacuo. Purification by flash column chromatography (20–60% EtOAc/hexanes) 
afforded the pure title compound as a pale-yellow oil (24 mg, 84%). 
1H NMR (700 MHz, CDCl3): d 7.26 (t, J = 7.5 Hz, 2H), 7.17 (d, J = 7.7 Hz, 2H), 4.19 (q, J = 
7.1 Hz, 2H), 2.77 (s, 1H), 2.69 (td, J = 12.9, 4.7 Hz, 1H), 2.38 – 2.31 (m, 2H), 2.17 (td, J = 12.9, 
5.4 Hz, 1H), 2.13 (d, J = 11.8 Hz, 1H), 2.06 (td, J = 12.7, 4.9 Hz, 1H), 1.31 – 1.27 (m, 9H); 
13C NMR (176 MHz, CDCl3): d 177.5, 141.8, 128.5, 128.4, 125.9, 61.3, 59.7, 54.1, 43.3, 43.1, 
32.3, 30.2, 30.1, 14.4; IR (cm-1): 3316, 2957, 2925, 1725, 1604, 1497, 1448, 1376, 1299, 1251, 
1213, 1175, 1097, 1063, 1025, 857, 776, 745, 698; HRMS: m/z calculated for C16H24NO2+ 

















Synthetic Modifications of Azetidine Products 
 
Tert-butyl 2-butyl-7,7-dimethyl-5-oxo-6-oxa-1-azaspiro[3.4]octane-1-carboxylate (3.141): A 
10-mL round-bottom flask equipped with a magnetic stir bar was charged with trans-3.140 (21 mg, 
0.1 mmol, 1.0 equiv.) and MeCN (2 mL). Boc2O (50 µL, 0.2 mmol, 2.0 equiv.) and DMAP 
(2.4 mg, 0.02 mmol, 0.2 equiv.) were added and the solution stirred at rt for 16 h. The reaction 
mixture was concentrated in vacuo and purified by flash column chromatography (5–40% 
EtOAc/hexanes) to afford the pure title compound as a white solid (24 mg, 78%). Characterization 
data is provided for a 1.7:1 mixture of rotamers (A/B). 
1H NMR (700 MHz, CDCl3): d 4.55 – 4.49 (m, 2.7H; A+B), 2.79 (d, J = 13.5 Hz, 1.7H; A), 2.75 
– 2.67 (m, 2.7H; A+B), 2.60 (d, J = 13.5 Hz, 1H; B), 2.37 (d, J = 13.4 Hz, 1H; B), 2.29 (d, J = 
13.5 Hz, 1.7H; A), 2.05 – 1.95 (m, 3.7H; A+B), 1.95 – 1.84 (m, 1.7H; A), 1.66 – 1.21 (m, 54H; 
A+B) 0.94 – 0.85 (m, 8.1H; A+B); 13C NMR (176 MHz, CDCl3): d 174.8, 174.7, 148.1 (d, J = 
356.0 Hz), 147.5 (d, J = 371.7 Hz), 85.2, 85.0, 82.1, 81.8, 68.0, 67.1, 60.9, 59.7, 47.0, 45.7, 36.2, 
35.8, 35.1, 35.0, 29.2, 29.1, 29.0, 28.9, 27.60, 27.58, 26.6, 26.1, 22.61, 22.57, 14.1 (2C); IR (cm-
1): 2977, 2934, 2872, 1797, 1762, 1722, 1468, 1398, 1372, 1237, 1134, 1095, 1057, 1026, 944, 
923, 890, 826, 762, 694, 666; HRMS: m/z calculated for C17H30NO4+ [M+H]+: 312.2169; found: 
312.2170. 
 
2-Butyl-7,7-dimethyl-1-tosyl-6-oxa-1-azaspiro[3.4]octan-5-one (3.142): A 10-mL round-
bottom flask equipped with a magnetic stir bar was charged with trans-3.140 (21 mg, 0.1 mmol, 

































0.3 mmol, 3.0 equiv.) were added and the reaction mixture heated at 80 ºC for 2.5 h. Then, the 
reaction was concentrated in vacuo and purified by flash column chromatography (5–40% 
EtOAc/hexanes) to afford the pure title compound as a viscous, colorless oil (36 mg, 99%). 
1H NMR (400 MHz, CDCl3): d 7.68 (d, J = 8.2 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 4.41 (qd, J = 
7.9, 3.9 Hz, 1H), 2.84 (d, J = 13.7 Hz, 1H), 2.55 (dd, J = 10.5, 8.0 Hz, 1H), 2.43 (s, 3H), 2.36 (d, 
J = 13.7 Hz, 1H), 2.02 (dd, J = 10.5, 7.4 Hz, 1H), 1.92 – 1.78 (m, 1H), 1.64 – 1.50 (m, 4H), 1.33 
(s, 3H), 1.30 – 1.11 (m, 4H), 0.85 (t, J = 7.1 Hz, 3H); 13C NMR (176 MHz, CDCl3): d 174.7, 
143.7, 136.7, 129.4, 127.7, 81.9, 70.5, 61.7, 48.2, 36.3, 35.2, 29.4, 29.0, 26.0, 22.5, 21.7, 14.0; IR 
(cm-1): 2931, 2861, 1769, 1598, 1453, 1333, 1294, 1152, 1090, 923, 813, 753, 730, 669, 640; 
HRMS: m/z calculated for C19H27NNaO4S+ [M+Na]+: 388.1553 found: 388.1548. 
 
7-Butyl-3,3-dimethyl-2-oxa-1-azabicyclo[3.2.0]heptane-5-carboxylic acid (3.147): A 10-mL 
round-bottom flask equipped with a magnetic stir bar was charged with exo-3.84 (51 mg, 
0.2 mmol, 1.0 equiv.) and a 3:1 mixture of MeOH/water (2 mL). Lithium hydroxide monohydrate 
(13 mg, 0.3 mmol, 1.5 equiv.) was added and the resulting solution stirred at rt for 16 h. The 
reaction mixture acidified with 1 M HCl solution (aq.) to pH 1–2 and subsequently extracted with 
CH2Cl2 (5x). The combined organic extracts were dried over Na2SO4, filtered, concentrated in 
vacuo, then dried using high-vac to afford the pure title compound as a colorless oil (44 mg, 97%). 
1H NMR (500 MHz, CDCl3): d 7.12 (b, 1H), 3.72 (p, J = 7.9 Hz, 1H), 2.98 (d, J = 12.9 Hz, 1H), 
2.55 (dd, J = 11.7, 8.9 Hz, 1H), 2.49 (d, J = 12.9 Hz, 1H), 2.14 (dd, J = 11.7, 8.1 Hz), 1.95 – 1.83 
(m, 1H), 1.73 – 1.62 (m, 1H), 1.53 (s, 3H), 1.42 – 1.26 (m, 4H), 1.24 (s, 3H), 0.90 (t, J = 7.0 Hz, 















22.5, 14.1; IR (cm-1): 2959, 2932, 2873, 1718, 1617, 1457, 1378, 1265, 1194, 1152, 854, 731, 700; 
HRMS: m/z calculated for C12H22NO3+ [M+H]+: 228.1594; found: 228.1594. 
 
7-Butyl-3,3-dimethyl-2-oxa-1-azabicyclo[3.2.0]heptan-5-yl)methanol (3.148): To a 10-mL 
round-bottom flask equipped with a magnetic stir bar containing a suspension of LiALH4 (10 mg, 
0.26 mmol, 1.35 equiv.) in Et2O (1.25 mL) was added exo-3.84 (50 mg, 0.2 mmol, 1.0 equiv.) as 
a solution in Et2O (0.75 mL) dropwise at 0 ºC. After stirring for 0.5 h at 0 ºC, water was added 
carefully, the reaction mixture diluted with Et2O and Rochelle salt solution (aq., sat.) and 
subsequently stirred for 12 h at rt. The organic layer was separated and the aqueous layer extracted 
with Et2O (3x). The combined organic extracts were dried over MgSO4, filtered and concentrated 
in vacuo, then dried using high-vac to obtain the pure title compound as a clear oil (40 mg, 96%). 
1H NMR (400 MHz, CDCl3): d 3.62 – 3.48 (m, 2H), 3.43 – 3.33 (m, 1H), 2.86 (d, J = 8.6 Hz, 1H), 
2.45 (d, J = 13.0 Hz, 1H), 2.17 (d, J = 13.0 Hz, 1H), 2.08 (dd, J = 11.0, 8.9 Hz, 1H), 1.92 (dd, J = 
11.0, 8.2 Hz, 1H), 1.69 – 1.53 (m, 4H), 1.53 – 1.40 (m, 1H), 1.40 – 1.18 (m, 7H), 0.88 (t, J = 
6.9 Hz, 3H); 13C NMR (126 MHz, CDCl3): d 87.7, 74.8, 66.2, 66.0, 51.4, 35.1, 31.7, 30.2, 27.8, 
27.6, 22.8, 14.2; IR (cm-1): 3386, 2955, 2928, 2858, 2361, 2337, 1457, 1380, 1303, 1249, 1226, 
1150, 1078, 1043, 971, 864, 773, 686, 668, 640;HRMS: m/z calculated for C12H24NO2+ [M+H]+: 
214.1802; found: 214.1805. 
 
Ethyl 7-butyl-3,3-dimethyl-2-oxa-1-azabicyclo[3.2.0]heptane-5-carbonyl)glycinate (3.149): 
A 10-mL round-bottom flask equipped with a magnetic stir bar was charged with exo-3.84 (51 mg, 


































(13 mg, 0.3 mmol, 1.5 equiv.) was added and the resulting solution stirred at rt for 2 h. The reaction 
mixture acidified with 1 M HCl (aq.) to pH 1–2 and subsequently extracted with CH2Cl2 (5x). The 
combined organic extracts were dried over Na2SO4, filtered, concentrated in vacuo, then dried 
using high-vac to afford pure 3.147. 
Next, the carboxylic acid (3.147) was dissolved in CH2Cl2 (5 mL) and DMAP (5 mg, 0.04 mmol, 
0.2 equiv.), glycine ethyl ester hydrochloride (56 mg, 0.4 mmol, 2.0 equiv.) and EDC•HCl (57 mg, 
0.3 mmol, 1.5 equiv.) were added sequentially. After stirring the resulting mixture for 16 h at rt, it 
was diluted with CH2Cl2 and washed with 1 M HCl solution (aq., 2x) and brine, dried over Na2SO4, 
filtered and concentrated in vacuo. Purification by flash column chromatography (20–40% 
EtOAc/hexanes) afforded the product as a colorless oil (58 mg, 93%). 
1H NMR (500 MHz, CDCl3): d 7.82 (t, J = 6.1 Hz, 1H), 4.20 (q, J = 7.2 Hz, 2H), 4.14 – 3.95 (m, 
2H), 3.50 (p, J = 8.0 Hz, 1H), 2.94 (d, J = 12.8 Hz, 1H), 2.52 – 2.38 (m, 2H), 1.79 (dd, J = 11.1, 
8.5 Hz, 1H), 1.74 – 1.65 (m, 1H), 1.58 – 1.46 (m, 4H), 1.42 – 1.21 (m, 7H), 1.17 (s, 3H), 0.90 (t, 
J = 6.9 Hz, 3H); 13C NMR (126 MHz, CDCl3): d 173.6, 169.5, 87.5, 73.2, 67.3, 61.4, 50.0, 41.0, 
35.3, 31.5, 29.2, 28.6, 27.5, 22.7, 14.2, 14.1; IR (cm-1): 3366, 2957, 2931, 2873, 2361, 2337, 1750, 
1671, 1516, 1457, 1369, 1255, 1188, 1098, 1028, 919, 862, 729, 668, 646; HRMS: m/z calculated 
for C16H29N2O4+ [M+H]+: 313.2122; found: 313.2120. 
 
7-Butyl-3,3-dimethyl-2-oxa-1-azabicyclo[3.2.0]heptan-5-yl)diphenylmethanol (3.150): To a 
10-mL round-bottom flask equipped with a magnetic stir bar containing a solution of exo-3.84 
(51 mg, 0.2 mmol, 1.0 equiv.) in THF (2 mL) was added freshly prepared PhMgBr (0.5 M in THF, 

















(aq., sat.) was added and the resulting mixture extracted with Et2O (3x), the combined organic 
extracts dried over MgSO4, filtered and concentrated in vacuo. Purification by flash column 
chromatography (5–10% EtOAc/hexanes) afforded the pure title compound as a colorless oil 
(69 mg, 95%). 
1H NMR (500 MHz, CDCl3): d 7.43 – 7.15 (m, 10H), 4.78 (s, 1H), 3.77 (p, J = 7.8 Hz, 1H), 2.59 
(q, J = 13.1 Hz, 2H), 2.34 (dd, J = 11.5, 9.4 Hz, 1H), 1.92 (dd, J = 11.5, 7.8 Hz, 1H), 1.59 (s, 3H), 
1.56 – 1.44 (m, 1H), 1.39 – 1.14 (m, 5H), 0.87 (t, J = 7.1 Hz, 3H), 0.52 (s, 3H); 13C NMR 
(126 MHz, CDCl3): d 144.9, 143.1, 128.1, 128.0, 127.8, 127.7, 127.3, 127.2, 89.8, 81.4, 80.6, 65.1, 
52.9, 34.7, 33.4, 32.1, 28.2, 27.6, 22.6, 14.2; IR (cm-1): 2957, 2858, 2246, 1493, 1447, 1366, 1298, 
1229, 1170, 1146, 1024, 907, 759, 728, 698, 668; HRMS: m/z calculated for C24H32NO2+ [M+H]+: 
266.2428; found: 266.2435. 
 
5-Butyl-3-(2-hydroxy-2-methylpropyl)pyrrolidin-2-one (3.152): A 25-mL round-bottom flask 
equipped with a magnetic stir bar was charged with exo-3.84 (50 mg, 0.2 mmol, 1.0 equiv.) and a 
9:1 mixture of 1 M HCl (aq.)/THF (5 mL). Zinc powder (128 mg, 2.0 mmol, 10.0 equiv.) was 
added and the resulting mixture heated at 80 ºC for 3 h. After cooling to rt, the reaction mixture 
was filtered and the filtrate brought to pH 10–11 with 2 M NaOH solution (aq.). The resulting 
cloudy mixture was extracted with CH2Cl2 (5x) and the combined organic extracts dried over 
Na2SO4, filtered and concentrated in vacuo. Purification by flash column chromatography (50–
100% EtOAc/hexanes) afforded the pure title compound as a colorless oil as a 2.6:1 mixture of 
















1H NMR (700 MHz, CDCl3): d 6.42 (s, 1H; minor), 6.35 (s, 2.6H; major), 4.92 (s, 2.6H; major), 
4.74 (s, 1H; minor), 3.64 – 3.51 (m, 3.6H; major+minor), 2.82 – 2.71 (m, 3.6H; major+minor), 
2.46 – 2.39 (m, 2.6H; major), 2.04 (t, J = 11.1 Hz, 1H; minor), 1.99 – 1.86 (m, 4.6H; major+minor), 
1.60 – 1.20 (m, 49.4H; major+minor), 0.93 – 0.86 (m, 10.8H; major+minor); 13C NMR (176 MHz, 
CDCl3): d 181.2, 180.9, 69.4, 69.2, 53.7, 53.1, 45.2, 45.1, 39.1, 37.0, 36.7, 36.3, 36.1, 35.3, 31.5 
(2C), 28.7 (2C), 28.3, 28.1, 22.7, 22.6, 14.11, 14.08; IR (cm-1): 3205, 2960, 2927, 2858, 1681, 
1662, 1456, 1378, 1362, 1317, 1274, 1186, 1151, 1084, 959, 907, 783, 731, 658; HRMS: m/z 
calculated for C12H23NNaO2+ [M+Na]+: 236.1621; found: 236.1621. 
 
Ethyl 3,3,7,7-tetramethyl-1,2-oxazepane-5-carboxylate (3.151): A Schlenk flask equipped with 
a magnetic stir bar was charged with 3.115 (45 mg, 0.2 mmol 1.0 equiv.) and the flask evacuated 
and refilled with nitrogen gas. This process was repeated twice, before adding a 2:1 mixture (v/v) 
of degassed THF/EtOH (2 mL). Next, the resulting solution was cooled to –78 ºC and a freshly 
prepared samarium(II) iodide solution (0.1 M in THF; 12 mL, 1.2 mmol, 6.0 equiv.) was added 
dropwise. The resulting dark-blue solution was allowed to gradually warm up to rt over 1 h. Then, 
the reaction vessel was opened up to air, the reaction mixture diluted with water and sodium 
thiosulfate solution (aq., sat.) and extracted with EtOAc (3x). The combined organic extracts were 
washed with water and brine, dried over MgSO4, filtered and concentrated in vacuo. Purification 
by flash column chromatography (2–10% EtOAc/hexanes) afforded the pure title compound as a 
pale-yellow oil (19 mg, 42%). 
1H NMR (400 MHz, CDCl3): d 4.43 (s, 1H), 4.11 (q, J = 7.1 Hz, 2H), 2.69 (t, J = 11.0 Hz, 1H), 














THF, –78 ºC to rt
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9H), 1.10 (s, 3H), 0.98 (s, 3H); 13C NMR (126 MHz, CDCl3): d 176.9, 77.6, 60.5, 56.1, 45.8, 43.4, 
37.9, 27.6, 26.8, 25.9, 24.6, 14.4; IR (cm-1): 2971, 1728, 1453, 1362, 1283, 1228, 1155, 1114, 




Stereo- and Regiochemistry of Azetidine Products 
 
Figure 3.35: Stereo- and regiochemistry of the azetidine products. (A) Selectivity of the [2+2] cycloaddition reaction (B) 1H NMR 











































A. Selectivity of [2+2] cycloaddition reaction
























































Diastereomer and regioisomer ratios of the intermolecular aza Paternò-Büchi reaction were 
determined by 1H NMR analysis of the crude reaction mixture. The reaction exhibits high 
regioselectivity (8:1 to >20:1 r.r.) for the azetidine product, in which the side of an alkene with a 
higher degree of substitution (2º > 1º) adds to the 2-isoxazoline nitrogen. For mono- and 1,1-
disubstituted alkenes the major diastereomer is typically the exo-isomer in which the larger 
substituent (RL) ends up opposite to the isoxazolidine ring with diastereoselectivities between 1:1 
to >10:1. For tertiary alkenes, the additional substituent was found to preferentially add in the endo 
position during the cycloaddition. Furthermore, in the case of monosubstituted 2-isoxazoline 
substrates, the cycloaddition occurs at the least hindered face. The regio- and stereochemical 
assignments for azetidine products were based on 1D NMR (1H, 13C), 2D NMR (gCOSY, 
gHMBCAD, gHSQCAD) and 1H NMR NOE analysis. Specifically, the regiochemistry was 
typically assigned according to the 13C NMR shift of the carbon signals adjacent to the azetidine 
nitrogen. The stereochemistry of the azetidine products was assigned based on NOE correlations 
of characteristic 1H NMR signals. For example, in the case of products arising from the reaction 
with a primary alkene, a strong NOE correlation was observed for proton Ha with the methylene 
group in the backbone of the substrate, which was not observed for the corresponding other 
diastereomer. The regio- and stereochemical assignments were further confirmed by the X-ray 
crystallographic analyses of compounds 3.119, 3.121 and trans-3.140.  
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Colorless plates of 3.119 were grown from a hexane solution of the compound at 22 ºC. A crystal 
of dimensions 0.12 x 0.10 x 0.03 mm was mounted on a Rigaku AFC10K Saturn 944+ CCD-based 
X-ray diffractometer equipped with a low temperature device and Micromax-007HF Cu-target 
micro-focus rotating anode (λ = 1.54187 A) operated at 1.2 kW power (40 kV, 30 mA). The X-ray 
intensities were measured at 85(1) K with the detector placed at a distance 42.34 mm from the 
crystal. A total of 2028 images were collected with an oscillation width of 1.0° in ω. The exposure 
times were 1 sec. for the low angle images, 3 sec. for high angle.  Rigaku d*trek images were 
exported to CrysAlisPro for processing and corrected for absorption. The integration of the data 
yielded a total of 13716 reflections to a maximum 2θ value of 138.76° of which 3286 were 
independent and 3158 were greater than 2σ(I). The final cell constants (Supplementary Table 9) 
were based on the xyz centroids of 9574 reflections above 10σ(I).  Analysis of the data showed 
negligible decay during data collection. The structure was solved and refined with the Bruker 
SHELXTL (version 2018/3) software package, using the space group P1bar with Z = 2 for the 
formula C17H28N2O5. All non-hydrogen atoms were refined anisotropically with the hydrogen 
 301 
atoms placed in idealized positions. The terminal methyl group (C17) is disordered over two sites. 
Full matrix least-squares refinement based on F2 converged at R1 = 0.0403 and wR2 = 0.1030 
[based on I > 2sigma(I)], R1 = 0.0411 and wR2 = 0.1039 for all data. Acknowledgement is made 
for funding from NSF grant CHE-0840456 for X-ray instrumentation. 
 
G.M. Sheldrick (2015) "Crystal structure refinement with SHELXL", Acta Cryst., C71, 3-8 (Open 
Access). 
 
CrystalClear Expert 2.0 r16, Rigaku Americas and Rigaku Corporation (2014), Rigaku Americas, 
9009, TX, USA 77381-5209, Rigaku Tokyo, 196-8666, Japan. 
 
CrysAlisPro 1.171.38.41 (Rigaku Oxford Diffraction, 2015). 
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Table 3.13: Crystallographic parameters and structure refinement for compound 3.119. 
Identification code 1-(Tert-butyl) 1'-ethyl 3',3'-dimethyl-4'-oxa-5'-
azaspiro[azetidine-3,6'-bicyclo[3.2.0]heptane]-1,1'-
dicarboxylate 
Empirical formula C17 H28 N2 O5 
Formula weight 340.41 
Temperature 85(2) K 
Wavelength 1.54184 A 
Crystal system, space group Triclinic,  P-1 
Unit cell dimensions a = 5.7853(2) A   alpha = 105.136(3) deg.  
b = 11.3896(3) A    beta = 97.310(3) deg.  
c = 14.8541(4) A   gamma = 100.774(3) deg. 
Volume 912.02(5) A^3 
Z, Calculated density 2,  1.240 Mg/m^3 
Absorption coefficient 0.748 mm^-1 
F(000) 368 
Crystal size 0.120 x 0.100 x 0.030 mm 
Theta range for data collection 3.137 to 69.386 deg. 
Limiting indices -7<=h<=6, -13<=k<=13, -16<=l<=17 
Reflections collected / unique 13716 / 3286 [R(int) = 0.0427] 
Completeness to theta = 67.684 97.90% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.84904 
Refinement method Full-matrix least-squares on F^2 
Data / restraints / parameters 3286 / 1 / 234 
Goodness-of-fit on F^2 1.066 
Final R indices [I>2sigma(I)] R1 = 0.0403, wR2 = 0.1030 
R indices (all data) R1 = 0.0411, wR2 = 0.1039 
Extinction coefficient 0.0137(12) 






Colorless needles of 3.121 were grown from a hexane solution of the compound at 0 ºC. A crystal 
of dimensions 0.13 x 0.03 x 0.03 mm was mounted on a Rigaku AFC10K Saturn 944+ CCD-based 
X-ray diffractometer equipped with a low temperature device and Micromax-007HF Cu-target 
micro-focus rotating anode (λ = 1.54187 A) operated at 1.2 kW power (40 kV, 30 mA). The X-ray 
intensities were measured at 85(1) K with the detector placed at a distance 42.00 mm from the 
crystal. A total of 2028 images were collected with an oscillation width of 1.0° in ω. The exposure 
times were 1 sec. for the low angle images, 4 sec. for high angle. Rigaku d*trek images were 
exported to CrysAlisPro for processing and corrected for absorption. The integration of the data 
yielded a total of 35611 reflections to a maximum 2θ value of 138.69° of which 8411 were 
independent and 8004 were greater than 2σ(I). The final cell constants (Supplementary Table 10) 
were based on the xyz centroids of 15622 reflections above 10σ(I). Analysis of the data showed 
negligible decay during data collection. The structure was solved and refined with the Bruker 
SHELXTL (version 2018/3) software package, using the space group Pn with Z = 2 for the formula 
C48H80N4O10. All non-hydrogen atoms were refined anisotropically with the hydrogen atoms 
placed in idealized positions. Full matrix least-squares refinement based on F2 converged at R1 = 
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0.0414 and wR2 = 0.1080 [based on I > 2sigma(I)], R1 = 0.0435 and wR2 = 0.1115 for all data. 
Acknowledgement is made for funding from NSF grant CHE-0840456 for X-ray instrumentation. 
 
G.M. Sheldrick (2015) "Crystal structure refinement with SHELXL", Acta Cryst., C71, 3-8 (Open 
Access). 
 
CrystalClear Expert 2.0 r16, Rigaku Americas and Rigaku Corporation (2014), Rigaku Americas, 
9009, TX, USA 77381-5209, Rigaku Tokyo, 196-8666, Japan. 
 
CrysAlisPro 1.171.38.41 (Rigaku Oxford Diffraction, 2015).  
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Table 3.14: Crystallographic parameters and structure refinement for compound 3.121. 
Identification code 8'-(Tert-butyl) 1-ethyl-3,3-dimethyl-4-oxa-5,8'-
diazaspiro[bicyclo[3.2.0]heptane-6,3'-
bicyclo[3.2.1]octane]-1,8'-dicarboxylate 
Empirical formula C48 H80 N4 O10 
Formula weight 873.16 
Temperature 85(2) K 
Wavelength 1.54184 A 
Crystal system, space group Monoclinic,  Pn 
Unit cell dimensions a = 17.6585(2) A   alpha = 90 deg.  
b = 6.09660(10) A    beta = 98.4520(10) deg.  
c = 22.7527(3) A   gamma = 90 deg. 
Volume 2422.88(6) A^3 
Z, Calculated density 2,  1.197 Mg/m^3 
Absorption coefficient 0.669 mm^-1 
F(000) 952 
Crystal size 0.130 x 0.030 x 0.030 mm 
Theta range for data collection 2.966 to 69.343 deg. 
Limiting indices -21<=h<=20, -7<=k<=7, -25<=l<=27 
Reflections collected / unique 35611 / 8411 [R(int) = 0.0621] 
Completeness to theta = 67.684 100.00% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.78867 
Refinement method Full-matrix least-squares on F^2 
Data / restraints / parameters 8411 / 2 / 573 
Goodness-of-fit on F^2 1.043 
Final R indices [I>2sigma(I)] R1 = 0.0414, wR2 = 0.1080 
R indices (all data) R1 = 0.0435, wR2 = 0.1115 
Absolute structure parameter 0.4(2) 
Extinction coefficient n/a 






Colorless needles of trans-3.140 were grown from a hexane solution of the compound at 0 ºC. A 
crystal of dimensions 0.18 x 0.09 x 0.03 mm was mounted on a Rigaku AFC10K Saturn 944+ 
CCD-based X-ray diffractometer equipped with a low temperature device and Micromax-007HF 
Cu-target micro-focus rotating anode (λ = 1.54187 A) operated at 1.2 kW power (40 kV, 30 mA). 
The X-ray intensities were measured at 85(1) K with the detector placed at a distance 42.00 mm 
from the crystal. A total of 2028 images were collected with an oscillation width of 1.0° in ω. The 
exposure times were 1 sec. for the low angle images, 5 sec. for high angle. Rigaku d*trek images 
were exported to CrysAlisPro for processing and corrected for absorption. The integration of the 
data yielded a total of 18752 reflections to a maximum 2θ value of 138.92° of which 2257 were 
independent and 2082 were greater than 2σ(I). The final cell constants (Supplementary Table 11) 
were based on the xyz centroids of 5417 reflections above 10σ(I). Analysis of the data showed 
negligible decay during data collection. The structure was solved and refined with the Bruker 
SHELXTL (version 2018/3) software package, using the space group P2(1)2(1)2(1) with Z = 4 for 
the formula C12H21NO2. All non-hydrogen atoms were refined anisotropically with the hydrogen 
atoms placed in a combination of refined and idealized positions. Full matrix least-squares 
refinement based on F2 converged at R1 = 0.0467 and wR2 = 0.1131 [based on I > 2sigma(I)], R1 
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= 0.0512 and wR2 = 0.1195 for all data. Acknowledgement is made for funding from NSF grant 
CHE-0840456 for X-ray instrumentation. 
 
G.M. Sheldrick (2015) "Crystal structure refinement with SHELXL", Acta Cryst., C71, 3-8 (Open 
Access). 
 
CrystalClear Expert 2.0 r16, Rigaku Americas and Rigaku Corporation (2014), Rigaku Americas, 
9009, TX, USA 77381-5209, Rigaku Tokyo, 196-8666, Japan. 
 
CrysAlisPro 1.171.38.41 (Rigaku Oxford Diffraction, 2015).  
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Table 3.15: Crystallographic parameters and structure refinement for compound 3.140. 
Identification code 2-Butyl-7,7-dimethyl-6-oxa-1-azaspiro[3.4]octan-5-
one 
Empirical formula C12 H21 N O2 
Formula weight 211.3 
Temperature 85(2) K 
Wavelength 1.54184 A 
Crystal system, space group Orthorhombic,  P2(1)2(1)2(1) 
Unit cell dimensions a = 6.15494(18) A   alpha = 90 deg.  
b = 8.5930(4) A    beta = 90 deg.  
c = 23.1982(8) A   gamma = 90 deg. 
Volume 1226.94(8) A^3 
Z, Calculated density 4,  1.144 Mg/m^3 
Absorption coefficient 0.611 mm^-1 
F(000) 464 
Crystal size 0.180 x 0.090 x 0.030 mm 
Theta range for data collection 3.811 to 69.462 deg. 
Limiting indices -7<=h<=7, -9<=k<=8, -27<=l<=28 
Reflections collected / unique 18752 / 2257 [R(int) = 0.0771] 
Completeness to theta = 67.684 98.60% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.76113 
Refinement method Full-matrix least-squares on F^2 
Data / restraints / parameters 2257 / 0 / 144 
Goodness-of-fit on F^2 1.063 
Final R indices [I>2sigma(I)] R1 = 0.0467, wR2 = 0.1131 
R indices (all data) R1 = 0.0512, wR2 = 0.1195 
Absolute structure parameter 0.2(4) 
Extinction coefficient n/a 
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